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Factors regulating apoptosis and shedding in mouse and rat 
small intestine 
Ahmed Hamed Elramli 
The gut barrier is composed of a single layer of intestinal epithelial cells which are 
connected together by junctional complexes and are covered by a layer of glycocalyx. 
Its function is to prevent the passage of harmful and toxic substances from the gut 
lumen into the blood circulation. Structural homeostasis in the small intestine is 
maintained by the shedding of intestinal epithelial cells at the villus tip and generation 
of new cells within the crypt compartment. Increased gut permeability can result 
when the rate of intestinal epithelial cell shedding is greater than the rate of 
generation of new crypt cells, and this phenomenon is associated with several 
gastrointestinal diseases including inflammatory bowel disease (IBD).  
Lipopolysaccharide (LPS) is an integral cell wall component of Gram negative bacteria 
and following intraperitoneal administration induces the pathological shedding of 
murine small intestinal epithelial cells (SIEC).  This thesis characterises the pathological 
apoptosis and shedding of SIECs induced by systemic LPS administration in wild-type 
mouse strains of different genetic background including C57BL/6J, Balb/C, CD1, FVB/N 
and DBA/2.  We have also determined whether murine age and LPS derived from 
different bacterial species are factors that modulate the severity of SIEC apoptosis and 
shedding in C57BL/6J mice.  Comparative studies were also conducted in Ludwig Olac 
Wistar rats following to determine whether this phenomenon occurred to the same 
extent within another species.  
SIEC apoptosis and shedding was additionally induced by the administration of other 
systemic stimuli to C57BL/6J mice including anti-CD3 antibody (to activate T cells), 
polyinosinic:polycytidylic acid (to mimic viral infection) and the putative downstream 
effector tumour necrosis factor (TNF).  The roles of NFκB transcription factor subunits 
in regulating SIEC apoptosis and shedding in villi and crypts induced by all stimuli at 
1.5 and 24 hours were assessed and compared with the responses to LPS. SIEC 
apoptosis and shedding was assessed morphologically and quantified by 
immunohistochemistry for active caspase-3.  
Ultrastructural analysis of SIEC apoptosis and shedding following LPS administration 
was conducted using transmission electron microscopy to determine the action of LPS 
on the intracellular components and how they may contribute to the breakdown of 
barrier function associated with this stimulus by modulating NFκB signalling. A broad 
spectrum proteomic analysis was also conducted to determine how LPS alters the 
small intestinal mucosal proteome to modulate susceptibility to SIEC apoptosis and 
shedding. 
Conclusion: In conclusion, this study has described the SIEC apoptosis and shedding 
that are induced by different stimuli including LPS, anti-CD3, poly I:C and TNF. 
Particularly it has indicated that LPS from different bacterial sources induces SIEC 
apoptosis and shedding in different mouse strains, at different ages and in both mouse 
and rats, but with different degrees of effectiveness. It has also indicated the role of 
the NFҡB signalling pathway in regulating this process.  
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1. Introduction 
The gut barrier is composed of a single layer of epithelial cells that are connected 
together by junctional complexes and a layer of glycocalyx. Its function is to prevent 
the passage of harmful and toxic substances from the gut lumen into the blood 
circulation. This structural homeostasis is maintained in a state of equilibrium by the 
shedding of intestinal epithelial cells at the villus tips and the generation of new cells 
within the intestinal crypt compartment. Increased gut permeability and gut barrier 
dysfunction can result when the rate of intestinal epithelial cell shedding is greater 
than the rate of generation of new crypt cells, and this phenomenon can be associated 
with several gastrointestinal diseases. 
 
1.1 Anatomy and histology of the small intestine 
The small intestine is a specialised convoluted tube contained within the abdominal 
cavity. It is in continuity with the pylorus of the stomach proximally and the colon 
distally via the ileocaecal valve. The large bowel surrounds it superiorly and laterally. 
Anteriorly it is related to the greater omentum and abdominal parities and it is 
connected posteriorly to the vertebral column by a fold of membranous tissue that 
arises from posterior wall of the peritoneal cavity. These membranous folds represent 
the mesentery (Standring et al., 2005). The mesentery contains the arteries and veins 
that supply the intestine, the superior and inferior mesenteric arteries and veins. The 
mesentery divides the small intestine into three segments. The C shaped duodenum 
is the first part of the small bowel and is connected to the pylorus via the 
pyloroduodenal junction and is surrounded by the head of the pancreas. It is about 
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20-25 cm in length in man and 7cm in mouse. It is considered to be the shortest part 
of the small intestine. The midsection of the small intestine is known as the jejunum; 
it is about 2.5 meters long in man and 32 cm in mouse. It connects the duodenum to 
the ileum. The ileum is the last part of the small intestine and joins to the caecum of 
the large intestine by the ileocecal junction and measures about 3 m in man and 4.3 
cm in mouse (Standring et al., 2005, Casteleyn et al., 2010). 
The small intestine increases 20 times in length during life from 200 cm in new-born 
infants to approximately 6 meters in the adult human (Feldman et al., 2015). 
Histologically the small intestine is a hollow tube composed of 4 main structures, 
including from the interior to the exterior; the mucosa, submucosa, muscularis 
externa and serosa (with the exception being the beginning of the duodenum which 
is retroperitoneal and possesses adventitia). The mucosa is further divided into 3 parts 
from interior to exterior, including; the epithelium, lamina propria and muscularis 
mucosa. Three kinds of luminal surface modification increase the absorptive surface 
area of the luminal surface of small intestine. The first is plicae circulares (valve of 
Kerkering); permanent transverse folds of the submucosa and mucosa which are more 
numerous in the distal part of the duodenum and the beginning of the jejunum which 
become reduced in size in the middle of the ileum. The second type of intestinal 
luminal surface modification is the presence of villi which are finger-like mucosal 
projections covering the whole surface of the small bowel. They are larger, broader, 
taller and more numerous in the duodenum than in the jejunum and ileum and are 
almost absent over the Peyer’s patches. The villi have a core of loose connective tissue 
(lamina propria) and are covered by a layer of simple columnar epithelium. The third 
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type of luminal modification is the presence of microvilli; cylindrical extensions of the 
plasma membrane of the enterocyte (Mescher, 2010). 
 
1.2 Diseases of the intestinal tract 
1.2.1 Inflammatory bowel disease (IBD)  
Inflammatory bowel diseases (IBD) are immune-mediated chronic intestinal 
conditions that are identified histologically by inflammation in the gastrointestinal 
tract. Ulcerative colitis (UC) and Crohn’s disease (CD) are the two major types of IBD. 
In addition, there are rarer forms termed microscopic (collagenous or lymphocytic) 
colitis. As with other chronic diseases, a person with IBD will generally run a waxing and 
waning course in which the disease flares up and causes symptoms, followed by periods 
in which symptoms decrease or disappear and the disease is said to be in remission. 
Symptoms range from mild to severe and generally depend upon which region of the 
intestinal tract is involved. CD is commonly seen in the small intestine and colon but can 
affect any part of gastrointestinal tract from mouth to anus (Freeman, 2014) while 
ulcerative colitis involves only the colon and rectum (Whitlow, 2004). The exact causes 
of IBD are unknown. However, a genetic component, dysregulated immune system in 
response to pathogen, increased epithelial barrier permeability, infectious microbes, and 
environmental factors (ethnic origin, cigarette smoking) have been associated with IBD 
(Baumgart and Carding, 2007, Xavier and Podolsky, 2007, Goyette et al., 2007). In 
addition to the previously described factors, impairment of the intestinal mucosal barrier 
that consists of outer mucosal barrier elements (commensal bacteria, mucus layer and 
immunoglobulin A), IECs and subepithelial immune cell, plays an important role in 
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intestinal inflammation and pathogenesis of IBD (Ukabam et al., 1983, Bjarnason et al., 
1995). Various studies have indicated the role of intestinal microbiota in inducing 
inflammation in IBD (Guarner, 2008, Manichanh et al., 2012). Disruption of the 
intestinal epithelium has been characterised as a hallmark of IBD and is associated 
with increased IEC apoptosis (Salim and Soderholm, 2011). Increased IEC apoptosis is 
seen in bacterial enteric infections but is also seen in UC and CD due to release of 
proinflammatory cytokines including TNF (Paesold et al., 2002, Di Sabatino et al., 
2003). By using confocal laser endoscopy Kiesslich and colleagues identified three 
related determinants to predict relapse in IBD. These determinants included intestinal 
epithelial cell shedding, flow of fluorescein into the gut lumen and formation of 
microerosions. These three criteria collectively indicated loss of gut barrier function 
that play a major role in pathogenesis of IBD (Kiesslich et al., 2011). Increased 
permeability of the gut barrier in IBD is largely related to dysregulation of tight 
junctions and increased IEC apoptosis. This disruption is functionally related to an 
uncontrolled immune response due to increased bacterial translocation and high 
expression of inflammatory cytokines such as TNF and IFNγ in CD and IL-13 in UC 
(Hindrycks and Laukens, 2012). 
 
1.2.2 Cancer of the intestine 
Many studies have indicated that chronic intestinal inflammation in IBD increases the 
risk of GIT cancer development and that includes colorectal cancer, small bowel 
adenocarcinoma, intestinal lymphoma and cholangiocarcinoma (Axelrad et al., 2016). 
Small intestinal cancer is a rare disease in which cancer cells form in the tissue of the 
small intestine. Specifically, there are five types of small bowel cancer including 
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adenocarcinoma that is recognised as the most common type of small intestinal 
cancer. Adenocarcinoma is most commonly found in the duodenum and affects small 
intestinal crypt epithelial cells. The other types include neuroendocrine tumours (also 
called carcinoid tumour), lymphoma (in lymphoid tissue of small intestine) and 
leiomyosarcoma that affects the smooth muscle of the small bowel wall and is mostly 
found in the ileum (Vagholkar and Mathew, 2009).  
Colorectal cancer is one of the most serious complications of IBD, however, the 
mechanism of developing cancer in relation to IBD is generally unclear (Vagefi and 
Longo. 2005). Experimental studies in IBD-related carcinogenesis have indicated that 
this cancer occurs in a multistep process including clonal growth that is characterised 
by genetic instability, clonal expansion, progressive accumulation of genetic 
abnormalities including abnormalities of tumour suppressor genes (such as p53, 
adenomatous polyposis coli gene (APC)) and development of dysplasia and carcinoma 
(Redston et al., 1995, Willenbucher et al., 1997). The tumour growth is significantly 
related to the disturbance of the balance between cell proliferation and cell apoptosis, 
however, decreased cell proliferation alone is not enough to reduce or prevent growth 
of tumour cells (Kulkarni et al., 1992, Holmgren et al., 1995). In contrast Sinicrope and 
colleagues in 1996 studied the proliferative and apoptosis indices in of human colonic 
adenocarcinoma and found a direct relationship between progression of the tumour 
and reduced apoptosis of colonic epithelial cells. 
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1.2.3 Sepsis 
Sepsis is a potentially life-threatening complication of an infection of any part of the body 
that has entered the blood stream resulting in the release of cytokines from the immune 
system. The most common sites of infection leading to sepsis are the lungs, urinary 
tract, peritoneal cavity, pelvis and skin (Jacob, 2012).  One of the first organs to be 
affected by excessive cytokine release during sepsis is the gastrointestinal tract 
(Rowlands et al., 1999). The number of people dying from sepsis has increased in the 
last 20 years. The number of patients who develop sepsis has increased for many 
reasons. For example, an increased aging population with a weakened immune 
system, increased antibiotic use resulting in many more resistant strains of bacteria, 
increased use of medications that weaken the body’s defence mechanism during 
cancer treatment and organ transplantation (Deustchman and Tracey, 2014). The 
most common causes of infection resulting in sepsis are bacterial, mainly Gram-
positive staphylococcal strains, but they can also be viral or fungal (Munford and 
Suffredini, 2014). These bacteria create a wide range of virulence factors that enable 
them to avoid the immune system and spread to remote organs (Ramachandran, 
2014). The most potent bacterial virulence factors are toxins including 
lipopolysaccharide (LPS), which is found in the outer membrane of the cell wall of 
Gram-negative bacteria and elicits a strong immune response from the host defence 
mechanism.  LPS is important for bacterial survival as it provides protection from their 
surrounding environment (Merrell and Flakow, 2004, Rosenfeld and Shai, 2006). Once 
inside the body, natural defence cells such as macrophages and monocytes recognise 
the bacteria as a foreign substance. This recognition process is mediated by the 
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antigens in bacteria which include the O-antigen of LPS. LPS are recognised as 
pathogen associated molecular patterns (PAMPs) by the pattern recognition receptors 
(PRRs), among them toll like receptors (TLRs) that are expressed on monocytes and 
macrophages to increase their phagocytic activity and cause secretion of 
proinflammatory cytokines such as TNF, IL-6, IFN-β (Ulevitch and Tobias, 1999).  LPS is 
then released into the blood circulation and binds to LPS binding molecules to exert 
deleterious effects, for example, small intestinal epithelial cell (SIEC) shedding. 
 
 1.3 Intestinal mucosal epithelium 
The epithelium lining the small intestine is a simple columnar epithelium and consists 
of a number of cells of different types and functions. These cells are connected tightly 
together by intercellular junctional complexes which are the zonula occludens, zonula 
adherens, desmosomes and gap junctions, and are also connected to the underlying 
basement membrane via hemidesmosomes. These junctional complexes play an 
important role in maintaining intestinal homeostasis and prevent subsequent 
intestinal leakage (Lai et al., 2013). The lamina propria of the intestinal mucosa 
consists of vascular and lymph vessels, nerve fibres, smooth muscle cells and diffuse 
lymphoid tissue which all form the core of intestinal villi (Mescher, 2010). The 
submucosa has larger blood and lymph vessels, and a plexus of neurons known as a 
Meissner’s plexus, while the distal part of the duodenum contains branched tubular 
glands called Brunner’s glands that secrete an alkaline mucus to neutralise the acidity 
of the chyme that comes from the stomach (Mescher, 2010). The well-developed 
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muscularis in the small intestine is composed of an inner circular and outer 
longitudinal smooth muscle layer with the myenteric or Auerbach’s nerve plexus in 
between. This plexus of nerves is responsible for producing peristaltic movements of 
the bowel. The small intestine is covered on its exterior surface by a thin layer of 
connective tissue known as the serosa (Mescher, 2010). 
 
1.4 Cell types in the intestinal epithelium 
Intestinal integrity is maintained by the self-renewal activity of intestinal epithelia. The 
intestinal epithelium consists of various cell types (Figure 1.1). They are held together 
by intercellular junctions forming a structural unity of one cell thickness that is folded 
to produce villi and crypts (Bjerknes and Cheng, 1999). 
 
 
Figure 1.1: Schematic diagram of the small intestinal crypts and villi showing different 
cell types of lining epithelium. 
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1.4.1 Intestinal epithelial stem cells 
Intestinal epithelial stem cells are pluripotential cells that are located in the basal part 
of the small intestinal crypt. They are undifferentiated cells with few intracellular 
organelles and little microvilli. These cells have a capability to proliferate for self-
maintenance and differentiation into the various different cell lineages (Bach et al., 
2000). The basal compartment of the intestinal crypts (proliferative compartment) 
contains undifferentiated and rapidly cycling cells that are responsible for cell 
turnover and protective niche for the epithelial stem cells (Umar, 2010). Several 
experimental studies have used methods to identify the location of stem cells in 
intestinal crypts. However, the true nature of their position still remains unclear. Two 
different hypotheses have suggested the position of intestinal stem cells among the 
epithelial lining of the crypts of Lieberkühn. The +4 hypothesis was proposed by Potten 
and colleagues in 1974 and 1977, and suggested that stem cells are located at cell 
position +4 in the crypt axis from the crypt base with the lower three positions 
occupied by mature Paneth cells. These cells were subsequently shown to be 
positively labelled for Bmi-1 (B-cell lymphoma Mo-MLV insertion region 1 homolog), but 
were only noted among the epithelial lining of proximal small intestinal crypts 
suggesting the existence of Bmi-1 negative stem cell in the other parts of the small 
intestine (Sangiorgi and Capecchi, 2008, Potten et al., 2009). The crypt base columnar 
cell hypothesis suggested the presence of undifferentiated columnar epithelial stem 
cells between the Paneth cells below position 4 from the crypt base (Cheng and 
Leblond, 1974, Bjerknes and Cheng, 1999). These crypt base columnar cells expressed 
the stem cell marker Lgr5 (Leucine-rich repeat containing G-protein coupled receptor 
5) and are characterised by their ability for self-renewal and capability to produce all 
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types of differentiated intestinal epithelial cells found along the crypt-villus axis 
(Barker et al., 2007).  
 
1.4.2 Absorptive cells (mature enterocytes) 
Enterocytes are absorptive cells that are specialised for nutrient transport from the 
intestinal lumen into the blood circulation. They are tall columnar cells with basally 
positioned nuclei. The apical surface of these cells is folded into finger-like projections 
called microvilli that appear under the light microscope as a brush border toward the 
intestinal lumen. The microvilli increase the absorptive surface area of enterocytes. 
Each microvillus consists of an actin microfilament core that extends vertically from 
the tips of microvilli into the apical cytoplasm and inserts into the terminal web playing 
a part in forming the cytoskeleton that stabilises the apical cell membrane. In addition 
to their absorptive function, enterocytes also have a secretory function. They secrete 
glycoproteins that are found in vesicles in the apical part of the cells just below the 
terminal web (Ross et al., 2007). The brush borders of enterocytes are covered with a 
layer of glycocalyx that contains the secretion from enterocytes (glycoproteins and 
carbohydrates) mixed with the mucopolysaccharides and trefoil factors that are 
secreted by goblet cells (Herdt, 1997). By electron microscopy (EM) the absorptive 
cells show heterochromatic nuclei, supra-nuclear Golgi complex, mitochondria, 
ribosomes, rough endoplasmic reticulum (rER), secretory granules and lysosomal 
bodies (Shoma, 1983). 
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1.4.3 Goblet cells 
Goblet cells are found in both the intestinal crypts and intestinal villi and increase in 
number from the duodenum to ileum. They produce mucus and trefoil factors that 
play a role in the maintenance of cell surface integrity and improve healing of the 
gastrointestinal mucosa by restitution (Barrera and Tortolero, 2016). The apical part 
of goblet cells appears to be empty in routine haematoxylin and eosin stained sections 
due to the loss of water soluble mucinogen that accumulates in this cellular region 
during section preparation. EM examination of goblet cells shows accumulation of 
mucinogen granules in the broad apical part of the cell while the narrow basal part 
that appears basophilic in histological sections contains a heterochromatic nucleus, 
Golgi complex, rER, free ribosomes and mitochondria (Ross et al., 2007). 
 
1.4.4 Paneth cells 
Paneth cells are found at the base of intestinal crypts and do not migrate along the 
crypt-villus axis. They have a basophilic basal cytoplasm containing the nucleus and 
supranuclear Golgi complex. These cells are easily recognised in routine histological 
sections as their apical portion contains large intensly eosinophilic granules that 
contain antibacterial enzymes, lysosyme, and other substances such as 
phospholipase, ribonuclease and tumour necrosis factor (TNF). Lysosyme breaks down 
the cell wall of some bacteria giving the cells a phagocytic activity. The action of 
antibacterial enzymes and the phagocytic activity of Paneth cells against certain 
bacteria suggest that these cells play a role in regulating the normal bacterial flora of 
the small intestine (Ross et al., 2007). 
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1.4.5 Enteroendocrine cells  
Enteroendocrine cells are found in the lower portion of intestinal crypts and migrate 
slowly along the crypt-villus axis, therefore they can be seen at all levels of the villi. 
They are considered to be part of the gut neuroendocrine system and produce 
hormones such as somatostatin, gastrin, secretin, cholecystokinin and enteroglucagon 
that regulate the physiological activities of the gastrointestinal tract (Strader and 
Woods 2005). 
 
1.4.6 Tuft cells  
Tuft cells are scattered throughout intestinal crypt and villi and represent about 0.4% 
of all epithelial cells.  In intestinal crypts they are located just above the level of stem 
cells; they are sometimes described as inactive stem cells with a slower proliferation 
rate (Gerbe and Jay, 2016). Tuft cells are characterised by a thick brush border of 
microvilli that project from their apical surface and by a well-developed 
tubulovascular system in the apical cytoplasm. These cells can be seen in different 
epithelial tissues but little is known about their function due to the lack of Tuft cell 
specific markers. However their specific morphological structure expresses signalling 
constituents typical of chemosensory cell types (Gerbe et al., 2012). Gerbe et al. in 
2011 described various proteins that are specifically expressed by Tuft cells including 
DCAMKL 1 (doublecortin-like kinase 1). They also found that Tuft cells secrete opioids 
and produce enzymes used for prostaglandin synthesis (Grebe et al., 2011). 
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1.5 Proliferation and differentiation of the small intestinal epithelium 
The small intestinal epithelium renews itself continuously by the processes of 
proliferation and differentiation. This renewing system serves to populate two main 
compartments, the crypts and villi. The proliferative (stem) cells are located in the 
lower part of the crypt compartment and give rise the other types of cells that line the 
crypt-villus axis (Wright, 2000). The stem cells proliferate and show gradual 
characteristic changes from undifferentiated cells in the crypt base to partially 
differentiated cells at higher crypt levels. At the top of the crypts, they stop dividing 
but continue to differentiate to become fully differentiated cells within the villus 
compartment (Cheng and Leblond, 1974). The stem cells at the crypt base start to 
divide symmetrically producing identical stem cells that maintain the stem cell 
compartment and asymmetrically producing transit-amplifying cells that continue to 
divide and differentiate while they migrate from the crypt along the crypt villus axis 
into enterocytes, goblet cells and enteroendocrine cells (Kolf et al., 2007). Also, a small 
number of transit-amplifying cells migrate downwards and differentiate into Paneth 
cells (Garabedian et al., 1997). 
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Figure 1.2: Schematic diagram illustrating the differentiation of stem cell into different 
types of intestinal epithelial lineage. 
 
Proliferation and differentiation of the small intestinal epithelium is crucial for 
maintaining tissue homeostasis. This means that the percentage of stem cell 
proliferation and differentiation is directly related to the number of cells that die at 
small intestinal villus apices (Booth and Potten, 2001).  
Parker and colleagues (2017) established a cell-tracking mathematical scheme to 
calculate the rate of small intestinal stem cell proliferation and migration under 
normal conditions including the time when proliferation starts to slowdown and when 
it is completely stopped. They found a direct relationship between the proliferation of 
stem cells in the intestinal crypt and the velocities of migration of differentiated cells 
along the villus axis, concluding that the proliferation of stem cells in intestinal crypts 
is the primary force that initiates and determines the migration rate of cells along the 
villus length (Parker et al., 2007). 
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There are two different major signalling pathways controlling intestinal stem cell 
proliferation and differentiation, Wnt signalling and Notch signalling (Vanuystel et al., 
2013 and vanDussen et al., 2012). 
 
1.5.1 Wnt signalling pathway 
The Wnt signalling pathway depends on the autocrine and paracrine interaction of 
secreted cysteine-rich Wnt-glycoprotein with the transmembrane receptor Frizzled 
and the co-receptor lipoprotein related protein (LRP) (Vanuystel et al., 2013). Binding 
of Wnt to its receptor activates the canonical pathway that increases cell proliferation 
by regulating progression through the cell cycle. Activation of Wnt/β-catenin signalling 
preserves the proliferative state of transit amplifying progenitors at the bottom of 
intestinal crypts. Inactivation of the Wnt signalling pathway by over expression of the 
inhibitor DKK1 leads to loss of crypt cell proliferation (Pinto et al., 2003 and Kuhnert 
et al., 2004). On the contrary, activation of the Wnt/β-catenin/T-cell factor (Tcf) 
pathway principally maintains the intestinal epithelial cells in a proliferative condition 
and suppresses differentiation (van de Wetering et al., 2002). Cytosolic β-catenin is 
the key mediator of the Wnt signalling pathway. It translocates into the nucleus and 
stimulates the subsequent transcriptional regulation of Wnt target genes such as the 
c-myc oncogene. Therefore, nuclear accumulation of β-catenin is considered to be an 
indicator of an activated canonical Wnt signalling pathway. In the absence of binding 
of Wnt to its receptor, the free cytoplasmic β-catenin is efficiently degraded by the 
tumour suppressor gene product adenomatous polyposis coli (APC) that is considered 
to act as a suppressor of the Wnt signalling pathway (Pinto and Clevers, 2005). 
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The role of Wnt signalling in inducing cell proliferation is thought to be mediated by 
down regulation of the cell cycle inhibitor p21CIP1/WAF1 that is mediated by upregulation 
of the C-myc proto-oncogene (Nakamura et al., 2007 and Furriols and Bray, 2001). 
 
1.5.2 Notch signalling pathway 
Both Wnt and Notch signalling pathways play important roles in maintaining a 
proliferative state in the intestinal crypt; many studies have suggested that the key 
element of cell fate and differentiation in the intestinal epithelium is the Notch 
signalling pathway. The Notch signalling pathway is based on the direct contact 
between Notch receptors and ligands of adjacent cells (Morimoto et al., 2012). This 
Notch receptor-ligand interaction leads to cleavage of an intracellular domain (ICD) 
from the transmembrane domain of the receptor and the subsequent translocation of 
ICD into the nucleus, where it binds to the DNA binding protein RBP-J (recombination 
signal binding protein for immunoglobulin kappa J region). Afterward this complex 
activates the transcription of Notch target genes such as Hes1 (Artavanis-Tsakonas et 
al., 1999 and Furriols and Bray, 2001). These Notch signalling pathway elements, 
ligands, receptors and the target gene Hes1, are expressed in the proliferative cell 
compartment of the intestinal crypt (Zecchini et al., 2005). Inhibition of the Notch 
signalling pathway by deletion of RBP-J leads to an increase in the expression of Math1 
(which is usually suppressed by active Notch signalling), and the replacement of the 
transit amplifying (proliferative) compartment by goblet cells. This was associated 
with suppression of all epithelial cell division whilst the Wnt signalling pathway 
remained active (van Es et al., 2005 and van Es and Clevers, 2005). Disruption of the 
33 
 
Notch signalling pathway also caused an increase in the population of goblet cells 
within the gut epithelium (Zecchini et al., 2005 and Crosnier et al., 2005). Murine 
intestinal epithelium deficient in Hes1 revealed an increase in the number of secretory 
cell types (goblet cells, enteroendocrine cells and Paneth cells) and a decrease in 
enterocytes. This indicated the role of Hes1 as a negative regulator of secretory cell 
type differentiation (Jensen et al., 2000). Moreover, Hes1 inhibits Math1 that is 
recognised as a positive regulator of secretory cell lineage differentiation. 
Additionally, deletion of Math1 noticeably indicated a reduction in intestinal epithelial 
goblet cells, enteroendocrine cells and Paneth cells without affecting the enterocyte 
population (Yang et al., 2001). Consequently, the equilibrium between expression of 
Hes1 and Math1 regulates the differentiation of progenitor cells into either absorptive 
or secretory cell types. Nevertheless, additional downstream regulation of Math1-
specified secretory cell lineages is crucial for the differentiation of individual secretory 
cell lineages. This downstream choice involves the zinc-finger transcriptional repressor 
Gfi1 which is absent in Math1-null embryonic intestines. The intestine of Gfi1-
knockout mice showed loss of Paneth cells and a drop in the number of goblet cells 
and by contrast indicated an increase in the number of enteroendocrine cells. This 
suggests a role of Gfi1 in regulating the differentiation of Paneth and goblet cells and 
not the differentiation of enteroendocrine cells (Shroyer et al., 2005). On the other 
hand, deletion of neurogenin 3 (Ngn3) in mice lead to the complete loss of 
enteroendocrine cells, however, the other three cell lineages (enterocytes, goblet cells 
and Paneth cells) developed normally indicating a specific role of Ngn3 in 
development of enteroendocrine cells (Jenny et al., 2002). 
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1.6 Cell death 
Cell death is defined as the point at which a cell fails to perform its vital functions. 
Some previous reviews defined cell death as an irreversible loss of cell membrane 
integrity (Kromer et al., 2009 and Alvarez et al., 2010). Historically cell death has been 
classified into regulated apoptosis and unregulated necrosis, but more recent 
research suggests that necrosis may also be implemented through another pathway 
termed necroptosis (Degterev et al., 2005). In addition to these three types of cell 
death, recent investigators have proposed another type of programmed cell death 
categorised as an inflammatory type of cell death that results from infections with 
intracellular pathogens (Salmonella and Shigella species) and is known as pyroptosis 
(Fink and Cookson, 2005). 
 
1.6.1 Necrosis 
The term necrosis describes the uncontrolled irreversible damage to a cell or tissue. It 
is a form of non-specific, unregulated, non-programmed cell death that is often 
associated with inflammation. Necrosis is frequently associated with pathological 
conditions and is prominent in ischaemia, trauma, and exposure to toxins or invasion 
by viruses or bacteria (Alvarez et al., 2010). Necrotic cells are characterised by 
numerous morphological changes including an increase in the size of the cell itself 
(swelling) and the size of its organelles with subsequent rupture of the cell membrane 
followed by dissolution and lysis of nuclear and cellular components. It usually occurs 
in groups of neighbouring cells (Kerr et al., 1972).  
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1.6.2 Apoptosis  
Apoptosis is a regulated form of cell suicide that is tightly controlled by a genetic 
mechanism (Yuan and Horvitz, 2004).  Apoptosis is achieved through either the 
extrinsic pathway via ligand binding receptor or via the intrinsic pathway involving the 
mitochondria as discussed in more detail below (Figure 1.3). Early apoptosis research 
focused on the important role of apoptosis or programmed cell death in development 
and the maintenance of normal tissue homeostasis (Yuan and Kroemer, 2010). As a 
mode of cell death, apoptosis has always shown a series of morphological and 
biochemical changes to cell architecture, including shrinkage of cells, chromatin 
condensation, blebbing of the nucleus and cytoplasm and breakdown of DNA (Majno 
and Joris, 1995). Apoptotic cells are recognised by phagocytes and are engulfed before 
they leak their contents (Martin and Henry, 2013). Programmed cell death removes 
aged, unwanted and injured cells with a reduced level of disturbance to neighbouring 
cells (Martin et al., 2012). Apoptosis complements mitosis as a means of regulating 
cell numbers in multicellular organisms and for this reason it is under molecular 
control by a dedicated set of enzymes and their regulators. Caspases, members of the 
family of cysteine proteases, become activated during apoptosis and regulate the 
events that take place to ensure the immediate recognition and removal of apoptotic 
cells (Riedl and Salvesen, 2007). 
The structural and functional efficiency of the gut barrier is only maintained if there is 
equilibrium between cell mitosis within the intestinal crypt and cell shedding at the 
tips of intestinal villi (Günther et al., 2013). Epithelial cells migrate from the crypt base 
to the villus tip in the small intestine where they undergo cell death and shedding. A 
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number of studies have shown that this process is actively regulated, and that it 
involves a subset of the caspase family of proteases including Caspase-3, -6, -7, -8, and 
-9 (Tylor et al., 2008 and Martin and Henry, 2013). 
Caspase-3 activation is often accompanied by morphological changes that are 
associated with cell shedding. On the other hand, no morphological changes were 
observed during gastrointestinal tract development in mice that were deficient for 
caspase 3, supporting the suggestion that caspase 3 may not play an important role in 
gut tissue homeostasis (Günther et al., 2013) or that there is functional redundancy 
with other proteins such as other caspases.  
 
1.6.3 Necroptosis 
Recently the term necroptosis has been used to describe a process of regulated 
necrosis that occurs in certain types of cells such as neurones (Degterve et al., 2005). 
It can be defined as a form of cell death that is negatively regulated by caspase 8. It is 
dependent on the receptor-interacting protein kinase 1 and 3 (RIPK1-RIPK3) complex, 
and this process can be inhibited by necrostatin-1 (Kaczmarek et al., 2013). 
Necroptotic cell death in vitro is confirmed by plasma membrane rupture and lacks 
apoptotic markers such as caspase activation and chromatin condensation 
(Kaczmarek et al., 2013). Necroptosis may be stimulated by TNF, Fas ligand and TNF-
related apoptosis inducing ligand; the same ligands that can activate apoptosis 
(Alvarez et al., 2010). Günther and colleagues in 2013 demonstrated that necroptosis 
is an alternative mode of cell death in the intestine which can drive intestinal 
inflammation. They described that intestinal inflammation in inflammatory bowel 
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disease patients can be evoked by an undesirable mechanism through dysregulation 
of the immune response and epithelial cell death due to strong inflammatory 
mediators such as TNF that are recognised as potent inducers of necroptosis.  
 
1.6.4 Pyroptosis 
Pyroptosis is a special type of programmed cell death that is considered as pro-
inflammatory and is induced by an infection with Salmonella and Shigella species 
(Cookson and Brennan, 2001). This type of cell death is uniquely dependent on 
caspase 1 (which is not involved in the apoptotic type of cell death). Activation of 
caspase 1 in bacterially infected macrophages causes activation of inflammatory 
cytokines (IL-1β and IL-18), leading to cell death that is distinctly different from 
apoptosis (cell death without inflammation). This type of cell death can be recognised 
in a variety of biological systems including the immune system, nervous system and 
cardiovascular system (Fink and Cookson, 2005). 
 
1.6.5 Autophagy 
Autophagy is a physiological self-destructive process that takes place within 
autophagy vacuoles of dying cells. It is a non-inflammatory mechanism that is 
regulated by GTPases and phosphatidylinositol kinases through the ubiquitin-like 
conjugation system and is characterised by the segregation of cytoplasmic 
components in double-membrane vacuoles forming autophagosomes that later fuse 
with cellular lysosomes to be destroyed by the action of lysosomal proteolytic 
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enzymes. In vivo, autophagic cells can be phagocytosed by adjacent cells (Fink and 
Cookson, 2005 and Glick et al., 2010).  
 
1.7 Cell death in the small intestine 
Structural and functional integrity of the gut barrier are maintained by the equilibrium 
between cell death and cell proliferation. Continuation of this equilibrium results in 
maintaining cellular functional efficiency and prevents the accumulation of damaged 
cells (Delgado et al., 2016). Under normal homeostatic conditions the majority of cell 
death occurs at the villus tip, however it can also be observed at the crypt base in the 
region where stem cells are located (Watson and Pritchard, 2000). The process of cell 
death was originally recognised based on morphological changes, but recently a 
number of studies have distinguished the cell death process based on the activity of 
biochemical pathways. The activation of more than one biochemical pathway can 
result in the same morphological endpoint while activation of an individual pathway 
may lead to different morphological features (Hacker and Karrin, 2000). Programmed 
cell death in the intestine was described as apoptosis that was dependent on a family 
of aspartic-acid specific proteases called caspases and necroptosis which involves 
caspase independent cell death mechanisms and is dependent on activity of receptor-
interacting protein (RIP) kinases (Delgado et al., 20016). The first programmed cell 
death response due to cellular stress is apoptosis. However, if the mechanism of 
apoptosis is impaired or blocked the alternative pathway will be necroptosis which 
causes rupture of the cell membrane, the release of cytoplasmic components and 
induction of inflammation (Delgado et al., 2016). 
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1.7.1 Mechanism of SIEC shedding during homeostasis 
An increase in the loss of SIECs or a decrease in the regenerative capacity of the 
intestine results in loss of epithelial layer integrity and increased gut barrier 
permeability, leading to the passage of harmful materials and microorganisms into the 
body. Despite the very high mitotic activity of the small intestine, a healthy intestinal 
mucosa has the ability to preserve its epithelial integrity and maintain intestinal 
barrier function by generating new epithelial cells to compensate for the loss of 
mature cells at the villus tip by shedding. Previously, shedding or the loss of mature 
epithelial cells was recognised to be a result of continuous cell maturation, possibly 
due to crowding of the epithelial cells at the tip of the villi. Nonetheless, the continuity 
of this process indicates that it is a complex sequence of coordinated events that seem 
to be important to maintain the integrity of the epithelium and gut barrier function. 
For this reason, the mechanism by which epithelial cells are shed from the tip of the 
villus into the lumen is crucial for understanding intestinal homeostasis in health and 
disease (Williams et al., 2015).  
The intestinal epithelium represents part of a renewing system that undergoes a series 
of active mitotic divisions throughout life (Leblond and Stevens, 1948). Generally 
intestinal epithelial cells arise from stem cells located at the base of intestinal crypts. 
These cells undergo three or four mitotic divisions before they start to migrate up 
through the crypt-villus axis to eventually be shed at the villus tips into the gut lumen 
(Watson et al., 2009). 
The early description of cell shedding in the intestinal epithelium was made by Leblond 
and Stevens, 1948. They studied the mitotic activity of rat intestinal epithelial cells as 
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a powerful regulatory process following the damage that resulted from the action of 
bacterial enzymes (Leblond and Stevens, 1948). In the mouse, the process of cell 
migration to the villus tip takes two to three days and approximately 1400 cells per 
villus are shed every day (Yuan and Kroemer, 2010). Different morphological features 
have been observed during the shedding of intestinal epithelial cells in different 
animals. In mice, extrusion of whole cells into the lumen has been noted, whereas in 
guinea pigs the epithelial cells undergo a series of events leading to cell fragmentation 
and these fragments are pinched off leaving intact junctional complexes between the 
neighbouring cells (Mayhew et al., 1999). In humans the type of cell shedding is by 
whole cell extrusion which is similar to the intestinal epithelial cell shedding process 
observed in mice and rats, suggesting that these species are the appropriate models 
to study the regulation of human cell shedding (Williams et al., 2015).  
The equilibrium between the production of newly synthesised cells in intestinal crypts 
and the shedding of epithelial cells from the villus tip should be matched. Many factors 
may affect this balance, either by inhibiting cell proliferation such as by chalones such 
as bone morphogenic proteins (van der Filer and Clevers, 2009) or by increasing the 
rate of cell shedding at villus tips by factors including growth factors and the intestinal 
microbiota (Dong et al., 2014).  
Although shedding of intestinal epithelial cells at villus tips occurs in all living species, 
variations in the morphological features of epithelial cell shedding were clearly noted 
between different species. A whole cell extrusion type of shedding was noted in mice 
and rats, while in guinea pigs the epithelial apoptotic bodies are pinched out from the 
shedding cells leaving intact junctional complexes between the adjacent cells 
(Mayhew et al., 1999). Recently, various studies have shown that the shedding of small 
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intestinal epithelial cells (SIECs) in humans has whole cell extrusion features (Bullen et 
al., 2006).  However, several different SIEC shedding mechanisms may be present with 
different degrees of abundance within each species to maintain intestinal barrier 
function as effectively as possible. 
Maintenance of the intestinal barrier following shedding of epithelial cells is a 
complicated process that involves the integration of microtubules, microfilaments and 
membrane components to remove the apoptotic cells. This process is complemented 
by redistribution of junctional proteins including zonula occludens 1 (ZO-1) to the 
lateral membrane of the shedding cells (Figure 1.3). This protein eventually forms a 
funnel around the shedding cell that preserves the integrity of the gut barrier. In 
addition other junctional proteins including claudin, E-cadherin, F-actin, myosin II, 
Rho-associated kinase (ROCK) and myosin light chain kinase (MLCK) are also 
redistributed to the lateral membrane (Marchiando et al., 2012). Guan et al., 2011 
demonstrated that the primary indicator of cell shedding was ZO-1 redistribution 
which also appears as a marker of tight junction movement to maintain the intestinal 
barrier function during cell extrusion. Furthermore, they suggested that ZO-1 may 
bind to both the basolateral membrane and cell cytoskeleton that when contracts 
produces a force causing extrusion of the shedding cell and ZO-1 redistribution to the 
apical tight junction complex (Guan et al., 2011).  Additionally, Kiesslich and colleagues 
in 2012 using intravenous fluorescein, found that in the healthy human intestine, 
fluorescein filled the intercellular spaces up to the apical border and did not leak into 
the lumen suggesting that these spaces were occluded by tight junctions. 
In patients with active IBD or patients around to undergo relapse of their IBD, 
fluorescein was observed leaking through paracellular spaces into the lumen 
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indicating that they had increased intestinal permeability. This leakage across tight 
junctions may predict the onset of IBD relapse (Kiesslich et al., 2012). 
 
 
Figure 1.3: Schematic diagram illustrating the events of epithelial cell shedding and 
redistribution of tight junction to maintain the epithelial barrier integrity. 
 
 
Shedding of intestinal epithelial cells either at the villus tip or crypt base leads to 
activation of the main initiators of apoptosis, the caspase family of proteins (Bullen et 
al., 2006, Günther et al., 2013, Williams et al., 2015, Delgado et al., 2015). Various 
recent studies have indicated differences in the apoptotic response in crypts and villi 
between different wild type mouse strains after exposure to different stimuli. 
Pritchard et al., in 2000 found that Balb/c mice displayed more ralitrexed induced 
intestinal apoptosis than DBA/2 mice, they also demonstrate greater histopathological 
damage in the colon associated with diarrhoea and loss of body weight. Similar results 
were generated by Clarke et al. in 2000 who noted villus atrophy in the murine small 
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intestine 24 hours after ralitrexed injection which was more pronounced in Balb/c 
mice than in DBA/2 mice. Furthermore in 2012 Browne et al. investigated the effect 
of LPS on the hippocampus of two different mouse strains and they found that LPS 
administration significantly increased TNF mRNA expression in the hippocampus of 
Balb/c mice but not in C57BL/6J mice, however, significantly increased the mRNA 
expression of IL-1β in both mouse strains suggesting that LPS administration affects 
various tissues and that cytokines released by these tissues (such as TNF) may have 
systemic effects including on the gastrointestinal tract. 
The small intestinal flora consists of many microorganisms. In the duodenum and 
jejunum there are about 103-104 bacteria/ml of intestinal contents, mostly acid-
tolerant lactobacilli and streptococci. The microflora of the ileum is more similar to 
that of the colon compared with other regions of the small intestine and consists of 
around 107-108 bacteria/ml of the intestinal contents (Hao and Lee, 2004). Gram 
negative bacteria are a constituent of the commensal microorganisms that form the 
intestinal microbiota. Lipopolysaccharide (LPS) is an integral cell wall component of 
Gram negative bacteria and has the ability to evoke the host immune system.  The LPS 
molecule is composed of three different domains that include a lipid A domain, an 
oligosaccharide core and an O-antigen (Figure 1.5). The lipid A domain is the part 
responsible for the toxicity of LPS whereas the O- antigen gives antigenic specificity to 
the bacterial LPS (Van Amersfoort et al., 2003, Williams et al., 2013).  
In many previous studies the LPS used to induce endotoxic shock and clearly induce 
pathological SIEC apoptosis and shedding in mice has been the LPS derived from 
Escherichia coli serotype O111:B4 given its reported relationship to the occurrence of 
infant gastroenteritis (Campos et al., 1994, Williams et al., 2013).   
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Mathiak et al. in 2003 investigated the stimulatory effect of purified LPS from various 
different bacterial sources on the production of cytokines and chemokines that 
measured in whole blood assay by enzyme-linked immunosorbent assay (ELISA) and 
indicated that LPS originating from different bacterial sources demonstrated different 
effects upon the production of inflammatory mediators. However, there is currently 
no previous literature indicating the role of LPS from different bacterial species in 
inducing apoptosis and shedding of murine SIECs. 
 
1.8 Genetic regulation of apoptosis in the gastrointestinal tract 
Apoptosis is considered to be a genetically controlled self-destruction process. The 
failure of cells to undergo apoptosis may lead to neoplastic transformation (Pritchard 
and Watson, 1996 and Potten et al., 1997). Although apoptosis can be initiated by 
numerous stimuli, it involves one of two main cellular pathways; the mitochondrial 
pathway (intrinsic) and the membrane pathway (extrinsic) (Zhang and Fang, 2007). 
Extrinsic apoptosis is induced by extracellular stimuli that bind to specific 
transmembrane receptors termed death receptors, leading to the assembly of the 
death initiation signalling complex (DISC) that subsequently activates the caspase 
cascade. The intrinsic pathway is activated as a result of internal cellular stimuli such 
as DNA damage that affect the mitochondrial outer membrane causing cessation of 
ATP production and the release of a group of proteins that contribute to caspase 
activation (Favaloro et al., 2012 and Figure 1.4). 
Zhang and Fang in 2007 demonstrated that the modulation of different proteins, some 
pro-apoptotic and others anti-apoptotic, determine whether a cell will live or die by 
regulating activity of the apoptotic pathway. 
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Figure 1.4: Schematic representation of the main molecular pathways leading to 
apoptosis. 
 
1.8.1 Bcl-2 and related genes 
The B cell Lymphoma/Leukaemia 2 (Bcl-2) oncogene has an important role in 
regulating apoptosis through the mitochondrial cascade (Edelblum et al., 2006 and 
Zhang and Fang, 2007). There are two groups of Bcl-2 family members that have 
opposite cellular effects on apoptosis; some are involved in suppressing apoptosis and 
these include Bcl-2, bcl-xL, mcl1, bag-1, bfl-1, brag-1 and bcl-w. Conversely, bax, bad, 
bcl-xs, bak and bik are members that promote the process of apoptosis (Pritchard and 
Watson, 1996 and Potten et al., 1997). 
In response to apoptotic signals, Bax (a pro-apoptotic protein) accumulates inside the 
mitochondria resulting in the release of two important apoptotic factors which are 
cytochrome C and SMAC/DIABLO into the cell cytosol. Cytochrome C binds to APAF1, 
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causing activation of caspases 3, 7 and 9 while SMAC/DIABLO prevents the apoptotic 
inhibitory action of the apoptosis inhibitors by masking them (Zhang and Fang, 2007). 
In 2000, Pritchard and colleagues described the roles of Bcl-2 in the gastrointestinal 
tract (GIT) and found that Bcl-2 has a role in regulation of colonic epithelial cell 
apoptosis but did not appear to have the same anti-apoptotic action on small 
intestinal epithelial cells. However, Bcl-w was shown to play a crucial role in regulating 
apoptosis in the small intestinal epithelium. 
There are other Bcl-2 family members that play roles in the inhibition or promotion of 
apoptosis. Bcl-xL and bcl-w are apoptosis inhibitors as they inhibit the Fas signalling 
pathway while Bax and Bak promote cell death. Bax is one of the principal promoters 
of apoptosis in the intestinal epithelium (Pritchard et al., 2000, Bowen et al., 2006). 
Duckworth and Pritchard in 2009 found that the proapoptotic protein Bak plays a 
major role in regulating colonic epithelial cell homeostasis, but it does not appear to 
have the same effect in the murine small intestine. Bim is a BH-3-domain only protein, 
the only such member of the Bcl-2 family that is expressed through the intestine and 
its role is relatively similar to Bax as its expression is seen at the base of colonic crypts 
and in intestinal villi (Bowen et al., 2006). 
 
1.8.2 p53 
p53 is a tumour suppressor protein that has two different roles. It has been recognised 
as an apoptosis mediator and also functions as a transcription factor to promote the 
activation of a variety of genes that are necessary for normal cell cycle regulation. It is 
responsible for the up-regulation of Fas and TNFR1 signalling in several cell types 
(Edelblum et al., 2006). Many studies have shown that p53 deficient transgenic mice 
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develop normally, indicating that this gene has little involvement in controlling 
developmental processes or basal amounts of apoptosis (Potten et al., 1997). 
However, examination of the changes that occur in p53 expression in the small 
intestine following exposure to ionising radiation indicate a role for p53 in this tissue.  
Ionising radiation can induce apoptosis in the position of intestinal stem cells with the 
peak of apoptosis being noted 3-6 hours following radiation exposure indicating the 
role of p53 either in initiating apoptosis or in holding the cells in the G1 or G2 phase 
of the cell cycle until repair of DNA damage has occurred (Potten et al., 1997, Potten 
and Grant, 1998). 
 
1.8.3 Tumour necrosis factor family 
TNF, FasL, and TNF-related apoptosis inducing ligand (TRAIL) are members of the TNF 
superfamily. All of these three mediators are known to have a role in promoting cell 
death by activation of a death receptor pathway (extrinsic pathway). Briefly, activation 
of the death receptor pathway by TNF will activate FADD (Fas-associated death 
domain protein) and TRADD (Tumour necrosis factor-associated death domain 
protein) that subsequently activate the caspases which initiate the apoptosis of 
intestinal epithelial cells (Zhang and Fang, 2007). TNF is a strong stimulator for 
intestinal epithelial cell shedding in mice. Sixty minutes after intraperitoneal 
administration of TNF, marked atrophy of duodenal villi is observed (Williams et al., 
2013). The cellular interleukin 1B (IL-1B) as well as bacterial lipopolysaccharide (LPS) 
and other bacterial products can strongly regulate the action of TNF on intestinal 
epithelial cells by stimulating two TNF receptors, TNFR1 (which contains a death 
domain) and TNFR2 that does not have a death domain (Slebioda and Kmiec, 2014). 
48 
 
1.8.4 C-myc proto-oncogene 
C-myc is a proto-oncogene which has high expression in many tumours. It has two 
functional properties as it can induce uncontrolled cell proliferation as a result of 
preventing the cell from leaving the cell cycle, however it can also induce apoptosis 
(Pritchard and Watson, 1996). C-myc is a crucial regulator for a number of cellular 
processes that include apoptosis, cell cycle regulation, metabolism, ribosome 
biogenesis, protein synthesis and mitochondrial function. By contrast it can supress 
many genes that are involved in cell adhesion and cellular growth (Wilkins and 
Sansom, 2008). 
C-myc has an ability to make cells sensitive to many apoptotic stimuli including DNA 
damaging agents which are triggered through p53 activation and are mediated by 
BH3. C-myc also induces apoptosis by increasing the effectiveness of the death 
receptors Fas and TRAIL (Watson, 2004). 
 
 
1.9 Stimuli that cause pathological intestinal epithelial cell apoptosis 
and shedding 
Spontaneous apoptosis occurs at a low rate in intestinal crypts and is usually observed 
at position 4 and 5 from the crypt base. This type of apoptosis is not related to any 
known stimuli (Potten, 1992). Correspondingly, physiological apoptosis and shedding 
of SIECs from intestinal villi are also seen on rare occasions (Bullen et al., 2006). This 
suggests that physiological apoptosis and shedding does not affect gut barrier 
function. 
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Pathological apoptosis and shedding of SIECs have previously been induced by 
administration of different stimuli including TNF (Piguet et al., 1998, Marchiando et 
al., 2011, Watson and Hughes, 2012), bacterial LPS (Williams et al., 2013, Yue et al., 
2013, Guo et al., 2013), anti-CD3 antibody (Miura et al., 2005), 
Polyinosinic:polycytidylic acid (McAllister et al., 2013, Zhao et al., 2017) and 
indomethacin (Shi et al., 2014). 
 
1.9.1 Bacterial lipopolysaccharide (LPS) 
LPS is an integral cell wall component of Gram negative bacteria and has the ability to 
evoke the host immune system.  The LPS molecule is composed of three different 
domains that include a lipid A domain, an oligosaccharide core and an O-antigen 
(Figure 1.5). The lipid A domain is responsible for the toxicity of LPS whereas the O- 
antigen gives antigenic specificity to the bacterial LPS (Van Amersfoort et al., 2003, 
Williams et al., 2013). The LPS molecule is a complex amphiphilic molecule and 
consists of two structural components, a hydrophobic component termed lipid A and 
a hydrophilic component which consists of both an oligosaccharide core region and an 
O-specific antigen chain (Guo et al., 2013). The highest concentration of LPS was noted 
in the intestinal lumen due to the residency of huge number of commensal bacteria. 
However, under normal physiologic conditions LPS cannot penetrate through the 
healthy gut barrier (Benoit et al., 1998, Ge et al., 2000).  
Toll like receptor 4 (TLR 4) is expressed on myeloid-derived cells such as macrophages 
and dendritic cells as well as in some epithelial and endothelial cells and is considered 
to be a crucial component of the innate immune response (Kawai and Akira, 2010). 
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LPS signalling via TLR4 ligation was found to be dependent on several other molecules 
including lipopolysaccharide-binding protein and myeloid differentiation protein. This 
co-receptor mediates the ligation and transfer of LPS to TLR4 (Poltorak et al., 2000, 
van der Mark et al., 2017). Ligation induces the dimerisation of TLR4 and causes 
activation of the MyD88-independent signalling pathway that leads to production of 
proinflammatory cytokines such as TNF, interleukin 1(IL-1) and interleukin 6 (IL-6) (Lee 
et al., 2012).  
 
Figure 1.5: The components of LPS molecules, modified from: James and Hurley; 
2013.Toxins, 5(12), 2589-2620 
 
 
LPS represents a pathogen-associated molecular pattern. When administrated 
systemically it is recognised by TLR4 on the wall of mononuclear phagocytic cells 
initiating a systemic inflammatory response involving nuclear factor kappa B (NFĸB). 
This inflammatory response evokes mononuclear phagocytic cells to release TNF into 
the circulation. TNF subsequently binds to tumour necrosis factor receptor 1 (TNFR1) 
on the basolateral membrane of intestinal epithelial cells stimulates apoptosis and 
shedding of intestinal epithelial cells if NFκB2 signalling dominates, or cell survival if 
NFκB1 signalling dominates (Williams et al., 2013).  
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Figure 1.6: Diagram summarising the putative mechanism by which LPS induces 
apoptosis in SIECs. Modified from Williams et al., 2013. Dis Mod Mech 6(6):1388-99 
 
1.9.2 Anti-mouse CD3e antibody 
The anti-mouse CD3 antibody is widely used for prevention and treatment of clinical 
organ allograft rejection because of its immunosuppressive properties. However, the 
clinical use of this antibody is accompanied by a number of symptoms including fever, 
nausea, vomiting, headache and diarrhoea due to a release of numerous cytokines 
including interleukin 2 (IL-2), TNF, interferon-ɤ (IFN-ɤ) and IL-6 (Bloemena et al., 1990, 
Vossen et al., 1995). Anti-CD3e antibody targets the T cell receptor-CD3 (TCR-CD3) 
complex on the surface of circulating T-lymphocytes leading to activation of T-cells. 
This activation of T- cells results in the release of the proinflammatory cytokines 
described above (Carpenter et al., 2000). In vivo activation of T-lymphocytes has been 
demonstrated to be the cause of intestinal damage that is characterised by increased 
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gut permeability, loss of intestinal villi and increased crypt apoptosis (Zhou et al., 
2004).  
Miura and colleagues in 2005 investigated the effect of anti-CD3 antibody in the 
activation of T-lymphocytes and interestingly they found that an IP administration of 
anti-CD3 antibody induced a biphasic apoptosis and cell shedding of murine SIECs at 
both villus and crypt levels. The first phase consisted of apoptosis at the villus tip which 
was observed 2 hours post IP injection of 12.5mg/kg anti-CD3 antibody and reached a 
peak 4 hours post administration with a decline thereafter. The second observed 
phase was crypt epithelial cell apoptosis that increased gradually to reach a peak 
amount 24 hours post administration. The authors also noted an inflammatory 
infiltration of mononuclear phagocytic cells and indicated that all of these pathological 
features returned to normal by 4 days post administration (Miura et al., 2005). 
 
1.9.3 Polyinosinic: polycytidylic acid (Poly I:C) 
Poly I:C is a synthetic analogue of double stranded RNA (dsRNA), a virus associated 
molecular pattern. Injection of poly I:C into mice markedly induced rapid but 
reversible damage of the intestinal mucosa with significant villus shortening and 
increased enterocyte apoptosis (McAllister et al., 2013).  
Araya and colleagues, 2014 showed that intramural administration of poly I:C into 
C57BL/6J mice resulted in a severe enteropathy characterised by blunting of intestinal 
villi and oedema, with increased cell infiltration in the underlying lamina propria. 
These features were clearly observed 12 hours post poly I:C injection with decreased 
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villus/crypt ratio in comparison to PBS-treated C57Bl/6J mice. Full recovery was 
observed 72 hours post poly I:C treatment. The small intestine of poly I:C treated mice 
showed increased IFNβ expression 2 hours post injection whereas C-X-C motif 
chemokine 10 (CXCL10) and TNF peaked 6 hours following poly I:C treatment. The 
authors also indicated that MDA5 (Melanoma Differentiation-Associated protein 5), 
RIG-I (Retinoic acid-Inducible Gene-I-like receptor) and TLR3 mRNA were equally 
upregulated in the small intestine following poly I:C injection, furthermore the highest 
expression of these three receptors was observed 6 hours post intraluminal 
administration. 
Recognition of poly I:C by TLR3 activates the transcription factor interferon regulatory 
factor 3 (IRF3) through the adapter protein Toll-IL1 receptor (TIR) domain- containing 
adapter inducing INFβ.  Activation of IRF3 leads to increased production of IFNβ 
(Yamamoto et al., 2003). On the contrary, involvement of TNF receptor associated 
factor 6 (TRAF6) or receptor interacting protein 1 (RIP1) with  
the subsequent activation of the transcription factors NF-κB and AP-1 triggers the 
production of inflammatory cytokines and chemokines such as TNF, IL-6 and CXCL10 
(Kawai and Akira, 2008). 
 
1.9.4 Tumour necrosis factor (TNF) 
TNF was historically known as TNF and tumour necrosis factor superfamily 2 (TNFSF2). 
It is a member of a family that consist of 19 ligands and 29 receptors identified as the 
tumour necrosis factor superfamily (TNFSF) (Aggarwal et al., 2012). The expression, 
form and structural characteristics of these constituents allows these family members 
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to activate various signalling pathways that control different cellular mechanisms 
including cell proliferation, cell differentiation, cell survival and apoptosis (Aggarwal 
et al., 2003). TNF is expressed by different cells including macrophages, T-
lymphocytes, B-lymphocytes, natural killer (NK) cells, mast cells, endothelial cells, 
fibroblasts and neurons. This expression is strongly up-regulated through a number of 
proinflammatory components such as LPS and IL-1β (Locksley et al., 2001, Wajant et 
al., 2003, Aggarwal et al., 2012). Two types of TNF receptors have been identified, TNF 
receptor 1 (TNFR1 or p55 or TNFRSF1A) that contains the death domain and is 
essentially expressed on almost all mammalian cells and activated by both soluble and 
transmembrane forms of TNF. The second receptor is TNFR2 (p75 or TNFRSF1B) which 
does not contain the death domain and is only activated by the transmembrane form 
of TNF. The expression of TNFR2 is strictly regulated and found in T-lymphocytes, 
endothelial cells, microglia, neurons, oligodendrocytes, cardiac myocytes, thymocytes 
and mesenchymal stem cells (Wajant et al., 2003, Aggarwal et al., 2012, Faustman et 
al., 2013).   
Marchiando et al. in 2011 indicated that administration of TNF leads to shedding of 
intestinal epithelial cells due to activation of caspase-3 through TNF induced activation 
of the NFκB signalling pathway and proapoptotic pathway. Many previous studies 
have indicated the role of TNF in intestinal inflammation due to intestinal penetration 
of luminal materials as a result of intestinal epithelial barrier disruption (Ma et al., 
2004, Watson et al., 2009).  
Various studies have indicated the presence of TNFR1 in the intestinal epithelium 
(Song et al., 2005, Lau et al., 2011). Lau and colleagues in 2011 found that the 
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responses to systemic TNF were variable in the different parts of the small intestine. 
The percentage of TNF induced apoptosis was much higher in the duodenum and 
decreased toward the ileum. The authors also related this variation to higher 
expression of TNFR1 in duodenum that decreased in the ileum.   
 
1.10 Nuclear factor kappa B (NFκB) signalling  
NFκB epitomises a family of highly evolutionarily preserved cytosolic proteins that 
regulates a large spectrum of genes implicated in various processes of the immune 
responses and inflammation (Oeckinghaus and Ghosh, 2009). The NFκB family consists 
of five members that are structurally related. They are NFκB1 (p50 and its precursor 
p105), NFκB2 (p52 and its precursor p100), RelA (p65), RelB and c-Rel. All these 
proteins share an N-terminal Rel homology domain that mediates homo- and 
heterodimerisation as well as being responsible for sequence-binding. Furthermore, 
the precursor protein of NFκB1 (p105) and NFκB2 (p100) act as an IκB-like protein as 
their C-terminal portion resembles the structure of IκB and has a NFκB inhibitory 
function. RelA, RelB and c-Rel also contain a C-terminal transcription activation 
domain (TAD) that facilitates gene transcription. Most of these members (with the 
exception of RelB) can homodimerise but also have the ability to form heterodimers 
with each other (Tak and Firestein, 2001). Generally, NF-κB proteins are impounded 
in the cytoplasm by an action of a family of inhibitory proteins (IκB family members 
and related proteins) that are characterized by the presence of ankyrin repeats (Sun, 
2011).  
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Activation of the NFκB family of proteins occurs through two major signalling 
pathways, the canonical (classical) and non-canonical (alternative) pathways (Figure 
1.7). Each of these two pathways plays a critical role in the regulation of immune and 
inflammatory responses despite their differences in signalling mechanism (Sun, 2011 
and Vallabhapurapu and Karin, 2009). 
 
1.10.1 Canonical NFᴋB signalling pathway 
The canonical pathway responds to various stimuli including ligands of different 
cytokine receptors, pattern recognition receptors (PPRs), TNFR, also T- and B- cell 
receptors (Zhang and Sun, 2015). Activation of the canonical pathway results from 
phosphorylation of IκBα through the action of multi-subunit IκB kinase (IƘƘ) that is 
composed of two catalytic subunits, IƘƘα and IƘƘβ and regulatory subunit known as 
NFκB essential modulator (NEMO) or IƘƘᵧ (Karin and Delhase, 2000, Sun and Ley, 2008 
and Oeckinghaus and Ghosh, 2009). Activation of IƘƘ is triggered through different 
stimuli such as cytokines, stress agents and microbial components leading to 
phosphorylation of IκBα which is targeted through ubiquitin-dependent degradation 
to the proteasome resulting in release of NFκB members p50/relA and p50/c-Rel 
dimers in the cytoplasm that afterwards undergo nuclear translocation to bind to the 
DNA binding sites and regulate target gene transcription (Karin and Delhase, 2000, 
Neinke and Ley, 2004 and Hayden and Ghosh, 2008). 
 
1.10.2 Non-canonical NFᴋB signalling pathway 
In contrast to the canonical pathway, the non-canonical pathway specifically responds 
to a particular group of stimuli such as ligands of TNFR including lymphotoxin β 
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receptor (LTβR), B-cell activating factor receptor (BAFFR, also known as tumour 
necrosis factor receptor superfamily member 13C (TNFRSF13C)), CD40 and receptor 
activator of NFκB (RANK). Furthermore, the non-canonical pathway does not involve 
IκBα degradation but depends on processing of NFκB2 precursor protein, p100 (Su, 
2011 and Su and Liu, 2012). One of the main signalling molecules in the non-canonical 
pathway is NFκB inducing kinase (NIK) which is responsible for activation of IΚΚα that 
mediates phosphorylation of p100 which in turn causes NFκB2 ubiquitination and 
processing (Xiao et al., 2001 and Senftleben et al., 2001). Processing NFκB2 involves 
degradation of the C-terminal IκB like structure and the formation of mature NFκB2 
p52 followed by nuclear translocation of the NFκB complex p52/RelB (Su, 2011 and 
Zhang and Su, 2015). In general, activation of the non-canonical NFκB signalling 
pathway is slower than the canonical pathway and appears to have evolved as a 
complementary signalling axis that cooperates with the canonical pathway to induce 
a coordinated and continuous immunological response (Merga et al., 2016). 
In 2011 Guma and colleagues indicated that the activation of NFᴋB canonical pathway 
signalling in the intestine does not generate an acute inflammation in small intestinal 
tissue accompanied with apoptosis of SIECs and disruption of gut barrier function 
unless there is a concurrent activation of mitogen-activated protein kinase (MAPKs). 
Williams et al., 2013 interestingly demonstrated that NFᴋB1-/- mice (mice that lack the 
NFᴋB family member that signals through the canonical pathway) develop more SIEC 
apoptosis and shedding in response to TNF than wild-type mice and by contrast, 
NFᴋB2-/- mice (mice deficient in an NFᴋB family member that signals via the non-
canonical pathway) were more resistant to SIEC apoptosis and shedding in response 
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to TNF suggesting an important role of non-canonical NFκB signalling in intestinal 
epithelial cell apoptosis and shedding. 
 
 
Figure 1.7: Schematic diagram summarising NFᴋB signalling pathways. Modified from 
Sun, 2011, Cell Research 21:71-85. Doi:10.1038/cr.2010.177 
 
1.11 Proteomics approaches in the intestine 
Proteomic analysis is the complete study of proteins that are produced and expressed 
in a biological system at a particular point in time.  The term proteomics was first 
described in 1997 after Marc Wilkins (while he was a PhD student at University of 
Macquarie) used the term proteome to describe an entire set of proteins that were 
produced by an organism in response to an effector (Parker et al., 2010). Proteomics 
relies on three basic technologies including methods of protein complex fractionation, 
mass spectrometry to identify individual proteins, and bioinformatics to analyse and 
collect the mass spectrometry data (Yu et al., 2010). Specific disease biomarkers in 
body fluids (such as serum, plasma, and urine), tissues, and other biologic samples 
59 
 
have been highly investigated using proteomic analysis (Sahab et al., 2007, Ahram et 
al., 2008). Proteins are characterised by hundreds of various posttranslational 
modifications whose functional state differs based on their particular modifications, 
structural alteration, transport, and translocation (Duan and Walther, 2015). 
Moreover, the challenging aspect in proteomics is not only presented by the 
techniques that need precise protein fractionation, identification, quantification and 
proteome-bioinformatics, but also by the need for careful selection and reproducible 
processing of tissues/samples to be analysed (Titz et al., 2014). This continuous 
evolution in protein technologies in association with data collection and analysis will 
enhance our capability to recognise the intestinal inflammatory proteomes that play 
a critical role in IBD pathogenesis (Alex et al., 2009). Recently abundant research has 
focused on proteomic studies to identify IBD biomarkers in order to investigate 
disease aetiology and help establish an accurate diagnosis of IBD (Bennike et al., 
2014).  
Apoptosis is known to be induced by various chemical compounds such as 
chemotherapeutic agents and pollutants due to their effect on the caspase cascade 
(Riedl and Shi, 2004). Apoptotic failure plays a major role in cancer development and 
resistance to cancer treatment. Proteomic analysis has been used to identify the 
substrates for proteases and protein kinases which play an important role for 
apoptosis and inflammation (Wang and Chen, 2011). Using proteomic analysis to 
analyse and identify crucial immune function related proteins and the detection of 
their modifications can widen our knowledge, not only to understand the clear 
difference in pathogenesis of IBD but also to fully understand the causes of intestinal 
60 
 
mucosal injuries and help in detection of medications to ameliorate IBD and other 
intestinal diseases related to loss of intestinal barrier function (Berndt et al., 2007). 
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1.12 Aims  
The intestinal epithelium exhibits a high turnover rate with a balance between 
shedding and generation of epithelial cells. Increased epithelial cell apoptosis over 
generation of new cells from intestinal crypts is one of the main causes of gut barrier 
dysfunction. It has been previously shown that pathological shedding of small 
intestinal villi epithelial cells takes place in mice injected with bacterial LPS indicating 
the role of NFκB Transcription proteins in regulating this phenomenon.  
The main objectives of this study were to determine whether a panel of different 
stimuli that cause or mimic human systemic disease result in increased SIEC apoptosis 
and shedding along the murine crypt-villus axis and to assess how this process was 
altered by NFκB signaling in order to elucidate potential therapeutic approaches for 
diseases associated with intestinal barrier dysfunction.   
The specific aims during this study were: 
1- To investigate whether systemic LPS from different bacterial species induces 
pathological SIEC apoptosis and shedding in wild-type mouse and rat strains 
from different genetic backgrounds and of different ages.  
2- To assess the role of the alternative NFκB signalling pathway subunit RelB in 
the regulation of murine SIEC apoptosis and shedding induced by LPS. 
3- To determine whether the administration of anti-CD3 antibody, poly I:C and 
TNF induces pathological small intestinal epithelial apoptosis and cell shedding 
in C57BL/6J mice and how the NFκB signaling pathway regulates the response 
of small intestinal villi and crypts to these stimuli in comparison to LPS. 
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4- To evaluate the ultrastructural features of SIEC apoptosis and shedding after 
administration of LPS to wild-type C57BL/6J, Nfҡb1-/-, Nfҡb2-/- and c-Rel-/- mice. 
5- To investigate how LPS alters the murine small intestinal mucosal proteome to 
modulate susceptibility to SIEC apoptosis and shedding and the ways in which 
this proteome is altered following the deletion of individual members of the 
NFκB family of transcription factors. 
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2.  Materials and Methods: 
2.1 Animals 
2.1.1 Mice 
Unless otherwise stated, all animals used in this work were adult female mice aged 
between 9-11 weeks. 
Mice from five different strains were purchased from Charles River laboratory 
(Margate, UK) or Harlan laboratories, UK limited (Bicester, UK) and were transferred to 
the biomedical services unit at the University of Liverpool. Mice were housed in groups 
of 3 mice per GR500 cage in the Techniplast Green Line System which is comprised of 
individually ventilated cages each provided with an individually heap filtered air supply 
and extraction. In addition to the mice, 6 Ludwig Olac Wistar rats (4 males and 2 
females) were used in one experiment. These rats were also from Charles River 
laboratories (Margate, UK) and were housed in group of 2 per GR1800 Double Decker 
cages in the Techniplast Green Line System. All rodents were provided with reverse 
osmosis water through an automatic watering system and maintained in a 
conventional specific pathogen free (SPF) unit with ad libitum food on a 12 hour light-
dark cycle at University of Liverpool’s Biomedical Services Unit. 
 
2.1.1.1 C57BL/6J mice 
In-bred, wild-type C57BL/6J mice were purchased from Charles River Laboratories 
(Margate, UK), kept for a one week acclimatisation period under standard animal 
house conditions before being used in various experiments. 
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Transgenic mice, including NFκB1-/-, NFκB2-/-, cREL-/- and RelB mice were bred at the 
Biomedical Services Unit (Prof. DM Pritchard team) at University of Liverpool in SPF 
conditions.  
NFκB1-/- mice were originally produced on a C57BL/6J genetic background by Sha et 
al. in 1995. The targeted disruption of NFκB1-/- gene was achieved by insertion of a 
linearised pp50KO construct with a phosphoglycerate kinase (PGK) neo cassette into 
exon 6 of the NFκB1 gene that encodes residues 134-187 that lie within the Rel 
homology domain that extends from residues 30-330. This disruption was shown to 
inhibit the synthesis of functional p105 and p50 due to production of inactive protein 
that failed to dimerise with other NFκB proteins or bind to DNA, but did not affect the 
production of IκBү from an internally promoted mRNA (Sha et al., 1995). This null 
colony does not demonstrate abnormal development, but shows nonspecific 
responses to infection and defective humoral immunity due to failure of B lymphocytes 
to proliferate in response to bacterial lipopolysaccharides. Additionally, studies 
regarding the function of macrophages in this colony have indicated normality of 
phagocytic activity and production of TNF and IL-1 while there was reduction in 
production of      IL-6. 
NFκB2-/- mice were generated on a C57BL/6J mice background by insertion of a PGK 
neo cassette into exon 4 to disrupt production of p100 or p52 (Caamano et al., 1998). 
This colony shows abnormalities in lymphoid organs with defective T- cell responses 
and low proliferative responses of B cells to LPS, CD40 and anti-IgD-dextran.  
c-Rel-/- mice were also generated on the C57BL/6J mice genetic background. Exons 4-
9 of the cREL gene encoding amino acids 145-588 of the c-Rel protein were replaced 
with a PGK-neo cassette. This disruption causes truncation of c-Rel proteins by 
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removing a sequence required for DNA binding and protein dimerisation (Kontgen et 
al., 1995). Although c-Rel null mice show normal haematopoiesis, they show 
impairment in activation of T and B lymphocytes.  
RelB-/- mice were also generated on the C57BL/6J mice background by Wieh et al., 
1995. Exons 2-7 of the Rel gene were targeted resulting in deletion of a 500bp in exon 
4 at the beginning of the DNA subdomain of the Rel homology domain followed by 
insertion of PGK-neo cassette. These mice show reduced κB-binding activity in the 
lymphoid tissue with multifocal lesions, infiltration of lymphatic tissue in several 
organs, myeloid hyperplasia and splenomegaly due to extra-medullary 
haematopoiesis (Wieh et al., 1995).  
2.1.1.2 Balb/c mice  
Inbred, wild-type Balb/c mice were purchased from Charles River Laboratories 
(Margate, UK), kept for a one week acclimatisation period under standard animal 
house conditions before being used in experiment. 
2.1.1.3 CD1 mice 
Outbred wild-type CD1 mice were purchased from Charles River Laboratories 
(Margate, UK), kept for a one week acclimatisation period under standard animal 
house conditions before being used in experiment. 
2.1.1.4 FVB/N mice 
Inbred, wild-type FVB/N mice were purchased from Charles River Laboratories 
(Margate, UK), kept for a one week acclimatisation period under standard animal 
house conditions before being used in experiment. 
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2.1.1.5 DBA/2 mice 
Inbred, wild-type DBA/2 mice were purchased from Harlan Laboratories, UK Limited 
(Bicester, UK), kept for a one week acclimatisation period under standard animal house 
conditions before being used in experiment. 
  
2.1.2 Ludwig Olac Wistar Rats  
Adult Ludwig Olac Wistar rats aged 10-11 weeks were purchased from Charles River  
Laboratories (Margate, UK), kept for a one week acclimatisation period under standard 
animal house conditions before being used in experiment. 
 
2.2 Animal procedures 
All animal procedures were performed under UK home office approval on project 
licences 40-3392 and 70-8457 as specified by the animals (Scientific Procedures) act 
1986. All experiments were conducted by the author as a UK home office personal 
licensee and undertaken within the University of Liverpool in specified rooms for 
animal procedures. 
 
2.3 Induction of Apoptosis and Shedding 
Based on previous literature, 4 different stimuli were used to induce small intestinal 
epithelial cell apoptosis and shedding. These included bacterial lipopolysaccharide 
(LPS), anti-CD3e antibody, polyinosinic:polycytidylic acid (Poly I:C) and tumor necrosis 
factor (TNF). 
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2.3.1 Bacterial Lipopolysaccharide (LPS) 
LPS was used from different bacterial species. This included Escherichia coli serotype 
O111:B4 as this was previously used in our laboratories to induce apoptosis and 
shedding of small intestinal epithelial cells (Williams et al., 2013). LPS from Salmonella 
enterica serotype enteritidis and Klebsiella pneumoniae was also used. 10 mg/kg was 
the dose administered in the majority of experiments, but 0.125 mg/kg LPS from 
Escherichia coli was injected into C57BL/6J mice for electron microscopy and 
proteomic analysis studies. All LPS used was purified by phenol-extraction and was 
purchased from Sigma Aldrich, UK, in the form of lyophilised powder. It was then 
dissolved in sterile phosphate buffered saline (PBS) in a biosafety cabinet at 2 different 
concentrations, 1 mg/ml and 12.5 µg/ml to prepare the used doses of 10 mg/kg and 
0.125 mg/kg body weight respectively. After reconstitution to a working 
concentration, the solution were filtered through a 0.2 µm syringe filter then aliquoted 
and frozen at -20°C before use. Before administration of LPS to experimental mice, it 
was thawed, vortexed and warmed to room temperature. 
 
2.3.2 Anti-mouse-CD3e antibody (145:2C11)  
Anti-mouse-CD3e functional grade purified antibody was obtained from 
eBioscienceTM, Thermo-Fisher Scientific, UK in liquid form at a concentration of 1 
mg/ml in sterile PBS and was stored at 4°C. It was then diluted in a biosafety cabinet 
prior to use into 50µg, 100µg, 200µg and 400µg/1 ml sterile PBS to make different 
concentrations of 0.5, 1, 2 and 4 mg/kg body weight that were administered via the 
intraperitoneal route to C57BL/6J mice.  
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2.3.3 Polyinosinic:polycytidylic acid sodium salt 
Poly I:C sodium salt-TLR tested from Sigma Aldrich, UK was obtained in the form of a 
lyophilised powder. It was dissolved in normal saline in a biosafety cabinet to preserve 
its ionic strength. The solution was heated to 50°C and then left to cool to room 
temperature to achieve annealing. It was administered at a concentration of 30 mg/kg 
body weight into C57BL/6J mice by intraperitoneal injection. 
 
2.3.4 Recombinant Tumour Necrosis Factor alpha (TNFα) 
Murine recombinant TNF from Escherichia coli was purchased from PeproTech Ltd., 
UK. It was dissolved in sterile water in a biosafety cabinet to a concentration of 200 
µg/ml, and then it was diluted to 0.33 mg/kg body weight prior to being injected 
intraperitoneally into C57BL/6J mice. 
 
2.4 Tissue collection and processing 
Following cervical dislocation, the entire small intestine was collected. The intestinal 
contents were flushed out using PBS followed by immersion of the small intestine in 
10% neutral buffered formalin for 24 hours for fixation. The small intestine was then 
divided into 3 parts representing the proximal, middle and distal segments. These 
segments were bundled with 3M micropore surgical tape separately then cut into 
small pieces of 0.5 cm length and then stored in histological cassettes in 70% ethanol. 
These cassettes containing the bundled pieces of small intestine were then transferred 
into a Thermo Shandon Pathcentre tissue processor to be dehydrated through 
increased concentrations of ethanol (70%, 90% and 3 changes of 100% ethanol) 
followed by clearing with 3 changes of xylene then infiltrated with 2 changes of soft 
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paraffin wax and finally embedded in paraffin wax using a Shandon histocentre 
embedder. Sections of 3-5µm were cut using a microtome then transferred into a 
waterbath  containing water heated to 40°C before  placement onto glass slides for 
haematoxylin and eosin staining or onto 3-aminopropyltriethoxylsilane (APES) coated 
slides for immunohistochemistry. 
 
2.5 APES slide coating for Immunohistochemistry 
To increase the adhesiveness of  tissue sections onto the glass slides used for 
immunohistochemistry, these slides were cleaned by immersion in 1% acid alcohol (1% 
concentrated hydrochloric acid, 70% ethanol and 29% H2O) for 30 minutes. The slides 
were then washed under running tap water for 5 minutes and immersed in distilled 
water for another 5 minutes, before removing them and leaving them to dry. After 
they had dried, the slides were immersed in 2 changes of acetone (2 minutes each) 
then in freshly prepared 2% (v/v) APES in acetone for 5 minutes followed by 2 changes 
of distilled water (2 minutes each) and finally were left to dry at 37°C in a fan assisted 
drying oven overnight before storage in dust free containers. 
 
2.6 Active caspase-3 Immunohistochemistry 
Human/Mouse active caspase-3 primary antibody (rabbit polyclonal) from R&D 
Systems Inc., UK, was reconstituted at 0.2 mg/ml in sterile PBS, aliquoted and stored 
at -20°C. This antibody was first titrated to determine the optimal dilution for staining 
procedures. After de-waxing of the tissue sections in xylene for 10 minutes, tissue 
rehydration was started by immersion of the sections in decreasing concentrations of 
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ethanol (from 100% to 70%). Endogenous peroxidase activity was blocked by dipping 
the sections in 3% hydrogen peroxide-methanol solution (9 ml hydrogen peroxide in 
300 ml methanol) for 5 minutes. Following washing in distilled water, tissue sections 
were microwaved for 20 minutes in antigen retrieval buffer (0.01M citrate buffer pH 
6.0). Sections were left to cool down for 20 minutes then were washed in tris-buffered 
saline, 0.1% Tween®20 (TBST) for 5 minutes. Afterwards the primary antibody was 
applied onto the tissue sections and this was incubated in a moist dark chamber for 2 
hours at room temperature. The slides were washed in TBST and incubated for 30 
minutes with the secondary antibody, Envision™ HRP labelled polymer anti-rabbit 
(Dako), for 30minutes at room temperature. Sections were washed twice with TBST 
then incubated with DAB chromogen and substrate liquid solution in the dark for 6 
minutes. Following washing with water, sections were counterstained with Gill no. 1 
haematoxylin for 2.5 minutes, then dehydrated and mounted with DPX mountant. 
 
2.7 Scoring of Active caspase-3 positively labelled cells 
Scoring of apoptotic and shedding small intestinal epithelial cells that positively 
labelled with active caspase-3 antibody was done based on the criteria that have been 
set out in Williams et al., in 2013. Small intestinal epithelial cells were attributed to 
one of three categories: 
Normal cells: if they had basophilic, basally located nuclei with no or weak non-specific 
brown staining cytoplasm. 
Apoptotic cells: if they had basophilic, basally located nuclei with defined, clearly 
brown stained cytoplasm. 
Shedding cells: if they had defined, clearly brown stained cytoplasm with apically 
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positioned nuclei or apically protruded cytoplasmic membranes. 
Scoring of intestinal epithelial cells based on these features was performed on 20 well 
oriented hemivilli or 50 hemicrypts per mouse using a light microscope at 400x 
magnification. Scoring of hemivilli started at the level of crypt-villus junction and 
proceeded to the mid-point of the villus tip and scoring of crypts was from the crypt 
base to the crypt-villus junction. 
Counting of positively immunolabelled cells was done by using SCORE software 
(Version 1, Beta 1, established by Stave Roberts, at the Paterson Institute for Cancer 
Research, Manchester, UK 1996) that facilitates quantification of the epithelial cells 
according to the previously mentioned criteria.  
Scored data were saved as individual files that were later analysed with WinCrypt© 
software version 1.00, Release 1.9, Cancer Research Campaign 1999. This software 
was also used to compare the cell positional data by adjusting the villus length to a 
fixed length of 100 cells that allowed expressing the percentage of villus length with 
0% representing the villus base and 100% indicating the villus tip. 
 
2.8 Haematoxylin and Eosin (H&E) staining protocol 
After de-waxing and rehydration of tissue sections, they were stained with Gill no. 1 
haematoxylin for 2.5 minutes. Following bluing of the sections under running tap 
water for 5-7 minutes, the sections were stained with eosin for 3.5 minutes. The excess 
of eosin was removed by rapid dipping of sections in water for a few seconds then 
sections were dehydrated with 2 changes of 90% ethanol for 1 minute each followed 
by 2 changes of 100% ethanol for a few seconds. Afterwards sections were cleared 
with xylene followed by mounting with DPX and they were left to dry prior to being 
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examined under the light microscope. 
 
2.9 Transmission Electron Microscopy (TEM) 
Following animal dissection a small segments measuring about 3 cm in length from 
the proximal small intestine were directly moved to small bottles containing a solution 
of 4% paraformaldehyde and 2% glutaraldehyde in 0.1 M phosphate buffer pH 7.4. 
They were then transferred to the TEM Unit in the Department of Cellular and 
Molecular Physiology at the University of Liverpool where the samples were further 
dissected before placing them in 2.5% glutaraldehyde in 0.1M phosphate buffer pH7.4 
on a rotator overnight at room temperature for fixation. The samples were then 
washed 3 times for 1 minute each in phosphate buffer pH 7.4 at room temperature 
before post-fixation with 1.5% potassium ferrocyanide reduced osmium tetroxide in 
0.1M phosphate buffer. The tissue was then rinsed 3 times for 5 minutes each in 
double distilled water at room temperature. Post-fixation was followed by en bloc 
staining for 1 hour in 1% uranyl acetate in double distilled water at room temperature 
followed by Walton lead aspartate in double distilled water for 30 minutes at room 
temperature then washed  overnight in a rotator. The samples were then dehydrated 
through a graded ethanol concentration series: 30%, 50%, 70% and 90 % followed by 
2 changes of 100 % ethanol then 2 changes of 100 % acetone, each for 10 minutes. 
Afterwards the samples were infiltrated and embedded in TAAB hard cure resin 
overnight at 60°C. Thin sections of 0.5µm were cut and mounted on copper grids and 
viewed with a Tecani G2 20 S TEM for imaging. 
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2.10 Preparation of tissue for proteomic analysis 
Following dissection of the proximal thirds of small intestine from control mice and 
mice injected with 0.125 mg/kg LPS; they were flushed several times with PBS and 
opened longitudinally and cut transversely into small pieces of 1 cm length, then 
washed thoroughly with PBS several times before harvesting into PBS on ice. Washing 
of these samples in PBS was continued several times by pipetting them up and down 
until a clear supernatant was produced. Subsequently, 20 ml of ice cold chelation 
buffer (2mM ethylenediaminetetraacetic acid [EDTA] stock in 500 ml PBS) was added 
to each sample and these were then left for 30 minutes on a roller in the cold room at 
4°C. Afterwards the chelation buffer was removed and the samples were placed in a 
shaking buffer (43.3mM sucrose, 59.4mM sorbitol in 500ml PBS) with continuous hand 
shaking until the crypts were released. Remnants of the intestinal wall were removed 
while the other contents were centrifuged for 4 minutes to precipitate the tissue 
pellet. Later, 0.25 ml of 0.1M triethylammonium bicarbonate (TEAB) in 0.1 % sodium 
dodecyl sulphate (SDS) was added with pipetting up and down to disrupt the tissue 
pellet, this was then left on ice for 30 minutes to lyse the cells. The lysed cells then 
were centrifuged at 13,000 rpm for 15 minutes at 4°C. Following spinning of the cells, 
the supernatant was transferred carefully into a new eppendorf tube clearly labelled 
with the mouse strain, mouse number and treatment. To determine the concentration 
of proteins in the extracted supernatant, the samples were assessed using an ultra-
violet spectrophotometer. 300 µg protein in 100 µl buffer was measured and stored in 
well labelled self-lock eppendorf tubes at -80°C. These were then posted in a package 
containing dry ice to the Proteomics Research Technology Platform at the University 
of Warwick for proteomic analysis. This proteomic experiment were designed to 
74 
 
compare the protein levels between the various tested mouse strains (C57BL/6J 
Nfҡb1-/-, Nfҡb2-/- and c-Rel-/-), and also before and after LPS administration (C57BL/6J 
vs LPS-treated C57BL/6J, Nfҡb1-/- vs LPS-treated Nfҡb1-/-, Nfҡb2-/- vs LPS-treated 
Nfҡb2-/- and c-Rel-/- vs LPS-treated c-Rel-/- mice). 
Protein extracts were further fractionated to reduce their complexity using sodium 
dodecyl sulfate–polyacrylamide gel (SDS-PAGE) electrophoresis followed by in-gel 
trypsin digestion to produce peptides that allow the identification and quantification 
of proteins by mass spectrometry using Tandem mass tags (TMT-10 plex assay that 
assayed 10 samples at once in a single mass spec experiment by labelling each sample 
with a different tag) (Plubell et al., 2017). Mass spectrometry started with 
chromatography of the peptides by reverse phase C18 attached to an electrospray 
ionisation source to calculate the mass of peptides and their fragments. Afterwards, 
matching of calculated protein digests and peptide fragments with the real peptide 
fragments acquired in the mass spectrometer was performed using protein and 
peptide identification search engine software and known protein sequences (Plubell 
et al., 2017). These searches used a reversed sequence decoy strategy to control the 
peptide false discovery rate and identifications were validated using Percolator 
software (an algorithm for improving the rate of confident peptide identification, Kall 
et al., 2007). Only peptides with a q score (adjusted p value using an optimised false 
discovery rate) ≤0.05 were accepted and only one peptide was required to match the 
protein record for identification (Plubell et al., 2017). After identification, a common 
combined internal standard was used to normalise the data across different TMT 
experiments. This enabled proteins to be presented with their individual intensity 
scale measurements rather than their relative intensities. Three reference values for 
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each protein were generated and were averaged to find the geometric mean from 
which a scaling factor was calculated (known as internal reference scaling (IRS)). 
Finally, protein abundances were determined and compared using IRS normalised 
total reporter ion intensities between different groups using the Bioconductor 
package edgeR that normalises, tests and calculates the false discovery rate to identify 
and quantify proteins and their modifications during the process of LPS induced SIEC 
apoptosis and shedding (Plubell et al., 2017). 
 
2.11 Data and Statistics 
Data are expressed as mean ± standard error of the mean (SEM). Statistical analysis 
was performed using one-way ANOVA with Dunnett post-hoc test for multiple 
comparisons with control for normally distributed data while non-parametric data 
were tested by ANOVA on ranks (Kruskal-Wallis). Differences were considered to be 
significant where p < 0.05. Data sets consisting of 2 groups were assessed by Student’s 
t-test. In some situations, the modified median test was used to evaluate the 
significant differences at individual cell positions. 
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3. Characterisation of the effects of lipopolysaccharide on proximal 
small intestinal epithelial cell apoptosis and shedding 
3.1 Introduction 
Maintenance of gut barrier haemostasis is determined by the equilibrium between 
the number of cells that are shed at the villus tips and the number of cells that are 
newly formed in intestinal crypts (Ikeda et al., 1997). The process of active 
programmed cell death termed apoptosis is characterised by various alterations in cell 
morphology including nuclear chromatin condensation, compaction of cytoplasmic 
organelles, membrane blebbing and fragmentation of the cell into apoptotic bodies 
(Kerr et al., 1972).  
LPS has been previously shown to induce pathological SIEC apoptosis and shedding in 
adult C57BL/6J mice (10-11 weeks old). This phenomenon is observed 1 hour after IP 
injection of LPS from Escherichia coli serotype O111:B4 then increases to reach the 
peak amount at 1.5 hours and resolves approximately 3 hours post LPS administration. 
These findings were characterised by marked villus atrophy with presence of large 
numbers of shedding cells detached into the small intestinal lumen (Williams et al., 
2013). 
Various different inbred mouse strains have previously been shown to respond 
differently to similar stimuli due to inherent genetic differences (Pritchard et al., 2000 
and Sellers et al., 2012). To establish the role of genetic differences in regulating LPS 
induced SIEC apoptosis and shedding, five different mouse strains were used to 
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investigate pathological small intestinal apoptosis and shedding 1.5 hours after IP 
injection of 10mg/kg LPS from Escherichia coli serotype O111:B4.  
IBD is a chronic disease that primarily starts in young adults and in elderly people. The 
majority of patients diagnosed with IBD are adults (between 20-40 years old), but 
lower incidence rates are also seen in elderly and young people (about 20% in children 
and 16% in adult over age of 65 years) (Prelipcean et al., 2013). To investigate whether 
any age related factors affect the process of SIEC apoptosis and shedding, three 
different age groups of C57BL/6J mice were studied representing three different 
periods of life (puberty, adulthood and old age). These groups were injected IP with 
10 mg/kg Escherichia coli serotype O111:B4 LPS and SIEC apoptosis and shedding was 
assessed after 1.5 hours. 
Mathiak and colleagues in 2003 tested the stimulatory effect of purified LPS from 
various different bacterial sources (E. coli, S. typhosa, P. aeruginosa, and K. 
pneumoniae) on the production of cytokines and chemokines. They found that LPS 
originating from different bacterial sources exhibited different effects upon the 
production of inflammatory mediators. We therefore investigated whether C57BL/6J 
female mice exhibited similar or different amount of SIEC apoptosis and shedding at 
1.5 hours post IP administration of 10 mg/kg LPS extracted from three different 
bacterial species namely Escherichia coli serotype O111:B4, Salmonella enterica 
serotype enteritidis and Klebsiella pneumoniae. 
Many previous studies have indicated morphological similarities between small 
intestinal apoptosis and shedding in humans, mice and rats (whole cell extrusion) and 
have suggested that these rodents can be used as reliable models for studying the 
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regulation of human SIEC apoptosis and shedding (Bullen et al., 2006 and Williams et 
al., 2015).  Based on this suggestion, we compared SIEC apoptosis and shedding in 
mice and rats treated with 10 mg/kg of Escherichia coli LPS serotype O111:B4 at 1.5 
hours post IP administration. 
The NFκB family of transcription factors regulate various different biological processes 
including the immune response and inflammation via two different signalling 
pathways. NFκB1, RelA and cRel signal via the canonical (classical) activation pathway, 
whereas NFκB2 and RelB signal via the non-canonical (alternative) activation pathway. 
A previous study in our laboratory described the role of three of these transcription 
factors in regulating SIEC apoptosis and shedding (NFκB1, c-Rel and NFκB2) and 
suggested an important role for the alternative NFκB2 signalling pathway in enhancing 
LPS induced small intestinal injury, while NFκB1 and c-Rel played important roles in 
suppressing LPS induced SIEC apoptosis and shedding (Williams et al., 2013). To 
further investigate the role of the alternative NFᴋB activation pathway in regulating 
LPS induced SIEC apoptosis and cell shedding we injected RelB null mice (RelB+/+, 
RelB+/- and RelB-/-) IP with 0.125 mg/kg Escherichia coli LPS serotype O111:B4 for 1.5 
hours. 
Having established the role of LPS in inducing SIEC apoptosis and shedding in the villus 
and recognising the role of the NFκB family of proteins in regulating this phenomenon 
we tested the role of these transcription factors in regulating LPS induced small 
intestinal crypt epithelial cell apoptosis 24 hours post administration of 0.125 mg/kg 
Escherichia coli LPS serotype O111:B4. 
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3.2 LPS caused apoptosis and shedding of proximal small intestinal 
epithelial cells in different mouse strains 
Our first investigation indicated increased numbers of apoptotic cells on the apical half 
of intestinal villi of all mouse strains treated with LPS (Figure 3.1). IP injection of LPS 
at 10 mg/kg, caused significant increases in the percentage of active caspase-3 
positively labelled intestinal epithelial cells (Figure 3.2) from 1.0 ±0.03, 0.8 ± 0.103, 0.6 
± 0.07, 0.3±0.03 and 0.8±0.07 % to 9.2 ±0.05, 6.4 ± 0.58, 6.9 ± 0.096, 6.6 ±0.03 and 6.9 
±0.12 % in C57BL/6J, Balb/C, CD1, FVB/N and DBA/2 mouse strains respectively (all 
P<0.0001, N = 6; ANOVA). This indicates that LPS increases the amount of pathological 
intestinal epithelial cell shedding in all mouse strains tested. There were no significant 
differences observed in the intestinal epithelial response to LPS between C57BL/6J, 
CD1 and DBA/2 mice and also between Balb/C, CD1, and FVB/N strains. However we 
observed minor differences between C57BL/6J and FVB/N mice (p<0.05) and between 
C57BL/6J and Balb/C mice (p<0.01). Based on cell positional plots (Figure 3.3), the 
effect of LPS appeared to occur predominantly in the apical portion of small intestinal 
villi in all mouse strains examined. 
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Figure 3.1: Active caspase-3 IHC in sections of proximal segment of small intestine of 
different tested mouse strains demonstrating the location of positively labelled SIEC 
along the villus axis (X40). 
 
 
 
Figure 3.2: Bar chart representing the percentage of IECs undergoing apoptosis and 
shedding in LPS treated versus untreated mice of different strains, LPS-treated groups 
vs. untreated groups (N=6); ****P<0.0001, **P<0.01, *P<0.05, ANOVA. 
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Figure 3.3: Cell positional graphs showing quantification of positively immuno-labelled 
IECs along the villus axis of treated mice compared to untreated mice for each mouse 
strain (N=6 mice per group). 
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3.3 No age related differences in small intestinal cell shedding or 
apoptosis were observed between six, ten and twenty eight week old 
C57BL/6J mice following administration of LPS 
We noted that in all age groups, active caspase-3 labelled cells were positioned in the 
upper half of intestinal villi 1.5 hours following LPS administration. There was also a 
significant increase in the percentage of intestinal epithelial cells undergoing shedding 
and apoptosis following administration of 10 mg/kg body weight of Escherichia coli 
LPS in all tested age groups of mice (Figure 3.4). The percentages of cell shedding and 
apoptosis were increased from 0.4±0.04, 1±0.03 and 1.1±0.06% to 8.2±0.20, 9.2±0.05 
and 8.8±0.17% in 6 week, 10 week and 28 week old mice respectively (all P<0.0001, 
N=6; ANOVA. Figure 3.5). This indicates that LPS at 10 mg/kg has the ability to cause 
an equal amount of pathological cell shedding and apoptosis in the small intestinal 
epithelia of C57Bl/6J mice in all tested age groups (representing puberty, young 
adulthood and mature periods of life). Again the cell positional plots (Figure 3.6) 
indicated that LPS appeared to cause greater effects at the villus tip than in the basal 
region of small intestinal villi in all three tested ages of mice. 
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Figure 3.4: Active caspase-3 IHC in sections of proximal segment of small intestine 
demonstrating the location of positively labelled SIEC along the villus axis in small 
intestine of 3 different age groups. (X40). 
      
Figure 3.5: Bar chart representing the percentage of intestinal epithelial cell shedding 
in LPS-treated versus untreated control C57BL/6J mice at different age groups, (N=6); 
****P<0.0001, ANOVA. 
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Figure 3.6: Cell positional graphs showing quantification of positively immuno-labelled 
IECs along the villus axis of LPS-treated mice compared to untreated C57BL/6J mice 
for each age group of mice (N=6 mice per group). 
 
3.4 LPS from different bacterial sources induced pathological apoptosis 
and shedding of small intestinal epithelial cells to different extents 
Interestingly we observed that LPS purified from three different bacterial species had 
the ability to induce apoptosis and shedding of small intestinal epithelial cells in 
C57BL/6J mice in the apical half of small intestinal villi (Figure 3.7). The percentage of 
pathological shedding and apoptosis was significantly increased from 1.1±0.03% in 
untreated mice to 9.2±0.06, 6.7±0.13 and 6.5±0.096% in mice injected with LPS from 
E. coli, Klebsiella pneumonia and Salmonella enterica respectively (all P<0.0001, N=6; 
ANOVA). On other hand, there was a significant difference in the percentage of small 
intestinal epithelial cell shedding between the 3 different LPS types used in this 
experiment (P<0.0001). The LPS from E. coli caused a higher degree of pathological 
SIEC apoptosis and shedding than the LPS from Klebsiella pneumonia and Salmonella 
enterica (Figure 3.8). Based on cell positional plots (Figure 3.9), LPS from all the 
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bacterial species used in this experiment again caused effects predominantly at the 
villus tips rather than in the basal parts of the intestinal villi. 
                                 
                                        
 
Figure 3.7: Active caspase-3 IHC in sections of proximal segment of small intestine 
demonstrating the location of positively labelled SIEC along the villus axis in the small 
intestine of C57BL/6J mice treated with LPS purified from different bacterial species. 
(X40). 
 
Figure 3.8: Bar chart demonstrating a comparison between the percentage of 
intestinal epithelial cell apoptosis and shedding in C57BL/6J mice treated with LPS 
purified from different bacterial sources against an untreated group, (N=6); 
****P<0.0001, ANOVA. 
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Figure 3.9: Cell positional graphs indicating the quantification of positively immuno-
labelled IECs along the villus axis of C57BL/6J mice treated with different types of 
bacterial LPS versus an untreated group (N=6 mice per group). 
 
3.5: Do rats and mice respond differently to systemically induced 
bacterial LPS? 
After finding that LPS induced murine small intestinal epithelial cell apoptosis and 
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epithelial cells. Ludwig Olac Wistar rats were injected IP with 10 mg/kg LPS purified 
from Escherichia coli serotype O111:B4 and were euthanased after 1.5 hours. 
Interestingly, active caspase-3 immunohistochemistry clearly indicated positively 
labelled apoptotic and shedding epithelial cells in the rat small intestine (Figure 3.10). 
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However, there was a significant difference between the percentage of SIEC apoptosis 
and shedding in C57BL/6J mice and Ludwig Olac Wistar rats (9.2±0.05% and 4.0±0.22% 
respectively, P<0.0001, one way ANOVA). Nonetheless, we demonstrated that LPS has 
an ability to induce SIEC apoptosis and shedding in rats in the same way as in mice 
(Figure 3.11-A). In spite of the significant difference in the degree of response between 
mice and rats, the cell positional plots (Figure 3.11-B) showed similar patterns of 
apoptosis and shedding of SIECs in LPS treated groups of mice and rats.  
 
                                      
                                     
Figure 3.10: Active caspase-3 IHC in sections of proximal small intestinal segment of 
C57BL/6J mice versus Ludwig Olac Wistar rats demonstrating the location of positively 
labelled SIEC along the villus axis. (X40) 
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Figure 3.11: A: Bar chart demonstrating a comparison between the percentage of 
intestinal epithelial cell apoptosis and shedding in C57BL/6J mice and Ludwig Wistar 
rats pre and 1.5 hours post 10mg/kg LPS administration. (N=6); ***P<0.001, 
****P<0.0001, ANOVA.    B: Cell positional graphs showing quantification of active 
caspase-3 positive IECs along the villus axis of LPS treated vs untreated mice in 
comparison to LPS treated vs untreated rats (N=3). 
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3.6 RelB does not regulate LPS induced SIEC apoptosis and shedding: 
Previous studies had indicated that LPS induced SIEC apoptosis and shedding were 
regulated by the NFᴋB signaling pathways. However this was only apparent using the 
lower LPS dose of 0.125 mg/kg. The RelB transcription factor is another member of 
the NFκB family that signals via the non-canonical activation pathway. After injecting 
3 genotypes of RelB mice (RelB+/+, RelB+/- and RelB-/-), with 0.125 mg/kg LPS we found 
the percentage of SIEC apoptosis and shedding after 1.5 hours was increased from 
0.6±0.09, 0.3±0.04 and 0.4±0.05% to 5.4±0.66, 5.2±0.66 and 5.5±0.63% in RelB+/+, 
RelB+/- and RelB-/- respectively (see Figure 3.13-A). The cell positional graph (Figure 
3.13-B) again showed similar features with more apoptotic and shedding cells being 
observed on the apical half of small intestinal villi in all tested RelB genotypes. These 
findings suggesting that the RelB transcription factor does not play a significant role in 
the regulation of LPS induced apoptosis and shedding.  
  
 
 
 
Figure 3.12: Active caspase-3 IHC in sections of proximal segment of small intestine of 
RelB mice (of different genotypes) demonstrating the location of positively labelled 
SIEC along the villus axis. (X40). 
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Figure 3.13:   A: Bar chart representing the percentage of SIEC apoptosis and shedding 
in different RelB genotypes 1.5 hours post injection of 0.125 mg/kg LPS (N=5, 
***P<0.001, ANOVA).   B: Cell positional graph demonstrating quantification of active 
caspase-3 positively labelled cells along the villus axis of RelB+/+, RelB+/- and RelB-/- mice 
1.5 hours after 0.125 mg/kg LPS. 
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LPS for 24 hours, we observed an increases in the number of active caspase-3 
positively labelled crypt epithelial cells (accompanied by some non-stained cells which 
had cell death characteristics that represent non-apoptotic cell death) in  Nfҡb1-/- and 
c-Rel-/- mice but not in wild-type and Nfҡb2-/- mice (Figure 3.14). Quantification of 
apoptotic cells (Figure 3.15) showed that the percentage of apoptotic small intestinal 
crypt epithelial cells (caspase-3 positive cells) was 0.2±0.09% in Nfҡb1-/- whereas it 
was 0.1±0.03%, 0.1±0.03% and 0.1±0.05% in wild-type C57BL/6J, Nfҡb2-/- and c-Rel-/- 
mice respectively. Furthermore, percentage of the cells with non-apoptotic cell death 
was significantly increased in Nfҡb1-/- and c-Rel-/- mice representing 0.5±0.05% and 
0.04±0.07% respectively (P<0.01 and P<0.05, ANOVA, Kruskal-Wallis test for non-
parametric data) while it was 0.2±0.03% and 0.3±0.03% in C57BL/6J and Nfҡb2-/- mice 
respectively. Moreover, the cell positional graphs (Figure 3.16) did not show an 
obvious pattern in all tested groups. In order to determine the position of the crypt 
cells that contributed to the significant alteration in Nfҡb1-/- and c-Rel-/- mice we used 
the modified median test and this indicated that the majority of cell death seen was 
between cell position 6 and 12 from the base of the small intestinal crypts.  
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Figure 3.14: Active caspase-3 IHC in sections of proximal segment of small intestine of 
C57BL6J mice (different genotypes) injected with 0.125mg/kg LPS for 24 hours 
demonstrating the location of positively labelled SIEC along the crypt axis. (X40). 
 
                        
Figure 3.15: Quantification of apoptotic (positive active caspase-3) and non-apoptotic 
(negative active caspase-3) cells in proximal small intestinal crypt epithelial cells 24 
hours after IP injection of 0.125 mg/kg LPS, (N=6, *P<0.05, **P<0.01). 
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                        (Position of significant apoptosis, Modified median test)  
                    
Figure 3.16: Cell positional graph indicating the apoptotic cell positions (based on 
modified median test) in different C57BL/6J mice genotypes (wild-type, Nfҡb1-/-,      
Nfҡb2-/- and c-Rel-/-) 24 hours post administration of 0.125 mg/kg LPS, (N=6). 
 
 
3.8 Discussion 
The data provided in this chapter provide more detailed information on the effect of 
LPS on murine and rat proximal small intestinal epithelial cells. We firstly investigated 
whether LPS induced the pathological shedding of small intestinal epithelial cells in 
five different mouse strains. Our results showed that 10 mg/kg LPS significantly 
induced pathological cell shedding and apoptosis in murine small intestinal epithelial 
cells in all tested mouse strains. However, the highest amount of cell shedding and 
apoptosis was observed in C57BL/6J mice (Williams et al., 2013), whereas Balb/C mice 
showed lower amounts (see Figure 3.2). Various mouse strains have also previously 
been shown to respond differently to other drugs and chemicals (Pritchard et al., 
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2000) and this may explain the difference in the degree of response among the tested 
strains. 
Xiao et al., 2001 examined age related changes in the proliferation and apoptosis of 
intestinal epithelial cells and found that the number of apoptotic cells decreased with 
age. Other studies have indicated that inflammatory bowel disease occurs most 
commonly in young adulthood, but also sometimes presents in childhood and elderly 
people (Duricova et al., 2014). To clarify the role of age in influencing LPS induced 
small intestinal epithelial cell apoptosis and shedding, we tested three different age 
groups of mice representing puberty, young adulthood and the older periods of life. 
Our results indicated that there were no age related changes in response to LPS as the 
three age groups responded similarly to the administered dose of LPS. 
One of the most interesting results shown in this chapter was obtained when we 
tested LPS from 3 different bacteria (Escherichia coli, Klebsiella pneumonia and 
Salmonella enterica). We found that the E. coli LPS more strongly induced the 
shedding and apoptosis of intestinal epithelial cells than the other two types of 
bacterial LPS. The LPS purified from Escherichia coli is the most commonly utilised 
serotype for inducing endotoxic shock responses in mice (Compos et al., 1994) and 
this difference may be due to the antigenic specificity of the LPS molecule (Van 
Amersfoort et al., 2003). However, LPS from all three bacterial sources significantly 
induced pathological cell shedding in the murine small intestinal epithelium. The cell 
positional distribution of apoptosis and cell shedding had similar patterns in all strains 
and all ages of mice with all bacterial sources of LPS tested, with the exception that in 
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Balb/C mice the distribution tended to be more basal whereas pathological cell 
shedding occurred more often in the apical part of intestinal villi in all other cases. 
Most of the previous studies describing the mechanism and morphology of intestinal 
epithelial cell apoptosis and shedding have used mice due to the similarity between 
the physiological process of apoptosis and cell shedding between mice and humans 
(Bullen et al., 2006 and Williams et al., 2015). To investigate whether another rodent 
species, the rat, responded similarly, we tested whether LPS induced small intestinal 
epithelial cell apoptosis and shedding after administration of 10 mg/kg LPS. The 
number of apoptotic small intestinal epithelial cells was dramatically increased in both 
mice and rats (see Figure 3.11 A & B), although there was a significant difference 
between species. In a previous study to explore the sepsis induced by LPS in rats and 
mice, Thomas RC et al., 2014 assessed the responses to different doses of LPS in mice 
and rats and found that the dose that resulted in an inflammatory response in 
C57BL/6J mice might or might not elicit a similar response in Wistar rats. This may 
explain the difference in the degree of response between C57BL/6J mice and Ludwig 
Wistar rats that we used in the current assessment of LPS induced small intestinal 
epithelial cell apoptosis and shedding. 
Previous studies have demonstrated an important role of the non-canonical NFᴋB 
signalling pathway in activation of pathological apoptosis and shedding of small 
intestinal epithelial cells (Williams et al., 2013). We therefore assessed the role of the 
RelB subunit. Unexpectedly RelB+/+, RelB+/- and RelB-/- mice treated with 10 mg/kg LPS 
for 1.5 hours showed no differences in the response to LPS suggesting that the RelB 
protein has no major role in preventing or enhancing the process of SIEC apoptosis.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
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Most previous studies describing the small intestinal injury associated with sepsis and 
endotoxic shock have focused on the intestinal pathology that occurs at time points 
later than 4 hours. (Alscher et al., 2001, Mura et al., 2005, Guma et al., 2011). These 
late phase effects were observed on small intestinal crypt epithelial cells. Previous 
work in our laboratory quantifying apoptosis in small intestinal crypt epithelial cells 
using active caspase-3 immunohistochemistry indicated non-significant changes 
during the time course from 1.5 hours up to 6 hours post administration of LPS 
(Williams et al., 2013). This result was however based on quantifying active caspase-3 
positively labelled crypt cells only and ignored any morphological signs in non-labelled 
crypt epithelial cells. In the study described in this chapter we injected the different 
C57BL/6J mice genotypes with 0.125 mg/kg LPS and 24 hours later we prepared the 
proximal small intestine for active caspase-3 immunohistochemistry. We counted the 
cells that undergo programmed cell death based on two criteria; active caspase-3 
positively labelled cell (apoptotic cell death) and active caspase-3 negatively labelled 
cells (non-apoptotic cell death). Based on active caspase-3 IHC, positively labelled 
crypt epithelial cells were slightly increased in Nfҡb1-/- mice but not in Nfҡb2-/- and      
c-Rel-/- mice in comparison to wild-type C57BL/6J mice. This result supports the 
previous result in our laboratory, by Williams et al., 2013, which indicated that LPS did 
not significantly cause an increase in the percentage of apoptotic cells in small 
intestinal crypts. However, when we counted the cells based on morphological 
features of cell death, the percentage of cell death (including positive and negative 
caspase-3 labelled cells) was found to be significantly increased in Nfҡb1-/- and c-Rel-/- 
mice but not in Nfҡb2-/- mice relative to wild-type C57BL/6J mice (see Figure 3.15). 
Some cells which had morphological features of cell death were 
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immunohistochemically negative for active caspase-3. These could represent cells at 
the later stages of apoptosis, when processes such as DNA fragmentation are taking 
place and the cells no longer express active caspase-3 (Glamočlija et al., 2005). 
Alternatively they could represent cells which are dying via a non-caspase-3 associated 
apoptotic process such as necroptosis (Kaczmarek et al., 2013) or pyroptosis (Fink and 
Cookson, 2005). 
In summary, the studies presented in this chapter confirm that LPS induces 
pathological small intestinal epithelial cell apoptosis and shedding in all tested mouse 
strains and ages and also in Ludwig Olac Wistar rats, but with different degree of 
effectiveness. Different sources of LPS caused different effects and RelB did not 
appear to be an important regulator of this process. However, NFᴋB family members 
were shown to regulate crypt apoptosis 24 hours after LPS administration in a similar 
manner to that observed in the villus after 1.5 hours. 
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4. Ultrastructural changes within the small intestinal epithelial cells of 
wild-type and transgenic mice treated with bacterial lipopolysaccharide 
(LPS). 
Introduction 
The features of LPS-induced SIEC apoptosis have been well described in many previous 
studies, particularly at the light microscope level and based on morphological criteria 
using H&E staining and immunohistochemistry (Williams et al., 2013, Guo et al., 2013, 
Nighot et al., 2017). However, to our knowledge there has been no previous study 
describing the morphological features within SIECs after IP administration of bacterial 
LPS using transmission electron microscopy (TEM). A number of previous publications 
have however, evaluated the ultrastructure of SIECs in certain conditions or diseases 
using TEM (Sohma 1983, Miura et al., 2005 Leite et al., 2013). The ultrastructure of 
enterocytes under normal physiological conditions was described by Sohma and 
colleagues, where they reported well developed apical microvilli, numerous 
mitochondria scattered in the apical and basal cytoplasm, rough endoplasmic 
reticulum and free ribosomes, lysosome-like bodies and a well-developed Golgi 
apparatus located apical to the basally positioned oval nucleus (Sohma et al., 1983). 
Leite and colleagues have reported ultrastructural changes in SIECs in children who 
were infected with HIV, describing frequent structural changes that include cell 
extrusion toward the intestinal lumen, vacuolation of mitochondria, disruption and 
loss of microvilli, intensive intracytoplasmic vacuolation with well-defined intercellular 
spaces and a large number of vesicular bodies found within all areas of the cell 
cytoplasm (Leite et al., 2013). He et al., in 2015 studied the role of heat stress-induced 
small intestinal injury and showed desquamation of intestinal epithelial cells, and 
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destruction of both intestinal microvilli and mitochondria. They also observed that NFB 
signalling pathway regulated such intestinal injury (He et al., 2015). 
Marchiando et al., in 2011 have indicated the role of junctional proteins in barrier 
maintenance using TEM. They showed that redistribution of ZO-1 and occludin from the 
tight junction to basolateral membranes along with the recruitment of claudins, E-
cadherin, tubulin, F-actin, Rho-associated protein kinase (ROCK) and Myosin light-chain 
kinase (MLCK) to basolateral membranes caused contraction of the cell and the 
development of a funnel that ejected the apoptotic cell (Marchiando et al., 2011). 
In this chapter, we aimed to evaluate the ultrastructure of proximal SIECs from wild-type 
C57BL/6J mice and various transgenic strains on a C57BL/6J background, including      
Nfҡb1-/-, Nfҡb2-/- and c-Rel-/- mice, housed under normal conditions and 1.5h post 
administration of 0.125 mg/kg LPS from Escherichia coli serotype O111:B4. 
 
4.1 Ultrastructural comparison of proximal small intestinal epithelium 
of untreated wild-type C57BL/6J and various transgenic Nfҡb subunit 
global knockout mice.  
Previous immunohistochemistry results in our laboratory of LPS induced SIEC 
apoptosis and shedding showed differences in the degree of responsiveness of wild-
type C57BL/6J mice and transgenic mice (Nfҡb1-/-, Nfҡb2-/- and c-Rel-/-) to 
intraperitoneal LPS (Williams et al., 2013). Ultrastructural analysis of small intestinal 
epithelium in wild-type C57BL/6J mice showed well-defined microvilli on the apical 
surface of enterocytes oriented toward the intestinal lumen, elongated tubular 
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mitochondria that were scattered throughout the cytoplasm and a basally located, 
well-defined nucleus surrounded by a clear nuclear membrane (Figure 4.1). The cell 
boundaries appeared very clear, indicating the unity of the epithelium by different 
junctional components. The morphological structure of SIECs in Nfҡb1-/- mice 
appeared similar to wild-type SIECs, with TEM again revealing a normal brush border,  
normally distributed cytoplasmic organelles, mitochondria aggregated in both the 
apical and basal aspect of cells, and the basal nuclei again surrounded by a well-
defined nuclear envelope with clear eccentric nucleoli and well distributed 
heterochromatin and euchromatin material. The only exception was that numerous 
paracellular spaces were noted close to the lateral membranes (Figure 4.2). Likewise, 
small intestine of Nfҡb2-/- mice (Figure 4.3) were also morphologically indistinct from 
wild-type C57BL/6J mice SIECs, as was the morphology observed in the proximal 
segment of c-Rel-/- mouse small intestine (Figure 4.4). The only noted minor difference 
was the appearance of dark opaque vesicular bodies in the apical cytoplasm of                
c-Rel-/- SIECs (Figure 4.4). 
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Figure 4.1: Transmission electron microscopy (TEM) of proximal SIECs from 
untreated wild-type C57BL/6J mice. Arrowheads indicate a well distributed brush 
border microvilli; N is the nucleus, white arrows indicate mitochondria. 
Representative images from N=3 mice. Magnification from X 2,550 to 8,200. 
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Figure 4.2: TEM of normal proximal SIECs from untreated Nfҡb1-/- mice. Black 
arrowheads indicate well distributed brush border microvilli; N is the nucleus; white 
arrows indicate the mitochondria; red arrows indicate presence of paracellular spaces; 
G is a goblet cell. Representative images from N=3 mice. Magnification from X 2,550 
to 8,200. 
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Figure 4.3: TEM of normal proximal SIECs from untreated Nfҡb2-/- mice. Black 
arrowheads indicate well distributed brush border microvilli; N is the nucleus; white 
arrows indicate the mitochondria. Representative images from N=3 mice. 
Magnification from X 2,550 to 8,200. 
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Figure 4.4: TEM of normal proximal SIECs from untreated c-Rel-/- mice. Black 
arrowheads indicate well distributed brush border microvilli; N is the heterochromatic 
nucleus; white arrows indicate the mitochondria; V indicates a dark opaque vesicular 
body. Representative images from N=3 mice. Magnification from X 2,550 to 8,200. 
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4.2 Examination of the action of LPS on SIEC ultrastructural morphology 
Intraperitoneal administration of LPS is known to induce pathological apoptosis and 
shedding of murine small intestinal epithelial cells in wild-type C57BL/6J mice, with 
Nfҡb2-/- mice showing resistance to shedding (Williams et al., 2013). However, the 
ultrastructural characteristic features of apoptosis and shedding have not previously 
been described. In this section, the ultrastructural changes that were observed in 
different transgenic Nfҡb subunit global knockout mouse strains treated with low 
dose (0.125 mg/kg) IP injection of LPS for 1.5 h will be described. 
 
4.2.1 Inter- and intra-cellular vacuolisation was a key feature observed in wild-type 
C57BL/6J mice after LPS treatment 
TEM of the proximal segments of small intestine from C57BL/6J mice showed some 
key ultrastructural changes 1.5h following IP administration of 0.125 mg/kg LPS. The 
most obvious features noted were the appearance of marked amounts of intracellular 
vacuolisation and the appearance of intercellular spaces (red arrows) in LPS treated 
wild-type mice (Figure 4.5). In addition, dark (opaque) vesicular bodies (black arrows) 
were also observed in the apical portions of the SIECs in all treated wild-type mice 
(Figure 4.5). Remarkably however, despite these perceptible morphological changes, 
normal cell shape and distribution of brush border microvilli were preserved, with 
nuclei (N) of normal appearance and that remained positioned basally, and 
mitochondria which also retained a normal shape and orientation throughout all the 
sections examined. 
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4.2.2 Nfҡb1-/- mouse proximal small intestine was more sensitive to LPS than other 
strains as demonstrated by multiple, distinct morphological changes 
Following intraperitoneal injection of 0.125 mg/kg LPS to Nfҡb1-/- mice, multiple 
distinct morphological structural changes were observed 1.5h post-administration 
that affected almost all cellular components (Figure 4.6). The brush border microvilli, 
whilst appearing to be preserved in some areas, were markedly disrupted or lost in 
some areas of the cell surface membrane (black arrowheads; Figure 4.6). 
Intracytoplasmic vacuoles and intercellular spaces (red arrows) were large in size and 
increased in number compared to those observed in wild-type C57BL/6J mice. Obvious 
whole cell extrusions (black arrows; Figure 4.6) were seen in all LPS-treated Nfҡb1-/- 
mice indicating the presence of shedding SIECs. Vesicular bodies (blue arrows) 
appeared in the apical cytoplasm in some cells (Figure 4.6). Vacuolated and expanded 
mitochondria (green arrowheads), with loss of their characteristic cisternae, were also 
noted in all LPS treated Nfҡb1-/- mice. The nuclei appeared to retain a normal shape 
(N) in some cells but were fragmented with loss of their usual chromatin distribution 
(white arrowheads) within exfoliated cells (Figure 4.6).  
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Figure 4.5: TEM of proximal SIECs treated with 0.125 mg/kg LPS versus untreated 
wild-type C57BL/6J mice. Morphological changes include appearance of inter- and 
intracellular vacuoles and numerous opaque vesicular bodies. (Black arrowheads: 
microvilli, N: nucleus, black arrows: vesicular bodies, red arrows: vacuolation, and G: 
goblet cells). Representative images from N=3 mice. Magnification X 2,550 to 8,200.  
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Figure 4.6: TEM of proximal SIECs of 0.125 mg/kg LPS treated versus untreated 
Nfҡb1-/- mice, (N=3). Gross morphological changes include: loss of microvilli (black 
arrowheads), shedding cells (black arrows), inter- and intra-cellular vacuoles (red 
arrows), indented nuclei (white arrows), vacuolated mitochondria (green arrows), and 
vesicular bodies (blue arrows), N is the normal nuclei. Representative images from 
N=3 mice. Magnification X 2,550 to 8,200. 
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4.2.3 No morphological changes were identified in the SIECs of LPS treated Nfҡb2-/- 
mice 
No obvious morphological changes were observed 1.5h post IP injection of 0.125 
mg/kg LPS into Nfҡb2-/- mice compared to untreated mice of same strain, excepting 
for the appearance of some small vesicular bodies (red arrows) that may represent 
increased levels of endocytic activity (see Figure 4.7). All other cellular structures, 
including the brush border microvilli, nuclei and cytoplasmic organelles appeared 
normal, retaining their shape and distribution (Figure 4.7). These observations further 
confirm the ability of Nfҡb2 null mice to resist LPS-induced apoptosis and shedding of 
SIECs.  
 
4.2.4 c-Rel-/- mice show an intermediate response to LPS treatment 
Administration of 0.125 mg/kg LPS to c-Rel-/- mice for 1.5 hours resulted in only subtle 
morphological changes within SIECs (Figure 5.8). These changes included focal areas 
of cell surface microvilli disruption (B), along with increased presence of well-defined 
intercellular spaces and intracellular vacuoles (red arrows) and the appearance of 
some funnel shaped cells (F) within the epithelial layer of small intestine (see Figure 
4.8). The latter were characterised by a narrow base and wide apex, with a darker 
cytoplasm in comparison to adjacent epithelial cells. The appearance of large vesicular 
bodies (black arrows) within the apical zone of SIECs was one of the most noticeable 
changes seen 1.5h post IP administration of low dose LPS. Other than these small but 
distinct ultrastructural changes, all other cellular components seemed to be normal in 
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size, location and appearance, including nuclei (N), retaining an intact nuclear 
envelope surrounded by normally distributed chromatin.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.7: TEM of proximal SIECs from 0.125 mg/kg LPS treated versus untreated 
Nfҡb2-/- mice. No morphological changes were observed indicating that the Nfҡb2-/- 
strain was resistant to the actions of LPS. Microvilli (black arrowheads) and vesicular 
bodies (red arrows) were of normal shape and distribution. Nuclei (N) and 
mitochondria (black arrows) were of normal shape and position. Representative 
images from 3 mice. Magnification from X 2,550 to 8,200. 
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Figure 4.8: TEM of proximal SIECs of 0.0125 mg/kg LPS treated versus untreated         
c-Rel-/- mice. Subtle morphological changes include increased number of vacuoles (red 
arrows), vesicular bodies (black arrows), appearance of funnel shaped cells (F) and 
disrupted cell surface microvilli (B). Nuclei appear of normal shape and position (N).  
G indicate goblet cells, and black arrowheads indicate microvilli of normal shape and 
distribution. Representative images from three mice. Magnification from X 2,550 to 
8,200. 
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4.3 Transmission electron microscopy highlights key morphological 
changes and dynamic events of cellular apoptosis and shedding induced 
by LPS in murine small intestinal epithelium.  
The light microscopic features of LPS induced apoptosis and shedding have been 
presented in a previous report (Williams et al., 2013). In this study, a series of TEM 
images highlight the major features of small intestinal epithelial apoptosis and 
shedding in mice following injection of 0.125 mg/kg IP injection of E. coli LPS.  
Increased intracellular vacuolisation and intercellular spaces are clearly seen in the 
epithelial cells of wild-type C57BL/6J mice following injection of bacterial LPS (Figure 
4.9). At higher magnification (X 9,900 and X 16,500) the vacuolisation and spaces 
noted may indicate an increase in autophagocytic/phagocytic activity (to support 
degradation of proteins, other macromolecules and organelles), and detachment from 
adjacent cells. However, the mitochondria surrounding these spaces still appeared to 
retain a normal ultrastructure. 
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Figure 4.9: Higher magnification TEM of SIECs from wild-type C57BL/6J mouse treated 
with 0.125 mg/kg LPS highlights the large intracellular vacuoles and intercellular 
spaces. 
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Gross morpholigical changes were seen in LPS-treated Nfҡb1-/- mice (Figures 4.10, 4.11 
and 4.12). At higher magnification (X 4,200, X 6,000, X 8,200 and X 9,900), these 
ultrastructural changes included extrusion of epithelial cells toward the intestinal 
lumen, with loss of microvilli from their apical surfaces (black arrowhead), nuclear 
fragmentation (white arrowhead), increased vacuolation and loss of mitochondria 
(Figure 4.10 and 4.11). Intracellular vacuolisation and the appearance of intercellular 
spaces were also noted in other LPS treated mouse groups (Figure 4.9 and 4.12). 
Intraepithelial lymphocytes (Figure 4.13) were also observed to be located basal to 
the intestinal epithelial cells.  
 
 
                                     
                              
Figure 4.10: Small intestinal TEM of LPS-treated Nfҡb1-/- mouse showing epithelial cell 
extrusion (black arrowhead), nuclear fragmentation (white arrowheads).  
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Figure 4.11: Small intestinal TEM of LPS-treated Nfҡb1-/- mouse showing 
mitochondrial vacuolation and loss of cisternae (black arrows). 
 
 
                            
 
Figure 4.12: Small intestinal TEM of LPS-treated Nfҡb1-/- mouse showing intracellular 
vacuolation and intercellular space formation. 
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Figure 4.13: Small intestinal TEM of LPS-treated Nfҡb1-/- mouse showing an 
intraepithelial lymphocyte underlying the small intestinal epithelial cell layer. 
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In c-Rel-/- mice, the most obvious morphological changes seen after low dose IP 
injection of LPS were disruption of microvilli (Figure 4.14), the appearance of funnel 
shaped cells (Figure 4.15) and the development of intra- and inter-cellular vacuolation.  
                                   
Figure 4.14: Small intestinal TEM showing disruption of intestinal microvilli in a                
c-Rel-/- mouse injected with 0.125 mg/kg IP LPS for 1.5 hours. 
 
 
Figure 4.15: Small intestinal TEM showing a funnel shaped epithelial cell (white arrow) 
and vacuolation (red arrows) in a c-Rel-/- mouse after LPS administration      (X 4,200). 
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5.4 Discussion 
The data presented in this chapter provide further characterisation of LPS-induced 
apoptosis and shedding in the murine small intestinal epithelium. Work described 
earlier in this thesis and previous light microscopy studies undertaken by Williams and 
colleagues (Williams et al., 2013) have indicated that pathological SIEC apoptosis and 
shedding is induced by bacterial LPS in wild-type C57BL/6J mice. Maximal SIEC 
apoptosis and shedding post intraperitoneal administration of low dose (0.125 mg/kg) 
LPS was seen at 1.5 hours and was more pronounced in Nfҡb 1-/- mice, as also seen by 
Williams and colleagues (Williams et al., 2013). c-Rel-/- mice showed an intermediate 
response to LPS relative to wild-type and Nfҡb1-/- mice, whilst Nfҡb2-/- mice appeared 
to be more resistant to LPS-induced SIEC apoptosis and shedding, again as previously 
observed (Williams et al., 2013). 
To date, there have been no previous reports describing the characteristic features of 
LPS-induced apoptosis and shedding of murine SIECs using TEM, although a few 
studies have described ultrastructural changes in the small intestinal epithelium under 
other conditions, including starvation (Sohma, 1983), following injection of mice with 
anti-CD3e antibody (Miura et al., 2005), and also in African children infected with HIV 
(Leite et al., 2013) 
In our study, the ultrastructural features of normal murine intestinal absorptive cells 
included well-developed brush border microvilli and numerous mitochondria within 
the apical zone surface, just below the terminal web and around the basal zone below 
the level of the nucleus. Nuclei located in the basal zone of the cell contained 
prominent nucleoli, peripherally arranged heterochromatin just beneath the nuclear 
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envelope and normal centrally distributed euchromatin. Other cytoplasmic 
organelles, such as rough endoplasmic reticulum, the Golgi complex, ribosomes and 
lysosomes, were also observed to be of normal appearance (size, shape and position) 
within the cell cytoplasm. These features were similar to those described for duodenal 
absorptive cells in a previous study (Sohma, 1983).   
After administration of LPS, the SIECs of wild-type C57BL/6J mice showed increased 
intra- and inter-cellular vacuolation, with the appearance of dark (opaque) vesicular 
bodies in the apical cell compartment. The appearance of vesicular bodies of different 
size was also previously highlighted by Sohma, and described as lysosome-like bodies 
(Sohma, 1983) potentially indicating an increase in the endocytic and/or 
autophagocytic activity of epithelial cells (Luzio et al., 2014).  
The most interesting ultrastructural features were noted in Nfҡb1-/- mice following LPS 
administration. We observed shedding or extrusion of enterocytes that were 
detached from adjacent cells toward the intestinal lumen as whole cells containing 
their nuclei and without rupturing their cell membranes. This type of apoptosis is 
similar to that seen in both human and mouse small intestine (Bullen et al., 2006, 
Williams et al., 2013). Moreover, a large number of intracellular vacuoles and 
intercellular spaces were noted in all LPS-treated Nfҡb1-/- mice suggesting detachment 
of apoptotic cells from their neighbouring cells and an increase in cell endocytic 
activity. Similar vacuolation and spaces were also seen in wild-type C57BL/6J and          
c-Rel-/- mice, but to a lower extent.  
In 2005, Mura and colleagues described electron microscopic findings of murine small 
intestinal epithelial cells 24 hours following anti-CD3 antibody injection (Mura et al., 
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2005). They described that the nuclei of the intestinal epithelial cells showed a 
significant degree of condensation and fragmentation, and that the mitochondria 
showed marked expansion and vacuolation, with accompanying loss of their 
characteristic cisternae. Similar features were observed in our study, especially in 
Nfҡb1-/- mice 1.5 hours after IP injection of E. coli LPS. Additionally, that epithelial 
microvilli were lost or disrupted in association with the formation of multivesicular 
bodies, again perhaps indicative of endocytic activity as had been previously 
suggested (Sohma, 1983). 
The most remarkable finding seen in c-Rel-/- mice, in addition to increased levels of 
intra- and inter-cellular vacuolation, was the appearance of funnel shaped cells with 
characteristic narrow bases and a wider apical cell surface membrane. This distinctive 
cellular morphology may be due to repositioning/re-localisation of cytoskeletal 
elements (including microtubules and microfilaments), resulting in contraction of the 
shedding cell, and the role played by junctional complexes in the lateral membrane of 
the cell, so as to maintain integrity of the barrier between shedding and adjacent 
healthy epithelial cells (Marchiando et al., 2012). 
Nfҡb2-/- mice showed no ultrastructural differences between LPS treated and 
untreated groups, supporting our previous finding of the resistance of this genotype 
to pathological apoptosis and shedding induced by LPS. 
In conclusion the ultrastructural morphological changes observed in mouse SIECs 
following LPS injection can be summarised as follows:  
i. Extrusion of shedding cells toward the intestinal lumen 
121 
 
ii. Fragmentation and condensation of nuclei 
iii. Appearance of intracellular vacuolation and intercellular spaces 
iv. Vacuolation and expansion of mitochondria 
v. Formation of multivesicular bodies 
vi. Appearance of funnel shaped cells 
 
In summary, the data described in this chapter support our previous results from 
immunohistochemistry which have indicated the role of bacterial LPS in inducing 
pathological SIEC apoptosis and shedding. 
Our results support previous observations that Nfҡb1-/- mice were more susceptible 
and Nfҡb2-/- mice were more resistant to LPS induced SIEC apoptosis and shedding. 
Furthermore, or results indicate that wild-type C57BL/6J and c-Rel-/- mice showed an 
intermediate response to LPS relative to Nfҡb1-/-  and Nfҡb2-/- mice. 
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5. Proteomic analysis of murine small intestinal tissue pre- and post-
administration of LPS 
Previous studies in our laboratory and my current work presented in chapter 3 of this 
thesis indicated that LPS induces maximal small intestinal epithelial cell apoptosis and 
shedding in C57BL/6J mice at 1.5 hours post LPS administration.  We have also shown 
that apoptosis and shedding of murine SIECs following LPS administration was 
dependent on the expression of the NFκB family of proteins with signalling via NFκB1 
transcription favouring cell survival and signalling via NFκB2 activation favouring cell 
apoptosis (Williams et al., 2013). 
To the best of our knowledge there have been no prior studies using large scale 
analyses of the mouse small intestinal mucosal proteome in responses to LPS.  
However, there have been several studies that have identified proteins that are 
differentially expressed in the whole murine small intestine in response to starvation 
or dietary supplementation. For instance, Lenaerts and colleagues used a 2 
dimensional electrophoresis proteomic approach to determine starvation-induced 
adaptations at the molecular level in mouse small intestine.   From a total of around 
1500 proteins identified, they found that several proteins involved in glycolysis were 
down regulated in early starvation and this resulted in a decrease in activity of 
glycolysis and citric acid cycle enzymes in the intestine. They also noted a strong 
upregulation of regenerative proteins I and II (reg I and reg II) that are expressed in 
crypt epithelial cells but not villus epithelial cells, suggesting that these proteins play 
a role in growth and the early differentiation states of the intestinal epithelium 
(Lenaerts et al., 2006).  We have similarly used a combination of proteomic data 
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analysis and literature searches to identify whether proteins are present in crypt or 
villus epithelial cells, in order to suggest the likely regions of the crypt-villus axis that 
respond to LPS.    
Wang et al., in 2009 tested the effect of zinc supplementation on the expression of 
proteins related to glutathione metabolism and apoptosis in the jejunum of piglets. 
They indicated from a total of 22 significantly upregulated and 19 significantly 
downregulated proteins that zinc oxide supplementation increased the expression of 
A-Raf-1 (Serine/threonine-protein kinase A-Raf) and calregulin (also called calreticulin) 
that are known to activate cell proliferation and inhibit apoptosis in small intestinal 
epithelium. Furthermore, they also found that zinc oxide supplementation reduced 
the expression of active caspase-3 that plays a crucial role in cell apoptosis.  A 
proteomic approach is therefore suitable for the detection of apoptosis related 
proteins such as caspases within the intestine.   
Inhibition of the intestinal immune response has been seen as a result of 
enterotoxigenic Escherichia coli induced diarrhoea in piglet jejunum (Ren et al., 2016). 
In this study Ren and colleagues demonstrated that downregulation of the NFκB 
transcription factor p65 subunit and other proteins from the mitogen-activated 
protein kinase (MAPK) family (including serine/threonine protein kinase 4, 
serine/threonine phosphatase, caspase-3, protein phosphatase 1B, calcineurin 
homologous protein 1, and ribosomal protein S6 kinase) inhibited the NFκB and MAPK 
pathways in piglet jejunum. Also, they found that ETEC-infected piglets had low mRNA 
expression of Toll-like receptors on the epithelial cell surface including TLR4, 5, 2, 6 
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and 10 suggesting the role of ETEC-induced diarrhoea in suppression of immune 
responses in the jejunum (Ren et al., 2016). 
In this chapter I aimed to identify the proteomic changes related to LPS induced small 
intestinal apoptosis and shedding in C57BL/6J mice 1.5 hours post intraperitoneal 
administration of LPS and to understand whether there are any differences in the 
small intestinal proteome between wild type C57BL/6J and their counterpart 
transgenic mice (Nfҡb1-/-, Nfҡb2-/- and c-Rel-/-) that may explain the different degrees 
of responses of these strains to LPS induced small intestinal epithelial cell apoptosis 
and shedding and therefore identify future targets to ameliorate intestinal disease. 
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5.1 Nfκb transgenic mice exhibit differences in the small intestinal 
mucosal proteome 
Nfҡb1-/-, Nfҡb2-/- and c-Rel-/- mice were all previously generated on a C57BL/6J wild-
type background. Following a comparative analysis of the small intestinal protein 
profile for the transgenic mouse strains with the proteome of C57BL/6J mice, we 
determined multiple proteomic changes that resulted from the deletion of individual 
Nfκb subunits (Figure 5.1). 499 significant proteomic changes were detected in    
Nfҡb1-/- small intestinal mucosa in comparison to the comparable wild-type C57BL/6J 
mouse proteome. Among these changes, 250 proteins (representing 50.1% of the total 
changes) were upregulated while the remaining 249 proteins (49.9%) were 
downregulated in expression. In contrast, 2173 significant changes were seen in the 
protein profile of Nfҡb2-/- compared to wild-type C57BL/6J small intestinal mucosa. 
The total number of upregulated proteins was 1036 (47.7% of the total changes) and 
1137 proteins were downregulated in expression. We identified 363 significant 
protein changes in the small intestinal mucosa of c-Rel-/- mice, 220 (60.6%) proteins of 
which were upregulated and 143 (39.4%) proteins were downregulated in comparison 
to C57BL/6 wild type control mice.  
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Figure 5.1: Pie chart showing the total number of statistically significantly upregulated 
and downregulated proteins in Nfҡb1-/-, Nfҡb2-/- and c-Rel-/- small intestinal mucosa 
compared to C57BL/6J, comparison of multiple means tested by Student’s t-test. N=4 
 
5.1.1 Nfκb1-/- 
Tables 5.1-A and 1-B show the greatest fold changes of 10 significantly upregulated 
and downregulated proteins in the small intestinal mucosa of Nfҡb1-/- mice compared 
with C57BL/6 at baseline in addition to their corresponding expressions in Nfҡb2-/- and 
c-Rel-/- mice. Data are expressed as a log2 fold changes and were tested following 
logarithmic transformation by student t-test and p values are displayed as -log 10 (p-
value). We found that proteins that were significantly upregulated in the small 
intestinal mucosa of Nfҡb1-/- mice also appeared to be significantly upregulated in 
Nfҡb2-/- mice with the exception of  nucleoplasmin-3 and gastrotropin which were not 
significantly expressed and downregulated respectively (Table 5.1-A). Similarly,              
c-Rel-/- mouse small intestinal mucosa showed upregulated expression of the top 10 
upregulated Nfκb1-/- proteins with the exception of RNA-binding protein 3 that was 
 Nfҡb1-/- 
ᴋB1
-/-
 
Nfҡb2-/- c-Rel
-/-
 
Total changes: 2173 
      Upregulated proteins           Downregulated 
proteins 
Total changes: 363 Total changes: 499 
249 
=49.9% 
250 
= 50.1% 
1137 
= 52.3% 
1036 
= 47.7% 
143 
= 39.4% 
220 
= 60.6% 
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not significantly expressed and RIKEN cDNA 2200002D01, a 28kDa heat-and acid-
stable phosphoprotein that was downregulated. 
Table 5.11.B indicates the top 10 downregulated proteins in the Nfҡb1-/- mouse small 
intestinal mucosal proteome compared with C57BL/6 at baseline.  These proteins also 
appeared to be either downregulated or showed no significantly altered regulation in 
Nfҡb2-/- and c-Rel-/- small intestinal mucosa compared with C57BL/6 wild type mice as 
indicated.   
 
5.1.2 Nfκb2-/- 
There were a large number of proteins identified in Nfҡb2-/- small intestinal mucosal 
samples that were differentially expressed compared with C57BL/6 mice (2173 total 
changes as shown in appendix A). The majority of the top 10 up- and downregulated 
proteins of this genotype appeared not to be-significantly expressed in c-Rel-/- mice, 
while Nfҡb1-/- mice exhibited a similar proteomic profile with the exception of pyridine 
nucleotide-disulphide oxidoreductase domain 2, adenosine deaminase and 
proteasome subunit beta type-5 that were not significantly expressed in the Nfҡb1-/- 
small intestinal mucosa in comparison to C57BL/6 (Tables 5.2.A and 5.2.B). 
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5.1.3 c-Rel-/- 
There were a smaller number of differentially expressed proteins observed in c-Rel-/- 
small intestinal mucosa in comparison to C57BL/6 mice compared with the proteomic 
differences observed between C57BL/6 and Nfҡb1-/- and Nfҡb2-/- transgenic mice, 
indicating that the small intestinal mucosa of c-Rel-/- mice may function more normally 
compared to the other transgenic strains.  The top 10 up- or downregulated proteins 
within the c-Rel-/- small intestinal mucosa exhibited either reverse or non-significant 
expression in Nfҡb1-/- and Nfҡb2-/- mice (Tables 5.3-A and B). 
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Nfҡb1-/- 
Expression in other 
genotypes 
Protein names Gene names 
Regulation 
fold change 
P value Nfҡb2-/- c-Rel
-/-
 
Nucleoplasmin-3 Npm3 10.99 0.0078 None Up 
Tubulin-specific chaperone A Tbca 7.926 0.0002 Up None 
Calcium-regulated heat stable protein 
1 
Carhsp1 6.542 0.0002 Up Up 
Gastrotropin Fabp6 6.458 0.0012 Down Up 
Copper transport protein ATOX1 Atox1 5.072 0.0093 Up Up 
RNA-binding protein 3 Rbm3 4.864 0.0041 Up None 
RIKEN cDNA 2200002D01 gene 
2200002D01
Rik 
4.831 0.0013 Up Down 
Cysteine-rich with EGF-like domain 
protein 2 
Creld2 4.392 0.0076 Up Up 
Regenerating islet-derived protein 3-
beta 
Reg3b 4.312 0.0024 Up Up 
28kDa heat-and acid-stable 
phosphoprotein 
Pdap1 3.58 0.0216 Up Down  
 
Table 5.1.A: indicates the top upregulated proteins in Nfҡb1-/-small intestinal mucosa 
and their expression in Nfҡb2-/- and c-Rel-/- mice all in comparison to wild-type 
C57BL/6J mice, N=4 (Up: significant upregulation, Down: significant downregulation, 
None: non-significant expression). 
 
 
Nfҡb1-/- 
Expression in other 
genotypes 
Protein name Gene name 
Regulation 
fold change 
P value Nfҡb2
-/-
 c-Rel
-/-
 
Reticulon-3 Rtn3 -11.26 0.0376 None None 
Defensin, alpha, 27 Gm15299 (Defa 27) -9.762 0.0004 Down Down 
Lysozyme C-1;Lysozyme C-2 Lyz1;Lyz2 -6.755 0.0018 Down None 
Alpha-defensin 20 Defcr20;Defa20 -5.563 0.0341 Down None 
Protein FAM83F Fam83f -4.679 0.0014 Down Down 
Cysteine dioxygenase type 1 Cdo1 -4.138 0.001 Down None 
Intelectin-1a Itln1 -4.132 0.0013 Down None 
Lactase-like protein Lctl -4.106 0.0386 Down Down 
Ig alpha chain C region Igha -3.978 0.0001 Down None 
Alpha-defensin 23 Defa23 -3.968 0.0037 Down Down 
 
Table 5.1.B: indicates the top downregulated proteins in Nfҡb1-/- small intestinal 
mucosa and their expression in Nfҡb2-/- and c-Rel-/- mice all in comparison to wild-type 
C57BL/6J mice, N=4 (Down: Downregulation, None: non-significant expression). 
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Nfҡb2
-/-
 
Expression in other 
genotypes 
Protein names Gene names 
Regulation 
fold change 
P value Nfҡb1 
-/-
 c-Rel
-/-
 
Cytochrome b Mt-Cyb 6.3045 0.0006 Up None 
Tubulin-specific chaperone A Tbca 6.2372 0.0001 Up None 
Calumenin Calu 4.5687 0.0006 Up None 
Histocompatibility 2, class II antigen,A, 
alpha 
H2-Aa 4.4762 0.0082 Up Up 
Copper transport protein ATOX1 Atox1 4.4345 0.0005 Up Up 
Pyridine nucleotide-disulfide 
oxidoreductase domain 2 
Pyroxd2 4.3738 0.0001 None None 
40S ribosomal protein S28 Rps28;Gm10263 4.1087 0.0001 Up None 
Guanine nucleotide-binding protein 
subunit beta-2-like 1 
Gnb2l1 3.8836 0.0005 Up Up 
Adenosine deaminase Ada 3.8046 0.0018 None Down 
Cysteine-rich with EGF-like domain protein 
2 
Creld2 3.5998 0.0001 Up Up 
 
Table 5.2.A: indicates the top upregulated proteins in Nfҡb2-/- small intestinal mucosa 
and their expression in Nfҡb1-/- and c-Rel-/- mice all in comparison to wild-type 
C57BL/6J mice, N=4 (Up: upregulation, Down: downregulation, None: non-significant 
expression). 
 
Nfҡb2
 -/- Expression in other genotypes 
Protein names Gene names Regulation 
fold change) P value Nfҡb1
-/- c-Rel-/- 
Ig alpha chain C region Igha -11.05 0.0007 Down None 
Ig kappa chain C region Igkc -7.942 0.0007 Down None 
Alpha-defensin 20 Defcr20;Defa20 -6.753 0.0049 Down None 
Protein disulfide-isomerase A2 Pdia2 -6.4 0.001 Down None 
Lysozyme C-1;Lysozyme C-2 Lyz1;Lyz2 -5.614 0.0014 Down None 
predicted gene 7849 Gm7849 -5.596 0.0011 Down None 
Histone H2B type 1-C/E/G;Histone H2B 
type 1-M;Histone H2B type 2-B;Histone 
H2B type 1-H 
Hist1h2bc;Hist1h
2bm;Hist2h2bb;
Hist1h2bh 
-5.554 0.001 Down None 
Proteasome subunit beta type-5 Psmb5 -5.379 0.0004 None None 
Alpha-defensin-related sequence 1 Gm14851;Defa-
rs1 -5.286 0.001 Down None 
Zymogen granule membrane protein 16 Zg16 -5.125 0.0005 Down None 
 
Table 5.2.B: indicates the top downregulated proteins in Nfҡb2-/- small intestinal 
mucosa and their expression in Nfҡb1-/- and c-Rel-/- mice all in comparison to wild-type 
C57BL/6J mice, N=4 (Up: upregulation, Down: downregulation, None: non-significant 
expression).  
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c-Rel
-/-
 
Expression in 
other genotypes 
Protein names Gene names 
Regulation 
fold change 
P value Nfҡb1
-/-
 Nfҡb2
 -/-
 
Solute carrier family 35 member A4 Slc35a4 16.79 0.0001 None None 
Glutathione peroxidase 2 Gpx2 4.246 0.0002 Up Up 
Unconventional myosin-IXb Myo9b 2.89 0.0001 Down Down 
Transformation/transcription domain-
associated protein 
Trrap 2.793 0.0065 None Noe 
MAU2 chromatid cohesion factor homolog Mau2 2.42 0.0119 Down Down 
Dual oxidase 2 Duox2 2.293 0.029 Noe Down 
Mucosal pentraxin 2 Mptx2 2.154 0.0237 Down Down 
Lactase-like protein Lctl 2.126 0.0037 Down Down 
Uncharacterized protein KIAA0556 
D430042O09Rik; 
Kiaa0556 
2.079 0.0289 None Up 
1,4-alpha-glucan-branching enzyme Gbe1 2.074 0.0022 None None 
 
Table 5.3.A: indicates the top upregulated proteins in c-Rel-/- small intestinal mucosa 
and their expression in Nfҡb1-/- and Nfҡb2-/- mice all in comparison to wild-type 
C57BL/6J mice, N=4 (Up: upregulation, Down: downregulation, None: non-significant 
expression). 
 
 
c-Rel
-/- Expression in other genotypes 
Protein names Gene names Regulation 
fold change P value Nfҡb1
-/- Nfҡb2 -/- 
E3 ubiquitin-protein ligase AMFR Amfr -2.17 0.0227 None Down 
Galactokinase Galk1 -2.31 0.0302 None None 
Guanine deaminase Gda -2.33 0.0369 Up Up 
Proteasome subunit alpha type-1 Psma1 -2.4 0.0014 None Up 
6-pyruvoyl tetrahydrobiopterin synthase Pts -2.45 0.0012 Up Up 
Semaphorin-4G Sema4g -2.49 0.0113 Up Up 
Mitochondrial import inner membrane 
translocase subunit Tim8 A Timm8a1 -2.67 0.011 Up Up 
Proteasome subunit alpha type-7 Psma7 -2.82 0.0132 None Up 
Proteasome subunit alpha type-5 Psma5 -3.23 0.0427 Up Up 
Serine/threonine-protein kinase 25 Stk25 -10.9 0.0106 Down Down 
 
Table 5.3.B: indicates the top downregulated proteins in c-Rel-/- small intestinal 
mucosa and their expression in Nfҡb1-/- and Nfҡb2-/- mice all in comparison to wild-
type C57BL/6J mice, N=4 (Up: upregulation, Down: downregulation, None: not-
significant expression). 
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5.1.4 Summary of the previously investigated biological roles of the identified 
proteins in intestinal mucosa 
The changes in protein expression in the small intestinal mucosa of Nfκb transgenic 
mice in comparison to wild-type C57BL/6J mice indicated some similar differences in 
Nfҡb1-/- and Nfҡb2-/- mucosal proteins when the proteins which showed the greatest 
upregulations and downregulations were compared.  However, c-Rel-/- mice showed 
the least variation from C57BL/6 mice and had different profiles within the 10 proteins 
which showed the greatest upregulations and downregulations compared with  
Nfҡb1-/- and Nfҡb2-/- mice. Some of these proteins have previously been shown to play 
roles in regulating intestinal cellular processes. 
Tbca was significantly upregulated in the small intestinal mucosa of Nfҡb1-/- and 
Nfҡb2-/- mice and has previously been shown to play an essential role in regulating cell 
viability with loss of this protein leading to cell cycle arrest and cell death (Nolasco et 
al., 2005). Similarly, Carhsp1 was previously indicated to be an important enhancer 
required for TNF production (Pfeiffer et al., 2011); this protein showed significantly 
upregulated expression in all transgenic mice used in our study. Downregulation of 
gastrotropin (Fabp6) has been shown to cause a disturbance in enterohepatic bile acid 
circulation and lipid metabolism (Collado-Romero et al., 2015) and transcription of this 
protein is controlled by NFκB signalling (Fang et al., 2007).  We observed an 
upregulation of gastrotropin in Nfҡb1-/- and c-Rel-/- small intestinal mucosa, however, 
this protein was downregulated at baseline in Nfҡb2-/- mice. Rbm3 was upregulated 
in Nfҡb1-/- and Nfҡb2-/- mice but was unaltered in c-Rel-/- small intestinal mucosa and 
this protein has previously been shown to promote cell proliferation and inhibit 
apoptosis (Al-Astal et al., 2016). Reg3b was upregulated in the small intestinal mucosa 
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of all transgenic mouse strains and has previously been shown to inhibit cell 
proliferation and induce cell apoptosis in the colon (Liu et al., 2017). Lysozyme and 
various defensins were also significantly downregulated within the small intestinal 
mucosa of Nfҡb1-/- and Nfҡb2-/- but not c-Rel-/- mice at baseline.  These components 
are secreted by Paneth cells in small intestinal crypts and have important roles as 
mediators of enteric innate immunity (Mastroianni and Ouellette., 2009). Defensins 
also induce the secretion of inflammatory cytokines by activating NFκB signalling 
pathways (Lin et al., 2004). Psmb5 protein was downregulated in Nfҡb2-/- small 
intestinal mucosa at baseline but this was not observed in Nfҡb1-/- and c-Rel-/- strains. 
Psmb5 was previously identified as activating NFκB signalling pathways leading to the 
regulation of various pro-inflammatory cytokines including TNF and also regulating 
cell differentiation and apoptosis (Goldberg et al., 1995). Gpx2 was up-regulated in 
the small intestinal mucosa of all Nfκb transgenic strains and has previously been 
shown to have a role in reducing colonic crypt epithelial cell apoptosis (Florian et al., 
2010). Myo9b was upregulated in c-Rel-/- but downregulated in Nfҡb1-/- and Nfҡb2-/- 
small intestinal mucosa and has been reported to be involved in the regulation of 
epithelial barrier function and to cause increased intestinal permeability in Crohn’s 
disease (Prager et al., 2014 and Wang et al., 2016). Mau2 was upregulated in c-Rel-/- 
but downregulated in Nfҡb1-/- and Nfҡb2-/- small intestinal mucosa and previous 
reports suggest that it maintains immune homeostasis in mice by regulating the 
interaction between intestinal microbiota and the mucosa and its overexpression 
increases susceptibility to IBD (Grasberger et al., 2015). Finally, the expression of Stk25 
was downregulated in the small intestinal mucosa of all Nfκb transgenic mice and this 
protein has previously been shown to elicit apoptotic cell death by activating the 
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intrinsic apoptosis pathway (Nogueria et al., 2008).  The remaining proteins have not 
yet been investigated or identified to have any biological role in the small intestinal 
mucosa. 
 
5.2 Does systemic LPS cause any changes in the intestinal mucosal 
proteome? 
5.2.1 LPS resulted in 884 changes in the small intestinal mucosal proteome of 
C57BL/6J mice 
The total number of proteins that were detected in the small intestinal mucosa of 
untreated wild type C57BL/6J mice was 5845  and this number was similar in Nfҡb1-/- 
(5678 proteins), Nfҡb2-/- (5686 proteins) and c-Rel-/- (5750 proteins) mice suggesting 
standardisation and validity across all data sets. Following intraperitoneal 
administration of 0.125 mg/kg LPS into wild-type C57BL/6J mice for 1.5 hours we 
recorded 884 protein expression changes. 255  (28.85%) of the proteins were 
upregulated while  629 proteins (71.15%) were downregulated in expression (Figure 
5.2). The top 10 proteins with the greatest fold changes that were significantly up- or 
downregulated in expression in C57BL/6J mice following intraperitoneal injection of 
LPS are shown below in tables 5.4.A and 5.4.B. 
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Figure 5.2: Pie charts representing the total significant up and downregulated changes 
in small intestinal mucosal proteome of Nfҡb1-/-, Nfҡb2-/- and c-Rel-/- mice 1.5 hours 
post intraperitoneal administration of bacterial LPS compared with untreated mice of 
the same strain (N=4). 
 
 
 
255
= 28.85%
629
= 71.15%
Total changes: 884 
C57BL/6J 
No 
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Nfҡb1
-/-
 
7
= 50%
7
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Total changes: 14
Nfҡb2
-/-
 
1
=100%
Total changes: 1
c-Rel
-/-
 
 
 
      Upregulated proteins           Downregulated 
proteins 
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Protein names 
 
Gene names 
Regulation fold 
change 
P value 
PHD finger protein 10 Phf10 10.67 0.0017 
THAP domain-containing protein 4 Thap4 5.444 0.0004 
Lactase-like protein Lctl 5.103 0.0354 
Nucleolar protein 9 Nop9 5.018 0.0181 
Reticulon;Reticulon-1 Rtn1 2.785 0.0189 
Metastasis-associated protein MTA1 Mta1 2.602 0.0057 
Catenin alpha-3 Ctnna3 2.396 0.0041 
Proto-oncogene c-Fos Fos 2.192 0.0009 
Acyl-CoA-binding protein Dbi 1.967 0.0207 
Clathrin light chain B Cltb 1.914 0.0354 
 
Table 5.4-A: The top 10 proteins showing the greatest difference in log2 fold change 
that were significantly upregulated in C57BL/6J small intestinal mucosa after 
intraperitoneal administration of 0.125 mg/kg LPS. 
 
 
 
Protein names 
 
Gene names 
Regulation fold 
change 
P value 
Otolin-1 Otol1 -4.16 0.0162 
Carboxypeptidase A1 Cpa1 -3.4 0.0141 
Myosin heavy chain 11 Myh11 -2.58 0.005 
Tropomodulin-1 Tmod1 -2.55 0.0198 
collagen type VI alpha 3 chain Col6a3 -2.55 0.007 
Tubulointerstitial nephritis antigen-like Tinagl1 -2.4 0.0418 
Protein disulfide-isomerase A2 Pdia2 -2.29 0.0133 
Tropomyosin alpha-1 chain Tpm1 -2.22 0.0309 
carboxypeptidase B1 Cpb1 -2.17 0.0204 
Peptidyl-prolyl cis-trans isomerase FKBP11 Fkbp11 -2.16 0.0001 
 
Table 5.4.B: The top proteins showing the greatest difference in log2 fold change that 
were significantly downregulated in the small intestinal mucosa of C57BL/6J mice 
following 0.125 mg/kg LPS. 
 
 
Some proteins that showed significant up- or downregulation expression post LPS 
injection into C57BL/6J mice have previously been demonstrated to play roles in 
regulating cellular adhesion and apoptosis. For example, reduced expression of Phf10 
caused suppression of caspase-3 and inhibited apoptosis in human gastric cancer (Wei 
137 
 
et al., 2010) suggesting that it may be partially responsible for LPS-induced apoptosis 
within the small intestinal epithelium. Despite the well-known role of Ctnna3 as a cell-
cell adhesion gene, it has also been shown to have a central role in the inhibition of 
cell proliferation, migration and invasion in hepatocellular carcinoma (He et al., 2016). 
Additionally, upregulation of Cpb1 in breast cancer patients caused activation of NFκB 
and increased a cell survival mechanism (Bouchal et al., 2015). 
 
5.2.2 LPS did not induce any significant changes in the small intestinal mucosal 
proteome of Nfҡb1-/- mice 
Although we identified a total of 5678 proteins contributing to the small intestinal 
mucosal proteome of untreated Nfҡb1-/- mice, surprisingly none of these proteins 
showed significant differences in protein expression between untreated and LPS 
treated Nfҡb1-/- mice (Figure 5.2).  This suggests that the 884 protein changes 
identified in C57BL/6 small intestinal mucosal samples following LPS are in some way 
(directly or indirectly) either a result of Nfκb1 activation or that Nfκb1-/- mice already 
express many of these 884 proteins at similar levels at baseline to those observed 
following LPS administration to C57BL/6 mice and they are not further altered by LPS 
administration. This may at least partly account for the increased susceptibility of 
Nfκb1-/- mice to LPS-induced SIEC apoptosis and shedding. 
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5.2.3 The small intestinal mucosal proteome of Nfҡb2-/- and c-Rel-/- mice showed 
minimal changes in response to LPS 
Only 14 proteins from a total of 5686 proteins identified in the small intestinal mucosa 
of Nfҡb2-/- mice were shown to have significant differences in expression following 
administration of 0.125 mg/kg LPS. Seven proteins were upregulated, and 7 proteins 
were downregulated in expression (Figure 5.2 and Table 5.5).  
Myob9 was significantly upregulated in Nfҡb2-/- small intestinal mucosa following LPS 
treatment, however, this protein was downregulated at baseline when compared with 
C57BL/6 wild-type mucosa. Myob9 plays a role in the regulation of epithelial barrier 
function and has been shown to increase gut permeability in Crohn’s disease (Preger 
et al., 2014 and Wang et al., 2016). Additionally, Klhdc4 and Irf8 were significantly 
downregulated post LPS injection. Decreased expression of Klhdc4 was previously 
demonstrated to induce spontaneous apoptosis in nasopharyngeal carcinoma cells 
due to an increase in cleaved caspase-3 (Lian et al., 2016), while Irf8 has been 
considered to be an essential regulator in Fas-mediated apoptosis and disruption of 
its function inhibited the activation of cytochrome C, caspase-9 and caspase-3 in a 
human colon carcinoma cell line in vitro and in murine primary mammary carcinoma 
and lung metastases in vivo (Yang et al., 2007 and Yang et al., 2009).  These proteins 
may therefore contribute to the reduced susceptibility of Nfҡb2-/- mice to LPS-induced 
SIEC apoptosis and shedding. 
Following LPS administration into c-Rel-/- mice, we only identified a significant change 
in a single protein (Ig heavy chain V region VH558 A1/A4) from 5750 proteins analysed. 
This protein showed a significant upregulation in expression following LPS treatment 
in comparison to untreated c-Rel-/- mice (Table 5.6). This protein has not been 
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previously shown to play any biological role in the small intestinal mucosa, although 
as it is an immunoglobulin, it may have a role in humoral immunity. 
 
 
Protein names Gene names 
Regulation 
fold change 
P value 
Protein FAM50A Fam50a 2.567 0.0049 
NADH dehydrogenase [ubiquinone] 1 alpha 
subcomplex assembly factor 5 
Ndufaf5 2.549 0.0155 
Snf2 related CREBBP activator protein Srcap 1.892 0.0001 
Pre-B-cell leukemia transcription factor 1;Pre-B-cell 
leukemia transcription factor 2 
Pbx1;Pbx2 1.765 0.0003 
Translation factor Guf1, mitochondrial Guf1 1.682 0.0011 
Transmembrane protein 253 Tmem253 1.602 0.0036 
Unconventional myosin-IXb Myo9b 1.376 0.0003 
L-lactate dehydrogenase;L-lactate dehydrogenase B 
chain 
Ldhb -2.549 0.0047 
60S ribosomal protein L18 Rpl18 -1.972 0.0025 
Solute carrier family 35 member E2 Slc35e2 -1.505 0.0014 
Peptidyl-prolyl cis-trans isomerase-like 3;Peptidyl-
prolyl cis-trans isomerase 
Ppil3 -1.434 0.0003 
Kelch domain-containing protein 4 Klhdc4 -1.424 0.0012 
Interferon regulatory factor 8 Irf8 -1.357 0.0005 
F-box only protein 25 Fbxo25 -1.329 0.0005 
 
Table 5.5: indicating the changes in small intestinal mucosal proteome of Nfҡb2-/- mice 
following LPS administration compared to untreated mice of the same genotype. The 
top half shows the significantly upregulated proteins (blue) while the lower section 
shows significantly downregulated proteins (orange) (N=4). 
 
 
Protein names Gene names 
Regulation 
fold change 
P value 
Ig heavy chain V region VH558 
A1/A4 
Ighv1-23;Ighv1-81;Ighv1-77;Ighv1-
78;Ighv1-62-2;Ighv1-80;Ighv1-63;Ighv1-
54;Ighv1-7;Ighv1-4;Gm5629 
5.242 0.0017 
 
Table 5.6: Upregulation of proteins in the small intestinal mucosal proteome in               
c-Rel-/- mice following LPS administration compared with untreated c-Rel-/- (N=4). 
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5.3 LPS exclusively induces 298 proteomic changes in Nfҡb1-/- small 
intestinal mucosa compared with C57BL/6J mice 
We have described the differences in baseline protein expression changes between 
transgenic mice with different deletions in Nfκb subunits (section 5.1) and have 
identified the protein changes within the mucosa in response to LPS within each 
genotype (section 5.2).  We now aim to characterise the differences in small intestinal 
mucosal protein expression between LPS treated transgenic mice of each genotype 
and LPS treated C57BL/6 mice whilst taking into consideration the baseline differences 
in small intestinal mucosal proteome between transgenic and C57BL/6 wild-type mice.  
To identify the specific changes in small intestinal mucosal proteome of Nfҡb1-/- mice 
in comparison to the proteome of wild type C57BL/6J mice following LPS treatment 
we made a comparison between two different comparisons (untreated Nfҡb1-/- vs 
untreated C57BL/6J against LPS-treated Nfҡb1-/- vs LPS-treated C57BL/6J). Based on 
this comparison we identified 797 total significant differences between the small 
intestinal mucosal proteome of Nfҡb1-/- mice and C57BL/6J mice. 49.4% of these 
changes appeared to be significantly upregulated proteins while 50.6% represented 
proteins with downregulated expression (Figure 5.3).   
Interestingly, 208 proteins representing 83.2% from a total of 250 proteins with 
significant upregulation differences were exclusively seen between untreated      
Nfҡb1-/- and untreated C57BL/6J mice. By contrast, from a total of 144 upregulated 
proteins with significant differences between LPS-treated Nfҡb1-/- and LPS-treated 
C57BL/6J mice, only 102 proteins were exclusively noted in the LPS treated 
comparison. The remaining 42 proteins were seen significantly upregulated in both 
LPS-treated and untreated comparison groups. (Figure 5.3-A).  
141 
 
Correspondingly, we found 403 proteins which showed significant downregulation 
between Nfκb1-/- and C57BL/6J small intestinal mucosa (Figure 5.3-B). 178 proteins 
(representing 71.5% of the total 249 proteins) that were downregulated between 
untreated Nfҡb1-/- and untreated C57BL/6J small intestinal mucosa exclusively 
appeared in the untreated comparison group. 83 proteins were exclusively identified 
between LPS treated Nfκb1-/- and C57BL/6J mice. A further 71 proteins were 
significantly down regulated in both LPS-treated and untreated comparisons between 
Nfκb1-/- and C57BL/6J small intestinal mucosa (Figure 5.3-B).  
 
 
 
 
 
 
 
 
Figure 5.3: Venn graph indicating a comparison of significant proteomic changes 
between Nfҡb1-/- and C57BL/6J mice before and after IP injection of 0.125 mg/kg LPS 
(N=4). A) shows upregulated and B) shows downregulated protein numbers. E= 
proteomic changes that exclusively seen in the corresponding comparison. 
 
In summary, the total significant proteomic changes that were exclusively noted 
between Nfҡb1-/- and C57BL/6J mice following administration of LPS at 0.125mg/kg 
were 102 proteins that were significantly upregulated and 83 proteins which showed 
significant downregulation. 
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Tables 5.7 and 5.8 describe the top 10 up- and downregulated proteins with the 
greatest differences in fold change between LPS-treated Nfҡb1-/- and LPS-treated 
C57BL/6J small intestinal mucosa excluding the protein differences that were 
observed at baseline between these genotypes. We identified that some proteins 
were downregulated between untreated Nfκb1-/- and C57BL/6J mice but were 
upregulated after administration of LPS between the same genotypes and vice versa. 
Among the top 10 upregulated proteins only one protein has previously been 
indicated to have a biological role in the small intestinal mucosa. Pla2g6 is an enzyme 
that catalyses the release of fatty acids from phospholipids. It was previously shown 
to promote intestinal epithelial cell apoptosis and inhibit crypt cell regeneration 
causing damage to the intestinal barrier and exacerbating colitis (Jialo et al., 2015). 
Overexpression of Pla2g6 may therefore contribute to the increased susceptibility of 
Nfκb1-/- mice to LPS-induced SIEC apoptosis and shedding.  
Phf10 and Stx3 were significantly downregulated in Nfκb1-/- versus C57BL/6 small 
intestinal mucosa following LPS administration and both proteins have been 
previously investigated. Phf10 supressed caspase-3 activation and inhibited apoptosis 
in a gastric cancer cell line (Wei et al., 2010), while loss of Stx3 caused the variant 
microvillus inclusion disease “congenital enteropathy of apical microvilli” (Wiegerinck 
et al., 2014 and Hong et al., 2016) suggesting that these proteins may modulate 
susceptibility to LPS-induced SIEC apoptosis and shedding. The remaining proteins 
listed in tables 5.7 and 5.8 have not previously been investigated or identified to have 
a biological role in the small intestinal mucosa. 
 
143 
 
                                   Proteomics comparison 
 LPS-treated  
(Nfҡb1
-/- 
vs C57BL/6J) 
untreated  
(Nfҡb1
-/- 
vs C57BL/6J) 
Protein names Gene names 
Regulation 
fold change 
P value 
Regulation 
fold change 
P value 
Solute carrier family 35 member B1 Slc35b1 7.642 0.0034 1.659 0.537 
NADH-ubiquinone oxidoreductase chain 
5 
Mtnd5 3.766 0.0301 1.31 0.7079 
NADH:ubiquinone oxidoreductase core 
subunit S1 
Ndufs1 3.546 0.0005 1.84 0.123 
85/88 kDa calcium-independent 
phospholipase A2 
Pla2g6 3.246 0.0002 1.485 0.0741 
Protein transport protein Sec61 subunit 
gamma 
Sec61g 3.158 0.0007 1.495 0.2344 
Oligosaccharyltransferase complex 
subunit OSTC 
Ostc 3.012 0.0442 -1.29 0.7943 
Apolipoprotein C-I;Truncated 
apolipoprotein C-I 
Apoc1 2.749 0.0042 1.05 0.6761 
ATP synthase subunit e, mitochondrial Atp5i;Atp5k 2.615 0.0005 1.659 0.0257 
interferon gamma induced GTPase Igtp 2.526 0.0014 1.58 0.123 
DNA-dependent protein kinase catalytic 
subunit 
Prkdc 2.488 0.0005 1.165 0.5012 
 
Table 5.7: The top 10 upregulated proteins with greatest log2 differences in Nfҡb1-/- 
small intestinal mucosa in comparison to C57BL/6J  post LPS administration and the 
log2 differences at baseline (untreated) between Nfҡb1-/- and C57BL/6 small intestinal 
mucosa for these proteins. (N=4) 
 
                                        Proteomics comparison 
LPS-treated  
(Nfҡb1
-/- 
vs C57BL/6J) 
Untreated  
(Nfҡb1-/- vs C57BL/6J) 
Protein names 
Gene 
names 
Regulation 
fold change 
P value 
Regulation 
fold change 
P value 
PHD finger protein 10 Phf10 -7.91 0.0005 1.39 0.5129 
THAP domain-containing protein 4 Thap4 -7.04 0.0003 -1.1 0.6166 
Serine (or cysteine) peptidase inhibitor, 
clade B, member 9b and 9c 
Serpinb9b;S
erpinb9c 
-3.5 0.001 -1.8 0.1549 
Aminoacylase-1 Acy1 -3.39 0.0401 -1.6 0.0214 
Reticulon;Reticulon-1 Rtn1 -3.36 0.0022 -1.5 0.2455 
Liver carboxylesterase 1 Ces1 -2.99 0.0016 -1.5 0.302 
Syntaxin-3 Stx3 -2.77 0.0003 -1.4 0.2138 
Solute carrier family 15 member 1 Slc15a1 -2.68 0.0006 -1.5 0.0813 
Ectonucleotide 
pyrophosphatase/phosphodiesterase 3 
Enpp3 -2.61 0.0078 -1.3 0.166 
ADP-ribosyl cyclase/cyclic ADP-ribose 
hydrolase 2 
Bst1 -2.55 0.0008 -1.3 0.4266 
 
Table 5.8: The top 10 downregulated proteins with greatest log2 differences in     
Nfҡb1-/- small intestinal mucosa in comparison to C57BL/6J post LPS administration 
and log2 differences at baseline (untreated) between Nfҡb1-/- and C57BL/6 small 
intestinal mucosa for these proteins. (N=4) 
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5.4 118 significant small intestinal mucosal proteomic changes were 
identified exclusively in LPS-treated Nfҡb2-/- mice compared to LPS-
treated C57BL/6J mice  
Following the administration of LPS we found 915 significant changes in the small 
intestinal mucosal proteome of Nfҡb2-/- mice in comparison to LPS-treated C57BL/6J 
mice.  419 proteins were significantly upregulated (representing 45.8% of the total 
proteomic changes) while the remaining 496 proteins (54.2%) were downregulated. 
To determine the significant proteomic changes that arose exclusively following LPS 
administration (i.e. excluding baseline differences between Nfҡb2-/- and C57BL/6J 
mice from the analysis) we compared all significant changes that were observed 
between these two genotypes before and after LPS administration. Interestingly we 
found that only 46 proteins (representing 11% from the total upregulation changes 
post LPS injection) were upregulated in LPS-treated Nfҡb2-/- mice compared to LPS-
treated C57BL/6J mice when baseline differences in the small intestinal mucosal 
proteome of Nfҡb2-/- and C57BL/6J mice were excluded (Figure 5.4-A). We also found 
that only 72 proteins (14.5%) (from a total of 496 significantly downregulated 
proteins) in LPS-treated Nfҡb2-/- compared to LPS-treated C57BL/6J mice showed 
significant changes as a result of LPS administration (Figure 5.4-B). The majority of up- 
and downregulated proteins (89% and 85.5% respectively) observed between     
Nfҡb2-/- and C57BL/6J small intestinal mucosa were identified both before and after 
IP administration of LPS (Figure 5.4). 
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Figure 5.4: Venn graph indicating a comparison of significant proteomic changes 
between Nfҡb2-/- and C57BL/6J mice before and after IP injection of 0.125mg/kg LPS 
(N=4). A) shows upregulated and B) shows downregulated protein numbers. E= 
proteomic changes that were exclusively seen in the corresponding comparison. 
 
Tables 5.9 and 5.10 show the top 10 log2 fold up- and downregulations in protein 
expression in the small intestinal mucosa of LPS-treated Nfҡb2-/- versus C57BL/6J 
mouse groups and the expression of these proteins in the Nfҡb2-/- versus C57BL/6J 
untreated groups comparison. The majority of these proteins have not previously 
been investigated or identified as having a biological role in the small intestinal 
mucosa.  
We identified some proteins that were significantly downregulated in untreated 
Nfҡb2-/- mouse small intestinal mucosa that were significantly upregulated in LPS 
treated Nfҡb2-/- mice when compared against untreated and LPS treated C57BL/6 
small intestinal mucosa respectively; these were Guf1 and Cdc42bpa. Guf1 has not 
previously been shown to play any role in small intestinal mucosal homeostasis, but 
Cdc42bpa has been shown to be downregulated in jejunal epithelial cells of 
enterotoxigenic E. coli (ETEC)-infected piglets resulting in NFκB and MAPK pathway 
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inhibition (Ren et al., 2016). We also identified proteins that were upregulated at 
baseline such as Mrpl21 (not previously identified to have a biological role in the small 
intestine) and Phf10 (described above; knockdown of Phf10 activated caspase-3 and 
induced apoptosis in gastric cancer cells; Wei et al., 2010) and these exhibited 
downregulation after LPS injection (Table 5.9 and 5.10). 
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                                           Proteomics comparison 
LPS-treated  
(Nfҡb2
-/- 
vs C57BL/6J) 
Untreated  
(Nfҡb2
-/- 
vs C57BL/6J) 
Protein names Gene names 
Log2  
(Differences) 
-Log10 
(p-value) 
Log2  
(Differences) 
-Log10 
(p-value) 
NADH dehydrogenase [ubiquinone] 1 alpha 
subcomplex assembly factor 5 
Ndufaf5 2.962 0.0019 1.21 0.389 
Peripherin Prph 2.149 0.0033 1.09 0.8318 
Interferon-induced guanylate-binding 
protein 2 
Gbp2 1.809 0.0065 1.16 0.389 
Ras-related protein Rab-8B Rab8b 1.795 0.0004 1.23 0.0759 
Volume-regulated anion channel subunit 
LRRC8A 
Lrrc8a 1.672 0.0003 1.14 0.0363 
Translation factor Guf1, mitochondrial Guf1 1.596 0.0016 -1.1 0.1047 
Annexin Anxa6 1.595 0.0161 1.21 0.2042 
Serine/threonine-protein kinase MRCK 
alpha 
Cdc42bpa 1.586 0.0019 -1.1 0.6457 
Disheveled-associated activator of 
morphogenesis 1 
Daam1 1.582 0.0112 1.17 0.263 
Ufm1-specific protease 2 Ufsp2 1.566 0.0012 1.24 0.0661 
 
Table 5.9: The top 10 upregulated proteins with greatest log2 differences in Nfҡb2-/- 
small intestinal mucosa in comparison to C57BL/6J post LPS administration and log2 
differences at baseline (untreated) between Nfҡb2-/- and C57BL/6 small intestinal 
mucosa for these proteins. (N=4) 
 
                                           Proteomics comparison 
LPS-treated  
(Nfҡb2
-/- 
vs C57BL/6J) 
Untreated  
(Nfҡb2
-/- 
vs C57BL/6J) 
Protein names Gene names 
Regulation 
fold change 
P value 
Regulation 
fold change 
P value 
PHD finger protein 10 Phf10 -9.49 0.0004 1.18 0.6761 
Ly6/PLAUR domain-containing protein 8 Lypd8 -1.84 0.0122 -1.09 0.871 
39S ribosomal protein L21, 
mitochondrial 
Mrpl21 -1.75 0.0016 1.14 0.3162 
Hepatoma-derived growth factor-
related protein 2 
Hdgfrp2 -1.69 0.0025 -1.16 0.1585 
Protein phosphatase 1 regulatory 
subunit 12C 
Ppp1r12c -1.68 0.0001 -1.03 0.8318 
Bcl-2-like protein 15 Bcl2l15 -1.67 0.0314 -1.24 0.1122 
ER lumen protein-retaining receptor 1, 
receptor 2 and receptor 3 
Kdelr1, Kdelr2, 
Kdelr3 
-1.67 0.0353 -1.02 0.912 
Kinesin-like protein KIF11 Kif11 -1.66 0.0003 -1.19 0.0182 
Essential MCU regulator, mitochondrial Smdt1 -1.66 0.0067 -1.21 0.2042 
Cell division cycle protein 23 homolog Cdc23 -1.64 0.0076 -1.01 0.912 
 
Table 5.10: The top 10 downregulated proteins with greatest log2 differences in  
Nfҡb2-/- small intestinal mucosa in comparison to C57BL/6J post LPS administration 
and log2 differences at baseline (untreated) between Nfҡb2-/- and C57BL/6 small 
intestinal mucosa for these proteins (N=4). 
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5.5 Small intestinal mucosal proteomic analysis of c-Rel-/- mice identified 
176 changes in comparison to C57BL/6J  
Comparison of the c-Rel-/- small intestinal mucosal proteome with C57BL/6J after IP 
administration of 0.125mg/kg LPS indicated 176 significant protein changes. 83 
proteins (47.16% of the total proteins) were significantly upregulated while the 
remaining 93 proteins (52.84%) were significantly downregulated. 57 upregulated 
proteins (68.7% of total proteins with upregulated expression) and 63 down regulated 
proteins (67.7% of total downregulated proteins) were expressed exclusively in              
c-Rel-/- versus C57BL/6J LPS treated mouse small intestinal mucosae and showed no 
significant differences at baseline between c-Rel-/- and C57BL/6 strains. (Figure 5.5) 
  
 
 
 
 
 
 
Figure 5.5: Venn graph indicating a comparison of significant protein changes between 
c-Rel-/- and C57BL/6J mice before and after IP injection of 0.125mg/kg LPS (N=4) A) 
shows upregulated and B) shows downregulated protein numbers. E= proteomic 
changes that exclusively seen in the corresponding comparison. 
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Tables 5.11 and 5.12 show the proteins with the greatest up- and downregulation log2 
fold changes in the c-Rel-/- small intestinal mucosal proteome compared with C57BL/6J 
following IP injection of 0.125mg/kg LPS that showed non-significant proteomic 
changes in the untreated c-Rel-/- vs C57BL/6J comparison. 
Myo9b (associated with increased gut permeability in Crohn’s disease, Prager et al., 
2014, Wang et al., 2016), Mpx2 (newly identified as a Paneth cell marker but its 
function is unknown, Haber et al., 2017) and Piger (which is downregulated in the 
colonic mucosa in ulcerative colitis, Bruno et al., 2015) were upregulated in c-Rel-/- 
small intestinal mucosa in comparison to C57BL/6J mice following LPS injection. By 
contrast Klf5, which is involved in the regulation of various biological processes 
including cell proliferation, differentiation, development and apoptosis and which is 
normally expressed in proliferating epithelial cells at the base of intestinal crypts, was 
significantly downregulated in LPS-treated c-Rel-/- mice in comparison to LPS-treated 
C57BL/6J small intestinal mucosa. 
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                                                          Proteomics comparison 
 LPS-treated  
(c-Rel
-/- 
vs C57BL/6J) 
untreated  
(c-Rel
-/- 
vs C57BL/6J) 
Protein names Gene names 
Regulation 
fold change 
P value 
Regulation 
fold change 
P value 
Unconventional myosin-IXb Myo9b 3.99 0.0018 1.61 0.4169 
Transformation/transcription 
domain-associated protein 
Trrap 3.88 0.0495 2.13 0.2042 
Mucosal pentraxin 2 Mptx2 3.25 0.0493 0.91 0.8318 
Uncharacterized protein 
KIAA0556 
D430042O09Rik; 
Kiaa0556 
3.00 0.019 1.43 0.3467 
1,4-alpha-glucan-branching 
enzyme 
Gbe1 2.71 0.0387 1.61 0.2399 
Regenerating islet-derived 
protein 3-gamma 
Reg3g 2.49 0.0003 1.31 0.5248 
Sorting nexin-3 Snx3 2.22 0.0002 1.33 0.182 
Polymeric immunoglobulin 
receptor 
Pigr 2.20 0.0003 1.4 0.1995 
MLV-related proviral Env 
polyprotein 
Transmembrane protein 1.97 0.0102 1.14 0.0363 
Nectin-2 Pvrl2 1.85 0.0007 1.18 0.0912 
 
Table 5.11: The top 10 upregulated proteins with greatest log2 differences in c-Rel-/- 
small intestinal mucosa in comparison to C57BL/6J post LPS administration and log2 
differences at baseline (untreated) between c-Rel-/- and C57BL/6 small intestinal 
mucosa for these proteins. (N=4) 
 
                                              Proteomics comparison 
 LPS-treated  
(c-Rel
-/- 
vs C57BL/6J) 
untreated  
(c-Rel
-/- 
vs C57BL/6J) 
Protein names Gene names 
Regulation fold 
change 
P value 
Regulation 
 fold change 
P value 
Krueppel-like factor 5 Klf5 -8.69 0.0005 1.04 0.9333 
Solute carrier family 2, facilitated 
glucose transporter member 5 
Slc2a5 -4.38 0.0006 -1.59 0.0955 
Sodium/potassium-transporting 
ATPase subunit alpha-4 
Atp1a4 -3.79 0.0019 1.18 0.1862 
Replication factor C subunit 2  -3.26 0.0013 -1.75 0.1175 
Acyl-coenzyme A thioesterase 2, 
mitochondrial 
Acot2 -2.24 0.0005 -1.2 0.257 
39S ribosomal protein L17, 
mitochondrial 
Mrpl17 -2 0.0004 -1.03 0.8318 
39S ribosomal protein L21, 
mitochondrial 
Mrpl21 -1.93 0.0002 -1.59 0.0676 
H/ACA ribonucleoprotein complex 
subunit 2 
Nhp2 -1.87 0.0281 -1.47 0.2089 
Trafficking protein particle complex 
subunit 5 
Trappc5 -1.85 0.0283 -1.39 0.1862 
Dehydrogenase/reductase SDR 
family member 4 
Dhrs4 -1.82 0.0046 1.06 0.7413 
 
Table 5.12: The top 10 downregulated proteins with greatest log2 differences in              
c-Rel-/- small intestinal mucosa in comparison to C57BL/6J post LPS administration and 
log2 differences at baseline (untreated) between c-Rel-/- and C57BL/6 small intestinal 
mucosa for these proteins. (N=4) 
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5.6 Discussion 
In this chapter we have studied the small intestinal mucosal proteome of C57BL/6J 
mice and how the proteome changed following the germline deletion of Nfҡb1, Nfҡb2 
and c-Rel. We have also investigated the role of LPS in inducing changes in the small 
intestinal mucosal proteome in C57BL/6J mice.  Using Nfҡb1-/-, Nfҡb2-/- and c-Rel-/- 
genotypes, we have identified proteins that may play important roles in the induction 
and resistance of pathological apoptosis and shedding of murine SIECs following 
systemic administration of bacterial LPS.  Furthermore, we studied these protein 
regulation changes to try to understand why Nfҡb2-/- mice were more resistant and 
Nfҡb1-/- mice were more susceptible to LPS- induced SIEC apoptosis and shedding. 
To date, there have been no studies discussing changes in the small intestinal 
proteome of Nfҡb1-/-, NfҡB2-/- and c-Rel-/- mice in comparison to C57BL/6J mice before 
and after the administration of bacterial LPS. The small intestinal proteome of these 
mice indicated differences in upregulated and downregulated proteins. For example, 
gastrotropin (also known as fatty acid binding protein 6) is regulated by NFκB 
activation (Fang et al., 2007) and was upregulated in NfҡB1-/- and c-Rel-/- small 
intestinal mucosa and downregulated in Nfҡb2-/- mice compared to C57BL/6J and has 
previously been reported to be overexpressed in colorectal cancer and adenomas 
compared with normal colonic epithelium (Ohmachi et al., 2006).  Gastrotropin may 
therefore contribute to the increased susceptibility of c-Rel-/- and reduced 
susceptibility of Nfҡb2-/- mice to Dextran sulphate sodium/azoxymethane induced 
colon tumours as previously observed in our laboratory (Burkitt et al., 2015) in 
addition to regulating how the small intestinal mucosa responds to damage-inducing 
stimuli such as LPS. Proteasome subunit beta type-5 (Psmb5) has a role in activation 
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of NFκB and regulates the expression of pro-inflammatory cytokines such as TNF and 
interleukins (Goldberg et al., 1995). Psmb5 was downregulated in Nfҡb2-/- mice but 
non-significantly expressed in Nfҡb1-/- and c-Rel-/- mice (see more differences in tables 
5.1, 5.2 and 5.3). These baseline differences in proteome may contribute to why these 
genotypes respond with different susceptibilities to induced SIEC apoptosis and 
shedding in response to bacterial LPS.  
Comparing the small intestinal proteomes of NfҡB1-/-, NfҡB2-/- and c-Rel-/- genotypes 
before and after LPS administration also indicated differences (see Figure 5.2, tables 
5.5 and 5.6). A previous study by Huang and colleagues in 2002 described the 
proteomic analysis of LPS induced apoptosis in rat pheochromocytoma cells (PC12 
cells) and found that LPS induced apoptosis was characterised by changes in proteins 
associated with endoplasmic reticulum, mitochondria and cell membrane including an 
increase in the level of calreticulin, calcium binding protein 50, endoplasmic reticulum 
protein 60, heat shock protein 60 and a decrease in the levels of amphoterin, 
cytochrome c oxidase poly peptide Vla-liver or endoplasmic reticulum protein 29 
(ERP29) (Huang et al., 2002). In our proteomic analysis we found that calreticulin 
protein (Calr) was upregulated in untreated Nfҡb1-/- and c-Rel-/- mice and 
downregulated after administration of LPS to these genotypes, whereas  it was 
upregulated pre- and post LPS administration in Nfҡb2-/- small intestinal mucosa. Plant 
homeodomain finger protein 10 (Phf10) was downregulated in the small intestinal 
mucosa of LPS-treated NfҡB1-/- and NfҡB2-/- mice compared with LPS-treated 
C57BL/6J mice. Proteins from this family are well documented to be capable of 
translocating to the nucleus and regulating transcription (see table 5.8 and 5.10). 
Phf10 protein expression was previously shown to supress active caspase 3 expression 
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and led to impaired apoptosis in gastric cancer cells (Wei et al., 2010). However, Phf10 
is likely to have many more functions as it is capable of modulating the transactivating 
capacity of several common NFκB dimers (both classical and alternative NFκB 
signalling pathways) in response to TNF (Ishizaka et al., 2012).  As Phf10 is one of the 
proteins that has been consistently identified as having one of the greatest fold 
changes within our analysis, this transcription factor/co-factor warrants further 
investigation into how important it is in regulating SIEC apoptosis and shedding in 
response to LPS and TNF. Furthermore, Bcl-2-like protein 15 contains the BH2 and BH3 
domains of the Bcl-2 family and is pro-apoptotic (Zhang et al., 2007).  Members of this 
family of proteins can be pro- or anti-apoptotic and have previously been shown to 
play important roles in regulating spontaneous and induced apoptosis along the 
intestinal epithelium (Pritchard et al., 2000, Duckworth and Pritchard, 2009). In our 
study Bcl-2-like protein 15 was significantly downregulated in LPS-treated Nfҡb2-/- 
small intestinal mucosa and upregulated in LPS-treated C57BL/6J and Nfҡb1-/- mice 
(see table 5.10 and appendices 4 and 5), suggesting that the reduced expression of 
this pro-apoptotic Bcl-2 family member in the Nfҡb2-/- small intestinal mucosa may 
prevent LPS-induced epithelial cell apoptosis and consequential  cell shedding.   
In summary, the proteomic analysis of the small intestinal mucosal proteome of 
Nfҡb1-/-, Nfҡb2-/- and c-Rel-/- mice indicated significant alterations with different 
regulatory expressions in comparison to the C57BL/6J small intestinal mucosal 
proteome. LPS caused various changes in protein expression in each Nfҡb transgenic 
mouse group reflecting the differences in response of these mice to pathological 
apoptosis and shedding induced by administration of bacterial LPS. The data 
presented in this chapter have identified several targets that need further and deeper 
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investigation by techniques such as western blot and immunohistochemistry, and by 
genetic knockdown/overexpression in small intestinal organoids or in vivo to identify 
the importance and localisation of these proteins in regulating the response to LPS 
induced SIEC apoptosis and shedding. 
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6. Investigation of stimuli other than LPS that induce small intestinal 
epithelial cell apoptosis and shedding 
6.1 Introduction 
Small intestinal epithelial cell apoptosis and shedding can be induced by agents other 
than bacterial lipopolysaccharide (LPS). Among these agents are anti-CD3 antibody, 
polyinosinic:polycytidylic (poly I:C) acid and tumour necrosis factor (TNF). 
Intraperitoneal administration of anti-CD3 antibody (clone 145-2C11) in vivo activates 
the T-lymphocytes that play a crucial role in gut epithelial cell inflammatory responses 
and results in increased small intestinal epithelial cell apoptosis and shedding (Merger 
et al., 2002 and Miura et al., 2005) and an increase in intestinal epithelial barrier 
permeability (Zhou et al., 2004).Yamamoto et al., 1998 showed that stimulation of 
intraepithelial T lymphocytes via the TCR-CD3 complex caused a high proliferation 
index in the intestinal mucosa with increased cytokine synthesis. Intestinal epithelial 
cells express toll-like receptors (TLRs) and when these are stimulated this leads to an 
increase in pathological apoptosis and shedding with loss of intestinal barrier function.  
Previous studies have indicated that stimulation of TLR4 by bacterial 
lipopolysaccharide and of TLR3 by poly I:C (a synthetic analogue of double-stranded 
RNA virus) induces the apoptosis and shedding of small intestinal epithelial cells. This 
subsequently influences mucosal homeostasis and increases gut barrier permeability 
(Williams et al., 2013 and McAllister et al., 2012). 
Binding of anti-CD3 antibody to the TCR-CD3 complex on the outer membrane of T-
Cells and poly I:C to TLR3 on the outer membrane of mononuclear phagocytic cells 
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respectively activates these immune cells to produce numerous cytokines including 
TNF (Merger et al., 2002 and Williams et al., 2013). 
A number of previous studies have described the role of TNF as a potent stimulus of 
pathological apoptosis and shedding in murine small intestinal epithelial cells through 
its binding to TNFR1 (Pfeffer et al., 1993 and Williams et al., 2013). Gut barrier function 
is disrupted in mice treated with TNF due to an increase in cell shedding and a failure 
of tight junction proteins to seal up the resulting barrier discontinuity (Watson and 
Hughes, 2012).  
In this chapter, we aimed to compare the small intestinal epithelial cell apoptosis and 
shedding that are induced by anti-CD3 antibody (T-cell mediated shedding), poly I:C 
(viral activation of shedding), TNF (expressed by macrophages, T-cells, B-cells, NK cells, 
mast cells, endothelial cells, fibroblasts and neurons) and LPS (macrophage mediated 
shedding) in terms of time of peak effect, the effective dose and genetic regulation by 
members of the NFκB family of proteins. 
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6.2 Anti-CD3 antibody induces T-cell mediated apoptosis and 
shedding in murine small intestinal epithelial cells  
6.2.1 Maximal induction of small intestinal epithelial cell apoptosis and 
shedding occurred 1.5 hours post intraperitoneal administration of anti-
CD3 antibody 
The monoclonal anti-CD3 antibody, at a dose of 1mg/kg induced small 
intestinal apoptosis and cell shedding in female C57BL/6J mice (Figure 6.1). 
This effect was initially observed 1 hour post IP administration (1.3±0.08%, 
P=0.696, N=3, ANOVA) but with no significant difference compared to 
untreated animals (1±0.05%). After 1.5 hours, the effect had reached its 
peak with the percentage of apoptosis and cell shedding having increased to 
2.3±0.09% (P<0.01, N=3; ANOVA). This significant effect continued at 2 
hours (2.1±0.098%) then slightly declined at 4 hours (2±0.23%, P<0.05, N=3, 
ANOVA). It continued to decline to reach 1.3±0.07% at 6 hours post 
administration of anti-CD3 antibody (P=0.775, N=3, ANOVA) (Figure 6.2). 
Based on the cell positional graph (Figure 6.3), the effect of anti-CD3 
antibody appeared to be more pronounced at the villus tips rather than in 
the basal parts of small intestinal villi. 
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Figure 6.1: Active caspase-3 IHC in sections of proximal segments of small 
intestine of female C57BL/6J mice injected with 1mg/kg anti-CD3 antibody 
at different time points. 
 
 
Figure 6.2: Bar chart representing the percentage of IEC apoptosis and shedding in 
female C57BL/6J mice treated with 1mg/kg anti-CD3 antibody at different time points, 
N=3; ANOVA, Dunnett post-hoc test for multiple comparisons with control **P<0.01 
and *P<0.05. 
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Figure 6.3: Cell positional graphs showing quantification of positively immuno-labelled 
IECs along the villus axis of C57BL/6J mice treated with 1mg/kg anti-CD3 antibody at 
different time points. 
 
 
6.2.2 A direct relationship was observed between anti-CD3 antibody dose 
and the percentage of small intestinal epithelial cell apoptosis and 
shedding in female C57BL/6J mice 1.5 post administration  
Interestingly we observed that mice which were treated with increasing 
doses of anti-CD3 antibody for 1.5 hours showed increases in the 
percentage of small intestinal epithelial cell apoptosis and shedding (Figure  
6.4). No significant increase was observed in mice treated with 0.5 mg/kg 
anti-CD3 antibody in comparison to untreated mice (1.8±0.33% and 
1±0.05% respectively, P=0.217, N=3; ANOVA). However significant increases 
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1 mg/kg, 2 mg/kg and 4 mg/kg (P<0.05, <0.001 and <0.0001 respectively, 
N=3; ANOVA) (Figure 6.5). On the other hand, mice that were treated with 
the anti-CD3 isotype control (Figure 6.7-A) actually showed a lower 
percentage of apoptosis and shedding than untreated mice (0.4±0.03% for 
mice injected with 1mg/kg isotype control and 0.3±0.05% for mice treated 
with 4 mg/kg isotype control). Furthermore, the cell positional plots again 
indicated that the greatest effect of anti-CD3 antibody occurred in the apical 
part rather than in the basal region of small intestinal villi in all groups 
(Figure 6.6 and 6.7-B). 
 
 
 
 
 
 
 
 
Figure 6.4: Active caspase-3 IHC in sections of proximal segments of small 
intestine of female C57BL/6J mice injected with increasing doses of anti-CD3 
antibody at 1.5 hours. X40 
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Figure 6.5: Percentage of active caspase 3 positively labelled IECs in C57BL/6J mice 
injected with differing doses of anti-CD3 antibody for 1.5 hours. N=3; ANOVA, Dunnett 
post-hoc test for multiple comparisons with control, *P<0.05, ***P<0.001, 
****P<000.1 
 
 
 
Figure 6.6: Cell positional graphs showing quantification of positively immuno-labelled 
IECs along the villus axis of C57BL/6J mice injected with differing doses of anti-CD3 
antibody for 1.5 hours. 
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Figure 6.7: Bar chart and cell positional plot representing the percentage (A) and 
distribution (B) of SIEC apoptosis and shedding in C57BL/6J mice injected with differing 
doses of anti-CD3 isotype control for 1.5 hours compared to untreated mice (N=3, 
*P<0.05,**P<0.01). 
 
6.2.3 Members of the NFκB family of proteins regulate the pathological 
small intestinal epithelial apoptosis and shedding induced by anti-CD3 
antibody: 
To further investigate the role of NFκB transcription factors in regulating 
anti-CD3 antibody induced SIEC apoptosis and cell shedding, active caspase-
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epithelial cell apoptosis and shedding was only 0.8±0.09% (P<0.001). An 
increase in the percentage of pathological small intestinal apoptosis and 
shedding was also observed in c-Rel-/- mice (4.8±0.62%), but this increase 
was not significantly different (P=0.093) from the percentage of apoptosis 
and shedding that was seen in wild-type C57BL/6J mice (all N=6; ANOVA). 
The cell positional graph (Figure 6.10) again indicated that the apoptosis and 
shedding of small intestinal epithelial cells in all strains of transgenic mice as 
well as in the wild-type group was more pronounced in the upper half of 
intestinal villi. 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.8: Active caspase-3 IHC in sections of proximal segments of small 
intestine of transgenic and wild-type C57BL/6J mice injected with 2 mg/kg 
anti-CD3 antibody at 1.5 hours. 
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Figure 6.9: Comparison between the percentage of active caspase 3 positively labelled 
IECs in Nfҡb1-/-, Nfҡb2-/-, c-Rel-/- and wild-type C57BL/6J mice. N=6; ANOVA, Dunnett 
post-hoc test for multiple comparison with control, *P<0.05, ***P<0.001. 
 
 
 
Figure 6.10: Cell positional graphs showing quantification of positively immuno-
labelled IECs along the villus axis of transgenic mice (Nfҡb1-/- , Nfҡb2-/-
 
and c-Rel-/-) 
compared to wild-type C57BL/6J mice, all treated with 2mg/kg anti-CD3 antibody for 
1.5 hours. 
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6.2.4 Anti-CD3 antibody also significantly induced apoptosis in murine 
small intestinal crypt epithelial cells 24 hours post IP administration 
A previous study by Miura et al; 2005 indicated that anti-CD3 antibody 
induces T-cell mediated bi-phasic apoptosis and shedding in murine small 
intestinal epithelial cells. Villus apoptosis was observed up to 4 hours, but 
apoptosis of intestinal crypt cells was also seen up to 24 hours post 
injection. Our results showed that after IP injection of 2 mg/kg anti-CD3 
antibody to wild-type C57BL/6J, Nfҡb1-/-, Nfҡb2-/- and c-Rel-/- mice for 24 
hours, we observed a marked increase in the number of apoptotic small 
intestinal crypt epithelial cells in Nfҡb1 and c-Rel knockout mice, whereas 
we noted small rise in the number of apoptotic crypt cells in Nfҡb2-/- mice 
(Figure 6.11). Statistically, there was a significant increase in the percentage 
of apoptotic small intestinal crypt epithelial cells from 0.4±0.03% in wild-
type C57BL/6J mice to 1.2±0.21% and 0.8±0.08% (P<0.001 and P<0.05 
respectively, ANOVA) in Nfҡb1-/- and c-Rel-/- mice. Although there was also 
an increase in the number of apoptotic crypt epithelial cells noted in    
Nfҡb2-/- mice (0.5±0.08%), this was not statistically significant (P=0.327, 
ANOVA). On the other hand, following addition of caspase-3 negatively 
labelled cells that representing non-apoptotic cell death, the percentage of 
cell death in small intestinal crypt epithelial cells was increased to 3.9±1.02% 
(P<0.05) and 2.7±0.26% (P=0.268) in Nfҡb1-/- and c-Rel-/- whereas Nfҡb2-/- 
mice showed a non-significant slightly decreased percentage of apoptotic 
crypt epithelial cells (1.2±0.13%, P=0.974, ANOVA) compared to 1.4±0.14% 
in treated wild-type C57BL/6J mice (Figure 6.12-A). Although the cell 
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positional graph (Figure 6.12-B) showed that apoptotic cells were more 
pronounced in the lower half of small intestinal crypts in all strains, the 
modified median test indicated that the apoptotic cells were significantly 
different between cell position 3 and 20 in Nfҡb1-/- mice compared to wild-
type C57BL/6J. 
 
 
 
 
 
 
 
 
 
Figure 6.11: Active caspase-3 IHC demonstrating apoptotic small intestinal 
crypt epithelial cells (black arrows) in transgenic and wild-type C57BL/6J 
mice injected with 2 mg/kg anti-CD3 antibody for 24 hours. (X40). 
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Figure 6.12: (A) Bar chart indicating the percentage of apoptotic small intestinal crypt 
epithelial cells in transgenic and wild-type C57BL/6J mice injected with anti-CD3 
antibody for 24 hours, N=6; ANOVA, Dunnett post-hoc test for multiple comparison 
with control, *P<0.05. (B) Cell positional graph demonstrating the position of 
apoptotic small intestinal crypt epithelial cells. 
 
 
6.3 Polyinosinic:polycytidylic acid (Poly I:C) induces murine 
small intestinal epithelial cell apoptosis and shedding mimicking 
the viral activation of shedding 
Poly I:C is a synthetic analogue of the ds-RNA that is found in some viruses. 
It is used experimentally to induce apoptosis and cell shedding that mimics 
the viral activation of cell shedding through its binding to TLR3 expressed on 
the surface of B-cells, macrophages and dendritic cells. In this chapter we 
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following IP administration of 30 mg/kg poly I:C and have investigated the 
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role of the NFκB family of proteins in regulating this response in both small 
intestinal villus and crypt cells. 
 
6.3.1 Poly I:C induces pathological apoptosis and shedding of murine small 
intestinal epithelial cells 
After IP administration of 30mg/kg poly I:C we found an increase in the 
number of apoptotic and shedding SIECs (Figure 6.13). The percentage of 
apoptotic and shedding cells was significantly increased from 1.1±0.05% in 
untreated mice to 1.9±0.07% after 1 hour (P<0.01, N=6; ANOVA) (Figure 
4.14). This increase in the percentage of SIEC apoptosis and shedding 
continued at 1.5 hours (5.4±0.64%) and reached its peak of 5.9±0.79% at 2 
hours post administration of poly I:C (P<0.0001 for both time-points, N=6; 
ANOVA). A marked decrease in the percentage of pathological apoptosis 
and shedding was then noted 3 hours post intraperitoneal injection of poly 
I:C (1.2±0.05%). Although the highest amount of apoptosis and shedding 
was observed 2 hours post poly I:C administration, there was no significant 
difference between the percentage of pathological apoptosis and cell 
shedding observed at 2 hours and 1.5 hours (P=0.2557, N=6; ANOVA). The 
cell positional data (Figure 6.15) showed similar distributions of apoptotic 
and shedding epithelial cells along the villus axis of the proximal segment of 
the small intestine to other inducing stimuli. The distribution again 
appeared to be most pronounced towards the villus tips. 
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Figure 6.13: Active caspase-3 IHC showing proximal small intestinal 
epithelial apoptosis and cell shedding in female C57BL/6J mice injected 
intraperitoneally with 30 mg/kg poly I:C for different periods of time.  
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Figure 6.14: Bar chart indicating the percentage of apoptotic and shedding IECs in the 
duodenal villi of C57BL/6J mice injected with 30mg/kg Poly I:C at different time points, 
N=3; ANOVA (Kruskal-Wallis test),  ** P<0.01, **** P<0.0001. 
 
 
 
Figure 6.15: Cell positional graphs indicating the quantification of positively immuno-
labelled IECs along the villus axis of C57BL/6J mice injected with 30mg/kg Poly I:C at 
different time points in comparison to untreated group. 
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6.3.2 Nfҡb2-/- mice were more resistant to poly I:C induced small intestinal 
epithelial cell apoptosis and shedding 
Following 30mg/kg poly I:C for 1.5 hours, Nfҡb1-/- and c-Rel-/- mice exhibited 
significant increases (Figures 6.16 and 6.17) in the percentage of small 
intestinal epithelial cell apoptosis and shedding (8.8±0.39% and 8.4±0.29% 
respectively, P<0.01, N=6; ANOVA) compared to similarly treated wild-type 
C57BL/6J mice (5.4±0.64%). However, Nfҡb2-/- mice given 30mg/kg poly I:C 
exhibited a significant reduction in the amount of small intestinal epithelial 
cell apoptosis and shedding at 3.4±0.39% (P<0.05, N=6; ANOVA). Based on 
the cell positional plots (Figure 6.17), poly I:C induced small intestinal 
epithelial cell apoptosis and shedding again occurred more obviously toward 
the villus tips rather than toward the villus bases.   
 
 
 
 
 
 
 
Figure 6.16: Active caspase-3 IHC in sections of proximal segments of small 
intestine of transgenic and wild-type female C57BL/6J mice injected with 
30mg/kg poly I:C for different periods of time. 
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Figure 6.17: Bar chart showing percentage of apoptotic and shedding SIECs in the 
duodenal villi of wild-type and transgenic C57BL/6J mice at 1.5h post IP injection of 
30mg/kg Poly I:C. N=6; ANOVA, Dunnett multiple comparison with control, * =P <0.05, 
**=P <0.01. 
 
 
 
Figure 6.18: Cell positional graphs showing quantification of positively immuno-
labelled IECs along the villus axis of transgenic mice (Nfҡb1-/-
 
, Nfҡb2-/-
 
and c-Rel-/-) 
compared to wild-type C57BL/6J mice. 
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6.3.3 Poly I:C has no effect on small intestinal crypt epithelial cell apoptosis and 
shedding at 24 hours post intraperitoneal administration 
We investigated whether 30mg/kg poly I:C induced small intestinal crypt epithelial cell 
apoptosis 24 hours post intraperitoneal administration. Apoptosis of small intestinal 
crypt epithelial cells based on active caspase-3 IHC was not observed in wild-type 
C57BL/6J and c-Rel-/- mice, while very few active caspase-3 positively labelled cells 
were seen in Nfҡb2-/- mice with a percentage of 0.2±0.046% (Figure 6.19). Based on 
the morphological characteristics of apoptosis the percentages were 0.9±0.05%, 
0.3±0.03% and 0.3±0.54% in wild-type C57BL/6J, c-Rel-/- and Nfҡb2-/- mice respectively 
(Figure 6.20-A). Unexpectedly, Nfҡb1-/- mice died 5 hours post administration of poly 
I:C, therefore we have no data on the effect of poly I:C on crypt intestinal epithelial 
cell apoptosis 24 hours post IP administration. From the cell positional graph (Figure 
6.20-B) the crypt apoptosis did not show an obvious cell positional pattern along the 
crypt axis. 
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Figure 6.19: Active caspase-3 IHC in sections of proximal segments of small intestine 
of transgenic and wild-type C57BL/6J mice injected with 30mg/kg poly I:C for 24 hours. 
(Blue arrows indicating apoptotic cells in H&E stained section) X40 
 
 
 
 
 
 
Figure 6.20: (A) Bar chart indicating the percentage of apoptotic small intestinal crypt 
epithelial cells in transgenic and wild type C57BL/6J mice injected with 30mg/kg poly 
I:C for 24 hours, (B) Cell positional graph indicated no obvious pattern of crypt 
apoptosis in all tested genotypes, N=6. 
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6.4 TNF caused significant apoptosis and cell shedding in proximal 
segment of murine small intestine 
TNF is an important cytokine that plays an important role in regulating gut barrier 
permeability. It’s systemic administration results in a SIEC pathological apoptosis and 
shedding (Watson and Hughes; 2012, Ślebioda and Kmieć; 2014). A previous study in 
our laboratory indicated that TNF caused a similar effect in the proximal part of the 
murine small intestine as LPS and suggested that TNF is a crucial key mediator of LPS- 
induced intestinal injury in wild-type C57BL/6J mice ( Williams et al; 2013). In this 
study we have investigated the role of TNF as a key mediator of small intestinal 
apoptosis and cells shedding in wild-type C57BL/6J mice in both villus and crypt 
compartments and have examined the role of the NFκB family of transcription factors 
in regulating TNF-induced SIEC apoptosis and shedding. 
 
6.4.1 0.33mg/kg TNF caused pathological apoptosis and shedding in proximal      
small intestinal villi at 1.5 hours equivalent to that caused by administration of          
10 mg/kg LPS 
Active caspase-3 IHC sections showed that an intraperitoneal administration of 
0.33mg/kg TNF into adult female C57BL/6J mice caused an increase in the number of 
apoptotic and shedding cells in small intestinal villi at 1.5 hours (Figure 6.21). 
Quantification of active caspase-3 positively labelled cells (Figure 6.22-B) indicated a 
significant increase in the percentage of apoptotic and shedding cells from 1.0±0.05% 
in untreated wild-type C57BL/6J mice to 6.0±0.92% in TNF-treated wild-type C57BL/6J 
mice (P<0.0001, ANOVA-Kruskal-Wallis multiple comparison). A further increase in 
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percentage of SIEC apoptosis and shedding to 11.4±0.34% were seen in TNF-treated 
Nfҡb1-/- (P<0.0001, ANOVA-Kruskal-Wallis multiple comparison) whereas c-Rel-/- mice 
showed non-significant reduction in percentage of SIEC apoptosis and shedding 
(4.2±0.37%, P=0.2432, ANOVA-Kruskal-Wallis multiple comparison) in compare to 
TNF-treated wild-type C57BL/6J (Figure 6.22-A). Similar to the other tested stimuli, 
Nfҡb2-/- mice appeared to be significantly resistant to TNF induced SIEC apoptosis and 
shedding in compare to TNF-treated C57BL/6J mice  presenting a percentage of 
1.6±0.16% apoptotic SIECs (P<0.0001, ANOVA-Kruskal-Wallis multiple comparison). 
Although of this substantial reduction in the number of apoptotic and shedding SIECs, 
Nfҡb2-/- mice indicated a slight increase in the percentage of SIEC apoptosis and 
shedding in compare to untreated wild-type C57BL/6J mice (1.6±0.16% and 1.0±0.05% 
respectively) but this increase did not reach statistical significance (P=0.2757, ANOVA-
Kruskal-Wallis multiple comparison).  The cell positional plots again indicated that TNF 
caused greater effects at the villus tip than in the basal region of small intestinal villi 
in all treated groups (Figure 6.23-A and B). 
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Figure 6.21: Active caspase-3 IHC in sections of proximal segments of small intestine 
of different mice groups injected with 0.33mg/kg TNF for 1.5 hours. 
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Figure 6.22: Bar charts (A) showing percentage of apoptotic and shedding SIECs in the 
duodenal villi of wild- and transgenic C57BL/6J mice 1.5h post IP injection of 
0.33mg/kg TNF and (B) showing percentage of apoptotic and shedding SIECs in TNF-
treated versus untreated C57BL/6J mice, N=6; ANOVA, Kruskal-Wallis multiple 
comparisons, **** =P <0.0001. 
 
     
Figure 4.23: Cell positional graph indicating the distribution of apoptotic SIECs along 
the villus length of TNF treated wild-type and transgenic C57BL/6J mice (A) and a 
comparison of TNF-treated to untreated C57BL/6J mice (B). N=6. 
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6.4.2 TNF at 24 hours post intraperitoneal administration induced small intestinal 
crypt apoptosis more in Nfҡb1 and c-Rel knockout mice than wild-type C57BL/6J 
mice, while Nfҡb2 null mice showed no significant change 
To identify the effect of TNF on small intestinal crypt apoptosis 24 hours post 
intraperitoneal injection of 0.33mg/kg recombinant TNF, we injected 6 wild-type adult 
female C57BL/6J mice together with the various transgenic groups (Nfҡb1-/-, Nfҡb2-/- 
and c-Rel-/-, all consisting of 6 mice). The small intestine was then processed for active 
caspase-3 IHC. Quantification of positively labelled active caspase-3 crypt cells 
indicated that the number of apoptotic cells was markedly increased in Nfҡb1-/- mice 
and to a lesser extent c-Rel-/- mice compared to wild-type C57BL/6J mice (Figure 6.24). 
The percentage of apoptotic crypt cells in wild-type C57BL/6J mice (0.7±0.26%) was 
significantly increased to 7.3±0.66% in Nfҡb1-/- mice (P<0.0001, N=6, ANOVA-Kruskal-
Wallis multiple comparison) and 1.2±0.19% in c-Rel-/- mice (P<0.05, N=6). On the other 
hand, there was a significant decrease in the percentage of apoptotic crypt cells in 
Nfҡb2-/- mice (0.3±0.08%, P<0.05, N=6) in comparison to wild-type C57BL/6J mice 
(Figure 6.25). Furthermore, following addition of caspase-3 negatively labelled cells 
(cells that indicate non-apoptotic cell death), the percentage of cell death in crypt 
epithelial cells slightly increased in all tested genotypes to 0.9±0.32%, 7.8±0.79%, 
0.5±0.07% and 1.4±0.20% in C57BL/6J, Nfҡb1-/-, Nfҡb2-/- and c-Rel-/- mice respectively. 
The cell positional plot (Figure 6.26) showed that the small intestinal crypt apoptosis 
was more obvious in the lower part of the intestinal crypt especially in Nfҡb1-/- mice. 
The modified median test showed that apoptotic cells were significantly different 
between cell positions 3 and 14 in Nfҡb1-/- mice and between cell positions 7 and 12 
in c-Rel-/- mice compared to wild-type. 
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Figure 6.24: Active caspase-3 IHC indicating the apoptosis of small intestinal crypt 
epithelial cells of wild-type and transgenic C57BL/6J mice at 24 hours post 
administration of 0.33mg/kg recombinant TNF. 
 
   
Figure 6.25: Bar chart representing the percentage of small intestinal crypt epithelial 
cell apoptosis in adult female wild-type C57BL/6J and transgenic mice injected with 
0.33mg/kg TNF for 24 hours. *P<0.05, ****P<0.0001, ANOVA-Kruskal-Wallis test for 
multiple comparison, N=6. 
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Figure 6.26: Cell positional graph indicating the position of apoptotic small intestinal 
crypt epithelial cell along the crypt axis of TNF treated wild-type and transgenic 
C57BL/6J mice. N=6. 
 
4.5 Discussion:  
In this chapter we have investigated the roles of substances other than LPS that have 
been shown to induce murine small intestinal apoptosis and cell shedding by 
activating receptors other than TLR4. We have tested these substances based on the 
time of peak effect, the dose needed to cause a maximal effect and the role of the 
NFκB family of proteins in regulating these responses. We have compared responses 
to our previous results using LPS. 
Miura et al; 2005 investigated the role of anti-CD3 antibody in inducing SIEC apoptosis 
and shedding by administering 12.5 µg of anti-CD3 antibody into C3H/HeN mice. They 
found that anti-CD3 antibody induced villus apoptosis starting 2 hours post 
intraperitoneal administration, this reached a peak at 4 hours and then started to 
decline thereafter. They also reported marked small intestinal crypt epithelial cell 
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apoptosis at 24 hours post injection. This continued up to 48 hours, then completely 
recovered 4 days post anti-CD3 antibody injection. Activation of T-lymphocytes by 
administration of anti-CD3 antibody was also shown to increase the number of 
apoptotic cells and cause shortening of intestinal villi in C57BL/6J mice at 2 hours and 
24-48 hours post administration of anti-CD3 antibody respectively. This was 
associated with increased serum concentrations of TNF (Zhou et al; 2004).  
Our current results indicated that an IP administration of 1 mg/kg anti-CD3 antibody 
into adult female C57BL/6J mice slightly increased the percentage of apoptosis and 
cell shedding in small intestinal villi after 1 hour. This response reached its peak at 1.5 
hours, continued until 2 hours post IP administration, started to slightly decline at 4 
hours, then the small intestine was recovered at 6 hours post injection. We also 
demonstrated a direct relationship between the dose of anti-CD3 antibody injected 
and the percentage of apoptotic and shedding SIECs (see Figure 6.5) as previously 
documented by Mura et al. in 2005. Moreover our results of investigating the role of 
the NFκB family of proteins in regulating the process of apoptosis and shedding 
induced by anti-CD3 antibody indicated similar patterns to those following 
administration of LPS. However the degree of response was a little less than that seen 
after LPS treatment. We found that expression the NFĸB2 transcription protein was 
associated with an increased percentage of apoptosis and shedding in C57BL/6J mice 
treated with 2 mg/kg anti-CD3 antibody for 1.5 hours, while NFĸB1 expression was 
associated with cell survival as previously reported by Williams et al., in 2013. A similar 
pattern of response was seen in the small intestinal crypt compartments at 24 hours, 
but the response was more pronounced after anti-CD3 antibody than LPS. These 
results suggest that both LPS and anti-CD3 antibody cause similar effects even though 
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they stimulate different immune cells namely macrophage-mediated apoptosis and T-
cell mediated apoptosis. It is likely that both stimuli eventually lead to a common 
pathway largely involving TNF. 
Poly I:C is another apoptosis stimulating substance that signals through TLR3 and 
which has previously been described to induce small intestinal injury in mice (Zhao et 
al; 2017 and McAllister et al; 2012). Günther et al; 2012 previously reported that 
activation of TLR3 by poly I:C and of TLR4 by LPS induced excessive intestinal epithelial 
cell death. Intraperitoneal administration of 30 mg/kg poly I:C increased the apoptotic 
activity of SIECs and this resulted in blunting of proximal small intestinal villi with a 
reduction in number of SIECs per villus that reached a peak 2 hours after poly I:C 
injection. Apoptosis was mainly localised at the upper half of the small intestinal villi, 
in contrast there were no increases in the number of apoptotic cells seen in the crypt 
region (McAllister et al; 2012). Our time course study after administration of 30mg/kg 
poly I:C into adult female C57BL/6J mice indicated a significant increase in the number 
of apoptotic and shedding cells after 1 hour that markedly increased at 1.5 hours and 
continued to reach its peak at 2 hours. This was followed by a sudden drop to nearly 
the level observed in untreated mice 3 hours post injection. These data support the 
previous data by McAllister et al., 2012. However our results also indicated no 
significant difference between the percentage of SIECs undergoing apoptosis and 
shedding at 1.5 and 2 hours. To examine the role of the NFκB family of proteins in 
regulating poly I:C induced small intestinal apoptosis and shedding and because no 
significant difference was seen in the percentage of apoptosis and shedding of SIECs 
at 1.5 and 2 hours, we injected wild-type C57BL/6J, Nfҡb1-/-, Nfҡb2-/- and c-Rel-/- mice 
with 30 mg/kg poly I:C for 1.5 hours and 24 hours to compare these data with the data 
184 
 
obtained following LPS treatment at similar time points. Interestingly we observed 
similar patterns of changes in the percentage of apoptosis and shedding in the villus 
compartment after 1.5 hours as those reported by Williams et al., in 2013 after 
injecting 0.125 mg/kg LPS. This result suggests that the NFĸB1 and NFĸB2 transcription 
factors regulate cell death and cell survival respectively following IP injection of both 
LPS and poly I:C. However we observed very little apoptosis in the crypt compartment 
of C57BL/6J, c-Rel-/- and Nfҡb2-/- mice following injection of poly I:C. This agrees with 
the previous result by McAllister et al., in 2012 who also observed no increase in the 
percentage of crypt apoptosis after poly I:C injection. Unfortunately Nfҡb1-/- mice died 
due to extensive fluid accumulation in the proximal small intestine and diarrhoea at 
4-6 hours post poly I:C injection. This is likely to be due to extensive loss of SIECs by 
apoptosis and shedding from the villus compartment. It was therefore not possible to 
test the effect of NFĸB1 deletion on poly I:C induced crypt apoptosis at 24 hours.   
A previous study in our laboratory indicated that exogenous TNF at 0.33 mg/kg caused 
murine small intestinal damage equivalent to that caused by 10 mg/kg LPS at 1.5 hours 
post IP administration. It also reported that the pathological process of apoptosis and 
shedding that was induced by both LPS and TNF was regulated in the same way by the 
NFκB signalling pathway (Williams et al., 2013). Our result confirmed that 0.33 mg/kg 
recombinant TNF induced apoptosis and shedding in the upper half of proximal small 
intestinal villi at 1.5 hours and that this was equivalent to that caused by LPS at the 
same time point. This effect was regulated by the NFκB signalling pathway and once 
again the NFĸB1 transcription protein supressed while the NFĸB2 transcription protein 
promoted pathological apoptosis and shedding of villus SIECs. The data reported in 
this chapter also indicated that Nfҡb1-/- mice were much more sensitive to TNF 
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induced crypt apoptosis than to the other stimuli that were used to induce small 
intestinal crypt apoptosis. This may be due to the accumulation of endogenous and 
exogenous TNF that may exaggerate the response of gut epithelial cells thus exhibiting 
a more potent response.  
As previously indicated in LPS induced small intestinal crypt epithelial cells (chapter 
3), some intestinal crypt epithelial cells were not labelled by antibodies against active 
caspase-3 but could be in the process of undergoing non-caspase-3-dependent cell 
death following administration of anti-CD3 antibody, poly I:C and TNF. Some of these 
cells appeared to be undergoing cell death by analysis of their morphology and may 
represent cells at a later stage of apoptosis due to fragmentation of the DNA 
(Glamočlija et al., 2005) or represent other types of non-caspase-3 dependent cell 
death such as pyroptosis (Fink and Cookson, 2005) and necroptosis (Kaczmarek et al., 
2013). 
In summary, the data reported in this chapter indicate that T-cell mediated, viral 
induced and exogenous TNF-induced SIEC apoptosis and shedding occur in similar 
ways to that seen following the administration of LPS. All of the stimuli that we used 
caused similar patterns of response in both villus and crypt epithelial cells (with the 
exception of poly I:C which did not induce small intestinal crypt apoptosis). All of these 
stimuli may result in an increase in the amount of TNF that binds to TNFR1 on the 
basolateral surfaces of SIECs, leading to pathological apoptosis and cell shedding. 
These processes seem to be consistently regulated by the expression of both NFĸB1 
and NFĸB2. 
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7. Discussion 
 
7.1 Major findings and subsequent concepts 
The primary aims of this project were to further improve our understanding of the 
processes of pathological apoptosis and cell shedding in murine small intestinal 
epithelial cells and their relationship to gut barrier dysfunction. As previously 
indicated in our laboratory by Williams et al., in 2013, systemic administration of 
Escherichia coli LPS (serotype O111:B4) induced pathological apoptosis and shedding 
of cells from the murine small intestinal epithelium at 1.5 hours post intraperitoneal 
administration and this phenomenon was regulated via NFκB signalling pathways with 
NFκB1 (p105/p50) and c-Rel promoting cell survival and NFκB2 (p100/p52) promoting 
cell apoptosis (Williams et al., 2013).  
It was previously demonstrated that LPS induced small intestinal epithelial apoptosis 
and cell shedding in C57BL/6J mice that peaked at 1.5 hours post IP administration 
(Williams et al., 2013). In the present study we have established that LPS-induced SIEC 
apoptosis and shedding occurred in different mouse strains and also in rats with a 
similar phenotype, but with different degrees of responsiveness. Also, we 
demonstrated that LPS-induced SIEC apoptosis and cell shedding occurred in all tested 
age groups of mice representing puberty, young adulthood and maturity. It was 
further demonstrated that LPS from different bacterial species induced apoptosis and 
shedding in C57BL/6J mice at 1.5 hours post IP injection. Testing of the role of the RelB 
transcription factor in LPS-induced SIEC apoptosis and shedding indicated no major 
role for this alternative pathway NFκB subunit in regulating this phenomenon. We also 
showed that LPS induced apoptosis in small intestinal crypt epithelial cells at 24 hours 
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post IP administration of 0.125 mg/kg and similarly our data indicated that this 
phenomenon was regulated by NFκB signalling pathways with NFκB1 (p105/p50) 
signalling supressing apoptosis and shedding of small intestinal villus and crypt 
epithelial cells while NFκB2 signalling promoted apoptosis and cell shedding.  The 
apoptosis that is observed within the crypt compartment within the stem cell zone at 
this later time point following LPS administration could impact on the regenerative 
capacity of the epithelium.    
Additionally, we confirmed that anti-CD3 antibody and TNF also induced SIEC 
apoptosis and shedding in small intestinal villi and crypts with similar patterns to that 
which occurred in LPS-treated mice. This suggests that TNF released by different 
circulating cell types (i.e. LPS acts mainly on monocytes and macrophages via TLR4, 
anti-CD3 stimulates T cells, poly I:C mimics viral infection and acts via TLR3) is able to 
exert effects on SIEC apoptosis and shedding. Furthermore, our results from mice 
treated with poly I:C indicated that the maximal degree of small intestinal epithelial 
apoptosis and cell shedding occurred 2 hours post IP injection in intestinal villi and was 
regulated by NFκB signalling pathways similarly to the regulation by LPS. However, our 
data did not indicate a role of NFκB transcription factors in regulating crypt epithelial 
cell apoptosis in response to this stimulus. 
The ultrastructural changes that were observed in the small intestinal epithelium 
within this study supported the previous immunohistochemical observations for LPS-
induced small intestinal epithelial cells. Ultrastructural changes were most marked in 
Nfҡb1-/- mice treated with 0.125 mg/kg LPS while no changes were observed in    
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Nfҡb2-/- mice before and after LPS IP administration suggesting that signalling via 
NFκB2 was necessary for these ultrastructural changes to occur.  
Proteomic analysis of the small intestinal mucosal proteome of C57BL/6 mice before 
and after the administration of LPS revealed several changes in protein expression 
within the small intestinal mucosa which were further modified by Nfҡb1, Nfҡb2 and 
c-Rel deletion. Some of these proteins may account for the different susceptibilities of 
the different mouse groups to LPS-induced small intestinal epithelial apoptosis and 
cell shedding.    
 
7.2 Limitations of the study 
Although the morphological features of small intestinal epithelial apoptosis and cell 
shedding in this study were obtained from mice and rats, the phenotypic changes 
associated with these phenomena were similar to those previously reported in human 
small intestinal epithelia (Mayhew et al., 1999 and Bullen et al., 2006). However, there 
are functional and anatomical variations between human and rodent intestines. 
Copeland et al., in 2005 indicated that humans are much more sensitive than mice and 
rats in terms of their immune responses, hence the doses of the various stimuli that 
were used in this study to induce SIEC apoptosis and shedding may be larger than 
those that would be needed to induce similar effects in the human small intestine. 
In this study we used the immunohistological and scoring procedures for active 
caspase-3 that had previously been used in our laboratory by Williams and colleagues 
to obtain a consistent dataset that could be compared with previous results described 
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for LPS-induced SIEC apoptosis and shedding (Williams et al., 2013).  The anti-active 
caspase-3 primary antibody has previously been validated and each new batch of 
antibody purchased was re-assessed for activity during this study. However, these 
data rely on the specificity of a single polyclonal antibody.  Active caspase-3 positive 
cells were however commonly associated with apoptotic morphology which further 
validated the antibody specificity.  
The ultrastructural changes that were observed by EM following the administration of 
0.125 mg/kg of bacterial LPS suggested similar sensitivities of Nfκb1-/-, Nfκb2-/- and      
c-Rel-/- mice to small intestinal epithelial apoptosis and cell shedding to that obtained 
by immunohistochemical analysis. However, both of these techniques did not indicate 
any discontinuity of the gut barrier as a result of cell loss from small intestinal epithelia 
which may have been more detectable using the higher dose of 10 mg/kg that has 
previously been shown to induce maximal rates of SIEC apoptosis and shedding.  
Histology and transmission electron microscopy are techniques that only capture the 
snapshot in time at which the tissue was fixed and consider a thin cross section 
through a tissue, which makes these techniques unreliable to assess intestinal barrier 
function.  More dynamic assays that are more technically challenging and which were 
beyond the scope of this thesis would be needed to assess loss of intestinal barrier 
function and potential gap formation upon treatment with LPS, anti-CD3 or poly I:C. 
Assays could include the oral gavage of a fluorescent probe/sugars such as FITC-
dextran and analysis of the concentration of this dye in the peripheral circulation 
(Williams et al., 2013), real-time confocal microscopy of small intestinal epithelia en 
face following topical or intravenous injection of dyes (Kiesslich et al., 2011) or the 
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establishment of permeability assays using microinjection techniques in enteroid 
culture (Thompson and Duckworth, unpublished methods).  
Proteomic analysis of the murine proximal small intestinal mucosa indicated a very 
large number of proteins that were altered in expression in C57BL/6 and NFκB 
transgenic mice 1.5 hours post administration of bacterial LPS. Initial interpretation of 
this dataset has involved determining the functional roles of proteins that were shown 
to have the largest fold up and down regulations from group sizes of 4 mice per group.  
Several of these proteins will be interesting to follow up and potentially validate in 
order to establish the extent to which they contribute towards the mechanisms 
responsible for pathological SIEC apoptosis and shedding.  However, there were many 
more proteins identified which showed significantly altered expressions following LPS 
administration that may also be important regulators of SIEC apoptosis and shedding 
and which also warrant full validation.  In depth analysis and validation of these 
proteins by western blot and immunohistochemistry has been beyond the scope of 
this thesis, but is now needed to determine the importance of these small intestinal 
mucosal proteome changes in contributing to pathological small intestinal apoptosis 
and cell shedding.  Further in depth analysis is also warranted to determine whether 
these proteomic changes are a cause or a consequence of SIEC apoptosis and shedding 
in order to identify potential therapeutic targets for conditions known to result from 
excessive epithelial cell death and loss of intestinal barrier function such as 
inflammatory bowel disease.   
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7.3 Future research plans 
Several possible future plans have already been discussed above and performing these 
experiments could help to answer several crucial questions and explain the molecular 
mechanisms associated with pathological apoptosis and cell shedding in regulating gut 
barrier function and subsequent intestinal pathology.  
Although the results of this study have indicated essential roles of NFκB signalling 
pathways in the regulation of pathological SIEC apoptosis and shedding following 
different damage-inducing stimuli and have identified numerous proteins that show 
altered expression due to the deletion of individual NFκB subunits, it would be 
fascinating to determine which of these proteins are drivers of intestinal epithelial 
apoptosis and cell shedding.  A selection of identified proteins (see chapter 5) should 
next be validated in a repeat experiment to confirm their altered expressions using 
immunohistochemistry for location and western blotting for quantitation.  Genetic 
manipulation using 3D small intestinal enteroid cultures could also be conducted to 
knockdown or overexpress these targets and modified enteroids would be compared 
against control enteroids following treatment with a stimulus such as TNF (which is 
believed to be the main mediator of small intestinal villus enterocyte apoptosis and 
shedding) to determine whether they are protected or sensitised to apoptosis and cell 
shedding.  
The small intestinal epithelium has a remarkable capacity to prevent breaches in 
barrier function.  There are likely to be several mechanisms in place to prevent the 
invasion of abundant inflammation-causing luminal microorganisms.  Understanding 
how these organisms gain entry across the intestinal epithelium (via bacterial-derived 
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and host factors which may be organism-dependent) and how NFκB signalling in the 
host epithelium contributes to this would help to further elucidate how the small 
intestine is homeostatically regulated. We would therefore like to further investigate 
the translocation of bacteria through discontinuities and gaps that may develop in the 
intestinal epithelium as a result of pathological apoptosis and shedding of SIECs.  This 
would be achievable using microinjection of enteroids in vitro and assessment via 
confocal microscopy in the first instance and translating these findings in vivo to 
identify how other cellular compartments such as the intestinal immune system may 
contribute to the regulation of these processes.  These experiments would improve 
our knowledge of the onset of gut barrier dysfunction in acute and chronic 
inflammatory diseases. 
Anti-CD3 antibody, poly I:C and recombinant TNF administration all resulted in SIEC 
apoptosis and cell shedding at the villus tip although the peak time of maximal 
apoptosis and cell shedding post administration was different between stimuli.  All 
mouse genotypes treated with these stimuli responded with similar sensitivities to 
those that resulted post administration of LPS (i.e. Nfκb1-/- were more sensitive and 
Nfκb2-/- were less sensitive than C57BL/6 controls) however, the mechanisms that 
ultimately resulted in apoptosis and cell shedding were different. Accordingly, it would 
be interesting to investigate the ultrastructural and proteomic changes of the small 
intestinal mucosal proteomes for different mouse groups treated with these stimuli 
to compare the similarities and differences to apoptosis and cell shedding induced by 
LPS to determine whether there is a single mechanism or multiple mechanisms 
responsible for epithelial damage in different intestinal diseases. 
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The ultimate aim of our studies was to improve understanding of pathological small 
intestinal epithelial apoptosis and cell shedding and how these processes affect gut 
barrier function and the development of inflammatory bowel disease. Therefore, it is 
now necessary to extend these studies into humans by using antibodies to 
characterise specific NFκB signalling-related proteins in human small intestinal 
epithelial cells and to derive small intestinal enteroids from human biopsies followed 
by their genetic manipulation to modulate NFκB signalling components and other 
targets identified from our proteomic analysis as contributing to apoptosis and cell 
shedding regulation.  Human enteroids will be stimulated with TNF and assessed by 
confocal microscopy and histology.  
Once targets have been validated by the experiments proposed above, a 
pharmacological or dietary approach could then be applied to modulate the small 
intestinal epithelial proteome to make the small intestinal epithelium less sensitive to 
the induction of apoptosis and cell shedding induced by genetic (e.g. susceptibility 
genes for IBD) or environmental (e.g. diet or chemotherapy) factors to preserve 
intestinal homeostasis and intestinal barrier function.  
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7.4 Translational impact 
Results obtained from these studies have indicated that pathological apoptosis and 
shedding of murine small intestinal epithelial cells may play an important role in the 
development of acute inflammation in the small intestine. This phenomenon may lead 
to increased gut barrier permeability and loss of tissue homeostasis. Increased gut 
barrier permeability due to increased intestinal epithelial cell shedding has previously 
been demonstrated in IBDs such as Crohn’s disease and ulcerative colitis which affect 
145 and 243 per 100,000 of the UK population respectively. Additionally, an increased 
percentage of apoptotic and shedding cells may also lead to the formation of 
discontinuities and gaps that allow the penetration of luminal bacteria into the blood 
circulation and contribute to the severity of systemic conditions such as metabolic 
endotoxaemia and sepsis which affect 260,000 of the UK population annually at a cost 
of £7.76 billion to the NHS (Hex et al., 2017). 
The data described in this work have also demonstrated a role of NFκB signalling 
pathways in regulating small intestinal epithelial apoptosis and cell shedding and have 
described several proteins that changed in abundance as a result of systemic LPS 
administration. With the follow up experiments described above, these findings could 
potentially be used to modulate the processes of pathological apoptosis and shedding 
in the gut and help in the early diagnosis and prevention of inflammatory 
gastrointestinal diseases.  
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7.5 Conclusions 
This study has described in detail the process of SIEC apoptosis and shedding induced 
by different stimuli including LPS, anti-CD3, poly I:C and TNF. In particular, it has 
demonstrated that LPS induces SIEC apoptosis and shedding in different mouse strains 
and also in rats. We have also determined that this phenomenon is not affected by 
age but is affected by mouse genotype. The alternative NFκB signalling pathway is a 
particularly important regulator of this process. We have described the effects of LPS 
on SIEC ultrastructure in detail and have proposed several proteins that may 
contribute to the SIEC apoptosis and shedding process. These now warrant further 
investigation as potential targets to ameliorate intestinal disease in humans.  
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Appendix: 
 
Appendix 1: significant proteomic changes in Nfҡb1-/- small intestinal mucosa in 
comparison to C57BL/6J mice 
Protein names Gene names 
Regulation 
fold change 
P value 
Nucleoplasmin-3 Npm3 10.99 0.0078 
Tubulin-specific chaperone A Tbca 7.926 0.0002 
Calcium-regulated heat stable protein 1 Carhsp1 6.542 0.0002 
Gastrotropin Fabp6 6.458 0.0012 
Copper transport protein ATOX1 Atox1 5.072 0.0093 
RNA-binding protein 3 Rbm3 4.864 0.0041 
RIKEN cDNA 2200002D01 gene 2200002D01Rik 4.831 0.0013 
Cysteine-rich with EGF-like domain protein 2 Creld2 4.392 0.0076 
Regenerating islet-derived protein 3-beta Reg3b 4.312 0.0024 
28 kDa heat- and acid-stable phosphoprotein Pdap1 3.58 0.0216 
60S acidic ribosomal protein P2 Rplp2 3.465 0.0152 
 Calu 3.335 0.0074 
40S ribosomal protein S28 Rps28;Gm10263 3.227 0.0003 
40S ribosomal protein S21 Rps21 3.113 0.0003 
D-dopachrome decarboxylase Ddt 3.077 0.0145 
LIM and SH3 domain protein 1 Lasp1 3.065 0.0095 
Prothymosin alpha;Prothymosin alpha, N-
terminally processed;Thymosin alpha 
Ptma 2.949 0.0197 
Cystatin-B Cstb 2.93 0.0139 
Acidic leucine-rich nuclear phosphoprotein 32 
family member E 
Anp32e 2.921 0.0097 
Cellular nucleic acid-binding protein Cnbp 2.907 0.0378 
Fatty acid-binding protein, liver Fabp1 2.902 0.0092 
Transthyretin Ttr 2.852 0.0052 
 Gm20441 2.785 0.0347 
Cathepsin L1;Cathepsin L1 heavy chain;Cathepsin 
L1 light chain 
Ctsl 2.781 0.0141 
Parathymosin Ptms 2.768 0.0218 
Chromatin modification-related protein MEAF6 Meaf6 2.735 0.0412 
Prefoldin subunit 4 Pfdn4 2.721 0.027 
Craniofacial development protein 1 Cfdp1 2.701 0.0149 
Caprin-1 Caprin1 2.695 0.0246 
Interferon alpha-inducible protein 27-like protein 
2B 
Ifi27l2b 2.68 0.0007 
Translationally-controlled tumor protein Tpt1 2.669 0.0068 
Protein phosphatase 1 regulatory subunit 1B Ppp1r1b 2.651 0.0182 
UV excision repair protein RAD23 homolog A Rad23a 2.635 0.0174 
Guanine nucleotide-binding protein subunit beta-
2-like 1 
Gnb2l1 2.626 0.0133 
Thioredoxin Txn 2.623 0.0268 
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H-2 class II histocompatibility antigen gamma 
chain 
Cd74 2.615 0.131 
Z-DNA-binding protein 1 Zbp1 2.614 0.0096 
60S acidic ribosomal protein P1 Rplp1;Gm10073 2.608 0.0136 
Thioredoxin domain-containing protein 17 Txndc17 2.569 0.0274 
Thioredoxin, mitochondrial Txn2 2.494 0.043 
Mesencephalic astrocyte-derived neurotrophic 
factor 
Manf 2.491 0.0262 
Protein SET Set 2.49 0.0267 
Calumenin Calu 2.459 0.0115 
Prefoldin subunit 2 Pfdn2 2.45 0.0361 
Phospholysine phosphohistidine inorganic 
pyrophosphate phosphatase 
Lhpp 2.41 0.0135 
Mth938 domain-containing protein Aamdc 2.409 0.0097 
Huntingtin-interacting protein K Hypk 2.398 0.022 
CD2-associated protein Cd2ap 2.394 0.0531 
40S ribosomal protein SA Rpsa 2.375 0.0066 
Protein FAM192A Fam192a 2.372 0.0888 
Stress-induced-phosphoprotein 1 Stip1 2.357 0.0056 
Ran-specific GTPase-activating protein Ranbp1 2.344 0.0085 
Acidic leucine-rich nuclear phosphoprotein 32 
family member A 
Anp32a 2.318 0.0154 
Retinol-binding protein 2 Rbp2 2.306 0.0028 
Small glutamine-rich tetratricopeptide repeat-
containing protein alpha 
Sgta 2.292 0.0247 
Protein S100-A11 S100a11 2.287 0.0157 
GDP-mannose 4,6 dehydratase Gmds 2.274 0.005 
Programmed cell death protein 5 Pdcd5 2.246 0.0435 
Cathepsin Z Ctsz 2.24 0.0012 
Transcription elongation factor A protein 1 Tcea1 2.239 0.0194 
Probable ATP-dependent RNA helicase DHX58 Dhx58 2.217 0.0025 
Galectin-3-binding protein Lgals3bp 2.204 0.0037 
WAS/WASL-interacting protein family member 3 Wipf3 2.202 0.0417 
Alcohol dehydrogenase class-3 Adh5 2.2 0.0058 
Peroxiredoxin-6 Prdx6 2.187 0.0037 
C-Myc-binding protein Mycbp 2.187 0.0042 
Eukaryotic translation initiation factor 3 subunit 
J-A;Eukaryotic translation initiation factor 3 
subunit J-B 
Eif3j1;Eif3j2 2.16 0.0121 
Serum albumin Alb 2.153 0.0024 
SH3 domain-binding glutamic acid-rich-like 
protein 
Sh3bgrl 2.148 0.093 
Heterogeneous nuclear ribonucleoprotein D-like Hnrnpdl 2.137 0.0182 
Protein-glutamine gamma-glutamyltransferase 2 Tgm2 2.134 0.0008 
Protein PRRC2A Prrc2a 2.128 0.0396 
Eukaryotic translation initiation factor 5A-
1;Eukaryotic translation initiation factor 5A 
Eif5a 2.126 0.004 
Proteasome subunit beta type-8;Proteasome 
subunit beta type 
Psmb8 2.114 0.0015 
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UPF0587 protein C1orf123 homolog 0610037L13Rik 2.098 0.0157 
U6 snRNA-associated Sm-like protein LSm3 Lsm3 2.088 0.007 
Glutathione reductase, mitochondrial Gsr 2.086 0.0029 
Adapter molecule crk Crk 2.067 0.0087 
Protein archease Zbtb8os 2.066 0.032 
Apoptosis-associated speck-like protein 
containing a CARD 
Pycard 2.057 0.0052 
Phosphatidylethanolamine-binding protein 1 Pebp1 2.03 0.0153 
U6 snRNA-associated Sm-like protein LSm7 Lsm7 2.03 0.0004 
L-lactate dehydrogenase;L-lactate 
dehydrogenase A chain 
Ldha 2.018 0.0234 
Creatine kinase B-type Ckb 2.011 0.0215 
Acylphosphatase;Acylphosphatase-1 Acyp1 2.01 0.0292 
Sperm-associated antigen 7 Spag7 2.007 0.0426 
Xanthine dehydrogenase/oxidase;Xanthine 
dehydrogenase;Xanthine oxidase 
Xdh 2.007 0.014 
Selenoprotein P Sepp1 2.007 0.0393 
MIP18 family protein FAM96A Fam96a 2.003 0.0437 
Aspartate aminotransferase, cytoplasmic Got1 2.002 0.0249 
Neuron-specific calcium-binding protein 
hippocalcin 
Hpca 1.993 0.0152 
Nardilysin Nrd1 1.992 0.0144 
Caspase-3 Casp3 1.983 0.0036 
Chromobox protein homolog 1 Cbx1 1.981 0.0239 
Cytosolic acyl coenzyme A thioester hydrolase Acot7 1.977 0.0054 
NEDD8 Nedd8 1.975 0.0172 
Phosphorylated adapter RNA export protein Phax 1.966 0.0324 
Hsc70-interacting protein St13 1.965 0.0022 
Pterin-4-alpha-carbinolamine dehydratase Pcbd1 1.961 0.0321 
Protein deglycase DJ-1 Park7 1.959 0.0029 
DAZ-associated protein 1 Dazap1 1.948 0.0008 
E3 ubiquitin-protein ligase UBR2 Ubr2 1.944 0.0063 
Protein S100-A10 S100a10 1.938 0.0155 
Prosaposin Psap 1.935 0.0313 
Proteasome subunit beta type-9 Psmb9 1.934 0.0089 
Fucose mutarotase Fuom 1.932 0.012 
Serine/threonine-protein phosphatase 4 catalytic 
subunit 
Ppp4c 1.93 0.0125 
Drebrin-like protein Dbnl 1.926 0.0241 
Adenosylhomocysteinase Ahcy 1.919 0.0367 
Caspase-6;Caspase-6 subunit p18;Caspase-6 
subunit p11 
Casp6 1.918 0.026 
DNA methyltransferase 1-associated protein 1 Dmap1 1.907 0.0325 
Mitochondrial import inner membrane 
translocase subunit Tim8 A 
Timm8a1 1.905 0.0123 
Cysteine and glycine-rich protein 1 Csrp1 1.905 0.0096 
Elongation factor 1-beta Eef1b;Eef1b2 1.904 0.0337 
Heterogeneous nuclear ribonucleoprotein A/B Hnrnpab 1.892 0.0172 
Filamin-binding LIM protein 1 Fblim1 1.884 0.0176 
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Prefoldin subunit 6 Pfdn6 1.872 0.0105 
Thioredoxin reductase 1, cytoplasmic Txnrd1 1.871 0.026 
High mobility group protein B2 Hmgb2 1.866 0.0445 
Myeloid-derived growth factor Mydgf 1.863 0.0111 
Transaldolase Taldo1 1.86 0.0262 
Peptidyl-prolyl cis-trans isomerase NIMA-
interacting 1 
Pin1;Pin1rt1 1.859 0.0142 
Heat shock protein 105 kDa Hsph1 1.858 0.0023 
Cytochrome c oxidase assembly factor 7 Coa7 1.849 0.0359 
Interferon-induced protein with 
tetratricopeptide repeats 1 
Ifit1 1.846 0.003 
Semaphorin-4G Sema4g 1.84 0.0002 
High mobility group protein B1 Hmgb1 1.837 0.0159 
Far upstream element-binding protein 1 Fubp1 1.837 0.0257 
Coiled-coil domain-containing protein 6 Ccdc6 1.829 0.029 
Growth factor receptor-bound protein 2 Grb2 1.82 0.0001 
Elongation factor 1-delta Eef1d 1.818 0.0021 
Polymeric immunoglobulin receptor;Secretory 
component 
Pigr 1.817 0.0058 
Mitochondrial import inner membrane 
translocase subunit Tim8 B 
Timm8b 1.817 0.0359 
14-3-3 protein sigma Sfn 1.812 0.0142 
Glutathione peroxidase 2 Gpx2 1.811 0.0099 
Myotrophin Mtpn 1.81 0.05 
Protein TSSC1 Tssc1 1.809 0.003 
Gamma-interferon-inducible lysosomal thiol 
reductase 
Ifi30 1.808 0.004 
Proteasome subunit alpha type-5 Psma5 1.795 0.0156 
Steroid receptor RNA activator 1 Sra1 1.788 0.0813 
Glucosidase 2 subunit beta Prkcsh 1.787 0.049 
Signal peptide peptidase-like 2A Sppl2a 1.785 0.035 
2-5-oligoadenylate synthase-like protein 2 Oasl2 1.784 0.006 
Lysosome-associated membrane glycoprotein 2 Lamp2 1.778 0.0082 
Serine/arginine-rich splicing factor 4 Srsf4 1.769 0.0189 
Crk-like protein Crkl 1.766 0.0266 
Cofilin-1 Cfl1 1.765 0.0011 
Mannose-1-phosphate guanyltransferase beta Gmppb 1.759 0.0068 
Thioredoxin domain-containing protein 12 Txndc12 1.758 0.0738 
Uridine phosphorylase 1 Upp1 1.757 0.0163 
6-phosphogluconate dehydrogenase, 
decarboxylating 
Pgd 1.755 0.037 
Heterogeneous nuclear ribonucleoprotein D0 Hnrnpd 1.754 0.0015 
Ketohexokinase Khk 1.754 0.0074 
Biotinidase Btd 1.749 0.0235 
6-pyruvoyl tetrahydrobiopterin synthase Pts 1.746 0.0419 
Copper chaperone for superoxide dismutase Ccs 1.744 0.0325 
BUB3-interacting and GLEBS motif-containing 
protein ZNF207 
Znf207;Zfp207 1.744 0.0044 
Major vault protein Mvp 1.743 0.0286 
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Hippocalcin-like protein 1 Hpcal1 1.733 0.0155 
 Gm14446 1.728 0.0395 
Acylamino-acid-releasing enzyme Apeh 1.725 0.0427 
Ribose-5-phosphate isomerase Rpia 1.725 0.0037 
Ubiquitin-conjugating enzyme E2 A Ube2a 1.725 0.0055 
Serine/arginine-rich splicing factor 3 Srsf3;Gm12355 1.724 0.0033 
Adenosylhomocysteinase;Putative 
adenosylhomocysteinase 3 
Ahcyl2 1.723 0.014 
N-acetyl-D-glucosamine kinase Nagk 1.721 0.0349 
Proteasomal ubiquitin receptor ADRM1 Gm9774;Adrm1 1.721 0.0335 
Serine/threonine-protein phosphatase 
5;Serine/threonine-protein phosphatase 
Ppp5c 1.713 0.0237 
Aminopeptidase B Rnpep 1.711 0.033 
Splicing factor 3B subunit 4 Sf3b4 1.711 0.0315 
Leukotriene A-4 hydrolase Lta4h 1.709 0.0382 
Succinate dehydrogenase assembly factor 2, 
mitochondrial 
Sdhaf2 1.708 0.0366 
Ribulose-phosphate 3-epimerase Rpe 1.705 0.002 
Ribonuclease inhibitor Rnh1 1.705 0.036 
Proteasome subunit alpha type-6 Psma6 1.702 0.0283 
Cytosolic 10-formyltetrahydrofolate 
dehydrogenase 
Aldh1l1 1.702 0.0357 
Peptidyl-prolyl cis-trans isomerase A;Peptidyl-
prolyl cis-trans isomerase A, N-terminally 
processed;Peptidyl-prolyl cis-trans isomerase 
Ppia;Gm5160 1.7 0.0219 
Heat shock 70 kDa protein 4 Hspa4 1.699 0.0063 
Calmodulin-like protein 4 Calml4 1.699 0.0282 
Heterogeneous nuclear ribonucleoproteins C1/C2 Hnrnpc 1.697 0.0034 
Transketolase Tkt 1.695 0.024 
Transducin-like enhancer protein 4;Transducin-
like enhancer protein 1 
Tle4;Tle1 1.693 0.0021 
Costars family protein ABRACL Abracl 1.691 0.0007 
Nicotinamide phosphoribosyltransferase Nampt 1.689 0.0317 
2-5-oligoadenylate synthase 1A Oas1a;Oas1g 1.688 0.0283 
Enhancer of rudimentary homolog Erh 1.684 0.0014 
Thiamin pyrophosphokinase 1 Tpk1 1.679 0.0126 
Small ubiquitin-related modifier 2 Sumo2;Sumo3 1.671 0.0034 
Vacuolar protein sorting-associated protein 26A Vps26a 1.669 0.0148 
Methylosome subunit pICln Clns1a 1.657 0.0212 
Xaa-Pro dipeptidase Pepd 1.654 0.0142 
39S ribosomal protein L15, mitochondrial Mrpl15 1.649 0.0012 
Protein PML Pml 1.647 0.0143 
Protein farnesyltransferase subunit beta Fntb 1.64 0.0097 
Fatty acid-binding protein, epidermal Fabp5 1.635 0.0014 
Proteasome activator complex subunit 1 Psme1 1.629 0.0035 
 Hnrnpd 1.626 0.0084 
PHD finger-like domain-containing protein 5A Phf5a 1.625 0.0043 
Transcription elongation factor B polypeptide 2 Tceb2 1.624 0.0026 
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Carboxypeptidase;Lysosomal protective 
protein;Lysosomal protective protein 32 kDa 
chain;Lysosomal protective protein 20 kDa chain 
Ctsa 1.612 0.0066 
Transgelin-2 Tagln2 1.611 0.0042 
 Hnrnph3 1.608 0.0002 
28S ribosomal protein S36, mitochondrial Mrps36 1.599 0.0036 
 Arhgef5 -1.556 0.0002 
RNA polymerase-associated protein RTF1 
homolog 
Rtf1 -1.564 0.0004 
Cell division cycle protein 27 homolog Cdc27 -1.568 0.0005 
Sorting nexin-6;Sorting nexin-6, N-terminally 
processed 
Snx6 -1.592 0.0021 
Serine/threonine-protein kinase 25 Stk25 -1.594 0.0021 
Peptidyl-prolyl cis-trans isomerase 
FKBP5;Peptidyl-prolyl cis-trans isomerase FKBP5, 
N-terminally processed 
Fkbp5 -1.601 0.002 
Adseverin Scin -1.601 0.002 
Cyclin-dependent kinase 2 Cdk2 -1.602 0.0025 
ATP-binding cassette sub-family F member 3 Abcf3 -1.613 0.0003 
AP-3 complex subunit beta-1 Ap3b1 -1.613 0.004 
Sorting nexin-4 Snx4 -1.614 0.0005 
Dynamin-3 Dnm3 -1.619 0.0042 
Serine/threonine-protein kinase 17B Stk17b -1.623 0.0043 
Rho guanine nucleotide exchange factor 16 Arhgef16 -1.627 0.0018 
Glycoprotein-N-acetylgalactosamine 3-beta-
galactosyltransferase 1 
C1galt1 -1.628 0.0071 
Charged multivesicular body protein 7 Chmp7 -1.628 0.0013 
Growth hormone-regulated TBC protein 1 Grtp1 -1.629 0.0016 
Ras-related protein Ral-A Rala -1.629 0.008 
Rhotekin Rtkn -1.629 0.0004 
Casein kinase I isoform alpha Csnk1a1 -1.63 0.0085 
Pyrroline-5-carboxylate reductase 2 Pycr2 -1.63 0.0042 
 Prdm2 -1.634 0.0002 
E3 ubiquitin-protein ligase NEDD4-like Nedd4l -1.635 0.0045 
ATPase family AAA domain-containing protein 3 Atad3 -1.635 0.0004 
E3 ubiquitin-protein ligase RLIM Rlim -1.637 0.0108 
Tyrosyl-DNA phosphodiesterase 2 Tdp2 -1.64 0.0001 
Leucine-rich repeat-containing protein 57 Lrrc57 -1.644 0.0013 
 Chn2 -1.644 0.0058 
Poly(A) RNA polymerase, mitochondrial Mtpap -1.644 0.0038 
 Gcn1l1 -1.646 0.0059 
Protein KTI12 homolog Kti12 -1.651 0.0084 
Zinc finger protein 512 Znf512 -1.654 0.0146 
Rho-related GTP-binding protein RhoG Rhog -1.655 0.0027 
 Slfn9 -1.656 0.0046 
Ras GTPase-activating-like protein IQGAP2 Iqgap2 -1.66 0.0011 
Nucleolar GTP-binding protein 2 Gnl2 -1.661 0.0011 
Alpha-parvin Parva -1.665 0.0028 
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Endophilin-A1 Sh3gl2 -1.668 0.003 
IST1 homolog Ist1 -1.67 0.0008 
DNA mismatch repair protein Msh6 Msh6 -1.671 0.0034 
Mortality factor 4-like protein 1 Morf4l1 -1.672 0.0071 
Methylsterol monooxygenase 1 Msmo1 -1.672 0.0223 
Calmegin Clgn -1.673 0.023 
Metalloendopeptidase OMA1, mitochondrial Oma1 -1.68 0.0166 
Chromodomain-helicase-DNA-binding protein 2 Chd2 -1.681 0.0182 
UPF0505 protein C16orf62 homolog 9030624J02Rik -1.683 0.0172 
GEM-interacting protein Gmip -1.683 0.0007 
Vacuolar fusion protein MON1 homolog A Mon1a -1.683 0.0016 
ATP-binding cassette sub-family F member 2 Abcf2 -1.683 0.0048 
 Myo6 -1.683 0.0153 
Ribosomal protein S6 kinase alpha-5 Rps6ka5 -1.684 0.0113 
cAMP-dependent protein kinase catalytic subunit 
alpha 
Prkaca -1.687 0.0292 
DNA ligase;DNA ligase 1 Lig1 -1.688 0.0211 
Serine/threonine-protein kinase MARK2 Mark2 -1.691 0.0019 
StAR-related lipid transfer protein 4 Stard4 -1.691 0.0006 
Mitochondrial import inner membrane 
translocase subunit TIM50 
Timm50 -1.695 0.0198 
Calcium-binding mitochondrial carrier protein 
SCaMC-1 
Slc25a24 -1.7 0.0285 
Golgi phosphoprotein 3 Golph3 -1.703 0.0035 
Mitogen-activated protein kinase 1 Mapk1 -1.703 0.0085 
 Pkp2 -1.706 0.001 
Ras-related protein Rab-22A Rab22a -1.707 0.0123 
Cytochrome c oxidase subunit 7A-related 
protein, mitochondrial 
Cox7a2l -1.708 0.0085 
Pinin Pnn -1.709 0.0024 
Sterol 26-hydroxylase, mitochondrial Cyp27a1 -1.71 0.0096 
Phosphatidylinositol 4,5-bisphosphate 3-kinase 
catalytic subunit beta isoform 
Pik3cb -1.713 0.0222 
Mitogen-activated protein kinase 3;Mitogen-
activated protein kinase 
Mapk3 -1.714 0.0065 
Dolichol-phosphate mannosyltransferase subunit 
3 
Dpm3 -1.714 0.0498 
Transmembrane protein 65 Tmem65 -1.715 0.0462 
DNA primase large subunit Prim2 -1.715 0.0027 
Mitochondrial ubiquitin ligase activator of NFKB 1 Mul1 -1.718 0.0201 
FERM, RhoGEF and pleckstrin domain-containing 
protein 1 
Farp1 -1.722 0.0009 
28S ribosomal protein S33, mitochondrial Mrps33 -1.722 0.0258 
 Ppp2r5d -1.724 0.0037 
5-AMP-activated protein kinase catalytic subunit 
alpha-2 
Prkaa2 -1.724 0.0037 
Multifunctional protein 
ADE2;Phosphoribosylaminoimidazole-
succinocarboxamide 
Paics -1.726 0.0211 
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synthase;Phosphoribosylaminoimidazole 
carboxylase 
Dedicator of cytokinesis protein 5 Dock5 -1.729 0.0013 
Phosphofurin acidic cluster sorting protein 2 Pacs2 -1.734 0.0008 
Chromodomain-helicase-DNA-binding protein 
8;Chromodomain-helicase-DNA-binding protein 9 
Chd8;Chd9 -1.735 0.0019 
Trinucleotide repeat-containing gene 6B protein Tnrc6b -1.736 0.034 
Protein FAM210A Fam210a -1.738 0.0444 
Cytochrome P450 2J6 Cyp2j6 -1.739 0.0498 
Putative hexokinase HKDC1 Hkdc1 -1.74 0.033 
Cytochrome b-c1 complex subunit 10 Uqcr11 -1.741 0.0231 
Protein disulfide-isomerase A5 Pdia5 -1.746 0.0176 
FACT complex subunit SSRP1 Ssrp1 -1.749 0.0033 
Synaptobrevin homolog YKT6 Ykt6 -1.749 0.0075 
Ras-related C3 botulinum toxin substrate 1;Ras-
related C3 botulinum toxin substrate 3 
Rac1;Rac3 -1.758 0.01 
DENN domain-containing protein 2D Dennd2d -1.759 0.0006 
cGMP-dependent protein kinase;cGMP-
dependent protein kinase 2 
Prkg2 -1.76 0.0024 
Mitochondrial fission 1 protein Fis1 -1.767 0.0009 
N-alpha-acetyltransferase 40 Naa40 -1.768 0.0039 
NADH dehydrogenase [ubiquinone] 1 alpha 
subcomplex subunit 13 
Ndufa13 -1.775 0.023 
Niban-like protein 1 Fam129b -1.777 0.015 
ATP synthase subunit epsilon, mitochondrial Atp5e -1.779 0.0082 
Abhydrolase domain-containing protein 4 Abhd4 -1.78 0.0065 
Transforming growth factor-beta-induced protein 
ig-h3 
Tgfbi -1.789 0.0219 
PX domain-containing protein kinase-like protein Pxk -1.79 0.0003 
Sterol O-acyltransferase 1 Soat1 -1.79 0.0184 
MOB kinase activator 2 Mob2 -1.792 0.0175 
ATP synthase subunit O, mitochondrial Atp5o -1.795 0.0386 
Pumilio homolog 1;Pumilio homolog 2 Pum1;Pum2 -1.796 0.0047 
Plasminogen receptor (KT) Plgrkt -1.797 0.0338 
Serine/threonine-protein kinase Nek3 Nek3 -1.798 0.0124 
EH domain-containing protein 1 Ehd1 -1.799 0.0033 
Integrin-linked protein kinase Ilk -1.801 0.0125 
Spermatogenesis-defective protein 39 homolog Vipas39 -1.803 0.0003 
Sorting nexin-3 Snx3 -1.808 0.0002 
DNA-directed RNA polymerase III subunit RPC3 Polr3c -1.809 0.0134 
Cyclin-dependent kinase 9 Cdk9 -1.809 0.0118 
Ribosomal protein S6 kinase;Ribosomal protein 
S6 kinase alpha-1 
Rps6ka1 -1.811 0.0072 
Platelet glycoprotein 4 Cd36 -1.811 0.006 
Non-syndromic hearing impairment protein 5 
homolog 
Dfna5 -1.812 0.0116 
Transmembrane protein 209 Tmem209 -1.813 0.0203 
Cytochrome P450 4B1 Cyp4b1 -1.816 0.0219 
Zinc finger CCCH domain-containing protein 18 Zc3h18 -1.818 0.0037 
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Protein NDRG1 Ndrg1 -1.818 0.0041 
Sorting and assembly machinery component 50 
homolog 
Samm50 -1.818 0.0334 
 Spcs3 -1.835 0.0302 
Lipoamide acyltransferase component of 
branched-chain alpha-keto acid dehydrogenase 
complex, mitochondrial 
Dbt -1.841 0.0002 
Sodium/nucleoside cotransporter Slc28a1 -1.844 0.0135 
Phosphatidylcholine transfer protein Pctp -1.853 0.0015 
EH domain-containing protein 2 Ehd2 -1.855 0.0031 
Sorting nexin-9 Snx9 -1.859 0.0026 
Nucleolar transcription factor 1 Ubtf -1.859 0.0039 
Sodium/potassium-transporting ATPase subunit 
alpha-4 
Atp1a4 -1.863 0.0031 
Signal peptidase complex catalytic subunit 
SEC11;Signal peptidase complex catalytic subunit 
SEC11A 
Sec11a -1.867 0.049 
Transmembrane protein 109 Tmem109 -1.868 0.013 
NADH dehydrogenase [ubiquinone] 1 alpha 
subcomplex assembly factor 5 
Ndufaf5 -1.869 0.0129 
Unconventional myosin-Id Myo1d -1.87 0.0015 
Death-associated protein kinase 3 Dapk3 -1.873 0.0012 
Probable ATP-dependent RNA helicase DDX17 Ddx17 -1.875 0.0124 
GTP-binding protein 8 Gtpbp8 -1.875 0.0023 
Unconventional myosin-VIIb Myo7b -1.876 0.0022 
Immediate early response 3-interacting protein 1 
Hdhd2;Ier3ip1;G
m10784 
-1.878 0.0261 
 Ak2 -1.881 0.0012 
Amino acid transporter;Neutral amino acid 
transporter B(0) 
Slc1a5 -1.893 0.0141 
Unconventional myosin-Ie Myo1e -1.894 0.004 
Ras suppressor protein 1 Rsu1 -1.896 0.0059 
Sulfotransferase 1 family member D1 Sult1d1 -1.897 0.0015 
Replication factor C subunit 4 Rfc4 -1.9 0.0037 
Amine oxidase [flavin-containing] B Maob -1.9 0.0345 
 Gls -1.902 0.0042 
MOB kinase activator 1A;MOB kinase activator 
1B 
Mob1b;Mob1a -1.905 0.0254 
Mitochondrial pyruvate carrier 1 Mpc1 -1.907 0.027 
ATP-dependent RNA helicase DDX3X;Putative 
ATP-dependent RNA helicase Pl10 
Ddx3x;D1Pas1 -1.908 0.0003 
Solute carrier family 12 member 2 Slc12a2 -1.909 0.0025 
 Dnm1l -1.924 0.0006 
N-acylneuraminate cytidylyltransferase Cmas -1.927 0.004 
Calcium-transporting 
ATPase;Sarcoplasmic/endoplasmic reticulum 
calcium ATPase 3 
Atp2a3 -1.936 0.0024 
Serine/threonine-protein kinase VRK1 Vrk1 -1.943 0.0053 
Mitogen-activated protein kinase 13 Mapk13 -1.945 0.0031 
Flap endonuclease 1 Fen1 -1.956 0.0049 
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Redox-regulatory protein FAM213A Fam213a -1.96 0.0301 
Unconventional myosin-Ia Myo1a -1.961 0.0067 
SUN domain-containing protein 1 Sun1 -1.971 0.0114 
Regulator of chromosome condensation Rcc1 -1.972 0.0023 
 Zfp780b -1.978 0.0139 
Ribonucleoside-diphosphate reductase large 
subunit 
Rrm1 -2.003 0.0107 
Histidine triad nucleotide-binding protein 3 Hint3 -2.007 0.0034 
Cytoplasmic FMR1-interacting protein 2 Cyfip2 -2.008 0.0417 
 Mptx2 -2.011 0.0125 
Endoplasmic reticulum-Golgi intermediate 
compartment protein 1 
Ergic1 -2.014 0.0063 
ATP-dependent RNA helicase DDX3Y Ddx3y -2.029 0.0221 
ADP-ribosylation factor 6 Arf6 -2.03 0.0031 
Histone H2A;Histone H2A type 2-A;Histone H2A 
type 2-C 
Hist1h2al;Hist2h2
aa1;Hist2h2ac 
-2.041 0.0202 
 Cyp2c66 -2.053 0.0365 
MAU2 chromatid cohesion factor homolog Mau2 -2.064 0.0057 
Iodotyrosine dehalogenase 1 Iyd -2.068 0.0119 
Signal peptidase complex subunit 1 Spcs1 -2.082 0.039 
E3 ubiquitin-protein ligase NEDD4 Nedd4 -2.091 0.0012 
Cyclin-dependent kinase 1 Cdk1 -2.094 0.0007 
 Akr1c14 -2.095 0.0021 
GTP-binding protein SAR1b Sar1b -2.102 0.0062 
Cyclin-dependent kinase 18;Cyclin-dependent 
kinase 17 
Cdk18;Cdk17 -2.104 0.0005 
15-hydroxyprostaglandin dehydrogenase 
[NAD(+)] 
Hpgd -2.107 0.0004 
 1700123L14Rik -2.112 0.0338 
pre-mRNA 3 end processing protein WDR33 Wdr33 -2.113 0.0018 
Cytochrome P450 3A11 Cyp3a11 -2.115 0.0364 
Protein disulfide-isomerase A2 Pdia2 -2.118 0.0489 
Estradiol 17-beta-dehydrogenase 2 Hsd17b2 -2.119 0.0039 
Adenylate cyclase type 6 Adcy6 -2.122 0.0013 
Inactive serine/threonine-protein kinase VRK3 Vrk3 -2.156 0.0002 
Unconventional myosin-IXb Myo9b -2.158 0.0029 
Histone H2B type 1-C/E/G;Histone H2B type 1-
M;Histone H2B type 2-B;Histone H2B type 1-H 
Hist1h2bc;Hist1h2
bm;Hist2h2bb;His
t1h2bh 
-2.179 0.0245 
FACT complex subunit SPT16 Supt16;Supt16h -2.196 0.0003 
Amine oxidase [flavin-containing] A Maoa -2.199 0.0195 
Guanine nucleotide-binding protein-like 3-like 
protein 
Gnl3l -2.229 0.0128 
Leiomodin-1 Lmod1 -2.275 0.03 
NADH-ubiquinone oxidoreductase chain 3 Mtnd3 -2.289 0.0154 
Core histone macro-H2A.1 H2afy -2.292 0.0074 
Histone H2B type 3-B;Histone H2B type 3-
A;Histone H2B type 2-E 
Hist3h2bb;Hist3h
2ba;Hist2h2be 
-2.315 0.031 
Acylglycerol kinase, mitochondrial Agk -2.316 0.0084 
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 Syne2 -2.353 0.0028 
 Col6a3 -2.368 0.0368 
Collagen alpha-1(VI) chain Col6a1 -2.37 0.0495 
Peptidyl-prolyl cis-trans isomerase FKBP11 Fkbp11 -2.389 0.0314 
Histone H2A type 1-F Hist1h2af -2.405 0.0113 
Sideroflexin-3 Sfxn3 -2.436 0.0266 
Probable ATP-dependent RNA helicase DDX5 Ddx5 -2.446 0.0009 
 Sar1a -2.452 0.0004 
Sorting nexin;Sorting nexin-18 Snx18 -2.509 0.0023 
Indoleamine 2,3-dioxygenase 1 Ido1 -2.52 0.0115 
Histone H2A type 2-B Hist2h2ab -2.54 0.0173 
 Tns1 -2.546 0.0053 
DNA topoisomerase 2-alpha Top2a -2.655 0.0052 
Histone H3.2 Hist1h3b -2.76 0.0435 
Histone H2A.V;Histone H2A.Z;Histone H2A H2afv;H2afz -2.783 0.0033 
Syndecan-4 Sdc4 -2.819 0.0017 
Histone H2B type 1-F/J/L;Histone H2B;Histone 
H2B type 1-P;Histone H2B type 1-K;Histone H2B 
type 1-B;Histone H2B type 1-A 
Hist1h2bf;Hist1h2
br;Hist1h2bp;Hist
1h2bk;Hist1h2bb;
Hist1h2ba 
-2.823 0.0011 
Histone H4 Hist1h4a -2.842 0.0046 
E3 ubiquitin-protein ligase TRIM23 Trim23 -2.876 0.0021 
Zymogen granule membrane protein 16 Zg16 -2.895 0.0269 
Histone H3.1 Hist1h3a -2.984 0.0052 
Ig kappa chain C region Igkc -3.021 0.0008 
RNA-binding protein with serine-rich domain 1 Rnps1 -3.022 0.0005 
Histone H2A type 1-K Hist1h2ak -3.211 0.0052 
Alpha-defensin 21;Alpha-defensin 22 Defa22;Defa21 -3.221 0.042 
ADP/ATP translocase 1 Slc25a4 -3.238 0.046 
Alpha-defensin-related sequence 1 
Gm14851;Defa-
rs1 
-3.273 0.0342 
Alpha-defensin 24 Defa24 -3.421 0.0155 
Histone H3.3;Histone H3.3C;Histone H3 H3f3a;H3f3c -3.62 0.0044 
Alpha-defensin 23 Defa23 -3.968 0.0037 
Ig alpha chain C region Igha -3.978 0.0001 
Lactase-like protein Lctl -4.106 0.0386 
Intelectin-1a Itln1 -4.132 0.0013 
Cysteine dioxygenase type 1 Cdo1 -4.138 0.001 
Protein FAM83F Fam83f -4.679 0.0014 
Alpha-defensin 20 Defcr20;Defa20 -5.563 0.0341 
Lysozyme C-1;Lysozyme C-2 Lyz1;Lyz2 -6.755 0.0018 
Defensin alpha, 27 
Gm15299 
 (Defa 27) 
-9.762 0.0004 
Reticulon-3 Rtn3 -11.26 0.0376 
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Appendix 2: significant proteomic changes in Nfҡb2-/- small intestinal mucosa in 
comparison to C57BL/6J mice 
Protein names Gene names 
Regulation 
fold change 
P value 
Cytochrome b Mt-Cyb 6.3045 0.0006 
Tubulin-specific chaperone A Tbca 6.2372 0.0001 
 Calu 4.5687 0.0006 
H-2 class II histocompatibility antigen, A-B alpha 
chain 
H2-Aa 4.4762 0.0082 
Copper transport protein ATOX1 Atox1 4.4345 0.0005 
Pyridine nucleotide-disulfide oxidoreductase 
domain-containing protein 2 
Pyroxd2 4.3738 0.0001 
40S ribosomal protein S28 Rps28;Gm10263 4.1087 0.0001 
Guanine nucleotide-binding protein subunit beta-
2-like 1 
Gnb2l1 3.8836 0.0005 
Adenosine deaminase Ada 3.8046 0.0018 
Cysteine-rich with EGF-like domain protein 2 Creld2 3.5998 0.0001 
H-2 class II histocompatibility antigen, A beta chain H2-Ab1 3.5825 0.0058 
 Igtp 3.3549 0.0006 
Class II histocompatibility antigen, M alpha chain H2-DMa 3.312 0.0023 
RNA-binding protein 3 Rbm3 3.254 0.0001 
 2200002D01Rik 3.1907 0.0014 
 Gls 3.1068 0.0028 
28 kDa heat- and acid-stable phosphoprotein Pdap1 3.0361 0.0002 
LIM and SH3 domain protein 1 Lasp1 2.9755 0.0001 
Serum albumin Alb 2.9712 0.0001 
Xanthine dehydrogenase/oxidase Xdh 2.9589 0.0001 
H-2 class II histocompatibility antigen gamma chain Cd74 2.9379 0.0522 
L-lactate dehydrogenase;L-lactate dehydrogenase 
B chain 
Ldhb 2.9315 0.0008 
Uridine phosphorylase 1 Upp1 2.8701 0.0001 
Proteasome subunit beta type-9 Psmb9 2.7254 0.0001 
40S ribosomal protein SA Rpsa 2.7206 0.0001 
Thioredoxin domain-containing protein 17 Txndc17 2.7121 0.0002 
Guanine deaminase Gda 2.6788 0.0016 
Aspartate aminotransferase, cytoplasmic Got1 2.6487 0.0002 
Deoxyribonuclease-1 Dnase1 2.6345 0.0003 
40S ribosomal protein S21 Rps21 2.6218 0.0003 
H-2 class II histocompatibility antigen H2-Eb1 2.6061 0.0322 
Granzyme B(G,H) Gzmb 2.5922 0.0498 
Cathepsin L1;Cathepsin L1 heavy chain;Cathepsin 
L1 light chain 
Ctsl 2.5852 0.0001 
Calumenin Calu 2.5429 0.0001 
60S acidic ribosomal protein P2 Rplp2 2.5234 0.0001 
Phospholysine phosphohistidine inorganic 
pyrophosphate phosphatase 
Lhpp 2.5142 0.0026 
Proteasome subunit beta type-8;Proteasome 
subunit beta type 
Psmb8 2.5091 0.0001 
UPF0587 protein C1orf123 homolog 0610037L13Rik 2.5087 0.0011 
Cytosolic acyl coenzyme A thioester hydrolase Acot7 2.4999 0.0001 
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Retinol-binding protein 2 Rbp2 2.4905 0.0003 
Nardilysin Nrd1 2.4899 0.0003 
D-dopachrome decarboxylase Ddt 2.4853 0.0004 
L-lactate dehydrogenase;L-lactate dehydrogenase 
A chain 
Ldha 2.4745 0.0009 
Class II histocompatibility antigen, M beta 1 chain 
H2-DMb1;H2-
DMb2 
2.4656 0.0009 
 Adh6a 2.4402 0.0017 
Cathepsin Z Ctsz 2.4143 0.0004 
Acidic leucine-rich nuclear phosphoprotein 32 
family member E 
Anp32e 2.4049 0.0002 
Proteasome subunit alpha type-6 Psma6 2.4029 0.0001 
Cellular nucleic acid-binding protein Cnbp 2.3924 0.0002 
NAD(P)H dehydrogenase [quinone] 1 Nqo1 2.3868 0.0023 
Proteasome subunit beta type-2 Psmb2 2.3819 0.0001 
Alcohol dehydrogenase 1 Adh1 2.3807 0.0087 
6-phosphogluconate dehydrogenase, 
decarboxylating 
Pgd 2.3503 0.0002 
Creatine kinase B-type Ckb 2.3401 0.0014 
Thiamin pyrophosphokinase 1 Tpk1 2.3284 0.0002 
Protein PRRC2A Prrc2a 2.324 0.0036 
Carbonic anhydrase 13 Ca13 2.3035 0.0033 
Parathymosin Ptms 2.2918 0.0039 
Tropomyosin beta chain Tpm2 2.2889 0.0099 
Glutathione reductase, mitochondrial Gsr 2.2736 0.0001 
Caspase-3;Caspase-3 subunit p17;Caspase-3 
subunit p12 
Casp3 2.2734 0.001 
Proteasome subunit alpha type-5 Psma5 2.2698 0.0003 
Acyl-CoA-binding protein Dbi 2.2533 0.0071 
Protein phosphatase 1 regulatory subunit 1B Ppp1r1b 2.2473 0.0001 
Proteasome subunit beta type-1 Psmb1 2.2384 0.0001 
Thioredoxin reductase 1, cytoplasmic Txnrd1 2.2323 0.0011 
Peptidyl-prolyl cis-trans isomerase NIMA-
interacting 1 
Pin1;Pin1rt1 2.2274 0.0006 
ATP synthase subunit s, mitochondrial Atp5s 2.2228 0.1511 
Adenosylhomocysteinase Ahcy 2.2221 0.0009 
Leukotriene A-4 hydrolase Lta4h 2.2188 0.0006 
Prothymosin alpha;Prothymosin alpha, N-
terminally processed;Thymosin alpha 
Ptma 2.1998 0.0013 
S-formylglutathione hydrolase Esd 2.199 0.0007 
Death-associated protein 1 Dap 2.1947 0.0066 
Caprin-1 Caprin1 2.193 0.0007 
Proteasome subunit alpha type-2 Psma2 2.1897 0.0001 
Cytoplasmic aconitate hydratase Aco1 2.1826 0.0012 
GRB2-related adaptor protein 2 Grap2 2.1798 0.0074 
60S ribosomal protein L35a Rpl35a 2.1785 0.0012 
Cystatin-B Cstb 2.1764 0.0005 
PHD finger-like domain-containing protein 5A Phf5a 2.1763 0.0001 
Protein-glutamine gamma-glutamyltransferase 2 Tgm2 2.1752 0.0001 
Polymeric immunoglobulin receptor;Secretory 
component 
Pigr 2.1716 0.0007 
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WD repeat-containing protein 1 Wdr1 2.1711 0.0003 
Mth938 domain-containing protein Aamdc 2.1711 0.0012 
Serine hydroxymethyltransferase;Serine 
hydroxymethyltransferase, cytosolic 
Shmt1 2.1585 0.0037 
Acylamino-acid-releasing enzyme Apeh 2.1502 0.0013 
Proteasome subunit alpha type-1 Psma1 2.1497 0.0001 
 Gm20441 2.1398 0.0077 
Unconventional myosin-Ib Myo1b 2.1324 0.0222 
GDP-mannose 4,6 dehydratase Gmds 2.1224 0.0004 
Z-DNA-binding protein 1 Zbp1 2.1202 0.0001 
60S acidic ribosomal protein P1 Rplp1;Gm10073 2.1126 0.0003 
Cysteine and glycine-rich protein 1 Csrp1 2.1125 0.0021 
Hyaluronan-binding protein 2;Hyaluronan-binding 
protein 2  
Habp2 2.112 0.0022 
Dipeptidyl peptidase 1;Dipeptidyl peptidase 1 
exclusion domain chain;Dipeptidyl peptidase 1 
heavy chain;Dipeptidyl peptidase 1 light chain 
Ctsc 2.1108 0.0001 
Huntingtin-interacting protein K Hypk 2.1084 0.0003 
Stress-induced-phosphoprotein 1 Stip1 2.1061 0.0002 
Major vault protein Mvp 2.1054 0.0009 
Protein deglycase DJ-1 Park7 2.0976 0.0002 
Cofilin-1 Cfl1 2.0862 0.0001 
Puromycin-sensitive aminopeptidase Npepps 2.0857 0.0022 
Mesencephalic astrocyte-derived neurotrophic 
factor 
Manf 2.0818 0.0002 
Prefoldin subunit 2 Pfdn2 2.079 0.0041 
Peroxiredoxin-6 Prdx6 2.0777 0.001 
Fucose mutarotase Fuom 2.0754 0.0032 
Aminopeptidase B Rnpep 2.0649 0.0003 
Cytosolic 10-formyltetrahydrofolate 
dehydrogenase 
Aldh1l1 2.0624 0.0014 
U1 small nuclear ribonucleoprotein C Snrpc 2.0538 0.0002 
Alcohol dehydrogenase class-3 Adh5 2.0502 0.0011 
 Irgm2 2.047 0.0029 
Xaa-Pro dipeptidase Pepd 2.0455 0.0008 
Regenerating islet-derived protein 3-gamma  Reg3g 2.0376 0.0003 
Lactoylglutathione lyase Glo1 2.0332 0.0033 
Vacuolar protein sorting-associated protein 29 Vps29 2.0294 0.0001 
Peptidyl-prolyl cis-trans isomerase A;Peptidyl-
prolyl cis-trans isomerase A, N-terminally 
processed;Peptidyl-prolyl cis-trans isomerase 
Ppia;Gm5160 2.0283 0.0017 
Aromatic-L-amino-acid decarboxylase Ddc 2.0273 0.0049 
Prefoldin subunit 4 Pfdn4 2.0254 0.0006 
Translationally-controlled tumor protein Tpt1 2.0223 0.0005 
Carbonic anhydrase 2 Ca2 2.0183 0.0033 
Ribosyldihydronicotinamide dehydrogenase 
[quinone] 
Nqo2 2.0155 0.0016 
Protein-tyrosine kinase 6 Ptk6 2.0151 0.0002 
U6 snRNA-associated Sm-like protein LSm7 Lsm7 2.0144 0.0003 
Myeloid-derived growth factor Mydgf 2.0137 0.002 
Mannose-1-phosphate guanyltransferase beta Gmppb 2.0111 0.0001 
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Serine/threonine-protein phosphatase 6 catalytic 
subunit 
Ppp6c 2.0111 0.0001 
Plasminogen activator inhibitor 1 RNA-binding 
protein 
Serbp1 2.0111 0.0077 
Protein S100-A11 S100a11 2.0084 0.0029 
Low molecular weight phosphotyrosine protein 
phosphatase 
Acp1 2.0011 0.0016 
Vacuolar protein sorting-associated protein 26A Vps26a 1.9969 0.0003 
Phosphoglycerate kinase 1;Phosphoglycerate 
kinase 
Pgk1 1.9948 0.0038 
Spermine synthase Sms 1.9931 0.0005 
UDP-glucose 4-epimerase Gale 1.989 0.0001 
Dehydrogenase/reductase SDR family member 11 Dhrs11 1.9856 0.0013 
40S ribosomal protein S12 Rps12 1.9843 0.0001 
Acidic leucine-rich nuclear phosphoprotein 32 
family member A 
Anp32a 1.9818 0.0039 
Ran-specific GTPase-activating protein Ranbp1 1.9807 0.0048 
N-acetyl-D-glucosamine kinase Nagk 1.9791 0.0041 
Aspartoacylase Aspa 1.9771 0.0022 
Macrophage migration inhibitory factor Mif 1.9759 0.0003 
Prolyl endopeptidase Prep 1.9752 0.0012 
Glucose-6-phosphate isomerase Gpi 1.9752 0.0022 
Ubiquitin-like protein 5 Ubl5;Gm16381 1.9748 0.0004 
Peroxisomal carnitine O-octanoyltransferase Crot 1.9737 0.0012 
Mitochondrial import inner membrane translocase 
subunit Tim8 B 
Timm8b 1.9732 0.0032 
Transaldolase Taldo1 1.9661 0.0058 
 Gbp6;Gbp10 1.9653 0.0009 
Proteasome subunit alpha type-3 Psma3 1.9647 0.0002 
Alanine aminotransferase 1 Gpt 1.9611 0.0055 
Protein FAM50A Fam50a 1.9603 0.0141 
Glutathione peroxidase 2 Gpx2 1.9557 0.0001 
Asparagine--tRNA ligase, cytoplasmic Nars 1.9502 0.0001 
Pro-cathepsin H;Cathepsin H mini chain;Cathepsin 
H;Cathepsin H heavy chain;Cathepsin H light chain 
Ctsh 1.9456 0.0003 
Bifunctional purine biosynthesis protein 
PURH;Phosphoribosylaminoimidazolecarboxamide 
formyltransferase;IMP cyclohydrolase 
Atic 1.9453 0.0007 
Protein SET Set 1.9389 0.0037 
Adenosylhomocysteinase;Putative 
adenosylhomocysteinase 3 
Ahcyl2 1.9351 0.0001 
 Gbp9 1.9296 0.004 
U6 snRNA-associated Sm-like protein LSm3 Lsm3 1.9283 0.007 
CD2-associated protein Cd2ap 1.9267 0.0029 
Small glutamine-rich tetratricopeptide repeat-
containing protein alpha 
Sgta 1.9263 0.001 
F-box only protein 3 Fbxo3 1.9254 0.0002 
O-phosphoseryl-tRNA(Sec) selenium transferase Sepsecs 1.9247 0.0072 
Calpastatin Cast 1.9196 0.0025 
Nicotinamide phosphoribosyltransferase Nampt 1.919 0.0033 
Triosephosphate isomerase Tpi1 1.9174 0.0035 
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Malate dehydrogenase, cytoplasmic Mdh1 1.9171 0.0031 
Acetyl-CoA acetyltransferase, cytosolic Acat2;Acat3 1.9158 0.0007 
DAZ-associated protein 1 Dazap1 1.9139 0.0002 
Serine/arginine-rich splicing factor 4 Srsf4 1.9129 0.0076 
Acetoacetyl-CoA synthetase Aacs 1.9124 0.0001 
Transketolase Tkt 1.9091 0.0008 
 Gimap9 1.9003 0.0686 
6-pyruvoyl tetrahydrobiopterin synthase Pts 1.8997 0.0065 
Pro-interleukin-16;Interleukin-16 Il16 1.8978 0.0058 
Sperm-associated antigen 7 Spag7 1.8967 0.0014 
Protein farnesyltransferase subunit beta Fntb 1.8922 0.0007 
Proteasome subunit beta type-10 Psmb10 1.888 0.0001 
Nuclease-sensitive element-binding protein 1 Ybx1 1.8878 0.0004 
Serine--tRNA ligase, cytoplasmic Sars 1.8874 0.0007 
Superoxide dismutase [Cu-Zn] Sod1 1.8874 0.0156 
Lambda-crystallin homolog Cryl1 1.884 0.0049 
Signal transducer and activator of transcription 1 Stat1 1.8825 0.0024 
Proteasome subunit alpha type-4 Psma4 1.88 0.0002 
Nitrilase homolog 1 Nit1 1.8791 0.0006 
Protein archease Zbtb8os 1.8736 0.0037 
Calcium-regulated heat stable protein 1 Carhsp1 1.872 0.0001 
Xaa-Pro aminopeptidase 1 Xpnpep1 1.8712 0.0006 
Protein phosphatase 1 regulatory subunit 14D Ppp1r14d 1.8701 0.0006 
Tyrosine-protein kinase ZAP-70 Zap70 1.8621 0.0443 
Transcription elongation factor A protein 1 Tcea1 1.8602 0.0015 
Aldose 1-epimerase Galm 1.8577 0.0032 
Ketohexokinase Khk 1.857 0.0011 
Serine/threonine-protein phosphatase 2A catalytic 
subunit alpha isoform 
Ppp2ca 1.857 0.0001 
ADP-sugar pyrophosphatase Nudt5 1.856 0.0008 
Eukaryotic translation initiation factor 1A,  
X-chromosomal 
Eif1ax;Eif1a;Gm5
039;Gm5662;Gm
8300;Gm2016;G
m21936;Gm2056;
Gm6803;Gm2035
;Gm2075 
1.8466 0.0002 
4-trimethylaminobutyraldehyde dehydrogenase Aldh9a1 1.8458 0.0003 
Carboxylic ester hydrolase Ces1f 1.8455 0.0477 
Zyxin Zyx 1.8432 0.0001 
Carboxypeptidase;Lysosomal protective 
protein;Lysosomal protective protein 32 kDa 
chain;Lysosomal protective protein 20 kDa chain 
Ctsa 1.8421 0.0016 
MIP18 family protein FAM96A Fam96a 1.8418 0.0224 
Craniofacial development protein 1 Cfdp1 1.8398 0.0034 
60S ribosomal protein L34 Rpl34 1.839 0.0103 
Proteasome subunit beta type-3 Psmb3 1.8361 0.0001 
Serine/threonine-protein phosphatase 2A catalytic 
subunit beta isoform 
Ppp2cb 1.8357 0.0001 
Heterogeneous nuclear ribonucleoprotein D0 Hnrnpd 1.8334 0.0001 
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Eukaryotic translation initiation factor 3 subunit J-
A;Eukaryotic translation initiation factor 3 subunit 
J-B 
Eif3j1;Eif3j2 1.8307 0.0025 
Ribose-5-phosphate isomerase Rpia 1.8273 0.0006 
1,5-anhydro-D-fructose reductase Akr1e2;Akr1e1 1.8267 0.0102 
Caspase-6;Caspase-6 subunit p18;Caspase-6 
subunit p11 
Casp6 1.8238 0.0014 
Gamma-glutamylaminecyclotransferase Ggact 1.8236 0.0005 
Transthyretin Ttr 1.8223 0.0047 
NADP-dependent malic enzyme;Malic enzyme Me1 1.8219 0.0479 
Antigen peptide transporter 1 Tap1 1.8199 0.0046 
Heterogeneous nuclear ribonucleoprotein A/B Hnrnpab 1.8196 0.0012 
Calcium channel flower homolog Cacfd1 1.8195 0.0001 
Histidine--tRNA ligase, cytoplasmic Hars 1.8187 0.0013 
U1 small nuclear ribonucleoprotein 70 kDa Snrnp70 1.816 0.0006 
Ribulose-phosphate 3-epimerase Rpe 1.8125 0.0002 
Serine/threonine-protein phosphatase 
5;Serine/threonine-protein phosphatase 
Ppp5c 1.8108 0.0016 
Adenylosuccinate lyase Adsl 1.807 0.0013 
Heterogeneous nuclear ribonucleoprotein U-like 
protein 1 
Hnrnpul1 1.8066 0.0001 
Exosome complex component CSL4 Exosc1 1.8062 0.0065 
E3 ubiquitin-protein ligase XIAP Xiap 1.8043 0.0001 
MOB-like protein phocein Mob4 1.8039 0.0001 
Alpha-enolase Eno1 1.8035 0.0009 
Aldose reductase-related protein 2 Akr1b8 1.8028 0.0179 
SH3 domain-binding glutamic acid-rich-like protein Sh3bgrl 1.8001 0.0034 
Biotinidase Btd 1.7998 0.0036 
Cytochrome c, somatic Cycs 1.7955 0.0167 
RNA-binding protein EWS Ewsr1 1.7955 0.0004 
Glutathione synthetase Gss 1.7915 0.0054 
Gamma-interferon-inducible lysosomal thiol 
reductase 
Ifi30 1.7909 0.0016 
Protein LZIC Lzic 1.7888 0.0061 
UPF0160 protein MYG1, mitochondrial Myg1 1.7884 0.0003 
Eukaryotic translation initiation factor 4B Eif4b 1.7851 0.0008 
Secernin-2 Scrn2 1.7815 0.0022 
Protein MEMO1 Memo1 1.7799 0.003 
Phosphoglycolate phosphatase Pgp 1.7799 0.0011 
Eukaryotic translation initiation factor 5A-
1;Eukaryotic translation initiation factor 5A 
Eif5a 1.7789 0.0005 
Purine nucleoside phosphorylase Pnp 1.7782 0.0001 
Fructose-bisphosphate aldolase A;Fructose-
bisphosphate aldolase 
Aldoa;Aldoart1 1.7764 0.0001 
Programmed cell death protein 5 Pdcd5 1.776 0.0014 
Fatty acid-binding protein, liver Fabp1 1.774 0.0018 
Drebrin-like protein Dbnl 1.7714 0.0005 
Interferon alpha-inducible protein 27-like protein 
2B 
Ifi27l2b 1.7695 0.0009 
Hsc70-interacting protein St13 1.7655 0.0012 
28S ribosomal protein S36, mitochondrial Mrps36 1.7651 0.001 
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N-acyl-aromatic-L-amino acid amidohydrolase 
(carboxylate-forming) 
Acy3 1.7617 0.0041 
Stathmin Stmn1 1.7596 0.0101 
Polyadenylate-binding protein 2 Gm20521;Pabpn1 1.7592 0.0023 
BUB3-interacting and GLEBS motif-containing 
protein ZNF207 
Znf207;Zfp207 1.759 0.0008 
Proteasome subunit alpha type-7 Psma7 1.7579 0.0002 
Alcohol dehydrogenase [NADP(+)] Akr1a1 1.755 0.0093 
Isocitrate dehydrogenase [NADP] cytoplasmic Idh1 1.7544 0.0345 
60S ribosomal protein L28 Rpl28 1.7515 0.0074 
Geranylgeranyl pyrophosphate synthase Ggps1 1.7506 0.0027 
Threonine--tRNA ligase, cytoplasmic Tars 1.7506 0.0013 
Dipeptidyl peptidase 3 Dpp3 1.7502 0.0023 
Phosphatidylethanolamine-binding protein 
1;Hippocampal cholinergic neurostimulating 
peptide 
Pebp1 1.7453 0.0011 
Nucleoside diphosphate kinase A;Nucleoside 
diphosphate kinase 
Nme1 1.7452 0.0024 
60S ribosomal protein L13a Rpl13a 1.745 0.001 
S-adenosylmethionine synthase isoform type-2 Mat2a 1.7444 0.0005 
Thioredoxin, mitochondrial Txn2 1.7431 0.0109 
Uncharacterized protein C1orf43 homolog 4933434E20Rik 1.7426 0.0294 
Tetratricopeptide repeat protein 38 Ttc38 1.742 0.0003 
Microsomal triglyceride transfer protein large 
subunit 
Mttp 1.7418 0.0026 
Rab GDP dissociation inhibitor alpha Gdi1 1.7391 0.003 
Protein canopy homolog 2 Cnpy2 1.7377 0.0029 
Epididymal secretory protein E1 Npc2 1.7374 0.0068 
Delta-1-pyrroline-5-carboxylate dehydrogenase, 
mitochondrial 
Aldh4a1 1.736 0.0007 
Glucosamine-6-phosphate isomerase 1 Gnpda1 1.7302 0.0002 
Small integral membrane protein 24 Smim24 1.7301 0.0094 
Protein FAM192A Fam192a 1.7292 0.0134 
Cathepsin D Ctsd 1.7286 0.0005 
Selenium-binding protein 1;Selenium-binding 
protein 2 
Selenbp1;Selenbp
2 
1.7286 0.0041 
Apoptosis-associated speck-like protein containing 
a CARD 
Pycard 1.7255 0.0007 
Heat shock 70 kDa protein 4 Hspa4 1.7248 0.0004 
Small ubiquitin-related modifier 2 Sumo2;Sumo3 1.7218 0.0021 
Cytochrome c oxidase assembly factor 7 Coa7 1.7201 0.007 
Delta-aminolevulinic acid dehydratase Alad 1.7199 0.0039 
 Parp4 1.7198 0.0005 
WAS/WASL-interacting protein family member 3 Wipf3 1.7197 0.0038 
Proliferation-associated protein 2G4 Pa2g4 1.7167 0.0007 
 Tpm3 1.7155 0.0106 
Retinoid-inducible serine carboxypeptidase Scpep1 1.7146 0.0002 
Sialate O-acetylesterase;Sialate O-acetylesterase 
small subunit;Sialate O-acetylesterase large 
subunit 
Siae 1.7121 0.0006 
Purine nucleoside phosphorylase Pnp2 1.7119 0.0001 
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Arylamine N-acetyltransferase 2 Nat2 1.7093 0.0075 
Aspartyl aminopeptidase Dnpep 1.7085 0.0004 
Enhancer of rudimentary homolog Erh 1.7067 0.0014 
Creatine kinase U-type, mitochondrial Ckmt1 1.7053 0.0071 
Peptidyl-prolyl cis-trans isomerase G Ppig 1.7045 0.0253 
Glutathione S-transferase P 1 Gstp1 1.7044 0.0022 
Serine/arginine-rich splicing factor 7 Srsf7 1.7043 0.0202 
Cystathionine gamma-lyase Cth 1.7035 0.0059 
Heterogeneous nuclear ribonucleoprotein D-like Hnrnpdl 1.7034 0.0018 
60S ribosomal protein L29 
Gm17669;Rpl29;G
m3550 
1.7003 0.0026 
Serine/threonine-protein phosphatase 4 catalytic 
subunit 
Ppp4c 1.697 0.0021 
Probable aminopeptidase NPEPL1 Npepl1 1.6965 0.0003 
Tyrosine--tRNA ligase;Tyrosine--tRNA ligase, 
cytoplasmic;Tyrosine--tRNA ligase, cytoplasmic, N-
terminally processed 
Yars 1.6931 0.0053 
Small nuclear ribonucleoprotein Sm D3 Snrpd3 1.693 0.0015 
Small nuclear ribonucleoprotein Sm D2 Snrpd2;Gm5449 1.6929 0.0003 
60S ribosomal protein L14 Rpl14 1.6922 0.0316 
Fructose-1,6-bisphosphatase isozyme 2 Fbp2 1.6901 0.0023 
 Acy1 1.6901 0.0082 
Elongation factor 2 Eef2 1.6895 0.0001 
Coiled-coil domain-containing protein 58 Ccdc58 1.6863 0.0268 
DNA-(apurinic or apyrimidinic site) lyase Apex1 1.6838 0.0016 
RNA-binding protein FUS Fus 1.6822 0.0018 
Aldose reductase-related protein 1 Akr1b7 1.6814 0.0049 
Ribonuclease inhibitor Rnh1 1.6805 0.0024 
Beta-enolase;Enolase Eno3 1.6774 0.0132 
Isopentenyl-diphosphate Delta-isomerase 1 Idi1 1.6748 0.002 
Heat shock protein 105 kDa Hsph1 1.674 0.0001 
Platelet-activating factor acetylhydrolase IB 
subunit alpha 
Pafah1b1 1.6726 0.0003 
Filamin-binding LIM protein 1 Fblim1 1.6717 0.0001 
Serine/arginine-rich splicing factor 2 Srsf2 1.6706 0.029 
Hepatoma-derived growth factor Hdgf 1.6702 0.0061 
Peroxiredoxin-5, mitochondrial Prdx5 1.6699 0.0026 
Peptidyl-prolyl cis-trans isomerase FKBP2 Fkbp2 1.6688 0.0001 
Thioredoxin Txn 1.6663 0.0006 
N-acetylglucosamine-6-sulfatase Gns 1.6661 0.0018 
60S ribosomal protein L36a Rpl36a 1.6649 0.0023 
Chloride intracellular channel protein 1 Clic1 1.6635 0.0001 
Adapter molecule crk Crk 1.6632 0.0018 
Prostaglandin reductase 2 Ptgr2 1.6631 0.0015 
RNA polymerase II subunit A C-terminal domain 
phosphatase SSU72 
Ssu72 1.6576 0.0063 
Bleomycin hydrolase Blmh 1.6572 0.0013 
Serine-threonine kinase receptor-associated 
protein 
Strap 1.6537 0.0001 
Glutathione peroxidase 1;Glutathione peroxidase Gpx1 1.6535 0.0007 
Mannose-1-phosphate guanyltransferase alpha Gmppa 1.6494 0.0006 
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Fatty acid-binding protein, intestinal Fabp2 1.6469 0.045 
Elongation factor 1-delta Eef1d 1.6436 0.0003 
Guanylate cyclase activator 2B;Uroguanylin Guca2b 1.6419 0.0211 
Ubiquitin-conjugating enzyme E2 A Ube2a 1.6403 0.002 
Serine/arginine-rich splicing factor 6 Srsf6 1.6381 0.0018 
Calreticulin Calr 1.6377 0.0027 
Transcription elongation factor B polypeptide 2 Tceb2 1.6358 0.0001 
 Hnrnpd 1.6351 0.0009 
High mobility group nucleosome-binding domain-
containing protein 5 
Hmgn5 1.6324 0.0131 
Inorganic pyrophosphatase Ppa1 1.6322 0.0004 
Negative elongation factor A Nelfa 1.6318 0.0165 
Coiled-coil domain-containing protein 6 Ccdc6 1.6299 0.0033 
Protein FAM136A Fam136a 1.6271 0.0138 
Interferon-induced protein with tetratricopeptide 
repeats 1 
Ifit1 1.6263 0.0002 
Microtubule-associated protein 4;Microtubule-
associated protein 
Map4 1.6252 0.0003 
26S proteasome non-ATPase regulatory subunit 9 Psmd9 1.6239 0.0043 
ATP synthase subunit e, mitochondrial Atp5i;Atp5k 1.6209 0.0163 
 Rabgap1l 1.6207 0.0016 
Aldehyde dehydrogenase family 16 member A1 Aldh16a1 1.6185 0.0002 
Carboxymethylenebutenolidase homolog Cmbl 1.6167 0.0134 
Uncharacterized protein KIAA0556 
D430042O09Rik;K
iaa0556 
1.616 0.0087 
Serine/arginine-rich splicing factor 9 Srsf9 1.6159 0.0071 
3-oxoacyl-[acyl-carrier-protein] synthase, 
mitochondrial 
Oxsm 1.6151 0.0049 
NEDD8 Nedd8 1.6055 0.0014 
Semaphorin-4B Sema4b 1.6032 0.0022 
Prostaglandin reductase 1 Ptgr1 1.6016 0.0348 
UV excision repair protein RAD23 homolog A Rad23a 1.5988 0.0002 
MAP/microtubule affinity-regulating kinase 3 Mark3 1.5978 0.0001 
Aldose reductase Akr1b1 1.5976 0.0036 
Tapasin Tapbp 1.5942 0.0016 
Dihydropteridine reductase Qdpr 1.5936 0.0113 
GMP reductase 2 Gmpr2 1.593 0.003 
Carboxypeptidase Q Cpq 1.5927 0.0001 
60S ribosomal protein L12 Rpl12 1.5895 0.0011 
Tropomyosin alpha-4 chain Tpm4 1.5884 0.0256 
Protein canopy homolog 3 Cnpy3 1.5882 0.0122 
Hydroxyacylglutathione hydrolase, mitochondrial Hagh 1.5882 0.0106 
Protein disulfide-isomerase A3 Pdia3 1.5857 0.0064 
40S ribosomal protein S17 Rps17 1.5844 0.0085 
Epithelial discoidin domain-containing receptor 1 Ddr1 1.5843 0.0004 
FYN-binding protein Fyb 1.5833 0.0417 
Cytosolic non-specific dipeptidase Cndp2 1.5825 0.0246 
Phenazine biosynthesis-like domain-containing 
protein 2 
Pbld2 1.5808 0.0362 
Beta-glucuronidase Gusb 1.5805 0.0021 
GDP-fucose transporter 1 Slc35c1 1.5801 0.0172 
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Signal transducer and activator of transcription Stat1 1.5767 0.0311 
Thioredoxin domain-containing protein 12 Txndc12 1.5752 0.0027 
Rab9 effector protein with kelch motifs Rabepk 1.5732 0.0009 
Deoxyribose-phosphate aldolase Dera 1.5722 0.0014 
E3 ubiquitin-protein ligase RNF126 Rnf126 1.5721 0.0026 
Nucleoside diphosphate kinase;Nucleoside 
diphosphate kinase B 
Gm20390;Nme2 1.5716 0.0043 
Eukaryotic translation initiation factor 4H Eif4h 1.5715 0.0007 
Glycogen phosphorylase, brain form Pygb 1.5693 0.0003 
Glutathione S-transferase Mu 5 Gstm5 1.5684 0.0007 
Gamma-parvin Parvg 1.5668 0.0273 
C-1-tetrahydrofolate synthase, 
cytoplasmic;Methylenetetrahydrofolate 
dehydrogenase;Methenyltetrahydrofolate 
cyclohydrolase;Formyltetrahydrofolate 
synthetase;C-1-tetrahydrofolate synthase, 
cytoplasmic, N-terminally processed 
Mthfd1 1.5668 0.0016 
60S ribosomal protein L4 Rpl4 1.5658 0.0037 
60S ribosomal protein L26 Rpl26 1.5658 0.041 
Guanylate kinase Guk1 1.561 0.0009 
Antigen peptide transporter 2 Tap2 1.5608 0.0088 
Protein phosphatase 1 regulatory subunit 14B Ppp1r14b 1.5601 0.003 
Small nuclear ribonucleoprotein-associated protein 
B;Small nuclear ribonucleoprotein-associated 
protein N 
Snrpb;Snrpn 1.5599 0.0006 
Leucine-rich repeat flightless-interacting protein 1 Lrrfip1 1.5594 0.0158 
Steroid receptor RNA activator 1 Sra1 1.5589 0.0076 
Succinyl-CoA:3-ketoacid coenzyme A transferase 1, 
mitochondrial;Succinyl-CoA:3-ketoacid-coenzyme 
A transferase 
Oxct1 1.5576 0.004 
Echinoderm microtubule-associated protein-like 2 Eml2 1.5575 0.0003 
Galactose-1-phosphate uridylyltransferase Galt 1.5559 0.0007 
 Taf15 1.5543 0.0097 
Haloacid dehalogenase-like hydrolase domain-
containing protein 2 
Hdhd2 1.5542 0.0066 
Exosome complex component MTR3 Exosc6 1.5536 0.0003 
Aftiphilin Aftph 1.5501 0.001 
DnaJ homolog subfamily C member 8 Dnajc8 1.5486 0.0003 
Protein RCC2 Rcc2 1.5477 0.0077 
U6 snRNA-associated Sm-like protein LSm4 Lsm4 1.5476 0.0001 
Tissue alpha-L-fucosidase Fuca1 1.547 0.0001 
Transducin-like enhancer protein 4;Transducin-like 
enhancer protein 1 
Tle4;Tle1 1.5466 0.0011 
39S ribosomal protein L30, mitochondrial Mrpl30 1.5462 0.0014 
Phosphorylated adapter RNA export protein Phax 1.5456 0.0376 
Putative adenosylhomocysteinase 2 Ahcyl1 1.545 0.0007 
Semaphorin-4G Sema4g 1.5443 0.0002 
Mitochondrial import inner membrane translocase 
subunit Tim13 
Timm13 1.5439 0.0033 
Group XIIB secretory phospholipase A2-like protein Pla2g12b 1.5429 0.0201 
 Serpinb9 1.5428 0.0356 
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40S ribosomal protein S20 Rps20 1.5425 0.0158 
60S ribosomal protein L3 Rpl3 1.5423 0.0053 
Mitotic checkpoint protein BUB3 Bub3 1.5415 0.0003 
Protein NipSnap homolog 3B Nipsnap3b 1.5412 0.0002 
NAD(P)H-hydrate epimerase Apoa1bp 1.5394 0.0002 
Serine/arginine-rich splicing factor 3 Srsf3;Gm12355 1.5393 0.0152 
 Gm8909 1.5391 0.0042 
N(4)-(beta-N-acetylglucosaminyl)-L-
asparaginase;Glycosylasparaginase alpha 
chain;Glycosylasparaginase beta chain 
Aga 1.5383 0.0007 
Cyclin-dependent kinase inhibitor 1B Cdkn1b 1.5378 0.0022 
Dynein light chain 1, cytoplasmic Dynll1;BC048507 1.5374 0.0003 
Glyoxylate reductase/hydroxypyruvate reductase Grhpr 1.5373 0.0218 
Arginyl-tRNA--protein transferase 1 Ate1 1.5355 0.0048 
Omega-amidase NIT2 Nit2 1.5353 0.0035 
High mobility group protein B1 Hmgb1 1.5343 0.0182 
WASH complex subunit FAM21 Fam21 1.5339 0.0189 
Coiled-coil domain-containing protein 43 Ccdc43 1.5336 0.0035 
Heterogeneous nuclear ribonucleoprotein U-like 
protein 2 
Hnrnpul2 1.5324 0.0002 
Fructose-bisphosphate aldolase C Aldoc 1.5324 0.0132 
Glycerol-3-phosphate dehydrogenase 
[NAD(+)];Glycerol-3-phosphate dehydrogenase 
[NAD(+)], cytoplasmic 
Gpd1 1.5315 0.0115 
DNA methyltransferase 1-associated protein 1 Dmap1 1.5311 0.0024 
Ribonuclease P protein subunit p30 Rpp30 1.531 0.0002 
60S ribosomal protein L6 Rpl6;Gm5428 1.5308 0.0128 
Protein arginine N-methyltransferase 1 Prmt1 1.5307 0.0001 
Chromobox protein homolog 3 Cbx3 1.5276 0.0089 
FAD-linked sulfhydryl oxidase ALR Gfer 1.5264 0.0039 
Stromal cell-derived factor 2-like protein 1 Sdf2l1 1.5263 0.0006 
60S ribosomal protein L22 Rpl22 1.5262 0.0006 
Ribosomal protein L15;60S ribosomal protein L15 Gm10020;Rpl15 1.5257 0.0134 
BolA-like protein 1 Bola1 1.5249 0.0181 
COX assembly mitochondrial protein homolog Cmc1 1.5239 0.0236 
14-3-3 protein gamma;14-3-3 protein gamma, N-
terminally processed 
Ywhag 1.5233 0.0117 
Proliferating cell nuclear antigen Pcna 1.5223 0.005 
Prefoldin subunit 6 Pfdn6 1.5223 0.0023 
Proteasome activator complex subunit 1 Psme1 1.5212 0.0006 
Kinetochore-associated protein 1 Kntc1 1.518 0.0079 
Myotrophin Mtpn 1.5175 0.0416 
Plasma alpha-L-fucosidase Fuca2 1.5163 0.0006 
Ubiquitin-conjugating enzyme E2 L3 Ube2l3 1.5155 0.0015 
Heterogeneous nuclear ribonucleoprotein A3 
Hnrnpa3;Gm9242
;Gm6793 
1.5155 0.0003 
U6 snRNA-associated Sm-like protein LSm1 Lsm1 1.5144 0.015 
Beta-lactamase-like protein 2 Lactb2 1.5126 0.0031 
40S ribosomal protein S19 Rps19 1.5125 0.013 
Eukaryotic translation initiation factor 6 Eif6 1.5106 0.0001 
Putative helicase MOV-10 Mov10 1.5099 0.0001 
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Adenylosuccinate synthetase isozyme 2 Adss 1.5096 0.0018 
Putative deoxyribonuclease TATDN1 Tatdn1 1.5087 0.0126 
Tripeptidyl-peptidase 2 Tpp2 1.5076 0.0001 
DnaJ homolog subfamily B member 11 Dnajb11 1.5068 0.0017 
GDP-L-fucose synthase Tsta3 1.5067 0.0101 
Far upstream element-binding protein 2 Khsrp 1.5051 0.0065 
Growth factor receptor-bound protein 2 Grb2 1.5028 0.0002 
Queuine tRNA-ribosyltransferase subunit QTRTD1 Qtrtd1 1.5024 0.0233 
Lysine--tRNA ligase Kars 1.5023 0.0001 
Serpin B6 
Serpinb6a;Serpinb
6 
1.5019 0.0006 
Small nuclear ribonucleoprotein G Snrpg 1.5013 0.0001 
THO complex subunit 6 homolog Thoc6 1.5008 0.0005 
Serotransferrin Tf 1.4999 0.0065 
Dihydropyrimidine dehydrogenase [NADP(+)] Dpyd 1.4988 0.001 
Malate dehydrogenase, mitochondrial Mdh2 1.498 0.0052 
Selenoprotein P Sepp1 1.4974 0.0116 
PDZ and LIM domain protein 2 Pdlim2 1.497 0.0009 
Heterogeneous nuclear ribonucleoproteins C1/C2 Hnrnpc 1.4967 0.0033 
Aldo-keto reductase family 1 member C13 Akr1c13 1.4967 0.0162 
Nuclear ubiquitous casein and cyclin-dependent 
kinase substrate 1 
Nucks1 1.4961 0.011 
60S ribosomal protein L9 Rpl9 1.4961 0.0085 
Na(+)/H(+) exchange regulatory cofactor NHE-RF1 Slc9a3r1 1.4943 0.004 
Dihydropyrimidinase-related protein 2 Dpysl2 1.4931 0.0008 
60S ribosomal protein L7 Rpl7 1.4925 0.0203 
Protein-glutamate O-methyltransferase Armt1 1.4924 0.0042 
10 kDa heat shock protein, mitochondrial Hspe1 1.4914 0.0077 
60S ribosomal protein L5 Rpl5 1.4904 0.005 
Cleavage stimulation factor subunit 2 Cstf2 1.4898 0.0033 
BAG family molecular chaperone regulator 3 Bag3 1.4887 0.0001 
Pirin Pir 1.4874 0.0031 
Protein disulfide-isomerase P4hb 1.4853 0.0343 
Proteasome subunit beta type-4 Psmb4 1.4843 0.0003 
Phosphoribosyl pyrophosphate synthase-
associated protein 1 
Prpsap1 1.4813 0.0001 
LDLR chaperone MESD Mesdc2 1.4799 0.0006 
Mitochondrial import inner membrane translocase 
subunit Tim8 A 
Timm8a1 1.4784 0.0007 
Neutral alpha-glucosidase AB Ganab 1.4779 0.0004 
Glucosidase 2 subunit beta Prkcsh 1.4775 0.0049 
Ubiquitin-like protein 4A Ubl4a 1.4774 0.0031 
THO complex subunit 7 homolog Thoc7 1.4764 0.0039 
182 kDa tankyrase-1-binding protein Tnks1bp1 1.4752 0.0074 
Crk-like protein Crkl 1.4747 0.0038 
Ribose-phosphate pyrophosphokinase 1 Prps1l3;Prps1 1.4739 0.0009 
Eukaryotic translation initiation factor 3 subunit D Eif3d 1.4738 0.0009 
TATA element modulatory factor Tmf1 1.4718 0.013 
Serine/threonine-protein phosphatase CPPED1 Cpped1 1.4717 0.0035 
60S ribosomal protein L30 Rpl30 1.4696 0.0139 
40S ribosomal protein S9 Rps9 1.4688 0.0249 
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Serine protease inhibitor A3K Serpina3k 1.4668 0.0112 
Geranylgeranyl transferase type-2 subunit beta Rabggtb 1.4662 0.0091 
39S ribosomal protein L41, mitochondrial Mrpl41 1.4662 0.0222 
UV excision repair protein RAD23 homolog B Rad23b 1.465 0.0015 
Glyceraldehyde-3-phosphate dehydrogenase Gapdh;Gm3839 1.4648 0.0034 
H-2 class I histocompatibility antigen, K-B alpha 
chain 
H2-K1 1.4648 0.0009 
Acid sphingomyelinase-like phosphodiesterase 3a Smpdl3a 1.4645 0.0016 
Pyruvate kinase PKM Pkm 1.4644 0.0001 
Telomerase protein component 1 Tep1 1.4641 0.0009 
Glutaredoxin-related protein 5, mitochondrial Glrx5 1.4635 0.0335 
SUMO-conjugating enzyme UBC9 Ube2i 1.463 0.0001 
 Tpm3-rs7 1.4618 0.0073 
Protein CREG1 Creg1 1.4616 0.0077 
14-3-3 protein zeta/delta Ywhaz 1.4615 0.0001 
60S ribosomal protein L21 Rpl21 1.4597 0.0058 
CCR4-NOT transcription complex subunit 3 Cnot3 1.4588 0.0279 
Cytosol aminopeptidase Lap3 1.4584 0.0011 
Cyclin-dependent kinase 12 Cdk12 1.4577 0.0054 
Galectin-3-binding protein Lgals3bp 1.4574 0.0032 
C-Myc-binding protein Mycbp 1.457 0.0061 
Methionine adenosyltransferase 2 subunit beta Mat2b 1.4565 0.0002 
Peptidyl-prolyl cis-trans isomerase NIMA-
interacting 4 
Pin4 1.4564 0.0046 
Alanyl-tRNA editing protein Aarsd1 Aarsd1;Gm27029 1.4561 0.0123 
Prefoldin subunit 5 Pfdn5 1.4559 0.0129 
Putative N-acetylglucosamine-6-phosphate 
deacetylase 
Amdhd2 1.4556 0.0008 
14-3-3 protein sigma Sfn 1.4547 0.0002 
Rab GDP dissociation inhibitor beta Gdi2 1.4545 0.0047 
Aconitate hydratase, mitochondrial Aco2 1.4538 0.0061 
RNA-binding protein 8A Rbm8a 1.4535 0.0053 
N-myc-interactor Nmi 1.4522 0.0001 
Adenylyl cyclase-associated protein 1 Cap1 1.4513 0.0036 
60S ribosomal protein L18a Rpl18a;Gm17541 1.4512 0.0195 
 Pop1 1.4508 0.0011 
Aspartate aminotransferase, mitochondrial Got2 1.4507 0.0062 
Quinone oxidoreductase-like protein 1 Cryzl1 1.4492 0.0093 
Inositol-3-phosphate synthase 1 Isyna1 1.4478 0.0003 
Microtubule-associated protein 1S;MAP1S heavy 
chain;MAP1S light chain 
Map1s 1.4478 0.0002 
 Aamp 1.4475 0.0026 
 Uba7 1.4472 0.0001 
Coiled-coil-helix-coiled-coil-helix domain-
containing protein 7 
Chchd7 1.445 0.0047 
60S ribosomal protein L13 Rpl13 1.4449 0.0222 
Protein N-terminal asparagine amidohydrolase Ntan1 1.4448 0.0001 
Pterin-4-alpha-carbinolamine dehydratase 2 Pcbd2 1.4433 0.0167 
Pyruvate kinase;Pyruvate kinase PKLR Pklr 1.4432 0.0001 
Enoyl-CoA hydratase, mitochondrial Echs1 1.4431 0.01 
Farnesyl pyrophosphate synthase Fdps 1.4425 0.0027 
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U6 snRNA-associated Sm-like protein LSm6 Lsm6 1.4418 0.0001 
Ribose-phosphate pyrophosphokinase 2 Prps2 1.4406 0.0011 
2-amino-3-ketobutyrate coenzyme A ligase, 
mitochondrial 
Gcat 1.4401 0.0017 
Cofilin-2 Cfl2 1.4396 0.0042 
Alpha-aminoadipic semialdehyde dehydrogenase Aldh7a1 1.4391 0.0005 
Beta-mannosidase Manba 1.4386 0.0172 
Peptidyl-prolyl cis-trans isomerase F, mitochondrial Ppif 1.4386 0.0109 
Proteasomal ubiquitin receptor ADRM1 Gm9774;Adrm1 1.4382 0.0055 
Carboxylesterase 1C Ces1c 1.4381 0.0387 
Beta-2-microglobulin B2m 1.4373 0.0001 
Probable cytosolic iron-sulfur protein assembly 
protein CIAO1 
Ciao1 1.4373 0.0064 
PDZ and LIM domain protein 1 Pdlim1 1.4373 0.0023 
Costars family protein ABRACL Abracl 1.4361 0.0011 
Acidic leucine-rich nuclear phosphoprotein 32 
family member B 
Anp32b 1.4355 0.0227 
Cathepsin S Ctss 1.4345 0.0028 
Protein LSM12 homolog Lsm12 1.4336 0.0001 
Proprotein convertase subtilisin/kexin type 5 Pcsk5 1.4328 0.0063 
Peroxiredoxin-2 Prdx2 1.432 0.0001 
Phosphomannomutase 2 Pmm2 1.4316 0.0014 
Paxillin Pxn 1.4313 0.0011 
Vacuolar protein sorting-associated protein 35 Vps35 1.4308 0.0012 
Fatty acid-binding protein, epidermal Fabp5 1.4307 0.0005 
Disks large-associated protein 4 Dlgap4 1.4298 0.01 
Toll-interacting protein Tollip 1.4294 0.002 
Histidine triad nucleotide-binding protein 1 Hint1 1.4292 0.0043 
Nuclear transport factor 2 Nutf2 1.4285 0.0004 
Glucose-6-phosphate 1-dehydrogenase X;Glucose-
6-phosphate 1-dehydrogenase 
G6pdx 1.4283 0.0002 
Protein N-terminal glutamine amidohydrolase Wdyhv1 1.428 0.0016 
Citrate synthase, mitochondrial Cs 1.4276 0.0066 
Calmodulin-like protein 4 Calml4 1.4275 0.0091 
Far upstream element-binding protein 1 Fubp1 1.4267 0.0046 
Sulfatase-modifying factor 1 Sumf1 1.4241 0.0184 
Mesoderm induction early response protein 1 Mier1 1.4234 0.0108 
Casein kinase II subunit beta Csnk2b 1.4233 0.004 
Nuclear autoantigenic sperm protein Nasp 1.4233 0.0058 
Nascent polypeptide-associated complex subunit 
alpha;Nascent polypeptide-associated complex 
subunit alpha, muscle-specific form 
Naca 1.423 0.0034 
Derlin-2 Derl2 1.422 0.0001 
E3 ubiquitin-protein ligase MYCBP2 Mycbp2 1.4218 0.0369 
Osteoclast-stimulating factor 1 Ostf1 1.4212 0.0009 
Acylphosphatase;Acylphosphatase-1 Acyp1 1.421 0.0002 
S-methyl-5-thioadenosine phosphorylase Mtap 1.4205 0.0001 
N-acetylglucosamine-1-phosphotransferase 
subunits alpha/beta 
Gnptab 1.4196 0.0062 
Splicing factor 3B subunit 4 Sf3b4 1.4175 0.0003 
Fructose-1,6-bisphosphatase 1 Fbp1 1.4168 0.0207 
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Protein phosphatase 1 regulatory subunit 12A Ppp1r12a 1.4167 0.001 
Acylpyruvase FAHD1, mitochondrial Fahd1 1.4162 0.0201 
SH3 domain-binding glutamic acid-rich-like protein 
3 
Sh3bgrl3 1.4138 0.0157 
Synapse-associated protein 1 Syap1 1.4135 0.0081 
45 kDa calcium-binding protein Sdf4 1.4133 0.0163 
GTP-binding nuclear protein Ran 
Ran;1700009N14
Rik 
1.413 0.0003 
2-aminoethanethiol dioxygenase Ado 1.4127 0.0021 
 Gm14446 1.4124 0.0479 
Exosome complex exonuclease RRP42 Exosc7 1.4124 0.0026 
Endoplasmic reticulum aminopeptidase 1 Erap1 1.4122 0.0001 
Thioredoxin reductase 2, mitochondrial Txnrd2 1.412 0.0053 
Alpha-1-antitrypsin 1-4 Serpina1d 1.4109 0.0106 
Y-box-binding protein 3 Ybx3 1.4108 0.0115 
Tetratricopeptide repeat protein 1 Ttc1 1.4102 0.0084 
40S ribosomal protein S23 Rps23 1.409 0.0336 
39S ribosomal protein L2, mitochondrial Mrpl2 1.4088 0.001 
40S ribosomal protein S11 Rps11 1.4085 0.0428 
Electron transfer flavoprotein subunit beta Etfb 1.4074 0.015 
 Nans 1.4073 0.0126 
Copper chaperone for superoxide dismutase Ccs 1.4067 0.0209 
Transmembrane protein 128 Tmem128 1.4054 0.0007 
Rootletin Crocc 1.4053 0.0129 
 2210016F16Rik 1.4052 0.0051 
Nucleoporin SEH1 Seh1l 1.4051 0.0025 
Heterogeneous nuclear ribonucleoprotein Q Syncrip 1.4041 0.0004 
Dynein light chain 2, cytoplasmic Dynll2 1.4032 0.0012 
Ribosomal protein L19;60S ribosomal protein L19 Rpl19 1.4032 0.0125 
Zinc phosphodiesterase ELAC protein 2 Elac2 1.4029 0.0012 
RING-box protein 2 Gm7075;Rnf7 1.3994 0.0076 
Phosphoglucomutase-1 Pgm1;Pgm2 1.3993 0.0226 
Ras-related GTP-binding protein D Rragd 1.3992 0.0005 
Palmitoyl-protein thioesterase 1 Ppt1 1.3988 0.0016 
Nucleolar MIF4G domain-containing protein 1 Nom1 1.3981 0.0381 
PITH domain-containing protein 1 Pithd1 1.397 0.0057 
40S ribosomal protein S15a Rps15a 1.397 0.0353 
Tyrosine-protein phosphatase non-receptor type 1 Ptpn1 1.3967 0.0128 
Serine/threonine-protein phosphatase PP1-gamma 
catalytic subunit 
Ppp1cc 1.3962 0.0007 
2-5-oligoadenylate synthase-like protein 1 Oasl1 1.3962 0.0018 
Phosphoribosyl pyrophosphate synthase-
associated protein 2 
Prpsap2 1.3961 0.0023 
FGFR1 oncogene partner 2 homolog Fgfr1op2 1.396 0.017 
Lysosomal alpha-glucosidase Gaa 1.3956 0.0184 
Iron-sulfur cluster assembly 2 homolog, 
mitochondrial 
Isca2 1.3952 0.0125 
Hydroxymethylglutaryl-CoA synthase, cytoplasmic Hmgcs1 1.3949 0.0118 
Heterogeneous nuclear ribonucleoprotein 
A1;Heterogeneous nuclear ribonucleoprotein A1, 
N-terminally processed 
Hnrnpa1 1.393 0.0003 
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60S ribosomal protein L36 Rpl36;Gm8973 1.3907 0.0156 
DNA damage-binding protein 1 Ddb1 1.3905 0.0017 
Short-chain specific acyl-CoA dehydrogenase, 
mitochondrial 
Acads 1.3894 0.019 
Protein disulfide-isomerase A4 Pdia4 1.3885 0.0031 
 Immt 1.3866 0.0259 
CAP-Gly domain-containing linker protein 2 Clip2 1.3864 0.0264 
Protein transport protein Sec31B Sec31b 1.3862 0.0357 
E3 ubiquitin-protein ligase RNF115 Rnf115 1.3857 0.0078 
WD40 repeat-containing protein SMU1;WD40 
repeat-containing protein SMU1, N-terminally 
processed 
Smu1 1.3852 0.0037 
Transmembrane protein 43 Tmem43 1.3846 0.0052 
Espin Espn 1.3833 0.0038 
Glutaredoxin-1 Glrx 1.3828 0.006 
Protein PRRC2C Prrc2c 1.3823 0.0012 
NIF3-like protein 1 Nif3l1 1.3812 0.0041 
Ribonuclease T2 Rnaset2 1.381 0.0114 
Coatomer subunit beta Copb2 1.3806 0.0001 
Optineurin Optn 1.3801 0.0312 
tRNA (adenine(58)-N(1))-methyltransferase non-
catalytic subunit TRM6 
Trmt6 1.3798 0.0021 
Annexin A6 Anxa6 1.3797 0.0275 
Nucleoporin Nup37 Nup37 1.3793 0.0157 
Pleiotropic regulator 1 Plrg1 1.3787 0.0081 
WD repeat-containing protein 61;WD repeat-
containing protein 61, N-terminally processed 
Wdr61 1.3763 0.0144 
Chromobox protein homolog 1 Cbx1 1.3759 0.004 
Glia maturation factor beta Gmfb 1.3737 0.0048 
Protein mago nashi homolog 2;Protein mago nashi 
homolog 
Magohb;Magoh 1.3728 0.0013 
Lupus La protein homolog Ssb 1.3727 0.0216 
Lipoma-preferred partner homolog Lpp 1.3721 0.001 
39S ribosomal protein L10, mitochondrial Mrpl10 1.3712 0.0002 
 Ifi47 1.3711 0.0451 
Signal peptide peptidase-like 2A Sppl2a 1.3711 0.0022 
Oxygen-dependent coproporphyrinogen-III 
oxidase, mitochondrial 
Cpox 1.3699 0.0489 
Propionyl-CoA carboxylase beta chain, 
mitochondrial 
Pccb 1.368 0.0066 
Small nuclear ribonucleoprotein Sm D1 Snrpd1 1.368 0.0002 
Transgelin-2 Tagln2 1.365 0.0014 
Protein S100-A13 S100a13 1.365 0.0437 
WD repeat-containing protein 37 Wdr37 1.3627 0.0026 
Exosome complex component RRP43 Exosc8 1.3626 0.0082 
Syntaxin-7 Stx7 1.361 0.0024 
Peroxiredoxin-4 Prdx4 1.3599 0.0014 
Coactosin-like protein Cotl1 1.3597 0.0299 
Tubulin-folding cofactor B Tbcb 1.3596 0.0037 
UDP-glucose 6-dehydrogenase Ugdh 1.3594 0.0166 
 Gm20425 1.3592 0.0021 
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Thyroid hormone receptor-associated protein 3 Thrap3 1.3591 0.0338 
Ras-related protein Rab-21 Rab21 1.358 0.0001 
39S ribosomal protein L32, mitochondrial Mrpl32 1.3573 0.0009 
Peptidyl-prolyl cis-trans isomerase-like 1 Ppil1 1.3571 0.0001 
Transcription factor p65 Rela 1.3571 0.0048 
Cleavage and polyadenylation specificity factor 
subunit 6 
Cpsf6 1.3566 0.0028 
Pre-mRNA-splicing regulator WTAP Wtap 1.356 0.015 
Multiple myeloma tumor-associated protein 2 
homolog 
Mmtag2 1.355 0.0057 
60S ribosomal protein L18 Rpl18 1.3544 0.0312 
pre-mRNA 3 end processing protein WDR33 Wdr33 1.3538 0.0029 
Lysosomal alpha-mannosidase Man2b1 1.3537 0.022 
Methylosome subunit pICln Clns1a 1.3531 0.0027 
Propionyl-CoA carboxylase alpha chain, 
mitochondrial 
Pcca 1.3529 0.0098 
Fumarate hydratase, mitochondrial Fh 1.3528 0.0382 
Protein S100-A10 S100a10 1.3526 0.0422 
CTTNBP2 N-terminal-like protein Cttnbp2nl 1.3523 0.0153 
Protein SEC13 homolog Sec13 1.3522 0.0001 
U2 small nuclear ribonucleoprotein B Snrpb2 1.352 0.0014 
Medium-chain specific acyl-CoA dehydrogenase, 
mitochondrial 
Acadm 1.3508 0.0135 
WD repeat and HMG-box DNA-binding protein 1 Wdhd1 1.3501 0.0016 
Exosome complex component RRP40 Exosc3 1.3499 0.0088 
ADP-ribose pyrophosphatase, mitochondrial Nudt9 1.3499 0.0179 
Electron transfer flavoprotein subunit alpha, 
mitochondrial 
Etfa 1.349 0.0276 
Phosphoglycerate mutase 1 Pgam1 1.3479 0.0026 
Cathepsin B;Cathepsin B light chain;Cathepsin B 
heavy chain 
Ctsb 1.3478 0.0213 
CD151 antigen Cd151 1.3478 0.0465 
Cleavage and polyadenylation specificity factor 
subunit 5 
Nudt21 1.3478 0.0024 
NEDD8-activating enzyme E1 regulatory subunit Nae1 1.3475 0.0005 
Heterogeneous nuclear ribonucleoprotein H Hnrnph1 1.3462 0.0001 
Tetratricopeptide repeat protein 39B Ttc39b 1.3457 0.0007 
Elongation factor G, mitochondrial Gfm1 1.3443 0.0015 
Protein YIPF;Protein YIPF1 Yipf1 1.3441 0.0001 
F-box-like/WD repeat-containing protein TBL1XR1 Tbl1xr1 1.3433 0.0006 
Adrenodoxin, mitochondrial Fdx1 1.3428 0.029 
Ribosomal protein;60S ribosomal protein L10a Rpl10a 1.3427 0.0106 
Proteasome activator complex subunit 2 Psme2 1.3425 0.0019 
Succinate-semialdehyde dehydrogenase, 
mitochondrial 
Aldh5a1 1.3403 0.0094 
Molybdenum cofactor biosynthesis protein 1 Mocs1 1.3402 0.0079 
NudC domain-containing protein 2 Nudcd2 1.3401 0.0104 
Mannose-6-phosphate isomerase Mpi 1.3395 0.0005 
14-3-3 protein eta Ywhah 1.3389 0.0001 
Thioredoxin-dependent peroxide reductase, 
mitochondrial 
Prdx3 1.3383 0.013 
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Alpha-N-acetylgalactosaminidase Naga 1.3378 0.0322 
Ubiquitin-associated protein 2-like Ubap2l 1.3366 0.0011 
U3 small nucleolar RNA-interacting protein 2 Rrp9 1.3361 0.0286 
Kynurenine--oxoglutarate transaminase 1 Ccbl1 1.336 0.0436 
Heat shock cognate 71 kDa protein Hspa8 1.3357 0.0091 
Actin-related protein 2/3 complex subunit 5 Arpc5 1.3351 0.0024 
Pyridoxine-5-phosphate oxidase Pnpo 1.3347 0.0219 
Arf-GAP domain and FG repeat-containing protein 
1 
Agfg1 1.3332 0.0001 
Amine oxidase;Amiloride-sensitive amine oxidase 
[copper-containing] 
Aoc1 1.3329 0.0214 
Nucleoporin p58/p45 Nupl1 1.3329 0.0363 
AMP deaminase 2 Ampd2 1.3329 0.0071 
Iron-sulfur cluster co-chaperone protein HscB, 
mitochondrial 
Hscb 1.3328 0.0058 
Actin-related protein 2/3 complex subunit 1A Arpc1a 1.3309 0.0002 
Hippocalcin-like protein 1 Hpcal1 1.3305 0.0253 
Prefoldin subunit 3 Vbp1 1.3292 0.002 
Transcription and mRNA export factor ENY2 Eny2 1.3292 0.0129 
Splicing factor 3B subunit 3 Sf3b3 1.329 0.0004 
Molybdenum cofactor sulfurase Mocos 1.3278 0.0005 
Vesicle-associated membrane protein 3;Vesicle-
associated membrane protein 2 
Vamp3;Vamp2 1.3276 0.013 
Cat eye syndrome critical region protein 5 homolog Cecr5 1.3272 0.0098 
Transformer-2 protein homolog alpha Tra2a 1.326 0.0281 
Serine/threonine-protein phosphatase 4 regulatory 
subunit 2 
Ppp4r2 1.3256 0.0014 
Peptidyl-prolyl cis-trans isomerase 
FKBP1A;Peptidyl-prolyl cis-trans isomerase 
Fkbp1a 1.3255 0.0015 
CD2 antigen cytoplasmic tail-binding protein 2 Cd2bp2 1.3245 0.023 
  1.3237 0.0019 
Lathosterol oxidase Sc5d 1.3215 0.0043 
Eukaryotic translation initiation factor 3 subunit I Eif3i 1.321 0.0145 
Small ubiquitin-related modifier 1 Sumo1 1.3205 0.0109 
Lys-63-specific deubiquitinase BRCC36 Brcc3 1.3199 0.0002 
39S ribosomal protein L19, mitochondrial Mrpl19 1.3197 0.0007 
Ral GTPase-activating protein subunit alpha-2 Ralgapa2 1.319 0.028 
Survival of motor neuron-related-splicing factor 30 Smndc1 1.3188 0.0275 
Polyadenylate-binding protein-interacting protein 
1 
Paip1 1.3185 0.0041 
Maspardin Spg21 1.3185 0.0035 
Peroxisomal sarcosine oxidase Pipox 1.3182 0.007 
V-type proton ATPase subunit G 1 Atp6v1g1 1.3174 0.0164 
Nucleolar protein 4-like Nol4l 1.3168 0.0368 
Bis(5-nucleosyl)-tetraphosphatase [asymmetrical] Nudt2 1.3166 0.0065 
Dynein light chain roadblock-type 1 Dynlrb1 1.3165 0.0017 
78 kDa glucose-regulated protein Hspa5 1.316 0.0281 
Nucleophosmin Npm1 1.3156 0.0193 
28S ribosomal protein S18a, mitochondrial Mrps18a 1.3152 0.0121 
Ribosome-recycling factor, mitochondrial Mrrf 1.3148 0.0177 
39S ribosomal protein L1, mitochondrial Mrpl1 1.314 0.0029 
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14 kDa phosphohistidine phosphatase Phpt1 1.314 0.0068 
Kunitz-type protease inhibitor 1 Spint1 1.3119 0.0006 
Protein BUD31 homolog Bud31 1.3119 0.0001 
17-beta-hydroxysteroid dehydrogenase type 6 Hsd17b6 1.3115 0.0392 
Nuclear autoantigen Sp-100 Sp100 1.3114 0.0266 
Beta-hexosaminidase subunit beta Hexb 1.3114 0.0279 
Splicing factor 1 Sf1 1.3107 0.0076 
Acyl-coenzyme A thioesterase 4 Acot4 1.309 0.0494 
Carnitine O-acetyltransferase Crat 1.3084 0.019 
Cleavage stimulation factor subunit 1 Cstf1 1.3074 0.0027 
U5 small nuclear ribonucleoprotein 200 kDa 
helicase 
Snrnp200 1.3071 0.0057 
39S ribosomal protein L45, mitochondrial Mrpl45 1.3067 0.0002 
Chloride intracellular channel protein 6 Clic6 1.305 0.044 
Heterogeneous nuclear ribonucleoprotein 
F;Heterogeneous nuclear ribonucleoprotein F, N-
terminally processed 
Hnrnpf 1.3046 0.0308 
Pyrroline-5-carboxylate reductase 3 Pycrl 1.3042 0.017 
60S ribosomal protein L37a Rpl37a 1.3038 0.0446 
 Aim1 1.3036 0.0023 
39S ribosomal protein L15, mitochondrial Mrpl15 1.3028 0.0005 
 Gbp7 1.3019 0.0105 
Kelch repeat and BTB domain-containing protein 
11 
Kbtbd11 1.3018 0.0071 
Apoptotic protease-activating factor 1 Apaf1 1.3005 0.0001 
Gamma-aminobutyric acid receptor-associated 
protein;Gamma-aminobutyric acid receptor-
associated protein-like 1 
Gabarap;Gabarap
l1 
1.3004 0.0074 
Small acidic protein 
Smap;1110004F1
0Rik 
1.2989 0.0201 
RNA polymerase II-associated protein 3 Rpap3 1.2986 0.0186 
RNA-binding protein 4B;RNA-binding protein 4 
Gm21992;Rbm14;
Rbm4;Rbm4b 
1.2985 0.0241 
 Hnrnph3 1.298 0.001 
39S ribosomal protein L13, mitochondrial Mrpl13 1.2969 0.0001 
40S ribosomal protein S3a Rps3a 1.2964 0.0471 
Protein TSSC1 Tssc1 1.2959 0.017 
Phosphatase and actin regulator 4 Phactr4 1.2951 0.0006 
Activating signal cointegrator 1 complex subunit 2 Ascc2 1.2934 0.0243 
Mitochondrial fission regulator 1-like Mtfr1l 1.2932 0.0009 
Peptidyl-prolyl cis-trans isomerase FKBP4;Peptidyl-
prolyl cis-trans isomerase FKBP4, N-terminally 
processed;Peptidyl-prolyl cis-trans isomerase 
Fkbp4 1.2922 0.0019 
28S ribosomal protein S30, mitochondrial Mrps30 1.2921 0.0007 
Heterogeneous nuclear ribonucleoproteins A2/B1 Hnrnpa2b1 1.292 0.0056 
Elongation factor 1-beta Eef1b;Eef1b2 1.2917 0.0139 
Activated RNA polymerase II transcriptional 
coactivator p15 
Sub1 1.2906 0.0095 
Putative transferase CAF17 homolog, 
mitochondrial 
Iba57 1.29 0.0004 
Leucine zipper protein 1 Luzp1 1.2899 0.0391 
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Peptidyl-prolyl cis-trans isomerase D Ppid 1.2895 0.0061 
Glucosamine 6-phosphate N-acetyltransferase Gnpnat1 1.2891 0.0071 
Actin-related protein 2/3 complex subunit 1B Arpc1b 1.289 0.0024 
Sequestosome-1 Sqstm1 1.2877 0.0014 
Pre-mRNA-splicing factor ISY1 homolog Isy1 1.2869 0.0154 
26S proteasome non-ATPase regulatory subunit 8 Psmd8 1.2869 0.0171 
26S proteasome non-ATPase regulatory subunit 10 Psmd10 1.2865 0.0016 
Serine hydroxymethyltransferase Shmt2 1.2858 0.0015 
 Acad12 1.285 0.0192 
Fructose-bisphosphate aldolase B Aldob 1.2844 0.0015 
Probable ATP-dependent RNA helicase DHX58 Dhx58 1.2837 0.0089 
Valacyclovir hydrolase Bphl 1.2834 0.0354 
Molybdopterin synthase catalytic subunit Mocs2 1.2815 0.0146 
Trimethyllysine dioxygenase, mitochondrial Tmlhe 1.2813 0.0198 
26S proteasome non-ATPase regulatory subunit 14 Psmd14 1.2813 0.0049 
TGF-beta-activated kinase 1 and MAP3K7-binding 
protein 1 
Tab1 1.2811 0.0285 
28S ribosomal protein S26, mitochondrial Mrps26 1.2806 0.0007 
Gamma-glutamylcyclotransferase Ggct 1.2805 0.0053 
Dipeptidyl peptidase 8 Dpp8 1.2801 0.0365 
Flavin reductase (NADPH) Blvrb 1.2798 0.0001 
Prostaglandin E synthase 3 Ptges3 1.2792 0.0003 
Anamorsin Ciapin1 1.2785 0.0385 
Choline transporter-like protein 1 Slc44a1 1.2763 0.0159 
Splicing factor, arginine/serine-rich 19 Scaf1 1.2752 0.0188 
E3 ubiquitin-protein ligase RNF114 Rnf114 1.275 0.0002 
Integrator complex subunit 2 Ints2 1.2743 0.0061 
mRNA export factor Rae1 1.2739 0.0042 
39S ribosomal protein L3, mitochondrial Mrpl3 1.2738 0.0015 
Isovaleryl-CoA dehydrogenase, mitochondrial Ivd 1.2718 0.0326 
NF-kappa-B essential modulator Ikbkg 1.2709 0.0031 
Splicing factor U2AF 65 kDa subunit U2af2 1.2708 0.0007 
Glutaryl-CoA dehydrogenase, mitochondrial Gcdh 1.2706 0.0014 
High mobility group protein B2 Hmgb2 1.2693 0.0346 
CCA tRNA nucleotidyltransferase 1, mitochondrial Trnt1 1.2685 0.0049 
Coiled-coil domain-containing protein 124 Ccdc124 1.2684 0.0365 
3-hydroxyisobutyryl-CoA hydrolase, mitochondrial Hibch 1.2684 0.0264 
2-oxoglutarate dehydrogenase, mitochondrial Ogdh 1.2683 0.0017 
60S ribosomal protein L17 Rpl17 1.2676 0.0341 
Copper homeostasis protein cutC homolog Cutc 1.2671 0.0202 
Protein canopy homolog 4 Cnpy4 1.2667 0.0225 
Selenocysteine lyase Scly 1.2664 0.0035 
 Nbeal1 1.2643 0.0138 
p21-activated protein kinase-interacting protein 1 Pak1ip1 1.2643 0.0052 
Adenylate kinase 2, mitochondrial;Adenylate 
kinase 2, mitochondrial, N-terminally processed 
Ak2 1.2624 0.0025 
SNARE-associated protein Snapin Snapin 1.2598 0.0221 
Interleukin-13 receptor subunit alpha-1 Il13ra1 1.2598 0.0002 
Multifunctional methyltransferase subunit 
TRM112-like protein 
Trmt112 1.2592 0.0427 
Histone deacetylase 2 Hdac2 1.259 0.0066 
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Immunity-related GTPase family M protein 1 Irgm1 1.2583 0.0311 
Hypoxia-inducible factor 1-alpha inhibitor Hif1an 1.2578 0.0138 
Growth arrest and DNA damage-inducible 
proteins-interacting protein 1 
Gadd45gip1 1.2571 0.0121 
14-3-3 protein epsilon Ywhae 1.2566 0.0006 
HIV Tat-specific factor 1 homolog Htatsf1 1.2561 0.0007 
 Sgsh 1.2557 0.0417 
 Sptan1 1.2556 0.0367 
SNW domain-containing protein 1 Snw1 1.2553 0.0137 
Protein angel homolog 2 Angel2 1.2552 0.0044 
Pre-mRNA-processing factor 17 Cdc40 1.2535 0.0065 
Cytosolic Fe-S cluster assembly factor NUBP1 Nubp1 1.2535 0.0024 
Scaffold attachment factor B1 Safb 1.2535 0.0294 
 Fuk 1.2527 0.0043 
Annexin A5 Anxa5 1.2518 0.0402 
H-2 class I histocompatibility antigen, D-B alpha 
chain 
H2-D1 1.2518 0.0101 
THO complex subunit 5 homolog Thoc5 1.2508 0.0202 
Nucleoside diphosphate-linked moiety X motif 19, 
mitochondrial 
Nudt19 1.2504 0.0008 
Isocitrate dehydrogenase [NAD] subunit alpha, 
mitochondrial 
Idh3a 1.2493 0.0301 
Kinase suppressor of Ras 1 Ksr1 1.2489 0.007 
Junctional adhesion molecule A F11r 1.2481 0.0034 
THO complex subunit 3 Thoc3 1.2481 0.0121 
Chloride channel protein;Chloride channel protein 
2 
Clcn2 1.2478 0.0074 
Signal recognition particle 19 kDa protein Srp19 1.2474 0.036 
DNA-directed RNA polymerases I, II, and III subunit 
RPABC3 
Polr2h 1.2471 0.0266 
U6 snRNA-associated Sm-like protein LSm8 Lsm8 1.2466 0.0146 
Four and a half LIM domains protein 2 Fhl2 1.2464 0.0109 
60S ribosomal protein L11 Gm10036;Rpl11 1.246 0.0195 
ATP-dependent (S)-NAD(P)H-hydrate dehydratase Carkd 1.2449 0.015 
FAS-associated death domain protein Fadd 1.2445 0.0279 
ES1 protein homolog, mitochondrial D10Jhu81e 1.2427 0.0182 
RNA-binding protein Raly Raly 1.2414 0.0061 
28S ribosomal protein S11, mitochondrial Mrps11 1.2402 0.0002 
39S ribosomal protein L39, mitochondrial Mrpl39 1.2402 0.0102 
Nuclear export mediator factor Nemf Nemf 1.2397 0.0022 
E3 ubiquitin-protein ligase UBR2 Ubr2 1.2395 0.0163 
Peptidyl-prolyl cis-trans isomerase;Peptidyl-prolyl 
cis-trans isomerase H 
Ppih 1.2392 0.0033 
High affinity cGMP-specific 3,5-cyclic 
phosphodiesterase 9A 
Pde9a 1.2391 0.0094 
Vam6/Vps39-like protein Vps39 1.2381 0.0217 
Macrophage-capping protein Capg 1.2373 0.0285 
Polyadenylate-binding protein 1 Pabpc1 1.2369 0.0017 
ELKS/Rab6-interacting/CAST family member 1 Erc1 1.2367 0.0263 
Nicotinate phosphoribosyltransferase Naprt 1.2362 0.0127 
Vacuolar protein sorting-associated protein 26B Vps26b 1.236 0.0052 
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Pre-mRNA-processing-splicing factor 8 Prpf8 1.235 0.0075 
THO complex subunit 1 Thoc1 1.2349 0.0089 
 Ankhd1 1.2348 0.0149 
39S ribosomal protein L4, mitochondrial Mrpl4 1.2331 0.006 
2-5-oligoadenylate synthase-like protein 2 Oasl2 1.2329 0.0182 
 Parp3 1.2326 0.0061 
ATP-dependent RNA helicase DDX39A Ddx39a 1.2326 0.001 
Transcription elongation factor B polypeptide 1 Tceb1 1.2325 0.0073 
28S ribosomal protein S7, mitochondrial Mrps7 1.2324 0.004 
Glycerol-3-phosphate dehydrogenase 1-like 
protein 
Gpd1l 1.2321 0.009 
Glycerol kinase Gyk;Gk 1.2316 0.0156 
Retinoid-binding protein 7 Rbp7 1.2314 0.0124 
Sorting nexin-14 Snx14 1.2312 0.0168 
Ataxin-2 Atxn2 1.2304 0.0004 
Splicing factor, proline- and glutamine-rich Sfpq 1.2298 0.0105 
Small nuclear ribonucleoprotein E Snrpe 1.2289 0.0011 
26S proteasome non-ATPase regulatory subunit 2 Psmd2 1.2288 0.0015 
V-type proton ATPase subunit B, brain isoform Atp6v1b2 1.2264 0.0013 
F-box only protein 22 Fbxo22 1.226 0.0049 
Peroxisomal acyl-coenzyme A oxidase 3;Acyl-
coenzyme A oxidase 
Acox3 1.2257 0.0009 
Succinate dehydrogenase [ubiquinone] 
flavoprotein subunit, mitochondrial 
Sdha 1.2253 0.002 
Trafficking protein particle complex subunit 4 Trappc4 1.2238 0.0001 
E3 ubiquitin-protein ligase AMFR Amfr -1.221 0.0003 
TBC1 domain family member 22A Tbc1d22a -1.224 0.002 
Coiled-coil domain-containing protein 93 Ccdc93 -1.225 0.0028 
Serine/threonine-protein kinase OSR1 Oxsr1 -1.225 0.0002 
Kinesin-1 heavy chain;Kinesin-like protein Kif5b -1.225 0.0024 
Stromal interaction molecule 2 Stim2 -1.226 0.0002 
Dolichol-phosphate mannosyltransferase subunit 1 Dpm1 -1.226 0.0046 
Unconventional myosin-VIIa Myo7a -1.227 0.0029 
Ras-related protein Rab-43 Rab43 -1.227 0.0004 
L-aminoadipate-semialdehyde dehydrogenase-
phosphopantetheinyl transferase 
Aasdhppt -1.228 0.0004 
Dual specificity mitogen-activated protein kinase 
kinase 4 
Map2k4 -1.228 0.0011 
Na(+)/H(+) exchange regulatory cofactor NHE-RF4 Pdzd3 -1.228 0.0047 
SRSF protein kinase 1 Srpk1 -1.229 0.0063 
Guanylate-binding protein 4 Gbp4 -1.229 0.0006 
Sodium/potassium-transporting ATPase subunit 
beta-3 
Atp1b3 -1.229 0.0004 
Syntaxin-binding protein 2 Stxbp2 -1.23 0.0022 
Oxysterol-binding protein 1 Osbp -1.23 0.0056 
Chloride channel CLIC-like protein 1 Clcc1 -1.231 0.0008 
Ras-related protein Rab-17 Rab17 -1.231 0.0021 
Mitochondrial import inner membrane translocase 
subunit TIM44 
Timm44 -1.231 0.0042 
Ubiquinone biosynthesis protein COQ4 homolog, 
mitochondrial 
Coq4 -1.231 0.0002 
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Transcription initiation factor TFIID subunit 12 Taf12 -1.231 0.0017 
Exocyst complex component 2 Exoc2 -1.232 0.0004 
Protein kinase C delta type;Protein kinase C delta 
type regulatory subunit;Protein kinase C delta type 
catalytic subunit;Protein kinase C 
Prkcd -1.233 0.0107 
SPRY domain-containing protein 7 Spryd7 -1.233 0.0129 
Protein FAM98A Fam98a -1.233 0.0033 
FAS-associated factor 1 Faf1 -1.233 0.0035 
Protein disulfide-isomerase TMX3 Tmx3 -1.234 0.0001 
Immunoglobulin superfamily member 3 Igsf3 -1.234 0.022 
ATP-binding cassette sub-family F member 3 Abcf3 -1.234 0.0149 
BRCA1-A complex subunit BRE Bre -1.234 0.0003 
CLIP-associating protein 1 Clasp1 -1.234 0.003 
Probable ATP-dependent RNA helicase YTHDC2 Ythdc2 -1.235 0.0005 
Serine/threonine-protein kinase 25 Stk25 -1.235 0.004 
Rho guanine nucleotide exchange factor 16 Arhgef16 -1.236 0.0217 
Ethylmalonyl-CoA decarboxylase Echdc1 -1.236 0.0126 
Serine/threonine-protein kinase WNK2 Wnk2 -1.236 0.011 
Ladinin-1 Lad1 -1.236 0.0277 
Methylmalonic aciduria type A homolog, 
mitochondrial 
Mmaa -1.237 0.0069 
Rab5 GDP/GTP exchange factor Rabgef1 -1.237 0.0016 
Hormone-sensitive lipase Lipe -1.237 0.0051 
Transmembrane emp24 domain-containing protein 
4 
Tmed4 -1.237 0.0079 
Protein FAM114A2 Fam114a2 -1.238 0.01 
Evolutionarily conserved signaling intermediate in 
Toll pathway, mitochondrial 
Ecsit -1.238 0.0065 
Probable gluconokinase Idnk -1.238 0.0012 
RWD domain-containing protein 2B Rwdd2b -1.238 0.0007 
AP-3 complex subunit sigma-1 Ap3s1 -1.238 0.0202 
Uncharacterized protein KIAA2013 Kiaa2013 -1.238 0.0026 
Guanine nucleotide-binding protein-like 3 Gnl3 -1.239 0.0065 
SRA stem-loop-interacting RNA-binding protein, 
mitochondrial 
Slirp -1.239 0.0066 
Annexin A11;Annexin Anxa11 -1.24 0.0011 
Leucine-rich repeat-containing protein 1 Lrrc1 -1.24 0.0086 
3-ketodihydrosphingosine reductase Kdsr -1.24 0.0187 
Ubiquitin-conjugating enzyme E2 G2 Ube2g2 -1.24 0.005 
Ubiquitin-conjugating enzyme E2 E1 Ube2e1;Ube2e2 -1.24 0.0015 
Exocyst complex component 1 Exoc1 -1.24 0.0014 
Forkhead box protein K1 Foxk1 -1.241 0.0289 
Endophilin-B1 Sh3glb1 -1.241 0.0022 
FAS-associated factor 2 Faf2 -1.241 0.0023 
Protein FAM83H Fam83h -1.241 0.0313 
Endophilin-B2 Sh3glb2 -1.241 0.0188 
Chloride channel protein;H(+)/Cl(-) exchange 
transporter 3 
Clcn3 -1.241 0.001 
Inositol hexakisphosphate kinase 1 Ip6k1 -1.242 0.0322 
ATP-dependent 6-phosphofructokinase, muscle 
type 
Pfkm -1.242 0.0194 
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Fermitin family homolog 1 Fermt1 -1.242 0.0007 
  -1.242 0.0131 
ATP-dependent RNA helicase SUPV3L1, 
mitochondrial 
Supv3l1 -1.243 0.0069 
D-3-phosphoglycerate dehydrogenase Phgdh -1.243 0.0076 
Microtubule-associated protein RP/EB family 
member 2 
Mapre2 -1.243 0.0009 
Coiled-coil domain-containing protein 132 Ccdc132 -1.243 0.0143 
ATP synthase subunit alpha, mitochondrial;ATP 
synthase subunit alpha 
Atp5a1 -1.243 0.0059 
3-phosphoinositide-dependent protein kinase 1 Pdpk1 -1.243 0.0006 
Mitochondrial import receptor subunit TOM70 Tomm70a -1.243 0.018 
SWI/SNF complex subunit SMARCC1 Smarcc1 -1.244 0.0131 
Vesicle-associated membrane protein 5 Vamp5 -1.244 0.0012 
Replication protein A 70 kDa DNA-binding subunit Rpa1 -1.244 0.0109 
Steroid hormone receptor ERR1 Esrra -1.245 0.0102 
Transmembrane and coiled-coil domains protein 1 Tmcc1 -1.245 0.0152 
C2 domain-containing protein 2-like C2cd2l -1.246 0.0024 
Exocyst complex component 6 Exoc6 -1.246 0.0005 
Transportin-1 Tnpo1 -1.246 0.0012 
NADH dehydrogenase [ubiquinone] 1 alpha 
subcomplex subunit 3 
Ndufa3 -1.246 0.0118 
Aflatoxin B1 aldehyde reductase member 2 Akr7a2 -1.246 0.0025 
Mothers against decapentaplegic 
homolog;Mothers against decapentaplegic 
homolog 1;Mothers against decapentaplegic 
homolog 5 
Smad1;Smad5 -1.246 0.0281 
Polymerase delta-interacting protein 2 Poldip2 -1.247 0.0002 
Replication protein A 32 kDa subunit Rpa2 -1.247 0.0008 
Nischarin Nisch -1.247 0.0218 
DNA replication licensing factor MCM2 Mcm2 -1.247 0.0256 
OCIA domain-containing protein 1 Ociad1 -1.247 0.0123 
Protein transport protein Sec61 subunit alpha 
isoform 1 
Sec61a1 -1.247 0.0492 
Twinfilin-1 Twf1 -1.247 0.0015 
Cytochrome c oxidase subunit 7A1, mitochondrial Cox7a1 -1.248 0.0302 
Golgi resident protein GCP60 Acbd3 -1.248 0.0029 
Protein C19orf12 homolog 1600014C10Rik -1.248 0.0066 
Bifunctional 3-phosphoadenosine 5-
phosphosulfate synthase 1;Sulfate 
adenylyltransferase;Adenylyl-sulfate kinase 
Papss1 -1.249 0.0043 
Eukaryotic translation initiation factor 3 subunit A Eif3a -1.249 0.0523 
LisH domain and HEAT repeat-containing protein 
KIAA1468 
2310035C23Rik;Ki
aa1468 
-1.249 0.0098 
Decaprenyl-diphosphate synthase subunit 1 Pdss1 -1.249 0.0031 
 BC030870 -1.249 0.0034 
28S ribosomal protein S22, mitochondrial Mrps22 -1.249 0.0019 
Cytochrome c oxidase assembly protein COX15 
homolog 
Cox15 -1.249 0.0327 
MMS19 nucleotide excision repair protein 
homolog 
Mms19 -1.25 0.0037 
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Transcription activator BRG1 Smarca4 -1.25 0.0346 
ATP synthase subunit g, mitochondrial Atp5l -1.25 0.02 
Uridine 5-monophosphate synthase;Orotate 
phosphoribosyltransferase;Orotidine 5-phosphate 
decarboxylase 
Umps -1.25 0.0045 
Tensin-3 Tns3 -1.25 0.0077 
Calcyclin-binding protein Cacybp -1.25 0.0181 
Spartin Spg20 -1.251 0.0118 
Calnexin Canx -1.251 0.0231 
Anoctamin-9 Ano9 -1.251 0.0075 
Endophilin-A2 Sh3gl1 -1.252 0.0144 
GPI transamidase component PIG-S Pigs -1.252 0.0011 
Mini-chromosome maintenance complex-binding 
protein 
Mcmbp -1.252 0.0016 
Golgi phosphoprotein 3-like Golph3l -1.252 0.0024 
 Kidins220 -1.253 0.0011 
Solute carrier family 12 member 9 Slc12a9 -1.254 0.0044 
Junction plakoglobin Jup -1.254 0.0012 
Vesicle transport protein USE1 Use1 -1.254 0.0007 
 Prdm2 -1.254 0.021 
Zinc finger protein 598 Znf598 -1.255 0.0125 
DNA (cytosine-5)-methyltransferase 1;DNA 
(cytosine-5)-methyltransferase 
Dnmt1 -1.255 0.0372 
28S ribosomal protein S33, mitochondrial Mrps33 -1.255 0.0124 
Integrin beta;Integrin beta-6 Itgb6 -1.255 0.0029 
Exocyst complex component 7 Exoc7 -1.255 0.0036 
Sorting nexin-12 Snx12 -1.255 0.0008 
 Golgb1 -1.255 0.0042 
Protein NipSnap homolog 1 Nipsnap1 -1.255 0.0058 
Vacuolar protein sorting-associated protein 13A Vps13a -1.256 0.0022 
Msx2-interacting protein Spen -1.256 0.022 
Vacuolar protein sorting-associated protein 33A Vps33a -1.256 0.0004 
Pleckstrin homology domain-containing family A 
member 8 
Plekha8 -1.257 0.0117 
Putative methyltransferase C9orf114 homolog D2Wsu81e -1.258 0.0258 
Protein NDRG3 Ndrg3 -1.258 0.0004 
Exportin-2 Cse1l -1.258 0.0021 
ER membrane protein complex subunit 4 Emc4 -1.258 0.0018 
ATP-dependent RNA helicase DDX19A Ddx19a -1.258 0.0136 
REST corepressor 1 Rcor1 -1.258 0.009 
NADH dehydrogenase [ubiquinone] 1 beta 
subcomplex subunit 4 
Ndufb4 -1.258 0.0469 
Anion exchange protein;Electrogenic sodium 
bicarbonate cotransporter 1 
Slc4a4 -1.259 0.0005 
Phosphatidylinositol 4-kinase type 2-beta Pi4k2b -1.259 0.0047 
ADP-ribosylation factor 1 Arf1 -1.26 0.0176 
Serine/threonine-protein phosphatase 2A 56 kDa 
regulatory subunit alpha isoform 
Ppp2r5a -1.26 0.0026 
NADH dehydrogenase [ubiquinone] 1 alpha 
subcomplex subunit 11 
Ndufa11 -1.26 0.0069 
Saccharopine dehydrogenase-like oxidoreductase Sccpdh -1.26 0.006 
257 
 
Apoptosis inhibitor 5 Api5 -1.26 0.0036 
Arfaptin-2 Arfip2 -1.261 0.0126 
Exocyst complex component 3-like protein 4 Exoc3l4 -1.261 0.0282 
MAGUK p55 subfamily member 5 Mpp5 -1.261 0.0035 
Polypeptide N-acetylgalactosaminyltransferase 4 Galnt4 -1.262 0.0069 
5-AMP-activated protein kinase catalytic subunit 
alpha-2 
Prkaa2 -1.262 0.0041 
Copper-transporting ATPase 1 Atp7a -1.263 0.0083 
Signal recognition particle subunit SRP72 Srp72 -1.263 0.0034 
Uncharacterized protein KIAA1467 Kiaa1467 -1.263 0.0084 
Exportin-5 Xpo5 -1.263 0.0111 
Bifunctional coenzyme A 
synthase;Phosphopantetheine 
adenylyltransferase;Dephospho-CoA kinase 
Coasy -1.264 0.0001 
Dolichol-phosphate mannosyltransferase subunit 3 Dpm3 -1.264 0.0001 
Protein diaphanous homolog 1 Diap1;Diaph1 -1.264 0.0005 
PDZ domain-containing protein 11 Pdzd11 -1.266 0.0001 
 Dnm2 -1.266 0.0005 
Protein Shroom2 Shroom2 -1.266 0.0113 
Leucyl-cystinyl aminopeptidase Lnpep -1.266 0.0011 
ATP-binding cassette sub-family B member 7, 
mitochondrial 
Abcb7 -1.266 0.0021 
Enoyl-CoA delta isomerase 2, mitochondrial Eci2 -1.266 0.0148 
Retinol dehydrogenase 14 Rdh14 -1.266 0.0035 
Serine/threonine-protein kinase A-Raf Araf -1.267 0.0305 
Translin-associated protein X Tsnax -1.267 0.0022 
Protein CASP Cux1 -1.268 0.0162 
Rab11 family-interacting protein 1 Rab11fip1 -1.268 0.0224 
Niban-like protein 1 Fam129b -1.268 0.002 
Tryptophan--tRNA ligase, mitochondrial Wars2 -1.269 0.0026 
Coiled-coil domain-containing protein 184 Ccdc184 -1.269 0.002 
Sister chromatid cohesion protein PDS5 homolog B Pds5b -1.27 0.0159 
Glycogen synthase kinase-3 beta Gsk3b -1.27 0.0177 
NADH dehydrogenase [ubiquinone] 1 alpha 
subcomplex assembly factor 3 
Ndufaf3 -1.27 0.0018 
Mitochondrial ribonuclease P protein 1 Trmt10c -1.271 0.0009 
Alpha-1,3/1,6-mannosyltransferase ALG2 Alg2 -1.271 0.0032 
Vitamin D3 receptor Vdr -1.271 0.0107 
Sulfhydryl oxidase 2 Qsox2 -1.271 0.0075 
Cytochrome P450 2S1 Cyp2s1 -1.271 0.0027 
Histone acetyltransferase KAT7 Kat7 -1.271 0.0158 
Apoptosis-inducing factor 1, mitochondrial Aifm1 -1.272 0.001 
Eukaryotic translation initiation factor 3 subunit E Eif3e -1.272 0.0141 
Methyl-CpG-binding domain protein 3 Mbd3 -1.272 0.0257 
Max-like protein X Mlx -1.273 0.0102 
Electron transfer flavoprotein-ubiquinone 
oxidoreductase, mitochondrial 
Etfdh -1.274 0.0026 
Structural maintenance of chromosomes protein 2 Smc2 -1.274 0.0099 
28S ribosomal protein S31, mitochondrial Mrps31 -1.274 0.0006 
Calcium-binding mitochondrial carrier protein 
Aralar2 
Slc25a13 -1.274 0.0217 
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Hepatocyte nuclear factor 4-alpha Hnf4a -1.274 0.003 
Synaptophysin-like protein 1 Sypl;Sypl1 -1.274 0.0147 
Developmentally-regulated GTP-binding protein 2 Drg2 -1.274 0.0107 
Coiled-coil domain-containing protein 22 Ccdc22 -1.275 0.0021 
U2 snRNP-associated SURP motif-containing 
protein 
U2surp -1.275 0.0011 
Ubiquinol-cytochrome-c reductase complex 
assembly factor 2 
Uqcc2 -1.275 0.02 
Telomerase-binding protein EST1A Smg6 -1.276 0.0064 
Cyclin-Y Ccny -1.276 0.0023 
UPF0505 protein C16orf62 homolog 9030624J02Rik -1.276 0.0003 
Activating signal cointegrator 1 Trip4 -1.276 0.003 
Transporter;Sodium- and chloride-dependent 
transporter XTRP3A;Sodium- and chloride-
dependent transporter XTRP3B 
Slc6a20a;Slc6a20
b 
-1.276 0.0362 
ER membrane protein complex subunit 2 Emc2 -1.276 0.0001 
Mitochondrial genome maintenance exonuclease 1 Mgme1 -1.277 0.0005 
 Btnl2 -1.277 0.0157 
Condensin complex subunit 1 Ncapd2 -1.278 0.0125 
Dolichyl-diphosphooligosaccharide--protein 
glycosyltransferase subunit 1 
Rpn1 -1.278 0.0061 
Volume-regulated anion channel subunit LRRC8D Lrrc8d -1.278 0.0003 
Lysine-specific histone demethylase 1A Kdm1a -1.278 0.0017 
Ubiquitin carboxyl-terminal hydrolase isozyme L5 Uchl5 -1.279 0.0014 
Cadherin-related family member 5 Cdhr5 -1.279 0.017 
EF-hand calcium-binding domain-containing 
protein 14 
Efcab14 -1.279 0.0317 
Sortilin Sort1 -1.279 0.0079 
Methyltransferase-like protein 13 Mettl13 -1.279 0.0015 
Chromodomain-helicase-DNA-binding protein 4 Chd4 -1.279 0.0022 
Peroxisomal trans-2-enoyl-CoA reductase Pecr -1.28 0.0034 
CB1 cannabinoid receptor-interacting protein 1 Cnrip1 -1.281 0.0428 
Uroporphyrinogen decarboxylase Urod -1.281 0.0001 
Zinc finger protein 512 Znf512 -1.282 0.0049 
ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2 Bst1 -1.282 0.0165 
Negative elongation factor B Nelfb -1.282 0.0012 
Basigin Bsg -1.282 0.0014 
Eukaryotic translation initiation factor 2D Eif2d -1.283 0.0023 
Serine/threonine-protein phosphatase 2A 56 kDa 
regulatory subunit epsilon isoform 
Ppp2r5e -1.283 0.0022 
Vacuolar protein-sorting-associated protein 25 Vps25 -1.283 0.0006 
Angiotensin-converting enzyme;Angiotensin-
converting enzyme, soluble form 
Ace -1.283 0.004 
 Malrd1 -1.284 0.0123 
General vesicular transport factor p115 Uso1 -1.285 0.0002 
DDRGK domain-containing protein 1 Ddrgk1 -1.285 0.0281 
Autophagy-related protein 2 homolog B Atg2b -1.285 0.0072 
55 kDa erythrocyte membrane protein Mpp1 -1.285 0.0007 
Clarin-3 Clrn3 -1.285 0.0045 
Torsin-1A-interacting protein 2 Tor1aip2 -1.285 0.0019 
Extended synaptotagmin-2 Esyt2 -1.286 0.0005 
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Inner nuclear membrane protein Man1 Lemd3 -1.286 0.0253 
Supervillin Svil -1.286 0.0139 
DNA replication licensing factor MCM4 Mcm4 -1.286 0.0069 
COMM domain-containing protein 3 Commd3 -1.287 0.022 
Plexin-B2 Plxnb2 -1.287 0.0014 
NADH dehydrogenase [ubiquinone] 1 beta 
subcomplex subunit 6 
Ndufb6 -1.287 0.0003 
Rho GTPase-activating protein 12 Arhgap12 -1.287 0.0037 
Mitochondrial glutamate carrier 1 Slc25a22 -1.287 0.0224 
Protein FAM83B Fam83b -1.288 0.0022 
Serum paraoxonase/arylesterase 2 Pon2 -1.288 0.0084 
Ribosomal protein S6 kinase alpha-5 Rps6ka5 -1.288 0.0078 
Protein FAM73B Fam73b -1.288 0.0123 
Switch-associated protein 70 Swap70 -1.288 0.0037 
Ubiquitin-protein ligase E3C Ube3c -1.288 0.0012 
Interferon-induced very large GTPase 1 Gvin1 -1.289 0.0012 
Tyrosine-protein kinase STYK1 Styk1 -1.289 0.004 
Ubiquitin-fold modifier 1 Ufm1 -1.289 0.0327 
ADP-ribosylation factor-like protein 2 Arl2 -1.289 0.0113 
ADP-ribosylation factor 5 Arf5 -1.289 0.0094 
Serine/threonine-protein kinase 17B Stk17b -1.29 0.0039 
FYVE, RhoGEF and PH domain-containing protein 4 Fgd4 -1.29 0.0092 
Eukaryotic translation initiation factor 3 subunit F Eif3f -1.29 0.0005 
Adaptin ear-binding coat-associated protein 1 Necap1 -1.292 0.0015 
Exocyst complex component 3 Exoc3 -1.292 0.0006 
Ras-related protein Rab-24 Rab24 -1.292 0.0006 
Guanine nucleotide exchange factor VAV2 Vav2 -1.292 0.0011 
GRAM domain-containing protein 1C Gramd1c -1.292 0.0004 
Magnesium transporter protein 1 Magt1 -1.292 0.0264 
Apoptosis regulator BAX Bax -1.293 0.0002 
Dimethylaniline monooxygenase [N-oxide-forming] 
4 
Fmo4 -1.293 0.0044 
G protein-coupled receptor kinase 6 Grk6 -1.294 0.0326 
 Pdzd8 -1.294 0.009 
Translocation protein SEC62 Sec62 -1.294 0.0032 
Leucine-rich repeat protein SHOC-2 Shoc2 -1.294 0.004 
Sister chromatid cohesion protein PDS5 homolog A Pds5a -1.295 0.0012 
Cytochrome c oxidase assembly factor 3 homolog, 
mitochondrial 
Coa3 -1.295 0.002 
Eukaryotic translation initiation factor 4 gamma 2 Eif4g2 -1.296 0.0002 
Pleckstrin homology domain-containing family G 
member 6 
Plekhg6 -1.296 0.0001 
ATP synthase protein 8 Mtatp8 -1.296 0.0043 
Alpha-(1,6)-fucosyltransferase Fut8 -1.296 0.0008 
Tyrosine-protein kinase FRK Frk -1.297 0.0028 
Transcription initiation factor IIB Gtf2b -1.297 0.0017 
RAC-alpha serine/threonine-protein kinase Akt1 -1.297 0.0092 
Golgi phosphoprotein 3 Golph3 -1.297 0.0003 
 Fmn1 -1.298 0.0292 
SH3 domain-binding protein 1 Sh3bp1 -1.298 0.0374 
Metal transporter CNNM4 Cnnm4 -1.298 0.0001 
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ATP-binding cassette sub-family B member 10, 
mitochondrial 
Abcb10 -1.298 0.0094 
ER membrane protein complex subunit 6 Emc6 -1.299 0.002 
Atlastin-3 Atl3 -1.299 0.0027 
Zinc finger protein 622 Znf622 -1.299 0.0002 
OTU domain-containing protein 4 Otud4 -1.299 0.0124 
NADH dehydrogenase [ubiquinone] 1 alpha 
subcomplex subunit 2 
Ndufa2 -1.3 0.0037 
Mitochondrial import receptor subunit TOM40 
homolog 
Tomm40 -1.3 0.0408 
Bcl 10-interacting CARD protein  -1.3 0.0006 
Nuclear RNA export factor 1 Nxf1 -1.3 0.0031 
Ras GTPase-activating-like protein IQGAP2 Iqgap2 -1.301 0.001 
Brain-specific angiogenesis inhibitor 1-associated 
protein 2-like protein 2 
Baiap2l2 -1.301 0.0315 
Oxysterol-binding protein;Oxysterol-binding 
protein-related protein 6 
Osbpl6 -1.301 0.0184 
Glycerophosphodiester phosphodiesterase 
domain-containing protein 1 
Gdpd1 -1.301 0.0231 
Ubiquitin-conjugating enzyme E2 R2 Ube2r2 -1.301 0.0375 
CDGSH iron-sulfur domain-containing protein 3, 
mitochondrial 
Cisd3 -1.302 0.0062 
RNA-binding protein 39 Rbm39 -1.302 0.0025 
C1GALT1-specific chaperone 1 C1galt1c1 -1.303 0.0014 
 Chn2 -1.303 0.0001 
Long-chain-fatty-acid--CoA ligase 3 Acsl3 -1.303 0.0012 
WD and tetratricopeptide repeats protein 1 Wdtc1 -1.303 0.0277 
Upstream-binding protein 1 Ubp1 -1.304 0.0059 
Transcription intermediary factor 1-alpha Trim24 -1.304 0.0308 
Rho-associated protein kinase;Rho-associated 
protein kinase 2 
Rock2 -1.304 0.0001 
Serine/threonine-protein kinase MRCK gamma Cdc42bpg -1.304 0.0182 
Chromobox protein homolog 5 Cbx5 -1.304 0.007 
Mothers against decapentaplegic 
homolog;Mothers against decapentaplegic 
homolog 2 
Smad2 -1.304 0.001 
GTPase KRas;GTPase KRas, N-terminally processed Kras -1.305 0.0001 
Lethal(2) giant larvae protein homolog 2 Llgl2 -1.305 0.0009 
Proteasome-associated protein ECM29 homolog Ecm29;AI314180 -1.306 0.0053 
Cytosolic 5-nucleotidase 3A Nt5c3a -1.306 0.0019 
Trafficking protein particle complex subunit 12 Trappc12 -1.307 0.0008 
Cytochrome b-c1 complex subunit 1, mitochondrial Uqcrc1 -1.307 0.0021 
Transmembrane protein 165 Tmem165 -1.307 0.0037 
cGMP-dependent protein kinase;cGMP-dependent 
protein kinase 2 
Prkg2 -1.308 0.0014 
COP9 signalosome complex subunit 7a Cops7a -1.308 0.0052 
Cytochrome b-c1 complex subunit 8 Uqcrq -1.308 0.0051 
Angiotensin-converting enzyme 2;Processed 
angiotensin-converting enzyme 2 
Ace2 -1.308 0.0254 
Phosphatidylinositol 5-phosphate 4-kinase type-2 
gamma 
Pip4k2c -1.309 0.0001 
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Arylacetamide deacetylase Aadac -1.309 0.0166 
Copine-2 Cpne2 -1.31 0.0083 
Thioredoxin-related transmembrane protein 1 Tmx1 -1.31 0.0028 
Vacuolar protein sorting-associated protein 4A Vps4a -1.31 0.0092 
Ras-related protein Rab-10 Rab10 -1.311 0.0047 
Endoplasmic reticulum-Golgi intermediate 
compartment protein 2 
Ergic2 -1.311 0.0003 
PC4 and SFRS1-interacting protein Psip1 -1.312 0.0478 
  -1.312 0.0028 
Ubiquitin carboxyl-terminal hydrolase;Ubiquitin 
carboxyl-terminal hydrolase 3 
Usp3 -1.312 0.0108 
Histone deacetylase complex subunit SAP18 Gm10094;Sap18 -1.313 0.0002 
Unconventional myosin-IXb Myo9b -1.313 0.0164 
Ataxin-10 Atxn10 -1.313 0.0008 
Signal recognition particle receptor subunit alpha Srpr -1.314 0.0014 
Retinol dehydrogenase 13 Rdh13 -1.314 0.0044 
GH3 domain-containing protein Ghdc -1.314 0.0021 
Protein SCO2 homolog, mitochondrial Sco2 -1.314 0.0019 
DnaJ homolog subfamily C member 10 Dnajc10 -1.315 0.0059 
RWD domain-containing protein 1 Rwdd1 -1.316 0.0311 
MOB kinase activator 1A;MOB kinase activator 1B Mob1b;Mob1a -1.316 0.0075 
Probable N-acetyltransferase CML5 Cml5 -1.316 0.0402 
Mitochondrial import receptor subunit TOM22 
homolog 
Tomm22 -1.317 0.0008 
Large neutral amino acids transporter small 
subunit 4 
Slc43a2 -1.317 0.0129 
Guanine nucleotide-binding protein G(i) subunit 
alpha-2 
Gnai2 -1.317 0.0001 
5-AMP-activated protein kinase subunit gamma-1 Prkag1 -1.317 0.0116 
Growth factor receptor-bound protein 7 Grb7 -1.317 0.015 
Ras GTPase-activating-like protein IQGAP1 Iqgap1 -1.318 0.0005 
Calcium and integrin-binding protein 1 Cib1 -1.319 0.0249 
Cytochrome c oxidase subunit NDUFA4 Ndufa4 -1.319 0.0033 
Probable rRNA-processing protein EBP2 Ebna1bp2 -1.319 0.0201 
Coxsackievirus and adenovirus receptor homolog Cxadr -1.32 0.0041 
 Gcn1l1 -1.32 0.0061 
Serine incorporator 3 Serinc3 -1.32 0.0482 
Tubulin beta-5 chain Tubb5 -1.321 0.0025 
Secretory carrier-associated membrane protein 1 Scamp1 -1.321 0.0001 
Nicotinamide/nicotinic acid mononucleotide 
adenylyltransferase 3 
Nmnat3 -1.321 0.0022 
Mitochondrial calcium uniporter regulator 1 Mcur1 -1.321 0.0029 
Sodium/hydrogen exchanger Slc9a2 -1.321 0.0065 
Integrin alpha-V;Integrin alpha-V heavy 
chain;Integrin alpha-V light chain 
Itgav -1.322 0.0018 
Optic atrophy 3 protein homolog Opa3 -1.322 0.0045 
Insulin-like growth factor 2 mRNA-binding protein 
2 
Igf2bp2 -1.322 0.0016 
Programmed cell death protein 2 Pdcd2 -1.322 0.0083 
Cyclin-dependent kinase 2 Cdk2 -1.323 0.0123 
Bifunctional apoptosis regulator Bfar -1.323 0.0098 
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NADH dehydrogenase [ubiquinone] flavoprotein 1, 
mitochondrial 
Ndufv1 -1.323 0.0065 
 Dnajc13 -1.324 0.0001 
Oxysterol-binding protein;Oxysterol-binding 
protein-related protein 11 
Osbpl11 -1.324 0.043 
Motile sperm domain-containing protein 2 Mospd2 -1.325 0.0026 
Type 2 lactosamine alpha-2,3-sialyltransferase St3gal6 -1.327 0.0002 
Very long-chain specific acyl-CoA dehydrogenase, 
mitochondrial 
Acadvl -1.327 0.0082 
O-acetyl-ADP-ribose deacetylase MACROD1 Macrod1 -1.327 0.0075 
Partitioning defective 6 homolog beta Pard6b -1.328 0.0032 
CAAX prenyl protease 1 homolog Zmpste24 -1.328 0.0136 
Cytochrome P450 3A25 Cyp3a25;Cyp3a59 -1.328 0.0395 
NADH dehydrogenase [ubiquinone] iron-sulfur 
protein 2, mitochondrial 
Ndufs2 -1.328 0.0011 
MARVEL domain-containing protein 2 Marveld2 -1.329 0.0018 
Cytoskeleton-associated protein 5 Ckap5 -1.329 0.0034 
Leukocyte surface antigen CD47 Cd47 -1.33 0.0005 
Advillin Avil -1.33 0.0186 
Charged multivesicular body protein 7 Chmp7 -1.33 0.0111 
UPF0668 protein C10orf76 homolog  -1.33 0.0026 
Cytochrome P450 20A1 Cyp20a1 -1.331 0.0041 
 Numa1 -1.331 0.0108 
Calcium uptake protein 1, mitochondrial Micu1 -1.331 0.0026 
Multivesicular body subunit 12A Mvb12a -1.331 0.007 
Translocon-associated protein subunit alpha Ssr1 -1.332 0.0004 
N-alpha-acetyltransferase 20 Naa20 -1.332 0.0001 
Carbonyl reductase [NADPH] 3 Cbr3 -1.332 0.0262 
NADH dehydrogenase [ubiquinone] 1 alpha 
subcomplex assembly factor 4 
Ndufaf4 -1.333 0.001 
 Ppp2r5d -1.333 0.0007 
Vacuolar protein sorting-associated protein 51 
homolog 
Vps51 -1.333 0.0011 
DnaJ homolog subfamily B member 6 Dnajb6 -1.333 0.0012 
 Slc2a9 -1.334 0.0058 
ATP-binding cassette sub-family F member 2 Abcf2 -1.334 0.0068 
Tetratricopeptide repeat protein 9C Ttc9c -1.334 0.0017 
Transmembrane emp24 domain-containing protein 
5 
Tmed5 -1.334 0.0012 
NACHT, LRR and PYD domains-containing protein 6 Nlrp6 -1.334 0.0111 
Sideroflexin-1 Sfxn1 -1.335 0.0124 
ADP-ribosylation factor 4 Arf4 -1.335 0.006 
 Pigg -1.336 0.0009 
Dynamin-3 Dnm3 -1.336 0.002 
Glucocorticoid receptor Nr3c1 -1.336 0.0111 
Probable arginine--tRNA ligase, mitochondrial Rars2 -1.336 0.0019 
Epidermal growth factor receptor kinase substrate 
8-like protein 3 
Eps8l3 -1.336 0.0316 
Cytosolic phospholipase A2;Phospholipase 
A2;Lysophospholipase 
Pla2g4a -1.336 0.0089 
Tight junction protein ZO-3 Tjp3 -1.336 0.0001 
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PDZ domain-containing protein GIPC2 Gipc2 -1.337 0.0066 
Glutamyl aminopeptidase Enpep -1.338 0.0239 
Cell surface A33 antigen Gpa33 -1.338 0.002 
Mitochondrial import receptor subunit TOM6 
homolog 
Tomm6 -1.338 0.002 
Eyes absent homolog;Eyes absent homolog 3 Eya3 -1.338 0.0169 
UBX domain-containing protein 6 Ubxn6 -1.339 0.0011 
Transmembrane protein 109 Tmem109 -1.339 0.0011 
Oxysterol-binding protein;Oxysterol-binding 
protein-related protein 3 
Osbpl3 -1.339 0.004 
Aldehyde dehydrogenase;Fatty aldehyde 
dehydrogenase 
Aldh3a2 -1.34 0.0197 
Fermitin family homolog 2 Fermt2 -1.34 0.0284 
Formin-binding protein 1-like Fnbp1l -1.34 0.0107 
Syntaxin-binding protein 1 Stxbp1 -1.341 0.0025 
Dual specificity mitogen-activated protein kinase 
kinase 2 
Map2k2 -1.341 0.0003 
PRA1 family protein 3 Arl6ip5 -1.341 0.0417 
N-alpha-acetyltransferase 11 Gm16286;Naa11 -1.342 0.0087 
Transmembrane protein 87A Tmem87a -1.342 0.0001 
PDZ domain-containing protein GIPC1 Gipc1 -1.342 0.0608 
Ras-related protein Rab-8A Rab8a -1.342 0.0001 
 Cyp4f13 -1.342 0.0047 
Synaptosomal-associated protein;Synaptosomal-
associated protein 23 
Snap23 -1.343 0.0038 
 Slc35d1 -1.343 0.0365 
 Mettl7a1 -1.344 0.028 
Guanine nucleotide-binding protein G(s) subunit 
alpha isoforms short;Guanine nucleotide-binding 
protein G(s) subunit alpha isoforms XLas 
Gnas -1.344 0.0018 
Transient receptor potential cation channel 
subfamily M member 4 
Trpm4 -1.344 0.0001 
Membrane magnesium transporter 1 Mmgt1 -1.345 0.0019 
Prenylcysteine oxidase Pcyox1 -1.345 0.0014 
DNA mismatch repair protein Msh2 Msh2 -1.345 0.0052 
Methylsterol monooxygenase 1 Msmo1 -1.345 0.0413 
Leucine-rich repeat-containing protein 57 Lrrc57 -1.347 0.0133 
NADH dehydrogenase [ubiquinone] 1 alpha 
subcomplex subunit 10, mitochondrial 
Ndufa10 -1.348 0.0007 
Ras-related protein Rab-35 Rab35 -1.348 0.0011 
BTB/POZ domain-containing protein KCTD12 Kctd12 -1.348 0.0023 
Mitofusin-2 Mfn2 -1.348 0.0002 
Mitogen-activated protein kinase 3;Mitogen-
activated protein kinase 
Mapk3 -1.348 0.0002 
NADH-cytochrome b5 reductase 3;NADH-
cytochrome b5 reductase 3 membrane-bound 
form;NADH-cytochrome b5 reductase 3 soluble 
form;NADH-cytochrome b5 reductase 
Cyb5r3 -1.349 0.023 
Interleukin-18 Il18 -1.349 0.022 
GTP-binding protein Rheb Rheb -1.349 0.0002 
Rho-related GTP-binding protein RhoG Rhog -1.349 0.0037 
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E3 ubiquitin-protein ligase NEDD4-like Nedd4l -1.35 0.0002 
Mitochondrial Rho GTPase 2 Rhot2 -1.35 0.0013 
Cyclin-dependent kinase 11B Cdk11b -1.35 0.0041 
Integrin alpha-6;Integrin alpha-6 heavy 
chain;Integrin alpha-6 light chain 
Itga6 -1.351 0.0001 
Leucine-rich repeat-containing protein 47 Lrrc47 -1.351 0.0006 
Nostrin Nostrin -1.351 0.0164 
Lamin-B2 Lmnb2 -1.351 0.0045 
Transmembrane protein 209 Tmem209 -1.351 0.0108 
Glutamine-rich protein 1 Qrich1 -1.352 0.0051 
Engulfment and cell motility protein 3 Elmo3 -1.352 0.0032 
 Sis -1.353 0.0037 
Dynamin-like 120 kDa protein, 
mitochondrial;Dynamin-like 120 kDa protein, form 
S1 
Opa1 -1.353 0.0013 
Probable lysosomal cobalamin transporter Lmbrd1 -1.353 0.007 
TBC1 domain family member 9B Tbc1d9b -1.355 0.0011 
Bifunctional polynucleotide 
phosphatase/kinase;Polynucleotide 3-
phosphatase;Polynucleotide 5-hydroxyl-kinase 
Pnkp -1.355 0.0119 
SWI/SNF-related matrix-associated actin-
dependent regulator of chromatin subfamily B 
member 1 
Smarcb1 -1.355 0.0004 
Annexin A7 Anxa7 -1.356 0.0006 
Caseinolytic peptidase B protein homolog Clpb -1.357 0.0005 
NADH dehydrogenase [ubiquinone] 1 beta 
subcomplex subunit 3 
Ndufb3 -1.358 0.0108 
Synaptobrevin homolog YKT6 Ykt6 -1.358 0.0117 
DNA ligase;DNA ligase 1 Lig1 -1.358 0.02 
Protein numb homolog Numb -1.359 0.0001 
E3 SUMO-protein ligase PIAS1;E3 SUMO-protein 
ligase PIAS2 
Pias1;Pias2 -1.359 0.0085 
Protein phosphatase methylesterase 1 Ppme1 -1.359 0.0004 
Dystrophin Dmd -1.359 0.0119 
Galectin;Galectin-3 Lgals3 -1.359 0.0043 
Transcription initiation factor TFIID subunit 
9B;Transcription initiation factor TFIID subunit 9 
Taf9;Taf9b -1.359 0.001 
Bone marrow stromal antigen 2 Bst2 -1.36 0.0053 
Unconventional myosin-Vb Myo5b -1.36 0.0001 
SOSS complex subunit C Inip -1.361 0.0075 
Calcium-binding mitochondrial carrier protein 
Aralar1 
Slc25a12 -1.361 0.0006 
 Ugt2b34 -1.361 0.0218 
Syntaxin-4 Stx4 -1.363 0.0001 
Cytochrome b-c1 complex subunit 2, mitochondrial Uqcrc2 -1.364 0.0004 
Unconventional myosin-Ic Myo1c -1.364 0.0038 
Transcriptional regulator ATRX Atrx -1.365 0.0064 
UDP-glucuronosyltransferase 1-7C Ugt1a7c -1.365 0.0469 
Phospholipid-transporting ATPase IC Atp8b1 -1.365 0.0001 
Peroxisomal membrane protein 11B Pex11b -1.366 0.0117 
Coiled-coil domain-containing protein 127 Ccdc127 -1.366 0.0022 
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Protein scribble homolog Scrib -1.366 0.0015 
Coiled-coil and C2 domain-containing protein 1A Cc2d1a -1.366 0.0018 
Probable glutamate--tRNA ligase, mitochondrial Ears2 -1.368 0.0001 
Ras GTPase-activating protein-binding protein 1 G3bp1 -1.368 0.0005 
Phosphoinositide phospholipase C;1-
phosphatidylinositol 4,5-bisphosphate 
phosphodiesterase delta-1 
Plcd1 -1.368 0.0001 
Normal mucosa of esophagus-specific gene 1 
protein 
AA467197;Nmes1 -1.369 0.0029 
Protein lin-7 homolog C Lin7c -1.37 0.0006 
Solute carrier family 25 member 45 Slc25a45 -1.371 0.0459 
Dedicator of cytokinesis protein 1 Dock1 -1.371 0.0003 
Tubulin alpha chain-like 3 Tubal3 -1.372 0.0046 
Sulfotransferase family cytosolic 1B member 1 Sult1b1 -1.372 0.0004 
Proline-serine-threonine phosphatase-interacting 
protein 2 
Pstpip2 -1.372 0.011 
Arf-GAP with dual PH domain-containing protein 2 Adap2 -1.373 0.0028 
L-seryl-tRNA(Sec) kinase Pstk -1.373 0.0002 
 Gstt3 -1.373 0.0012 
Ras-related C3 botulinum toxin substrate 1;Ras-
related C3 botulinum toxin substrate 3 
Rac1;Rac3 -1.374 0.0134 
Protein FAM210A Fam210a -1.375 0.0025 
Signal recognition particle subunit SRP68 Srp68 -1.375 0.0007 
ADP-ribosylation factor GTPase-activating protein 
1 
Arfgap1 -1.375 0.0331 
 Arhgef11 -1.375 0.001 
Poly(A) RNA polymerase, mitochondrial Mtpap -1.377 0.0022 
Adiponectin receptor protein 2 Adipor2 -1.377 0.0092 
Peripheral plasma membrane protein CASK Cask -1.377 0.0001 
Pyridoxal-dependent decarboxylase domain-
containing protein 1 
Pdxdc1 -1.377 0.0023 
Band 4.1-like protein 2 Epb41l2 -1.378 0.0085 
LIM domain kinase 2 Limk2 -1.378 0.0047 
Death-associated protein kinase 3 Dapk3 -1.378 0.0058 
Chromosome transmission fidelity protein 18 
homolog 
Chtf18 -1.378 0.0099 
Dual specificity mitogen-activated protein kinase 
kinase 1 
Map2k1 -1.379 0.0002 
NADH-ubiquinone oxidoreductase 75 kDa subunit, 
mitochondrial 
Ndufs1 -1.379 0.0013 
NADH dehydrogenase [ubiquinone] 1 alpha 
subcomplex subunit 5 
Ndufa5 -1.379 0.0001 
Endoplasmic reticulum-Golgi intermediate 
compartment protein 3 
Ergic3 -1.38 0.0057 
Mitofusin-1 Mfn1 -1.38 0.0001 
N-alpha-acetyltransferase 40 Naa40 -1.381 0.0242 
Protein kinase C and casein kinase substrate in 
neurons protein 2 
Pacsin2 -1.381 0.002 
DENN domain-containing protein 2D Dennd2d -1.381 0.0047 
Zinc transporter SLC39A7 Slc39a7 -1.382 0.0045 
Ras-related protein Ral-A Rala -1.382 0.0002 
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Coiled-coil domain-containing protein 90B, 
mitochondrial 
Ccdc90b -1.382 0.0103 
ATP-binding cassette sub-family G member 8 Abcg8 -1.383 0.0022 
Conserved oligomeric Golgi complex subunit 5 Cog5 -1.383 0.0049 
DnaJ homolog subfamily C member 5 Dnajc5 -1.383 0.0001 
General transcription factor II-I Gtf2i -1.384 0.0017 
Activating signal cointegrator 1 complex subunit 1 Ascc1 -1.384 0.0042 
 Baz2b -1.384 0.0295 
Monocarboxylate transporter 1 Slc16a1 -1.384 0.0052 
Glycosaminoglycan xylosylkinase Fam20b -1.384 0.0001 
Putative ATP-dependent RNA helicase DHX30 Dhx30 -1.384 0.0054 
UDP-glucuronosyltransferase 2A3 Ugt2a3 -1.386 0.001 
MAGUK p55 subfamily member 7 Mpp7 -1.386 0.0041 
Eukaryotic peptide chain release factor subunit 1 Etf1 -1.386 0.0091 
Signal recognition particle 54 kDa protein Srp54;Srp54c -1.387 0.0003 
Prostaglandin E synthase 2;Prostaglandin E 
synthase 2 truncated form 
Ptges2 -1.388 0.001 
Plakophilin-3 Pkp3 -1.388 0.0015 
Sorting nexin-2 Snx2 -1.388 0.0005 
TNF receptor-associated factor 4 Traf4 -1.389 0.0049 
Complement component receptor 1-like protein Cr1l -1.389 0.0008 
RNA polymerase-associated protein RTF1 homolog Rtf1 -1.389 0.0225 
Catechol O-methyltransferase domain-containing 
protein 1 
Comtd1 -1.389 0.0022 
Methylmalonate-semialdehyde dehydrogenase 
[acylating], mitochondrial 
Aldh6a1 -1.389 0.0003 
Unconventional myosin-VIIb Myo7b -1.39 0.0059 
WW domain-binding protein 2 Wbp2 -1.39 0.0152 
Transmembrane emp24 domain-containing protein 
2 
Tmed2 -1.39 0.0031 
Sphingomyelin phosphodiesterase 3 Smpd3 -1.391 0.0001 
N-acetylgalactosaminyltransferase 7 Galnt7 -1.391 0.0003 
Ribonuclease H2 subunit A;Ribonuclease Rnaseh2a -1.391 0.0017 
Vasodilator-stimulated phosphoprotein Vasp -1.391 0.0043 
Membrane-associated progesterone receptor 
component 1 
Pgrmc1 -1.392 0.0012 
Protein disulfide-isomerase A5 Pdia5 -1.392 0.0165 
Lysophosphatidic acid receptor 1 Lpar1 -1.392 0.0026 
Retinol dehydrogenase 7 Rdh7 -1.392 0.0187 
Transmembrane protein 186 Tmem186 -1.393 0.0273 
Vasoactive intestinal polypeptide receptor 1 Vipr1 -1.394 0.0018 
Phospholipase D1 Pld1 -1.394 0.0001 
Presenilins-associated rhomboid-like protein, 
mitochondrial;P-beta 
Parl -1.395 0.0113 
Guanine nucleotide-binding protein subunit alpha-
13 
Gna13 -1.396 0.0001 
Chromodomain-helicase-DNA-binding protein 
8;Chromodomain-helicase-DNA-binding protein 9 
Chd8;Chd9 -1.396 0.0097 
Methyltransferase-like protein;Methyltransferase-
like protein 16 
Mettl16 -1.396 0.0098 
Delta(24)-sterol reductase Dhcr24 -1.397 0.0048 
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Solute carrier family 25 member 51 Slc25a51 -1.397 0.0151 
TLD domain-containing protein 1 Tldc1 -1.398 0.0051 
Ras-responsive element-binding protein 1 Rreb1 -1.399 0.0031 
T-box transcription factor TBX3 Tbx3 -1.4 0.0115 
FERM, RhoGEF and pleckstrin domain-containing 
protein 2 
Farp2 -1.4 0.0016 
Growth hormone-regulated TBC protein 1 Grtp1 -1.401 0.0023 
Neutral and basic amino acid transport protein 
rBAT 
Slc3a1 -1.401 0.0028 
Probable ATP-dependent RNA helicase DDX6 Ddx6 -1.401 0.0025 
Alpha-actinin-1 Actn1 -1.401 0.0033 
Insulin receptor;Insulin receptor subunit 
alpha;Insulin receptor subunit beta 
Insr -1.401 0.0001 
Sorting nexin-6;Sorting nexin-6, N-terminally 
processed 
Snx6 -1.402 0.0019 
Cytoskeleton-associated protein 4 Ckap4 -1.402 0.0024 
Rho GTPase-activating protein 27 Arhgap27 -1.403 0.0002 
Up-regulated during skeletal muscle growth 
protein 5 
Usmg5 -1.404 0.0007 
Immediate early response 3-interacting protein 1 
Hdhd2;Ier3ip1;G
m10784 
-1.404 0.0027 
STE20-like serine/threonine-protein kinase Slk -1.405 0.0004 
Developmentally-regulated GTP-binding protein 1 Drg1 -1.406 0.0025 
Mitochondrial dicarboxylate carrier Slc25a10 -1.407 0.0099 
Heterogeneous nuclear ribonucleoprotein M Hnrnpm -1.407 0.0095 
NADH dehydrogenase [ubiquinone] 1 beta 
subcomplex subunit 9 
Ndufb9 -1.407 0.0011 
Abhydrolase domain-containing protein 4 Abhd4 -1.407 0.0042 
Prohibitin Phb -1.408 0.001 
Sulfotransferase 1 family member D1 Sult1d1 -1.409 0.0042 
Peroxisomal biogenesis factor 3 Pex3 -1.41 0.003 
ADP-ribosylation factor GTPase-activating protein 
3 
Arfgap3 -1.41 0.0005 
Ribosomal protein S6 kinase;Ribosomal protein S6 
kinase alpha-1 
Rps6ka1 -1.411 0.0007 
Interferon regulatory factor 2-binding protein 1 Irf2bp1 -1.411 0.0001 
 Myo6 -1.412 0.0002 
Pre-mRNA-splicing factor CWC22 homolog 
Cwc22;Gm13695;
Gm13697 
-1.412 0.0084 
RPA-interacting protein Rpain -1.412 0.0005 
Serine/threonine-protein kinase TAO3 Taok3 -1.412 0.0005 
Mortality factor 4-like protein 1 Morf4l1 -1.412 0.0003 
DnaJ homolog subfamily C member 9 Dnajc9 -1.413 0.001 
Alpha/beta hydrolase domain-containing protein 
11 
Abhd11 -1.414 0.0001 
Mortality factor 4-like protein 2 Morf4l2 -1.415 0.0014 
NADH dehydrogenase [ubiquinone] 1 beta 
subcomplex subunit 5, mitochondrial 
Ndufb5 -1.416 0.0059 
Apoptosis facilitator Bcl-2-like protein 14 Bcl2l14 -1.416 0.0008 
NADH dehydrogenase [ubiquinone] 1 alpha 
subcomplex subunit 12 
Ndufa12 -1.417 0.0006 
268 
 
DCC-interacting protein 13-alpha Appl1 -1.418 0.0001 
Galectin-4 Lgals4 -1.418 0.0045 
Cell cycle control protein 50B Tmem30b -1.418 0.0002 
NADH dehydrogenase [ubiquinone] 1 alpha 
subcomplex subunit 1 
Ndufa1 -1.418 0.0024 
RNA-binding protein 10 Rbm10 -1.42 0.0257 
Gastric intrinsic factor Gif -1.42 0.0103 
Band 4.1-like protein 5 Epb41l5 -1.42 0.0001 
Phospholipase DDHD1 Ddhd1 -1.422 0.0041 
SWI/SNF-related matrix-associated actin-
dependent regulator of chromatin subfamily A 
member 5 
Smarca5 -1.422 0.0059 
SH2 domain-containing protein 4A Sh2d4a -1.422 0.002 
DNA helicase INO80 Ino80 -1.422 0.0282 
Paraplegin Spg7 -1.422 0.0001 
Erlin-1 Erlin1 -1.422 0.0042 
[3-methyl-2-oxobutanoate dehydrogenase 
[lipoamide]] kinase, mitochondrial 
Bckdk -1.422 0.0001 
NAD-dependent protein deacetylase sirtuin-3 Sirt3 -1.423 0.001 
NADH dehydrogenase [ubiquinone] iron-sulfur 
protein 3, mitochondrial 
Ndufs3 -1.424 0.0001 
ATP-binding cassette sub-family A member 3 Abca3 -1.424 0.0061 
Protein LSM14 homolog A Lsm14a -1.424 0.0001 
Ras-related protein Ral-B Ralb -1.425 0.0015 
SH3 domain-containing protein 21 Sh3d21 -1.426 0.0116 
StAR-related lipid transfer protein 4 Stard4 -1.427 0.0018 
Selenoprotein T Selt -1.427 0.0035 
MOB kinase activator 2 Mob2 -1.427 0.0015 
Programmed cell death protein 4 Pdcd4 -1.428 0.0076 
Bcl-2 homologous antagonist/killer Bak1 -1.429 0.001 
Aspartyl/asparaginyl beta-hydroxylase Asph -1.429 0.0001 
Prostamide/prostaglandin F synthase Fam213b -1.429 0.0051 
Nucleoporin NDC1 Ndc1 -1.431 0.0149 
Hypermethylated in cancer 2 protein Hic2 -1.432 0.002 
DNA mismatch repair protein Msh6 Msh6 -1.432 0.0008 
Sortilin-related receptor Sorl1 -1.432 0.0011 
Flotillin-2 Flot2 -1.432 0.0442 
NADH dehydrogenase [ubiquinone] flavoprotein 2, 
mitochondrial 
Ndufv2 -1.435 0.0031 
Pyrroline-5-carboxylate reductase 2 Pycr2 -1.435 0.0001 
Dihydroorotate dehydrogenase (quinone), 
mitochondrial 
Dhodh -1.436 0.0003 
Golgi integral membrane protein 4 Golim4 -1.437 0.0002 
Nuclear prelamin A recognition factor Narf -1.437 0.001 
Transmembrane emp24 domain-containing protein 
3 
Tmed3 -1.437 0.033 
Multifunctional protein 
ADE2;Phosphoribosylaminoimidazole-
succinocarboxamide 
synthase;Phosphoribosylaminoimidazole 
carboxylase 
Paics -1.438 0.006 
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Rho GTPase-activating protein 1 Arhgap1 -1.438 0.0005 
ATP synthase F(0) complex subunit B1, 
mitochondrial 
Atp5f1 -1.439 0.0031 
NADH dehydrogenase [ubiquinone] iron-sulfur 
protein 6, mitochondrial 
Ndufs6 -1.439 0.0085 
NADH dehydrogenase [ubiquinone] 1 alpha 
subcomplex subunit 7 
Ndufa7 -1.439 0.0011 
Coiled-coil domain-containing protein 47 Ccdc47 -1.44 0.0001 
Protein 4.1 Epb4.1;Epb41 -1.441 0.0006 
AP-3 complex subunit beta-1 Ap3b1 -1.441 0.0147 
Solute carrier family 12 member 7 Slc12a7 -1.442 0.0001 
Laminin subunit beta-1 Lamb1 -1.443 0.0016 
Probable ATP-dependent RNA helicase DDX17 Ddx17 -1.443 0.0013 
MICOS complex subunit Mic27 Apool -1.443 0.0007 
Malignant T-cell-amplified sequence 1 Mcts1 -1.443 0.0299 
Carboxypeptidase E Cpe -1.443 0.0046 
Rho GTPase-activating protein 17 Arhgap17 -1.444 0.0022 
Ephexin-1 Ngef -1.446 0.0005 
Nuclease EXOG, mitochondrial Exog -1.446 0.0001 
Choline transporter-like protein 4 Slc44a4 -1.447 0.0024 
Transmembrane emp24 domain-containing protein 
9 
Tmed9 -1.448 0.0011 
Helicase-like transcription factor Hltf -1.449 0.0093 
CDGSH iron-sulfur domain-containing protein 2 Cisd2 -1.449 0.0038 
Fatty-acid amide hydrolase 1 Faah -1.449 0.0051 
Cytoplasmic FMR1-interacting protein 2 Cyfip2 -1.45 0.0039 
GEM-interacting protein Gmip -1.45 0.0004 
Solute carrier family 2, facilitated glucose 
transporter member 7 
Slc2a7 -1.452 0.0269 
Cytochrome c oxidase subunit 7A-related protein, 
mitochondrial 
Cox7a2l -1.452 0.001 
Cytochrome P450 4B1 Cyp4b1 -1.456 0.0202 
Coiled-coil and C2 domain-containing protein 1B Cc2d1b -1.458 0.0009 
Vacuolar protein sorting-associated protein 33B Vps33b -1.461 0.0035 
Uncharacterized protein C19orf43 homolog  -1.461 0.004 
Gamma-glutamyltranspeptidase 1;Gamma-
glutamyltranspeptidase 1 heavy chain;Gamma-
glutamyltranspeptidase 1 light chain 
Ggt1 -1.462 0.0027 
 Lct -1.464 0.0011 
N-terminal Xaa-Pro-Lys N-methyltransferase 1 Ntmt1 -1.465 0.0029 
Extended synaptotagmin-1 Esyt1 -1.465 0.0013 
Adseverin Scin -1.465 0.0001 
Bromodomain adjacent to zinc finger domain 
protein 2A 
Baz2a -1.465 0.0081 
Syntaxin-binding protein 5 Stxbp5 -1.465 0.0003 
Cysteine-rich and transmembrane domain-
containing protein 1 
Cystm1 -1.467 0.0025 
StAR-related lipid transfer protein 5 Stard5 -1.468 0.0034 
Kinesin-like protein;Kinesin-like protein KIF21A Kif21a -1.47 0.0013 
Unconventional myosin-Ia Myo1a -1.47 0.0006 
Tetraspanin-8 Tspan8 -1.47 0.0024 
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Nuclear pore membrane glycoprotein 210 Nup210 -1.471 0.0022 
Glutaminase kidney isoform, mitochondrial Gls -1.472 0.0003 
Bromodomain adjacent to zinc finger domain 
protein 1A 
Baz1a -1.473 0.0248 
Transmembrane protein 126A Tmem126a -1.474 0.0007 
Canalicular multispecific organic anion transporter 
1 
Abcc2 -1.474 0.0039 
Complex I intermediate-associated protein 30, 
mitochondrial 
Ndufaf1 -1.475 0.0001 
Prohibitin-2 Phb2 -1.476 0.0151 
ATPase family AAA domain-containing protein 1 Atad1 -1.476 0.0017 
  -1.477 0.0008 
Methyltransferase-like protein 17, mitochondrial Mettl17 -1.478 0.0002 
Golgin subfamily A member 7 Golga7 -1.478 0.0001 
Uncharacterized protein C18orf8 homolog Mic1 -1.478 0.0002 
Ribonucleoside-diphosphate reductase large 
subunit 
Rrm1 -1.479 0.0089 
Integrin-linked protein kinase Ilk -1.479 0.0005 
IST1 homolog Ist1 -1.479 0.0001 
Lymphocyte-specific helicase Hells -1.48 0.0362 
ATP-dependent RNA helicase DDX3Y Ddx3y -1.481 0.0008 
E3 ubiquitin-protein ligase UHRF1 Uhrf1 -1.481 0.0144 
Cysteine-rich with EGF-like domain protein 1 Creld1 -1.484 0.0002 
Very long-chain acyl-CoA synthetase Slc27a2 -1.485 0.0042 
Nucleolar GTP-binding protein 2 Gnl2 -1.486 0.0001 
Single Ig IL-1-related receptor Sigirr -1.487 0.0011 
AFG3-like protein 2 Afg3l2 -1.488 0.0003 
Numb-like protein Numbl -1.49 0.0003 
Cytochrome c oxidase subunit 4 isoform 1, 
mitochondrial 
Cox4i1 -1.491 0.0001 
Rhotekin Rtkn -1.491 0.0004 
NADH dehydrogenase [ubiquinone] iron-sulfur 
protein 8, mitochondrial 
Ndufs8 -1.491 0.0003 
DENN domain-containing protein 1B Dennd1b -1.492 0.0021 
NADH dehydrogenase [ubiquinone] 1 alpha 
subcomplex subunit 9, mitochondrial 
Ndufa9 -1.492 0.0044 
Metalloendopeptidase OMA1, mitochondrial Oma1 -1.493 0.0005 
Probable tRNA N6-adenosine 
threonylcarbamoyltransferase 
Osgep -1.494 0.0003 
Zinc finger CCCH domain-containing protein 18 Zc3h18 -1.494 0.0054 
Sorting nexin-27 Snx27 -1.494 0.0047 
Required for meiotic nuclear division protein 1 
homolog 
Rmnd1 -1.495 0.0012 
Iodotyrosine dehalogenase 1 Iyd -1.496 0.0124 
Glycoprotein-N-acetylgalactosamine 3-beta-
galactosyltransferase 1 
C1galt1 -1.496 0.0001 
X-ray repair cross-complementing protein 5 Xrcc5 -1.496 0.0003 
Guanine nucleotide-binding protein subunit alpha-
11 
Gna11 -1.497 0.001 
Deleted in malignant brain tumors 1 protein Dmbt1 -1.498 0.0044 
Tricarboxylate transport protein, mitochondrial Slc25a1 -1.498 0.024 
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Anoctamin-10 Ano10 -1.499 0.0005 
LEM domain-containing protein 2 Lemd2 -1.499 0.0001 
Cytochrome c oxidase subunit 5A, mitochondrial Cox5a -1.5 0.0478 
Mediator of RNA polymerase II transcription 
subunit 25 
Med25 -1.5 0.0025 
Tyrosyl-DNA phosphodiesterase 2 Tdp2 -1.502 0.0009 
Anoctamin-6 Ano6 -1.503 0.0025 
Pericentriolar material 1 protein Pcm1 -1.505 0.0012 
Cyclin-dependent kinase 18;Cyclin-dependent 
kinase 17 
Cdk18;Cdk17 -1.506 0.001 
Plasminogen receptor (KT) Plgrkt -1.506 0.0164 
NADH dehydrogenase [ubiquinone] iron-sulfur 
protein 4, mitochondrial 
Ndufs4 -1.506 0.0007 
Replication factor C subunit 1 Rfc1 -1.506 0.0022 
Secretory carrier-associated membrane protein 2 Scamp2 -1.507 0.0014 
Solute carrier family 15 member 1 Slc15a1 -1.507 0.0024 
Cdc42-interacting protein 4 Trip10 -1.508 0.0048 
Mitogen-activated protein kinase 13 Mapk13 -1.509 0.0008 
Mitochondrial fission 1 protein Fis1 -1.51 0.0001 
DNA-directed RNA polymerase III subunit RPC3 Polr3c -1.514 0.0184 
Mitochondrial import inner membrane translocase 
subunit TIM14 
Dnajc19 -1.515 0.0001 
Dephospho-CoA kinase domain-containing protein Dcakd -1.515 0.0037 
Signal peptidase complex subunit 2 Spcs2 -1.516 0.0054 
Coiled-coil domain-containing protein 134 Ccdc134 -1.516 0.0008 
Solute carrier family 2, facilitated glucose 
transporter member 2 
Slc2a2 -1.517 0.0001 
Glutathione S-transferase theta-1 Gstt1 -1.518 0.0015 
Phosphatidylserine decarboxylase proenzyme Pisd;Gm20671 -1.519 0.0066 
Aminoacylase-1 Acy1 -1.52 0.0177 
Zinc transporter 9 Slc30a9 -1.522 0.0025 
Choline-phosphate cytidylyltransferase A Pcyt1a -1.523 0.0032 
N-terminal kinase-like protein Scyl1 -1.524 0.0013 
Sorting nexin-7 Snx7 -1.524 0.0018 
Sphingomyelin phosphodiesterase 4 Smpd4 -1.524 0.0017 
Erlin-2 Erlin2 -1.525 0.0013 
Casein kinase I isoform alpha Csnk1a1 -1.526 0.0036 
Solute carrier family 12 member 6 Slc12a6 -1.526 0.0001 
Mitochondrial import inner membrane translocase 
subunit TIM50 
Timm50 -1.527 0.0009 
Casein kinase I isoform delta;Casein kinase I 
isoform epsilon 
Csnk1d;Csnk1e -1.531 0.0014 
Unconventional myosin-Ie Myo1e -1.531 0.0019 
Sodium/potassium-transporting ATPase subunit 
alpha-1 
Atp1a1 -1.531 0.0004 
GPI-anchor transamidase Pigk -1.532 0.0001 
ATP synthase subunit d, mitochondrial Gm10250;Atp5h -1.534 0.0005 
Protein ITFG3 Itfg3 -1.534 0.0008 
Serine/threonine-protein kinase MARK2 Mark2 -1.535 0.0046 
Methyl-CpG-binding protein 2 Mecp2 -1.536 0.0162 
E3 ubiquitin-protein ligase RLIM Rlim -1.536 0.0131 
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Cytochrome c oxidase subunit 5B, mitochondrial Cox5b -1.538 0.0181 
YTH domain-containing protein 1 Ythdc1 -1.538 0.0304 
Chromodomain-helicase-DNA-binding protein 1 Chd1 -1.539 0.0193 
THO complex subunit 4 Alyref -1.539 0.002 
Cytochrome b5 type B Cyb5b -1.54 0.0006 
All-trans-retinol 13,14-reductase Retsat -1.541 0.0029 
AFG3-like protein 1 Afg3l1 -1.542 0.0017 
Sorting nexin-4 Snx4 -1.544 0.0008 
Dual specificity mitogen-activated protein kinase 
kinase 6 
Map2k6 -1.546 0.0001 
ATP synthase subunit epsilon, mitochondrial Atp5e -1.549 0.0129 
ATP synthase subunit gamma;ATP synthase 
subunit gamma, mitochondrial 
Atp5c1 -1.55 0.0023 
Transcriptional repressor CTCF Ctcf -1.552 0.008 
Integrin beta;Integrin beta-5 Itgb5 -1.553 0.0004 
Protein FAM162A Fam162a -1.556 0.0003 
Gastric inhibitory polypeptide Gip -1.556 0.0404 
Pantetheinase Vnn1 -1.557 0.0034 
Butyrophilin-like protein 2 Btnl2 -1.557 0.0004 
Carnitine O-palmitoyltransferase 1, liver isoform Cpt1a -1.56 0.0028 
 Slc5a4b -1.56 0.0091 
Calcium-binding mitochondrial carrier protein 
SCaMC-1 
Slc25a24 -1.562 0.0005 
Protein ERGIC-53 Lman1 -1.563 0.0004 
Integrin alpha-2 Itga2 -1.563 0.0001 
Niemann-Pick C1-like protein 1 Npc1l1 -1.565 0.0007 
Plasma membrane calcium-transporting ATPase 1 Atp2b1 -1.566 0.0024 
N-acylneuraminate cytidylyltransferase Cmas -1.566 0.0148 
 Tor1aip1 -1.567 0.0004 
CDGSH iron-sulfur domain-containing protein 1 Cisd1 -1.567 0.0014 
ATP synthase subunit f, mitochondrial Atp5j2 -1.569 0.0012 
Tropomodulin-3 Tmod3 -1.569 0.0065 
Mitochondrial carrier homolog 2 Mtch2 -1.571 0.0387 
4F2 cell-surface antigen heavy chain Slc3a2 -1.572 0.002 
Sodium/potassium-transporting ATPase subunit 
beta-1 
Atp1b1 -1.573 0.0001 
Guanine nucleotide-binding protein G(q) subunit 
alpha 
Gnaq -1.575 0.0001 
YTH domain-containing family protein 2 Ythdf2 -1.575 0.002 
DEP domain-containing mTOR-interacting protein Deptor -1.576 0.0001 
 Myl12a -1.576 0.0012 
ATP-binding cassette sub-family B member 8, 
mitochondrial 
Abcb8 -1.577 0.0003 
Replication factor C subunit 4 Rfc4 -1.578 0.0005 
Cytochrome b-c1 complex subunit 7 Uqcrb -1.578 0.0003 
Mitochondrial ubiquitin ligase activator of NFKB 1 Mul1 -1.578 0.0009 
b(0,+)-type amino acid transporter 1 Slc7a9 -1.579 0.0068 
Feline leukemia virus subgroup C receptor-related 
protein 1 
Flvcr1 -1.579 0.0001 
Importin subunit alpha-1 Kpna2 -1.581 0.0002 
Inositol monophosphatase 3 Impad1 -1.581 0.0001 
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Syntaxin-16 Stx16 -1.584 0.0001 
ATP-dependent RNA helicase DDX3X;Putative ATP-
dependent RNA helicase Pl10 
Ddx3x;D1Pas1 -1.589 0.001 
Peptidyl-prolyl cis-trans isomerase FKBP5;Peptidyl-
prolyl cis-trans isomerase FKBP5, N-terminally 
processed 
Fkbp5 -1.589 0.0035 
Tripartite motif-containing protein 26 Trim26 -1.589 0.0008 
 Pkp2 -1.59 0.0001 
Serpin H1 Serpinh1 -1.59 0.0123 
Fibronectin;Anastellin Fn1 -1.591 0.0175 
UPF0585 protein C16orf13 homolog 0610011F06Rik -1.591 0.0001 
DnaJ homolog subfamily C member 1 Dnajc1 -1.594 0.0001 
Ras-related protein Rab-22A Rab22a -1.595 0.0021 
Circadian locomoter output cycles protein kaput Clock -1.595 0.0013 
Mitochondrial import receptor subunit TOM5 
homolog 
Tomm5 -1.595 0.0004 
Peptidyl-tRNA hydrolase 2, mitochondrial Ptrh2 -1.597 0.0002 
EH domain-containing protein 4 Ehd4 -1.598 0.0017 
Calcium uniporter protein, mitochondrial Mcu -1.599 0.0013 
Poly [ADP-ribose] polymerase 1 Parp1 -1.599 0.0004 
Transcription factor MafK;Transcription factor 
MafG 
Mafk;Mafg -1.599 0.0138 
Non-histone chromosomal protein HMG-17 Hmgn2;Gm16494 -1.603 0.1837 
Stomatin-like protein 2, mitochondrial Stoml2 -1.604 0.0001 
ATP synthase subunit O, mitochondrial Atp5o -1.605 0.0001 
N-acetylneuraminate lyase Npl -1.605 0.0145 
 Secisbp2 -1.606 0.0066 
Bcl-2-like protein 1 Bcl2l1 -1.607 0.0001 
Flap endonuclease 1 Fen1 -1.607 0.0025 
 Myo5c -1.609 0.0002 
Cytochrome b-c1 complex subunit 10 Uqcr11 -1.609 0.0167 
Platelet glycoprotein 4 Cd36 -1.61 0.0028 
Diacylglycerol kinase;Diacylglycerol kinase zeta Dgkz -1.612 0.0002 
DNA topoisomerase 1 Top1 -1.62 0.0042 
Histone H1.1 Hist1h1a -1.622 0.01 
ATP-binding cassette sub-family G member 5 Abcg5 -1.624 0.0001 
Voltage-dependent anion-selective channel 
protein 1 
Vdac1 -1.625 0.0106 
DnaJ homolog subfamily A member 3, 
mitochondrial 
Dnaja3 -1.633 0.0001 
Protein kinase C delta-binding protein Prkcdbp -1.638 0.0115 
Mitochondrial import inner membrane translocase 
subunit Tim23 
Timm23 -1.64 0.0002 
 Dlg3 -1.642 0.002 
 Gm20498 -1.644 0.0001 
NADH dehydrogenase [ubiquinone] 1 alpha 
subcomplex subunit 6 
Ndufa6 -1.645 0.0003 
Opioid growth factor receptor Ogfr -1.648 0.0182 
Replication factor C subunit 5 Rfc5 -1.649 0.0016 
Oxysterol-binding protein-related protein 2 Osbpl2 -1.649 0.0056 
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NADH dehydrogenase [ubiquinone] 1 alpha 
subcomplex subunit 13 
Ndufa13 -1.65 0.0001 
Signal peptidase complex catalytic subunit 
SEC11;Signal peptidase complex catalytic subunit 
SEC11A 
Sec11a -1.652 0.0196 
Neutral cholesterol ester hydrolase 1 Nceh1 -1.654 0.0005 
Sorting nexin-3 Snx3 -1.655 0.0003 
Histone H1.0;Histone H1.0, N-terminally processed H1f0 -1.656 0.004 
 Inpp5a -1.658 0.0001 
Protein KTI12 homolog Kti12 -1.658 0.001 
Coiled-coil domain-containing protein 51 Ccdc51 -1.659 0.0003 
Serine/threonine-protein kinase VRK1 Vrk1 -1.659 0.0009 
Annexin A13;Annexin Anxa13 -1.663 0.0041 
Phosphofurin acidic cluster sorting protein 2 Pacs2 -1.665 0.0004 
Myosin light chain 1/3, skeletal muscle 
isoform;Myosin light chain 3 
Myl1;Myl3 -1.665 0.0377 
Carboxypeptidase D Cpd -1.669 0.0001 
Cytochrome P450 3A11 Cyp3a11 -1.67 0.0352 
 Akr1c14 -1.675 0.001 
Succinate dehydrogenase cytochrome b560 
subunit, mitochondrial 
Sdhc -1.675 0.0078 
GTP-binding protein 8 Gtpbp8 -1.68 0.0014 
GTP-binding protein SAR1b Sar1b -1.681 0.0002 
Multidrug resistance protein 1A Abcb1a -1.684 0.0035 
 Myo6 -1.685 0.0019 
Signal peptidase complex subunit 1 Spcs1 -1.686 0.0002 
Tyrosine-protein kinase BAZ1B Baz1b -1.686 0.001 
Endophilin-A1 Sh3gl2 -1.687 0.0042 
 Ak2 -1.694 0.0007 
Calmodulin-regulated spectrin-associated protein 3 Camsap3 -1.701 0.0013 
Annexin A1 Anxa1 -1.707 0.0001 
Inactive serine/threonine-protein kinase VRK3 Vrk3 -1.707 0.0001 
Mucin-2 Muc2 -1.709 0.0021 
Krueppel-like factor 5 Klf5 -1.711 0.0054 
PX domain-containing protein kinase-like protein Pxk -1.712 0.0018 
EH domain-containing protein 1 Ehd1 -1.713 0.0006 
Pinin Pnn -1.714 0.0003 
Long-chain-fatty-acid--CoA ligase 1 Acsl1 -1.716 0.0001 
Trinucleotide repeat-containing gene 6B protein Tnrc6b -1.717 0.0007 
Protein XRP2 Rp2 -1.718 0.0001 
Phosphatidylcholine transfer protein Pctp -1.719 0.0013 
Barrier-to-autointegration factor;Barrier-to-
autointegration factor, N-terminally processed 
Banf1 -1.719 0.0131 
Syntaxin-3 Stx3 -1.721 0.0001 
 Cpb1 -1.722 0.17 
Putative hexokinase HKDC1 Hkdc1 -1.725 0.0003 
Unconventional myosin-Id Myo1d -1.726 0.0001 
ATP synthase F(0) complex subunit C1, 
mitochondrial;ATP synthase F(0) complex subunit 
C3, mitochondrial;ATP synthase F(0) complex 
subunit C2, mitochondrial 
Atp5g2;Atp5g1;At
p5g3 
-1.731 0.0071 
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A-kinase anchor protein 7 isoform alpha;A-kinase 
anchor protein 7 isoform gamma 
Akap7 -1.734 0.0055 
X-ray repair cross-complementing protein 6 Xrcc6 -1.737 0.0001 
SH2B adapter protein 1 Sh2b1 -1.74 0.0033 
Sorting and assembly machinery component 50 
homolog 
Samm50 -1.743 0.0014 
Synaptic vesicle membrane protein VAT-1 homolog Vat1 -1.75 0.0002 
Amine oxidase [flavin-containing] B Maob -1.752 0.0048 
Consortin Cnst -1.753 0.0046 
15-hydroxyprostaglandin dehydrogenase [NAD(+)] Hpgd -1.755 0.0006 
 Cyp2c65 -1.769 0.0065 
Amine oxidase [flavin-containing] A Maoa -1.769 0.0062 
Cytochrome P450 2C40 
Cyp2c68;Cyp2c67;
Cyp2c40;Cyp2c69 
-1.771 0.0001 
Apolipoprotein O Apoo -1.771 0.0004 
Lamina-associated polypeptide 2, isoforms 
beta/delta/epsilon/gamma 
Tmpo -1.774 0.0287 
Glypican-4;Secreted glypican-4 Gpc4 -1.776 0.0001 
Kinesin-like protein KIF3B;Kinesin-like protein 
KIF3B, N-terminally processed 
Kif3b -1.778 0.0123 
ADP-ribosylation factor 6 Arf6 -1.778 0.0031 
 Zfp780b -1.778 0.0022 
Sodium/hydrogen exchanger 1 Slc9a1 -1.778 0.0004 
Non-syndromic hearing impairment protein 5 
homolog 
Dfna5 -1.78 0.0002 
Amino acid transporter;Neutral amino acid 
transporter B(0) 
Slc1a5 -1.781 0.0003 
Transmembrane protein 65 Tmem65 -1.781 0.0002 
Syndecan-1 Sdc1 -1.781 0.0002 
Mitochondrial pyruvate carrier 1 Mpc1 -1.782 0.0002 
Uncharacterized aarF domain-containing protein 
kinase 5 
Adck5 -1.783 0.0001 
ATPase family AAA domain-containing protein 3 Atad3 -1.787 0.0001 
EH domain-containing protein 2 Ehd2 -1.791 0.0022 
Cyclin-dependent kinase 1 Cdk1 -1.792 0.0004 
 Xpnpep2 -1.796 0.008 
DNA primase large subunit Prim2 -1.8 0.0003 
Sarcolemmal membrane-associated protein Slmap -1.8 0.015 
Transmembrane protein 9B Tmem9b -1.805 0.0002 
Serine/threonine-protein kinase Nek3 Nek3 -1.807 0.0033 
Guanine nucleotide-binding protein-like 3-like 
protein 
Gnl3l -1.808 0.0197 
Spermatogenesis-defective protein 39 homolog Vipas39 -1.809 0.0003 
Transcriptional repressor protein YY1 Yy1 -1.81 0.0001 
E3 ubiquitin-protein ligase NEDD4 Nedd4 -1.811 0.0003 
Phospholipid scramblase 1 Plscr1 -1.82 0.0022 
MICOS complex subunit Mic60 Immt -1.827 0.0001 
Probable ATP-dependent RNA helicase DDX5 Ddx5 -1.828 0.0014 
 Rsf1 -1.828 0.0003 
 Apol9a;Apol9b -1.837 0.0091 
MICOS complex subunit Mic19 Chchd3 -1.84 0.0004 
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Sorting nexin-9 Snx9 -1.841 0.0001 
Peroxisomal acyl-coenzyme A oxidase 2 Acox2 -1.842 0.0036 
Meprin A subunit alpha Mep1a -1.846 0.0005 
Centromere protein V Cenpv -1.846 0.0107 
Sulfate transporter Slc26a2 -1.85 0.0001 
Decorin Dcn -1.857 0.0008 
NADH-cytochrome b5 reductase 1 Cyb5r1 -1.863 0.0005 
Synemin Synm -1.865 0.243 
Redox-regulatory protein FAM213A Fam213a -1.868 0.0011 
CKLF-like MARVEL transmembrane domain-
containing protein 6 
Cmtm6 -1.87 0.0001 
Metaxin-2 Mtx2 -1.883 0.0001 
Bile salt export pump Abcb11 -1.888 0.0079 
Metaxin-1 Mtx1 -1.901 0.0001 
 Spcs3 -1.902 0.0027 
N-acetylated-alpha-linked acidic dipeptidase-like 
protein 
Naaladl1 -1.909 0.0012 
Myosin light polypeptide 6 Myl6 -1.924 0.0094 
Diacylglycerol O-acyltransferase 1 Dgat1 -1.926 0.0025 
Sterol 26-hydroxylase, mitochondrial Cyp27a1 -1.929 0.0016 
 Actn1 -1.954 0.0143 
Cubilin Cubn -1.955 0.0019 
 Slfn9 -1.96 0.0003 
 Sar1a -1.967 0.0001 
Ras suppressor protein 1 Rsu1 -1.969 0.0002 
MAU2 chromatid cohesion factor homolog Mau2 -1.98 0.0011 
Lumican Lum -1.983 0.0009 
High mobility group protein 20A Hmg20a -1.985 0.0003 
Protein NDRG1 Ndrg1 -1.991 0.0001 
Acylglycerol kinase, mitochondrial Agk -1.994 0.0003 
Histone H3.2 Hist1h3b -1.997 0.0711 
Epoxide hydrolase 1 Ephx1 -2.009 0.0005 
 Bptf -2.009 0.0002 
FACT complex subunit SSRP1 Ssrp1 -2.012 0.0008 
Atypical kinase ADCK3, mitochondrial Adck3 -2.014 0.0001 
Lipoamide acyltransferase component of 
branched-chain alpha-keto acid dehydrogenase 
complex, mitochondrial 
Dbt -2.014 0.0001 
Regulator of chromosome condensation Rcc1 -2.016 0.0018 
Receptor expression-enhancing protein;Receptor 
expression-enhancing protein 5 
Reep5 -2.022 0.0001 
Histone H2B type 3-B;Histone H2B type 3-
A;Histone H2B type 2-E 
Hist3h2bb;Hist3h
2ba;Hist2h2be 
-2.033 0.013 
MLV-related proviral Env polyprotein;Surface 
protein;Transmembrane protein 
 -2.048 0.0002 
Anterior gradient protein 2 homolog Agr2 -2.051 0.0004 
Alpha-parvin Parva -2.051 0.0004 
Cell division cycle protein 27 homolog Cdc27 -2.072 0.0004 
Secretin Sct -2.073 0.0282 
Leiomodin-1 Lmod1 -2.078 0.0422 
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Transforming growth factor-beta-induced protein 
ig-h3 
Tgfbi -2.079 0.0028 
Protein QIL1 Qil1 -2.081 0.0001 
Histidine triad nucleotide-binding protein 3 Hint3 -2.09 0.0007 
Nuclear factor 1;Nuclear factor 1 A-type Nfia -2.106 0.0004 
Estradiol 17-beta-dehydrogenase 2 Hsd17b2 -2.151 0.0001 
E3 ubiquitin-protein ligase TRIM23 Trim23 -2.171 0.0062 
Sterol O-acyltransferase 1 Soat1 -2.174 0.0004 
Nucleolar transcription factor 1 Ubtf -2.184 0.001 
ETS-related transcription factor Elf-3 Elf3 -2.197 0.0007 
Endoplasmic reticulum-Golgi intermediate 
compartment protein 1 
Ergic1 -2.199 0.0001 
Solute carrier family 12 member 2 Slc12a2 -2.229 0.0001 
Integrin alpha-1 Itga1 -2.238 0.0011 
Alpha-defensin 23 Defa23 -2.247 0.0248 
Cytochrome P450 2J6 Cyp2j6 -2.256 0.0004 
FACT complex subunit SPT16 Supt16;Supt16h -2.258 0.0004 
SUN domain-containing protein 1 Sun1 -2.261 0.0005 
Myosin regulatory light chain 12B Myl12b -2.266 0.0043 
Calcium-activated chloride channel regulator 1 Clca1 -2.269 0.0001 
UDP-glucuronosyltransferase 2B17 
Ugt2b5;Ugt2b17;
Ugt2b38 
-2.272 0.0444 
BRI3-binding protein Bri3bp -2.274 0.0118 
Endoplasmic reticulum resident protein 27 Erp27 -2.278 0.0089 
Calcium-transporting 
ATPase;Sarcoplasmic/endoplasmic reticulum 
calcium ATPase 3 
Atp2a3 -2.284 0.0001 
Polymerase I and transcript release factor Ptrf -2.315 0.0086 
Core histone macro-H2A.1 H2afy -2.32 0.0012 
40S ribosomal protein S30 Fau -2.346 0.0138 
Sodium/potassium-transporting ATPase subunit 
alpha-4 
Atp1a4 -2.363 0.0006 
Sorting nexin;Sorting nexin-18 Snx18 -2.363 0.0005 
Unconventional myosin-XVIIIa Myo18a -2.382 0.0011 
Chymotrypsin-like elastase family member 2A Cela2a -2.384 0.0011 
Basement membrane-specific heparan sulfate 
proteoglycan core protein 
Hspg2 -2.391 0.0006 
Pancreatic alpha-amylase;Alpha-amylase Amy2;Amy2a1 -2.406 0.0248 
Thymidylate synthase Tyms -2.411 0.0005 
Fatty acid-binding protein, adipocyte Fabp4 -2.427 0.036 
RNA-binding protein with serine-rich domain 1 Rnps1 -2.43 0.0035 
 Ctrl -2.448 0.0012 
 1700123L14Rik -2.452 0.0194 
Adenylate cyclase type 6 Adcy6 -2.456 0.0002 
Histone H3.1 Hist1h3a -2.538 0.0034 
 Syne2 -2.618 0.0002 
Sideroflexin-3 Sfxn3 -2.618 0.0005 
DNA topoisomerase 2-beta Top2b -2.632 0.0002 
 Mptx2 -2.66 0.0057 
 Tns1 -2.679 0.0074 
Bile salt-activated lipase Cel -2.691 0.0056 
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Syndecan-4 Sdc4 -2.725 0.0001 
Chromodomain-helicase-DNA-binding protein 2 Chd2 -2.868 0.0006 
 Myl10 -2.873 0.0009 
 Cyp2c66 -2.93 0.0013 
Histone H2AX H2afx -2.962 0.0015 
Colipase Clps -3.039 0.0042 
DNA topoisomerase 2-alpha Top2a -3.067 0.0002 
Myosin-9 Myh9 -3.075 0.0004 
ADP/ATP translocase 1 Slc25a4 -3.08 0.0269 
Myosin-14 Myh14 -3.083 0.0006 
Pancreatic lipase-related protein 2 Pnliprp2 -3.144 0.0005 
Histone H2B type 1-F/J/L;Histone H2B;Histone H2B 
type 1-P;Histone H2B type 1-K;Histone H2B type 1-
B;Histone H2B type 1-A 
Hist1h2bf;Hist1h2
br;Hist1h2bp;Hist
1h2bk;Hist1h2bb;
Hist1h2ba 
-3.153 0.0004 
 Muc3 -3.27 0.0005 
Histone H4 Hist1h4a -3.324 0.0012 
Histone H2A type 2-B Hist2h2ab -3.34 0.0008 
Cytochrome P450 2C55 Cyp2c55 -3.424 0.0001 
Caveolin-1;Caveolin Cav1 -3.551 0.0005 
Histone H2A type 1-F Hist1h2af -3.674 0.0004 
Alpha-defensin 21;Alpha-defensin 22 Defa22;Defa21 -3.777 0.006 
Histone H3.3;Histone H3.3C;Histone H3 H3f3a;H3f3c -3.796 0.0021 
Peptidyl-prolyl cis-trans isomerase FKBP11 Fkbp11 -3.896 0.0005 
Histone H2A;Histone H2A type 2-A;Histone H2A 
type 2-C 
Hist1h2al;Hist2h2
aa1;Hist2h2ac 
-4.019 0.0004 
Collagen alpha-1(VI) chain Col6a1 -4.254 0.0022 
Lactase-like protein Lctl -4.285 0.033 
 Col6a3 -4.316 0.001 
Intelectin-1a Itln1 -4.367 0.0002 
Histone H2A type 1-K Hist1h2ak -4.386 0.0004 
Histone H2A.V;Histone H2A.Z;Histone H2A H2afv;H2afz -4.546 0.0035 
Myosin regulatory light polypeptide 9 Myl9 -4.614 0.0333 
Chymotrypsinogen B;Chymotrypsin B chain 
A;Chymotrypsin B chain B;Chymotrypsin B chain C 
Ctrb1 -4.645 0.0173 
 Myh11 -4.855 0.0165 
 Gm15299 -4.982 0.0003 
Alpha-defensin 24 Defa24 -5.1 0.0001 
Zymogen granule membrane protein 16 Zg16 -5.125 0.0005 
Alpha-defensin-related sequence 1 
Gm14851;Defa-
rs1 
-5.286 0.001 
Proteasome subunit beta type-5 Psmb5 -5.379 0.0004 
Histone H2B type 1-C/E/G;Histone H2B type 1-
M;Histone H2B type 2-B;Histone H2B type 1-H 
Hist1h2bc;Hist1h2
bm;Hist2h2bb;His
t1h2bh 
-5.554 0.001 
 Gm7849 -5.596 0.0011 
Lysozyme C-1;Lysozyme C-2 Lyz1;Lyz2 -5.614 0.0014 
Protein disulfide-isomerase A2 Pdia2 -6.4 0.001 
Alpha-defensin 20 Defcr20;Defa20 -6.753 0.0049 
Ig kappa chain C region Igkc -7.942 0.0007 
Ig alpha chain C region Igha -11.05 0.0007 
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Appendix 3: significant proteomic changes in c-Rel-/- small intestinal mucosa in 
comparison to C57BL/6J mice  
Protein names Gene names 
Regulation 
fold change 
P value 
Solute carrier family 35 member A4 Slc35a4 16.79 0.0001 
Glutathione peroxidase 2 Gpx2 4.246 0.0002 
Unconventional myosin-IXb Myo9b 2.89 0.0001 
Transformation/transcription domain-associated 
protein 
Trrap 2.793 0.0065 
MAU2 chromatid cohesion factor homolog Mau2 2.42 0.0119 
Dual oxidase 2 Duox2 2.293 0.029 
Mucosal pentraxin 2 Mptx2 2.154 0.0237 
Lactase-like protein Lctl 2.126 0.0037 
Uncharacterized protein KIAA0556 
D430042O09Rik;K
iaa0556 
2.079 0.0289 
1,4-alpha-glucan-branching enzyme Gbe1 2.074 0.0022 
Peripherin Prph 2.048 0.0154 
Regenerating islet-derived protein 3-
gamma;Regenerating islet-derived protein 3-
gamma 16.5 kDa form;Regenerating islet-derived 
protein 3-gamma 15 kDa form 
Reg3g 1.995 0.022 
Sorting nexin-3 Snx3 1.986 0.0082 
Polymeric immunoglobulin receptor;Secretory 
component 
Pigr 1.972 0.002 
Palmitoyl-protein thioesterase 1 Ppt1 1.97 0.0314 
Cathepsin L1;Cathepsin L1 heavy chain;Cathepsin 
L1 light chain 
Ctsl 1.96 0.0006 
Thymidylate synthase Tyms 1.96 0.0484 
MLV-related proviral Env polyprotein;Surface 
protein;Transmembrane protein 
 1.959 0.0357 
Dystrophin Dmd 1.954 0.0453 
Beta-galactosidase Glb1 1.927 0.0062 
Regenerating islet-derived protein 3-beta Reg3b 1.912 0.0004 
Mitochondrial pyruvate carrier 1 Mpc1 1.899 0.0421 
Uroporphyrinogen decarboxylase Urod 1.875 0.007 
Transcriptional repressor protein YY1 Yy1 1.867 0.0239 
Fatty acid-binding protein, epidermal Fabp5 1.863 0.0474 
Sideroflexin-3 Sfxn3 1.859 0.0081 
Glycerol-3-phosphate dehydrogenase 1-like 
protein 
Gpd1l 1.858 0.003 
 Parp3 1.855 0.0337 
 Chn2 1.849 0.0126 
Molybdenum cofactor biosynthesis protein 1 Mocs1 1.847 0.0112 
Sodium/hydrogen exchanger 1 Slc9a1 1.844 0.0109 
Serum paraoxonase/lactonase 3 Pon3 1.832 0.0002 
Protein NDRG1 Ndrg1 1.799 0.0092 
Protein-tyrosine kinase 6 Ptk6 1.798 0.0119 
 Syne2 1.792 0.0276 
O-phosphoseryl-tRNA(Sec) selenium transferase Sepsecs 1.792 0.0112 
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SH3 domain-containing protein 21 Sh3d21 1.79 0.0097 
Transmembrane protein 260 Tmem260 1.781 0.0032 
Adiponectin receptor protein 2 Adipor2 1.779 0.0233 
Conserved oligomeric Golgi complex subunit 5 Cog5 1.779 0.0059 
Histone H2A type 1-K Hist1h2ak 1.77 0.0163 
Aminoacylase-1 Acy1 1.754 0.0544 
S-methyl-5-thioadenosine phosphorylase Mtap 1.75 0.0259 
Serine/threonine-protein phosphatase 6 catalytic 
subunit;Serine/threonine-protein phosphatase 6 
catalytic subunit, N-terminally processed 
Ppp6c 1.735 0.0022 
Succinyl-CoA:3-ketoacid coenzyme A transferase 1, 
mitochondrial;Succinyl-CoA:3-ketoacid-coenzyme 
A transferase 
Oxct1 1.732 0.0021 
Purine nucleoside phosphorylase Pnp2 1.73 0.0035 
UPF0585 protein C16orf13 homolog 0610011F06Rik 1.728 0.0145 
Transmembrane protein 9B Tmem9b 1.726 0.0004 
b(0,+)-type amino acid transporter 1 Slc7a9 1.722 0.0403 
Proteasome subunit beta type-2 Psmb2 1.72 0.0045 
Peroxisomal 2,4-dienoyl-CoA reductase Decr2 1.714 0.022 
Arf-GAP domain and FG repeat-containing protein 
1 
Agfg1 1.71 0.0029 
Protein FAM134A Fam134a 1.71 0.0058 
 Tns1 1.708 0.0395 
 Rabgap1l 1.703 0.0207 
Zinc finger protein 512 Znf512 1.699 0.0463 
Ketohexokinase Khk 1.697 0.0479 
Probable RNA-binding protein 19 Rbm19 1.697 0.0189 
 Acy1 1.69 0.0093 
Long-chain specific acyl-CoA dehydrogenase, 
mitochondrial 
Acadl 1.689 0.0313 
Protein disulfide-isomerase A4 Pdia4 1.688 0.0111 
Acylamino-acid-releasing enzyme Apeh 1.687 0.0208 
Proteasome subunit beta type-9 Psmb9 1.684 0.001 
Eukaryotic translation initiation factor 2D Eif2d 1.682 0.0098 
  1.682 0.011 
Transaldolase Taldo1 1.678 0.02 
E3 ubiquitin-protein ligase RNF170 Rnf170 1.677 0.0082 
L-lactate dehydrogenase;L-lactate dehydrogenase 
A chain 
Ldha 1.673 0.001 
 Actn1 1.673 0.0244 
SH3 domain-binding protein 1 Sh3bp1 1.672 0.0009 
Nardilysin Nrd1 1.671 0.0001 
Phosphatidate cytidylyltransferase;Phosphatidate 
cytidylyltransferase 2 
Cds2 1.669 0.0076 
 Neb 1.667 0.0156 
Hemoglobin subunit beta-1;Hemoglobin subunit 
beta-2 
Hbbt1;Hbb-
bs;Hbb-b1;Hbb-b2 
1.66 0.0091 
CDGSH iron-sulfur domain-containing protein 3, 
mitochondrial 
Cisd3 1.654 0.0065 
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Clathrin light chain A Clta 1.653 0.0222 
Probable ATP-dependent RNA helicase YTHDC2 Ythdc2 1.651 0.0328 
TATA element modulatory factor Tmf1 1.65 0.0076 
Heterogeneous nuclear ribonucleoprotein D-like Hnrnpdl 1.649 0.0031 
Mth938 domain-containing protein Aamdc 1.649 0.0147 
THO complex subunit 6 homolog Thoc6 1.643 0.0062 
Uncharacterized aarF domain-containing protein 
kinase 5 
Adck5 1.641 0.0257 
 Gm20498 1.64 0.0025 
Helicase-like transcription factor Hltf 1.628 0.014 
BolA-like protein 3 Bola3 1.628 0.022 
Proto-oncogene vav Vav1 1.628 0.0105 
Cytosolic acyl coenzyme A thioester hydrolase Acot7 1.626 0.0275 
Alpha-mannosidase;Alpha-mannosidase 2C1 Man2c1 1.622 0.0043 
 Nbeal1 1.619 0.0078 
Nucleoside diphosphate kinase;Nucleoside 
diphosphate kinase B 
Gm20390;Nme2 1.618 0.0295 
Sulfatase-modifying factor 1 Sumf1 1.617 0.0058 
 Zfp780b 1.611 0.0274 
Bromodomain adjacent to zinc finger domain 
protein 2A 
Baz2a 1.609 0.0138 
Major vault protein Mvp 1.608 0.0048 
 Adh6a 1.603 0.0005 
Calmodulin-regulated spectrin-associated protein 3 Camsap3 1.603 0.0165 
Prefoldin subunit 4 Pfdn4 1.6 0.0419 
 Arhgef5 1.599 0.0239 
Acylphosphatase;Acylphosphatase-1 Acyp1 1.599 0.0045 
 Myh11 1.598 0.0054 
 Gm15299 1.598 0.0082 
 Ak2 1.597 0.0063 
Leiomodin-1 Lmod1 1.594 0.0458 
Adenylate cyclase type 6 Adcy6 1.594 0.0024 
Serine/threonine-protein kinase Nek3 Nek3 1.593 0.0462 
Adenosylhomocysteinase;Putative 
adenosylhomocysteinase 3 
Ahcyl2 1.592 0.011 
Serpin B6 
Serpinb6a;Serpinb
6 
1.591 0.0376 
Coiled-coil domain-containing protein 58 Ccdc58 1.589 0.0124 
Protein PRRC2A Prrc2a 1.584 0.0137 
 Gm20441 1.58 0.0354 
Serine hydroxymethyltransferase;Serine 
hydroxymethyltransferase, cytosolic 
Shmt1 1.58 0.0252 
Carboxypeptidase;Lysosomal protective 
protein;Lysosomal protective protein 32 kDa 
chain;Lysosomal protective protein 20 kDa chain 
Ctsa 1.578 0.0451 
S-formylglutathione hydrolase Esd 1.576 0.0378 
Copper transport protein ATOX1 Atox1 1.575 0.0059 
Proteasome subunit beta type-1 Psmb1 1.574 0.0214 
Glutathione S-transferase omega-1 Gsto1 1.573 0.0072 
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D-dopachrome decarboxylase Ddt 1.573 0.0318 
Acidic leucine-rich nuclear phosphoprotein 32 
family member A 
Anp32a 1.571 0.0201 
Annexin A3;Annexin Anxa3 1.568 0.0025 
Polymerase I and transcript release factor Ptrf 1.566 0.001 
Death-associated protein kinase 3 Dapk3 1.563 0.0024 
Proteasome subunit alpha type-3 Psma3 1.56 0.0135 
Prefoldin subunit 2 Pfdn2 1.557 0.0056 
Craniofacial development protein 1 Cfdp1 1.557 0.0435 
WD repeat-containing protein 1 Wdr1 1.556 0.0038 
Aromatic-L-amino-acid decarboxylase Ddc 1.554 0.0247 
Glucosamine-6-phosphate isomerase 1 Gnpda1 1.551 0.0072 
Aspartate aminotransferase, cytoplasmic Got1 1.551 0.0253 
Tubulin alpha-3 chain Tuba3a 1.55 0.0396 
Glucose-6-phosphate isomerase Gpi 1.549 0.0096 
Serum albumin Alb 1.549 0.0067 
Superoxide dismutase [Cu-Zn] Sod1 1.548 0.016 
Nucleolin Ncl 1.544 0.0075 
Phosphoglycerate kinase 1;Phosphoglycerate 
kinase 
Pgk1 1.543 0.0117 
Delta-aminolevulinic acid dehydratase Alad 1.541 0.0299 
Transcription elongation factor A protein 1 Tcea1 1.541 0.0001 
Beta-glucuronidase Gusb 1.538 0.0386 
Malate dehydrogenase, cytoplasmic Mdh1 1.536 0.0361 
Calreticulin Calr 1.535 0.0122 
Nucleoside diphosphate kinase A;Nucleoside 
diphosphate kinase 
Nme1 1.534 0.0219 
Peptidyl-prolyl cis-trans isomerase A;Peptidyl-
prolyl cis-trans isomerase A, N-terminally 
processed;Peptidyl-prolyl cis-trans isomerase 
Ppia;Gm5160 1.533 0.0012 
Triosephosphate isomerase Tpi1 1.529 0.0257 
Cofilin-1 Cfl1 1.524 0.0142 
Serpin H1 Serpinh1 1.524 0.0377 
Aldose reductase-related protein 1 Akr1b7 1.521 0.0251 
Protein-glutamine gamma-glutamyltransferase 2 Tgm2 1.516 0.0156 
Leukotriene A-4 hydrolase Lta4h 1.513 0.0028 
Protein disulfide-isomerase A3 Pdia3 1.511 0.0125 
Proteasome subunit beta type-8;Proteasome 
subunit beta type 
Psmb8 1.505 0.0224 
Cytoplasmic aconitate hydratase Aco1 1.505 0.0234 
DNA-(apurinic or apyrimidinic site) lyase;DNA-
(apurinic or apyrimidinic site) lyase, mitochondrial 
Apex1 1.504 0.0144 
Alcohol dehydrogenase class-3 Adh5 1.504 0.0011 
Acyl-CoA-binding protein Dbi 1.503 0.0024 
Ran-specific GTPase-activating protein Ranbp1 1.5 0.0052 
Protein phosphatase 1B Ppm1b 1.5 0.0011 
Transketolase Tkt 1.5 0.0007 
Vacuolar protein sorting-associated protein 26A Vps26a 1.491 0.0231 
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Glutathione reductase, mitochondrial Gsr 1.491 0.0256 
Fos-related antigen 2 Fosl2 1.49 0.0086 
Proteasome subunit alpha type-2 Psma2 1.487 0.0062 
Caveolin-1;Caveolin Cav1 1.481 0.0058 
Adenosylhomocysteinase Ahcy 1.481 0.0057 
Arylamine N-acetyltransferase 2 Nat2 1.478 0.0073 
Estradiol 17-beta-dehydrogenase 2 Hsd17b2 1.476 0.0006 
Ubiquitin-conjugating enzyme E2 E3;Ubiquitin-
conjugating enzyme E2 E2 
Ube2e3;Ube2e2 1.476 0.0064 
Uridine phosphorylase 1 Upp1 1.472 0.0084 
Cellular nucleic acid-binding protein Cnbp 1.466 0.0066 
Programmed cell death protein 5 Pdcd5 1.466 0.0049 
Elongation factor 2 Eef2 1.465 0.0108 
Telomerase-binding protein EST1A Smg6 1.463 0.0233 
DDB1- and CUL4-associated factor 7 Dcaf7 1.46 0.0013 
Mitochondrial import inner membrane translocase 
subunit Tim10 
Timm10 1.459 0.016 
40S ribosomal protein S29 Rps29 1.456 0.0025 
U6 snRNA-associated Sm-like protein LSm3 Lsm3 1.455 0.0201 
Serine/threonine-protein phosphatase 2A catalytic 
subunit beta isoform 
Ppp2cb 1.454 0.0084 
Myotrophin Mtpn 1.453 0.001 
Transcription elongation factor B polypeptide 2 Tceb2 1.453 0.0155 
Cytochrome c, somatic Cycs 1.449 0.0036 
Platelet-activating factor acetylhydrolase IB 
subunit alpha 
Pafah1b1 1.446 0.0028 
40S ribosomal protein S10 Rps10 1.444 0.0167 
Serine/threonine-protein phosphatase 2A catalytic 
subunit alpha isoform 
Ppp2ca 1.442 0.0074 
Actin, alpha cardiac muscle 1;Actin, alpha skeletal 
muscle 
Actc1;Acta1 1.439 0.0033 
Guanine nucleotide-binding protein subunit beta-
2-like 1;Guanine nucleotide-binding protein 
subunit beta-2-like 1, N-terminally processed 
Gnb2l1 1.436 0.0007 
Histone H3.1 Hist1h3a 1.434 0.0024 
Acid sphingomyelinase-like phosphodiesterase 3a Smpdl3a 1.431 0.0126 
Proteasome subunit beta type-7 Psmb7 1.427 0.0054 
Phosphatidylethanolamine-binding protein 
1;Hippocampal cholinergic neurostimulating 
peptide 
Pebp1 1.423 0.0001 
T-box transcription factor TBX3 Tbx3 1.422 0.002 
Fructose-1,6-bisphosphatase isozyme 2 Fbp2 1.416 0.0009 
Rho-related GTP-binding protein RhoG Rhog 1.412 0.0039 
Cysteine and glycine-rich protein 2 Csrp2 1.41 0.0122 
Serine/threonine-protein phosphatase 4 catalytic 
subunit 
Ppp4c 1.405 0.0084 
Dipeptidyl peptidase 1;Dipeptidyl peptidase 1 
exclusion domain chain;Dipeptidyl peptidase 1 
heavy chain;Dipeptidyl peptidase 1 light chain 
Ctsc 1.405 0.0021 
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Acidic leucine-rich nuclear phosphoprotein 32 
family member E 
Anp32e 1.404 0.0042 
Xanthine dehydrogenase/oxidase;Xanthine 
dehydrogenase;Xanthine oxidase 
Xdh 1.403 0.0033 
Epithelial discoidin domain-containing receptor 1 Ddr1 1.395 0.0055 
Creatine kinase B-type Ckb 1.392 0.0011 
Collagen alpha-1(VI) chain Col6a1 1.388 0.0044 
Cyclin-dependent kinase 18;Cyclin-dependent 
kinase 17 
Cdk18;Cdk17 1.384 0.001 
Retinol-binding protein 2 Rbp2 1.379 0.0094 
Bcl-2-like protein 15 Bcl2l15 1.368 0.0101 
Puromycin-sensitive aminopeptidase Npepps 1.367 0.0008 
Xaa-Pro dipeptidase Pepd 1.366 0.0002 
Zinc transporter SLC39A7 Slc39a7 1.366 0.0095 
S-adenosylmethionine synthase isoform type-2 Mat2a 1.364 0.0017 
PDZ and LIM domain protein 7 Pdlim7 1.362 0.0076 
Peptidyl-prolyl cis-trans isomerase CWC27 
homolog 
Cwc27 1.36 0.0073 
PEST proteolytic signal-containing nuclear protein Pcnp 1.357 0.0028 
Mesencephalic astrocyte-derived neurotrophic 
factor 
Manf 1.35 0.0044 
Heat shock 70 kDa protein 4 Hspa4 1.344 0.0066 
Abhydrolase domain-containing protein 4 Abhd4 1.344 0.0065 
MOB kinase activator 1A;MOB kinase activator 1B Mob1b;Mob1a 1.321 0.0005 
DAZ-associated protein 1 Dazap1 1.315 0.0012 
28 kDa heat- and acid-stable phosphoprotein Pdap1 1.29 0.0004 
MAP kinase-activated protein kinase 3 Mapkapk3 -1.28 0.0006 
 1700123L14Rik -1.28 0.0004 
Phosphatase and actin regulator 4 Phactr4 -1.29 0.0008 
Purine nucleoside phosphorylase Pnp -1.3 0.0004 
Alpha-defensin 23 Defa23 -1.3 0.0001 
Insulin-like growth factor 2 mRNA-binding protein 
2 
Igf2bp2 -1.32 0.0003 
RNA-binding protein EWS Ewsr1 -1.32 0.0014 
Presenilins-associated rhomboid-like protein, 
mitochondrial;P-beta 
Parl -1.33 0.003 
Growth factor receptor-bound protein 2 Grb2 -1.33 0.0036 
Heterogeneous nuclear ribonucleoprotein D0 Hnrnpd -1.33 0.0009 
Proteasome subunit beta type-6 Psmb6 -1.33 0.0033 
Stress-induced-phosphoprotein 1 Stip1 -1.33 0.0042 
Caprin-1 Caprin1 -1.33 0.0023 
Lamina-associated polypeptide 2, isoforms 
beta/delta/epsilon/gamma 
Tmpo -1.35 0.0045 
Kinase suppressor of Ras 1 Ksr1 -1.35 0.003 
Receptor tyrosine-protein kinase erbB-3 Erbb3 -1.35 0.0049 
Heat shock protein 105 kDa Hsph1 -1.35 0.0039 
Nucleophosmin Npm1 -1.36 0.0055 
U1 small nuclear ribonucleoprotein C Snrpc -1.36 0.009 
Sulfate transporter Slc26a2 -1.37 0.0053 
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Cystatin-B Cstb -1.37 0.0073 
Bile salt-activated lipase Cel -1.37 0.0105 
Peroxiredoxin-6 Prdx6 -1.37 0.0007 
Clathrin light chain B Cltb -1.37 0.0054 
ATP-binding cassette sub-family F member 1 Abcf1 -1.38 0.0009 
Synemin Synm -1.38 0.0031 
Ubiquitin domain-containing protein UBFD1 Ubfd1 -1.38 0.0003 
UPF0587 protein C1orf123 homolog 0610037L13Rik -1.39 0.0048 
Neutral alpha-glucosidase AB Ganab -1.39 0.0041 
Protein RCC2 Rcc2 -1.39 0.0091 
F-box only protein 38 Fbxo38 -1.39 0.0008 
Eukaryotic translation initiation factor 1A, X-
chromosomal;Eukaryotic translation initiation 
factor 1A 
Eif1ax;Eif1a;Gm5
039;Gm5662;Gm
8300;Gm2016;G
m21936;Gm2056;
Gm6803;Gm2035
;Gm2075 
-1.39 0.0117 
Golgi pH regulator Gpr89a -1.4 0.0063 
Mannose-1-phosphate guanyltransferase beta Gmppb -1.4 0.0104 
KN motif and ankyrin repeat domain-containing 
protein 2 
Kank2 -1.4 0.0068 
Phosphoglucomutase-like protein 5 Pgm5 -1.4 0.0052 
 Mettl7a1 -1.4 0.0158 
Rhotekin Rtkn -1.4 0.0158 
NHL repeat-containing protein 3 Nhlrc3 -1.4 0.0039 
Transmembrane protein 230 Tmem230 -1.4 0.0104 
AFG3-like protein 2 Afg3l2 -1.4 0.0148 
GDP-mannose 4,6 dehydratase Gmds -1.4 0.0034 
Sodium/myo-inositol cotransporter 2 Slc5a11 -1.4 0.0105 
Aldose 1-epimerase Galm -1.4 0.0006 
Protein farnesyltransferase subunit beta Fntb -1.41 0.0002 
NAD(P)H-hydrate epimerase Apoa1bp -1.42 0.0018 
Sulfite oxidase, mitochondrial Suox -1.42 0.0041 
Uncharacterized protein C1orf43 homolog 4933434E20Rik -1.42 0.0065 
Cytosolic 10-formyltetrahydrofolate 
dehydrogenase 
Aldh1l1 -1.42 0.0035 
Fucose mutarotase Fuom -1.42 0.0046 
Diphosphoinositol polyphosphate 
phosphohydrolase 2 
Nudt4 -1.42 0.0183 
Aspartoacylase Aspa -1.43 0.0003 
Interferon regulatory factor 2-binding protein 1 Irf2bp1 -1.44 0.0218 
Protein QIL1 Qil1 -1.44 0.0007 
Glycosaminoglycan xylosylkinase Fam20b -1.45 0.005 
Aminopeptidase B Rnpep -1.45 0.0012 
Heterogeneous nuclear ribonucleoprotein U-like 
protein 1 
Hnrnpul1 -1.45 0.0042 
Filamin-C Flnc -1.45 0.0033 
40S ribosomal protein S5;40S ribosomal protein S5, 
N-terminally processed 
Rps5 -1.46 0.0005 
286 
 
Hemoglobin subunit alpha 
haemaglobin 
alpha 2;Hba 
-1.46 0.0066 
Protein MEMO1 Memo1 -1.46 0.0039 
FERM, RhoGEF and pleckstrin domain-containing 
protein 2 
Farp2 -1.46 0.0013 
Stromal membrane-associated protein 1 Smap1 -1.47 0.0027 
Activating signal cointegrator 1 complex subunit 2 Ascc2 -1.47 0.0055 
Uncharacterized protein KIAA2013 Kiaa2013 -1.47 0.0142 
Pyridoxine-5-phosphate oxidase Pnpo -1.48 0.0196 
Cytochrome c oxidase assembly factor 7 Coa7 -1.48 0.0212 
Heterogeneous nuclear ribonucleoprotein A/B Hnrnpab -1.48 0.0291 
Cyclin-dependent kinase 9 Cdk9 -1.48 0.0119 
Nicotinamide/nicotinic acid mononucleotide 
adenylyltransferase 3 
Nmnat3 -1.48 0.0112 
 Sar1a -1.49 0.0154 
RNA-binding protein 10 Rbm10 -1.49 0.0094 
Lipolysis-stimulated lipoprotein receptor Lsr -1.5 0.0146 
Dipeptidyl peptidase 3 Dpp3 -1.5 0.0064 
Lambda-crystallin homolog Cryl1 -1.5 0.0204 
Peptidyl-prolyl cis-trans isomerase F, mitochondrial Ppif -1.5 0.0064 
Nucleolar GTP-binding protein 2 Gnl2 -1.51 0.0101 
Lysine--tRNA ligase Kars -1.51 0.0139 
 Cyp4f13 -1.52 0.0045 
Breast cancer metastasis-suppressor 1 homolog Brms1 -1.52 0.0045 
Myeloid-derived growth factor Mydgf -1.53 0.011 
Lactoylglutathione lyase Glo1 -1.54 0.0196 
Ribonuclease T2 Rnaset2 -1.54 0.01 
Myosin regulatory light polypeptide 9 Myl9 -1.55 0.0362 
GTP-binding protein SAR1b Sar1b -1.55 0.0297 
Protein NipSnap homolog 3B Nipsnap3b -1.56 0.0428 
Endoplasmic reticulum-Golgi intermediate 
compartment protein 3 
Ergic3 -1.56 0.0194 
Thioredoxin domain-containing protein 17 Txndc17 -1.56 0.0175 
U6 snRNA-associated Sm-like protein LSm7 Lsm7 -1.57 0.0435 
40S ribosomal protein S21 Rps21 -1.57 0.0215 
Thioredoxin domain-containing protein 12 Txndc12 -1.58 0.0071 
Adaptin ear-binding coat-associated protein 1 Necap1 -1.58 0.009 
Protein FAM136A Fam136a -1.58 0.0196 
OCIA domain-containing protein 1 Ociad1 -1.58 0.0002 
Bifunctional purine biosynthesis protein 
PURH;Phosphoribosylaminoimidazolecarboxamide 
formyltransferase;IMP cyclohydrolase 
Atic -1.59 0.0163 
U6 snRNA-associated Sm-like protein LSm4 Lsm4 -1.6 0.0334 
Cysteine-rich with EGF-like domain protein 2 Creld2 -1.6 0.0117 
5-methylcytosine rRNA methyltransferase NSUN4 Nsun4 -1.61 0.0353 
Threonine--tRNA ligase, cytoplasmic Tars -1.62 0.0065 
Peptidyl-prolyl cis-trans isomerase-like 1 Ppil1 -1.62 0.0109 
Peptidyl-prolyl cis-trans isomerase FKBP11 Fkbp11 -1.64 0.0236 
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Dolichol-phosphate mannosyltransferase subunit 3 Dpm3 -1.64 0.0106 
Low molecular weight phosphotyrosine protein 
phosphatase 
Acp1 -1.65 0.0068 
3-oxoacyl-[acyl-carrier-protein] synthase, 
mitochondrial 
Oxsm -1.69 0.0338 
SUN domain-containing protein 1 Sun1 -1.69 0.0009 
Mitochondrial glutamate carrier 1 Slc25a22 -1.69 0.0461 
Phospholysine phosphohistidine inorganic 
pyrophosphate phosphatase 
Lhpp -1.69 0.05 
 2200002D01Rik -1.69 0.0026 
Mitochondrial import inner membrane translocase 
subunit TIM50 
Timm50 -1.7 0.0317 
N-acetyl-D-glucosamine kinase Nagk -1.7 0.0405 
Abscission/NoCut checkpoint regulator Zfyve19 -1.72 0.0077 
Peroxisomal carnitine O-octanoyltransferase Crot -1.73 0.0122 
Ribosome biogenesis protein BRX1 homolog Brix1 -1.74 0.0379 
6-phosphogluconate dehydrogenase, 
decarboxylating 
Pgd -1.74 0.0042 
Apoptosis-associated speck-like protein containing 
a CARD 
Pycard -1.75 0.0001 
ADP-ribosylation factor GTPase-activating protein 
1 
Arfgap1 -1.77 0.0242 
Protein SET Set -1.77 0.0478 
LIM domain and actin-binding protein 1 Lima1 -1.79 0.0238 
Inositol-3-phosphate synthase 1 Isyna1 -1.85 0.0387 
Transcription and mRNA export factor ENY2 Eny2 -1.86 0.0251 
Signal peptide peptidase-like 2A Sppl2a -1.87 0.0359 
SH3 domain-binding glutamic acid-rich-like protein Sh3bgrl -1.88 0.0278 
Tyrosyl-DNA phosphodiesterase 2 Tdp2 -1.9 0.0085 
UPF0160 protein MYG1, mitochondrial Myg1 -1.91 0.0004 
BUB3-interacting and GLEBS motif-containing 
protein ZNF207 
Znf207;Zfp207 -1.93 0.0146 
Thioredoxin reductase 1, cytoplasmic Txnrd1 -1.93 0.0051 
Proteasome subunit alpha type-6 Psma6 -1.96 0.0081 
Prolyl endopeptidase Prep -1.97 0.0005 
Peptidyl-prolyl cis-trans isomerase NIMA-
interacting 1 
Pin1;Pin1rt1 -2.02 0.0243 
Protein canopy homolog 2 Cnpy2 -2.12 0.0025 
E3 ubiquitin-protein ligase AMFR Amfr -2.17 0.0227 
Galactokinase Galk1 -2.31 0.0302 
Guanine deaminase Gda -2.33 0.0369 
Proteasome subunit alpha type-1 Psma1 -2.4 0.0014 
6-pyruvoyl tetrahydrobiopterin synthase Pts -2.45 0.0012 
Semaphorin-4G Sema4g -2.49 0.0113 
Mitochondrial import inner membrane translocase 
subunit Tim8 A 
Timm8a1 -2.67 0.011 
Proteasome subunit alpha type-7 Psma7 -2.82 0.0132 
Proteasome subunit alpha type-5 Psma5 -3.23 0.0427 
Serine/threonine-protein kinase 25 Stk25 -10.9 0.0106 
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Appendix 4: significantly up- and downregulated proteins in C57BL/6J small 
intestinal mucosa post administration of 0.125mg/kg LPS 
Protein names Gene names 
Regulation 
fold change 
P value 
PHD finger protein 10 Phf10 10.67 0.0017 
THAP domain-containing protein 4 Thap4 5.444 0.0004 
Lactase-like protein Lctl 5.103 0.0354 
Nucleolar protein 9 Nop9 5.018 0.0181 
Reticulon;Reticulon-1 Rtn1 2.785 0.0189 
Metastasis-associated protein MTA1 Mta1 2.602 0.0057 
Catenin alpha-3 Ctnna3 2.396 0.0041 
Proto-oncogene c-Fos Fos 2.192 0.0009 
Acyl-CoA-binding protein Dbi 1.967 0.0207 
Clathrin light chain B Cltb 1.914 0.0354 
 2200002D01Rik 1.843 0.0266 
Sorbitol dehydrogenase Sord 1.815 0.0438 
Small ubiquitin-related modifier;Small ubiquitin-
related modifier 3 
Sumo3 1.81 0.0023 
Small acidic protein 
Smap;1110004F1
0Rik 
1.799 0.0003 
Ran-specific GTPase-activating protein Ranbp1 1.791 0.0297 
Caspase-3;Caspase-3 subunit p17;Caspase-3 
subunit p12 
Casp3 1.791 0.0058 
Copper transport protein ATOX1 Atox1 1.791 0.0451 
 Gm20441 1.787 0.0451 
39S ribosomal protein L21, mitochondrial Mrpl21 1.782 0.0077 
Guanine deaminase Gda 1.77 0.0239 
GDP-L-fucose synthase Tsta3 1.764 0.0065 
Isocitrate dehydrogenase [NADP] cytoplasmic Idh1 1.746 0.0379 
Cysteine-rich protein 1 Crip1 1.742 0.028 
Vacuolar protein sorting-associated protein 29 Vps29 1.732 0.0015 
Superoxide dismutase [Cu-Zn] Sod1 1.731 0.0466 
Cytochrome c, somatic Cycs 1.731 0.0225 
 Adh6a 1.697 0.0211 
Glucose-6-phosphate isomerase Gpi 1.693 0.009 
Prostaglandin reductase 1 Ptgr1 1.691 0.0254 
Mesencephalic astrocyte-derived neurotrophic 
factor 
Manf 1.683 0.0202 
Epididymal secretory protein E1 Npc2 1.681 0.0177 
Guanylate cyclase activator 2B;Uroguanylin Guca2b 1.671 0.026 
28 kDa heat- and acid-stable phosphoprotein Pdap1 1.666 0.0178 
Transaldolase Taldo1 1.663 0.0377 
Superoxide dismutase [Mn], mitochondrial Sod2 1.657 0.0057 
Malate dehydrogenase, cytoplasmic Mdh1 1.654 0.0128 
Hydroxyacylglutathione hydrolase, mitochondrial Hagh 1.639 0.0104 
L-lactate dehydrogenase;L-lactate dehydrogenase 
A chain 
Ldha 1.638 0.0297 
Xaa-Pro aminopeptidase 1 Xpnpep1 1.638 0.011 
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Ensconsin Map7 1.623 0.0024 
Protein LZIC Lzic 1.616 0.0341 
SH3 domain-binding glutamic acid-rich-like protein Sh3bgrl 1.615 0.0157 
Eukaryotic translation initiation factor 4H Eif4h 1.612 0.0017 
Lambda-crystallin homolog Cryl1 1.606 0.0184 
Creatine kinase B-type Ckb 1.599 0.0399 
Phosphoglycerate kinase 1;Phosphoglycerate 
kinase 
Pgk1 1.594 0.0312 
Phenazine biosynthesis-like domain-containing 
protein 2 
Pbld2 1.592 0.0399 
Creatine kinase U-type, mitochondrial Ckmt1 1.59 0.0196 
Acidic leucine-rich nuclear phosphoprotein 32 
family member B 
Anp32b 1.58 0.0332 
 Tfg 1.578 0.022 
Peptidyl-prolyl cis-trans isomerase A Ppia;Gm5160 1.576 0.0349 
Myeloid-derived growth factor Mydgf 1.574 0.0297 
Thioredoxin reductase 1, cytoplasmic Txnrd1 1.574 0.0212 
Protein disulfide-isomerase P4hb 1.571 0.033 
Glutathione S-transferase omega-1 Gsto1 1.563 0.0305 
Beta-hexosaminidase subunit alpha Hexa 1.561 0.0007 
Protein atonal homolog 7 Atoh7 1.559 0.0002 
Acylamino-acid-releasing enzyme Apeh 1.558 0.0224 
Hyaluronan-binding protein 2 Habp2 1.557 0.0492 
Alcohol dehydrogenase class-3 Adh5 1.551 0.0201 
Transgelin-2 Tagln2 1.549 0.0007 
Translationally-controlled tumor protein Tpt1 1.549 0.0465 
Essential MCU regulator, mitochondrial Smdt1 1.548 0.0168 
Fos-related antigen 2 Fosl2 1.547 0.0069 
Thioredoxin domain-containing protein 12 Txndc12 1.546 0.0165 
Cytidine deaminase Cda 1.544 0.0156 
Glycerol-3-phosphate dehydrogenase  Gpd1 1.544 0.0134 
Triosephosphate isomerase Tpi1 1.542 0.0288 
WD repeat-containing protein 1 Wdr1 1.541 0.0177 
GDP-mannose 4,6 dehydratase Gmds 1.535 0.0429 
Protein FAM136A Fam136a 1.534 0.0345 
Alcohol dehydrogenase [NADP(+)] Akr1a1 1.53 0.0338 
Serine/arginine-rich splicing factor 3 Srsf3;Gm12355 1.528 0.0078 
D-dopachrome decarboxylase Ddt 1.527 0.0372 
Mth938 domain-containing protein Aamdc 1.525 0.026 
Alpha-2-macroglobulin receptor-associated protein Lrpap1 1.515 0.0476 
Fatty acid-binding protein, liver Fabp1 1.507 0.036 
Stress-induced-phosphoprotein 1 Stip1 1.507 0.0386 
Alanine aminotransferase 1 Gpt 1.507 0.0483 
Src substrate cortactin Cttn 1.506 0.0008 
Clathrin light chain A Clta 1.496 0.0219 
Xanthine dehydrogenase/oxidase;Xanthine 
dehydrogenase;Xanthine oxidase 
Xdh 1.488 0.0191 
Taperin Tprn 1.484 0.0032 
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Ubiquitin-fold modifier 1 Ufm1 1.484 0.012 
Major vault protein Mvp 1.478 0.0268 
Xaa-Pro dipeptidase Pepd 1.474 0.0218 
Adrenodoxin, mitochondrial Fdx1 1.474 0.0162 
Serine/arginine-rich splicing factor 6 Srsf6 1.469 0.0188 
Beta-lactamase-like protein 2 Lactb2 1.469 0.0073 
Glutathione synthetase Gss 1.464 0.0445 
Nicotinamide phosphoribosyltransferase Nampt 1.464 0.0442 
Serine/arginine-rich splicing factor 1 Srsf1 1.463 0.0237 
Retinol-binding protein 2 Rbp2 1.463 0.0306 
 Fcgbp 1.462 0.0214 
V-type proton ATPase subunit G 1 Atp6v1g1 1.462 0.0035 
Aldose 1-epimerase Galm 1.459 0.0426 
Caspase-6;Caspase-6 subunit p18;Caspase-6 
subunit p11 
Casp6 1.455 0.0165 
Peroxiredoxin-6 Prdx6 1.455 0.0479 
Hypermethylated in cancer 2 protein Hic2 1.45 0.007 
Protein deglycase DJ-1 Park7 1.447 0.0115 
Na(+)/H(+) exchange regulatory cofactor NHE-RF1 Slc9a3r1 1.447 0.0082 
Calreticulin Calr 1.443 0.0388 
Cathepsin Z Ctsz 1.44 0.0221 
Peroxisomal carnitine O-octanoyltransferase Crot 1.44 0.0295 
Pterin-4-alpha-carbinolamine dehydratase Pcbd1 1.439 0.0121 
6-phosphogluconate dehydrogenase, 
decarboxylating 
Pgd 1.438 0.0346 
Acid sphingomyelinase-like phosphodiesterase 3a Smpdl3a 1.437 0.0104 
Serine/arginine-rich splicing factor 7 Srsf7 1.437 0.0204 
Cytochrome c oxidase assembly factor 7 Coa7 1.436 0.0457 
Cytoplasmic aconitate hydratase Aco1 1.435 0.0478 
Vacuolar protein sorting-associated protein 26A Vps26a 1.434 0.0237 
Prefoldin subunit 6 Pfdn6 1.432 0.0383 
Espin Espn 1.432 0.0255 
Aspartate aminotransferase, cytoplasmic Got1 1.429 0.0328 
Cofilin-1 Cfl1 1.428 0.0131 
DAZ-associated protein 1 Dazap1 1.423 0.0085 
Leukotriene A-4 hydrolase Lta4h 1.421 0.0436 
SRA stem-loop-interacting RNA-binding protein, 
mitochondrial 
Slirp 1.421 0.0061 
N-acetylglucosamine-6-sulfatase Gns 1.419 0.0161 
WAS/WASL-interacting protein family member 3 Wipf3 1.412 0.0442 
Phosphatidylethanolamine-binding protein 
1;Hippocampal cholinergic neurostimulating 
peptide 
Pebp1 1.406 0.0441 
Far upstream element-binding protein 2 Khsrp 1.401 0.038 
Calmodulin-like protein 4 Calml4 1.397 0.0122 
High mobility group protein B3 Hmgb3 1.396 0.0299 
Cytosolic acyl coenzyme A thioester hydrolase Acot7 1.387 0.0421 
Cingulin Cgn 1.386 0.0106 
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RNA-binding protein EWS Ewsr1 1.384 0.0258 
Guanine nucleotide-binding protein subunit beta-
2-like 1 
Gnb2l1 1.384 0.0353 
40S ribosomal protein S28 Rps28;Gm10263 1.382 0.0006 
14 kDa phosphohistidine phosphatase Phpt1 1.382 0.0168 
Microsomal triglyceride transfer protein large 
subunit 
Mttp 1.381 0.0293 
Protein phosphatase 1 regulatory subunit 12C Ppp1r12c 1.381 0.0003 
E3 ubiquitin-protein ligase MYCBP2 Mycbp2 1.38 0.0411 
Ladinin-1 Lad1 1.378 0.0039 
Pyridoxine-5-phosphate oxidase Pnpo 1.377 0.026 
39S ribosomal protein L12, mitochondrial Mrpl12 1.377 0.0374 
Fructose-1,6-bisphosphatase isozyme 2 Fbp2 1.376 0.0368 
Aldose reductase-related protein 1 Akr1b7 1.372 0.0235 
Isochorismatase domain-containing protein 1 Isoc1 1.369 0.0002 
Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, 
mitochondrial 
Ech1 1.366 0.0384 
Cystatin-B Cstb 1.365 0.0365 
Acetyl-CoA acetyltransferase, cytosolic Acat2;Acat3 1.364 0.0367 
Dynactin subunit 2 Dctn2 1.363 0.0293 
Nuclear transport factor 2 Nutf2 1.363 0.0024 
Peroxiredoxin-5, mitochondrial Prdx5 1.362 0.0269 
Nucleoside diphosphate kinase;Nucleoside 
diphosphate kinase B 
Gm20390;Nme2 1.362 0.043 
Ester hydrolase C11orf54 homolog 1.362 0.0459 
Protein disulfide-isomerase A4 Pdia4 1.36 0.0325 
Cathepsin S Ctss 1.358 0.0279 
Sulfiredoxin-1 Srxn1 1.354 0.0109 
Coiled-coil domain-containing protein 9 Ccdc9 1.35 0.0387 
PDZ and LIM domain protein 2 Pdlim2 1.347 0.0056 
Ankyrin repeat and SAM domain-containing 
protein 4B 
Anks4b 1.346 0.0329 
Alpha-enolase Eno1 1.346 0.028 
Serpin B6 
Serpinb6a;Serpinb
6 
1.346 0.0213 
b(0,+)-type amino acid transporter 1 Slc7a9 1.344 0.0391 
UDP-glucose 4-epimerase Gale 1.344 0.0319 
Galectin-2 Lgals2 1.343 0.0365 
Prostaglandin reductase 2 Ptgr2 1.341 0.0282 
Putative adenosylhomocysteinase 2 Ahcyl1 1.339 0.0049 
Trehalase Treh 1.339 0.0377 
Osteoclast-stimulating factor 1 Ostf1 1.337 0.0026 
Heat shock 70 kDa protein 4 Hspa4 1.335 0.0222 
Four and a half LIM domains protein 2 Fhl2 1.334 0.0046 
Uridine phosphorylase 1 Upp1 1.334 0.027 
Isocitrate dehydrogenase [NAD] subunit alpha, 
mitochondrial 
Idh3a 1.329 0.0224 
Spectrin alpha chain, non-erythrocytic 1 Sptan1 1.329 0.0157 
EF-hand domain-containing protein D2 Efhd2 1.328 0.0085 
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Serine/arginine repetitive matrix protein 1 Srrm1 1.328 0.0197 
 Sptan1 1.327 0.0364 
Polyglutamine-binding protein 1 Pqbp1 1.326 0.0269 
Thioredoxin Txn 1.326 0.0286 
Sulfite oxidase, mitochondrial Suox 1.325 0.0149 
14-3-3 protein sigma Sfn 1.325 0.009 
Ubiquitin-conjugating enzyme E2 L3 Ube2l3 1.324 0.0344 
Proteasome subunit alpha type-4;Proteasome 
subunit alpha type 
Psma4 1.322 0.0269 
Transcription and mRNA export factor ENY2 Eny2 1.32 0.0395 
PDZ and LIM domain protein 1 Pdlim1 1.318 0.0215 
 Lmo7 1.318 0.0136 
Caspase-7;Caspase-7 subunit p20;Caspase-7 
subunit p11 
Casp7 1.318 0.0164 
Xenotropic and polytropic retrovirus receptor 1 Xpr1 1.316 0.0225 
TBC1 domain family member 4 Tbc1d4 1.315 0.014 
N-acetylglucosamine-1-phosphotransferase 
subunits alpha/beta 
Gnptab 1.312 0.0274 
Epsin-1 Epn1 1.308 0.0095 
Syntaxin-3 Stx3 1.307 0.0001 
UV excision repair protein RAD23 homolog B Rad23b 1.307 0.0083 
Protein lin-7 homolog C Lin7c 1.303 0.0028 
Cytosol aminopeptidase Lap3 1.302 0.0129 
Leucine zipper protein 1 Luzp1 1.299 0.0276 
UMP-CMP kinase Cmpk1 1.296 0.0231 
Calcium-regulated heat stable protein 1 Carhsp1 1.295 0.0298 
Uncharacterized protein KIAA1211 
C530008M17Rik;
Kiaa1211 
1.294 0.0252 
Endoplasmic reticulum resident protein 29 Erp29 1.294 0.0266 
UV excision repair protein RAD23 homolog A Rad23a 1.291 0.0295 
Glyceraldehyde-3-phosphate dehydrogenase Gapdh;Gm3839 1.287 0.0096 
Synaptosomal-associated protein 29 Snap29 1.284 0.0037 
Chloride intracellular channel protein 1 Clic1 1.282 0.0106 
Gamma-glutamyltranspeptidase 1 Ggt1 1.282 0.0096 
Adenosylhomocysteinase;Putative 
adenosylhomocysteinase 3 
Ahcyl2 1.281 0.0088 
Aspartyl aminopeptidase Dnpep 1.28 0.0157 
Heterogeneous nuclear ribonucleoproteins A2/B1 Hnrnpa2b1 1.279 0.0106 
Protein MAL2 Mal2 1.276 0.0283 
Putative N-acetylglucosamine-6-phosphate 
deacetylase 
Amdhd2 1.276 0.0194 
Acetyl-CoA acetyltransferase, mitochondrial Acat1 1.276 0.0183 
Platelet-activating factor acetylhydrolase IB 
subunit gamma 
Pafah1b3 1.275 0.0142 
Heterogeneous nuclear ribonucleoprotein 
F;Heterogeneous nuclear ribonucleoprotein F, N-
terminally processed 
Hnrnpf 1.275 0.0175 
FGFR1 oncogene partner 2 homolog Fgfr1op2 1.271 0.0193 
Pyruvate kinase PKM Pkm 1.269 0.0006 
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Serine/threonine-protein phosphatase CPPED1 Cpped1 1.268 0.0258 
Heterogeneous nuclear ribonucleoproteins C1/C2 Hnrnpc 1.267 0.0209 
Phosphomannomutase 2 Pmm2 1.265 0.0197 
Endoplasmic reticulum resident protein 44 Erp44 1.263 0.0099 
N-acetylgalactosamine-6-sulfatase Galns 1.261 0.0083 
Cathepsin D Ctsd 1.26 0.0236 
Peptidyl-prolyl cis-trans isomerase B Ppib 1.257 0.0167 
Hephaestin Heph 1.257 0.0154 
Sorting nexin-3 Snx3 1.256 0.0028 
40S ribosomal protein S12 Rps12 1.251 0.01 
Scaffold attachment factor B1 Safb 1.25 0.005 
Semaphorin-4G Sema4g 1.248 0.004 
Gamma-soluble NSF attachment protein Napg 1.244 0.0057 
E3 ubiquitin-protein ligase UBR2 Ubr2 1.239 0.0154 
Ig alpha chain C region Igha 1.238 0.0174 
Plasma alpha-L-fucosidase Fuca2 1.236 0.0051 
Sorcin Sri 1.234 0.0036 
Clathrin interactor 1 Clint1 1.23 0.0153 
 Srsf11 1.227 0.0142 
UBX domain-containing protein 1 Ubxn1 1.22 0.001 
Protein cordon-bleu Cobl 1.22 0.0044 
Heterogeneous nuclear ribonucleoprotein A1 Hnrnpa1 1.218 0.0021 
E3 SUMO-protein ligase PIAS1;E3 SUMO-protein 
ligase PIAS2 
Pias1;Pias2 1.215 0.0108 
 Ppm1b 1.214 0.0019 
Arpin Arpin 1.212 0.0009 
Acyl-coenzyme A thioesterase 8 Acot8 1.209 0.0015 
Catenin delta-1 Ctnnd1 1.207 0.0006 
General transcription factor 3C polypeptide 4 Gtf3c4 1.204 0.0003 
Mannose-6-phosphate isomerase Mpi 1.2 0.0029 
U6 snRNA-associated Sm-like protein LSm2 Lsm2 1.19 0.0022 
ATP-dependent 6-phosphofructokinase;ATP-
dependent 6-phosphofructokinase, platelet type 
Pfkp 1.166 0.0001 
HEAT repeat-containing protein 5A Heatr5a -1.15 0.0003 
Vacuolar protein sorting-associated protein 33B Vps33b -1.15 0.0003 
Importin-11 Ipo11 -1.16 0.0004 
Helicase with zinc finger domain 2 Helz2 -1.16 0.0001 
Serine/threonine-protein phosphatase 2A 56 kDa 
regulatory subunit alpha isoform 
Ppp2r5a -1.16 0.0001 
Pannexin-1 Panx1 -1.16 0.0013 
Mitogen-activated protein kinase 1 Mapk1 -1.17 0.0001 
5-AMP-activated protein kinase catalytic subunit 
alpha-1 
Prkaa1 -1.17 0.0001 
Selenoprotein O Selo -1.17 0.001 
Histone-lysine N-methyltransferase EZH2 Ezh2 -1.17 0.0011 
E3 ubiquitin-protein ligase RNF31 Rnf31 -1.17 0.0016 
WD repeat-containing protein 13 Wdr13 -1.17 0.0006 
DNA-directed RNA polymerase II subunit RPB7 Polr2g -1.17 0.0012 
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Protein FAM98B Fam98b -1.17 0.0004 
Type 2 lactosamine alpha-2,3-sialyltransferase St3gal6 -1.17 0.0012 
Cytosolic Fe-S cluster assembly factor NUBP2 Nubp2 -1.17 0.0001 
Signal transducer and transcription activator 6 Stat6 -1.17 0.0019 
TBC1 domain family member 10B Tbc1d10b -1.17 0.0021 
Mitogen-activated protein kinase kinase kinase 2 Map3k2 -1.17 0.0014 
Palmitoyltransferase 
ZDHHC13;Palmitoyltransferase 
Zdhhc13 -1.17 0.0014 
NLR family CARD domain-containing protein 4 Nlrc4 -1.17 0.0021 
Zinc finger protein 622 Znf622 -1.18 0.0018 
Conserved oligomeric Golgi complex subunit 7 Cog7 -1.18 0.0004 
APOBEC1 complementation factor A1cf -1.18 0.0003 
Polypeptide N-acetylgalactosaminyltransferase 6 Galnt6 -1.18 0.0021 
Exocyst complex component 2 Exoc2 -1.18 0.0015 
Conserved oligomeric Golgi complex subunit 4 Cog4 -1.18 0.0026 
Vacuolar protein sorting-associated protein 53 
homolog 
Vps53 -1.18 0.0007 
Serine/threonine-protein kinase mTOR Mtor -1.18 0.0009 
Cytoplasmic tRNA 2-thiolation protein 2 Ctu2 -1.18 0.0008 
Vacuolar protein sorting-associated protein 51 
homolog 
Vps51 -1.18 0.0036 
X-ray repair cross-complementing protein 5 Xrcc5 -1.18 0.0017 
Anaphase-promoting complex subunit 2 Anapc2 -1.18 0.0024 
Ras-related GTP-binding protein C Rragc -1.18 0.0006 
Translocation protein SEC63 homolog Sec63 -1.18 0.0004 
THUMP domain-containing protein 3 Thumpd3 -1.19 0.0038 
39S ribosomal protein L23, mitochondrial Mrpl23 -1.19 0.0017 
Ketosamine-3-kinase Fn3krp -1.19 0.0027 
Inositol polyphosphate 1-phosphatase Inpp1 -1.19 0.0033 
GH3 domain-containing protein Ghdc -1.19 0.0022 
Protein phosphatase 1H Ppm1h -1.19 0.0002 
Interleukin enhancer-binding factor 3 Ilf3 -1.19 0.001 
Apoptosis-inducing factor 2 Aifm2 -1.19 0.0029 
Protein O-glucosyltransferase 1 Poglut1 -1.19 0.0014 
Nuclear factor NF-kappa-B p105 subunit;Nuclear 
factor NF-kappa-B p50 subunit 
Nfkb1 -1.19 0.0008 
E3 ubiquitin-protein ligase listerin Ltn1 -1.19 0.0038 
Kelch-like ECH-associated protein 1 Keap1 -1.19 0.0021 
 Brd1 -1.19 0.0041 
Patatin-like phospholipase domain-containing 
protein 2 
Pnpla2 -1.19 0.001 
Mitochondrial intermediate peptidase Mipep -1.19 0.0007 
Spermatogenesis-associated protein 5 Spata5 -1.2 0.0027 
Tubulin--tyrosine ligase-like protein 12 Ttll12 -1.2 0.0024 
3-keto-steroid reductase Hsd17b7 -1.2 0.0002 
Glycoprotein-N-acetylgalactosamine 3-beta-
galactosyltransferase 1 
C1galt1 -1.2 0.0014 
Myc-associated zinc finger protein Vezf1;Maz;Patz1 -1.2 0.0042 
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Protein-tyrosine kinase 2-beta Ptk2b -1.2 0.0013 
WD repeat and HMG-box DNA-binding protein 1 Wdhd1 -1.2 0.0031 
SWI/SNF-related matrix-associated actin-
dependent regulator of chromatin subfamily D 
member 1 
Smarcd1 -1.2 0.0002 
Ubiquitin carboxyl-terminal hydrolase;Ubiquitin 
carboxyl-terminal hydrolase 19 
Usp19 -1.2 0.0043 
Mitochondrial ribonuclease P protein 1 Trmt10c -1.2 0.0006 
Rhotekin Rtkn -1.2 0.0049 
TRMT1-like protein Trmt1l -1.2 0.007 
E2/E3 hybrid ubiquitin-protein ligase UBE2O Ube2o -1.2 0.0057 
Insulin-like growth factor 2 mRNA-binding protein 
2 
Igf2bp2 -1.2 0.0025 
N-alpha-acetyltransferase 25, NatB auxiliary 
subunit 
Naa25 -1.2 0.0034 
Sorting nexin-14 Snx14 -1.2 0.0044 
L-seryl-tRNA(Sec) kinase Pstk -1.2 0.0076 
Phosphatidylinositol 3-kinase;Phosphatidylinositol 
3-kinase catalytic subunit type 3 
Pik3c3 -1.2 0.0005 
Thioredoxin-interacting protein Txnip -1.2 0.0017 
Phosphatidylinositol transfer protein beta isoform Pitpnb -1.2 0.0009 
Uncharacterized protein C18orf8 homolog Mic1 -1.2 0.0008 
Unconventional myosin-VIIa Myo7a -1.2 0.0008 
Dynamin-1 Dnm1 -1.21 0.001 
Crooked neck-like protein 1 Crnkl1 -1.21 0.0006 
Probable ATP-dependent RNA helicase DDX47 Ddx47 -1.21 0.0012 
[Pyruvate dehydrogenase (acetyl-transferring)] 
kinase isozyme 1, mitochondrial 
Pdk1 -1.21 0.0067 
Serine/threonine-protein kinase SMG1 Smg1 -1.21 0.003 
Kinesin-like protein KIF3B;Kinesin-like protein 
KIF3B, N-terminally processed 
Kif3b -1.21 0.0022 
Myotubularin-related protein 12 Mtmr12 -1.21 0.0008 
Pentatricopeptide repeat-containing protein 2, 
mitochondrial 
Ptcd2 -1.21 0.0012 
Ubiquitin-conjugating enzyme E2 E3;Ubiquitin-
conjugating enzyme E2 E2 
Ube2e3;Ube2e2 -1.21 0.0077 
Protein FAM45A Fam45a -1.21 0.0032 
SHC-transforming protein 1 Shc1 -1.21 0.0026 
N-acetylglutamate synthase, mitochondrial;N-
acetylglutamate synthase long form;N-
acetylglutamate synthase short form;N-
acetylglutamate synthase conserved domain form 
Nags -1.21 0.0011 
Activity-dependent neuroprotector homeobox 
protein 
Adnp -1.21 0.0089 
Intron-binding protein aquarius Aqr -1.21 0.0012 
Probable proline--tRNA ligase, mitochondrial Pars2 -1.21 0.0004 
DnaJ homolog subfamily B member 14 Dnajb14 -1.21 0.0042 
Signal transducer and activator of transcription 
5B;Signal transducer and activator of 
transcription;Signal transducer and activator of 
transcription 5A 
Stat5b;Stat5a -1.21 0.0075 
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Mitogen-activated protein kinase;Mitogen-
activated protein kinase 8 
Mapk8 -1.21 0.0054 
Inhibitor of nuclear factor kappa-B kinase subunit 
alpha 
Chuk -1.21 0.0055 
Translocation protein SEC62 Sec62 -1.21 0.0032 
Choline/ethanolamine kinase Chkb -1.21 0.0026 
Selenoprotein H 
2700094K13Rik;S
elh 
-1.21 0.0005 
Cell cycle progression protein 1 Ccpg1 -1.21 0.0081 
Mimitin, mitochondrial Ndufaf2 -1.21 0.0097 
Importin-4 Ipo4 -1.21 0.0027 
 Fryl -1.21 0.0058 
Uncharacterized protein C7orf26 
homolog 
-1.21 0.003 
Serine/threonine-protein phosphatase PGAM5, 
mitochondrial 
Pgam5 -1.21 0.0084 
Poly(A) polymerase alpha Papola -1.21 0.0051 
Elongator complex protein 4 Elp4 -1.21 0.0002 
MAGUK p55 subfamily member 6 Mpp6 -1.21 0.0033 
GTP-binding protein Rheb Rheb -1.22 0.007 
UPF0505 protein C16orf62 homolog 9030624J02Rik -1.22 0.0051 
 Ttc37 -1.22 0.008 
Phospholipase DDHD1 Ddhd1 -1.22 0.0036 
Macrophage erythroblast attacher Maea -1.22 0.0006 
Mitochondrial ubiquitin ligase activator of NFKB 1 Mul1 -1.22 0.0065 
Large subunit GTPase 1 homolog Lsg1 -1.22 0.0079 
Nucleolysin TIAR Tial1 -1.22 0.0061 
Ubiquitin carboxyl-terminal hydrolase;Ubiquitin 
carboxyl-terminal hydrolase 24 
Usp24 -1.22 0.0006 
Dual specificity mitogen-activated protein kinase 
kinase 4 
Map2k4 -1.22 0.002 
Tudor domain-containing protein 7 Tdrd7 -1.22 0.0029 
Tyrosine-protein phosphatase non-receptor type 
11 
Ptpn11 -1.22 0.0049 
Exosome complex exonuclease RRP44 Dis3 -1.22 0.0075 
Fermitin family homolog 1 Fermt1 -1.22 0.0029 
RNA-binding protein 39 Rbm39 -1.22 0.0103 
Coiled-coil and C2 domain-containing protein 1A Cc2d1a -1.22 0.001 
Polypeptide N-acetylgalactosaminyltransferase 4 Galnt4 -1.22 0.002 
 Raph1 -1.22 0.0032 
Deubiquitinating protein VCIP135 Vcpip1 -1.22 0.0003 
Reticulon-3 Rtn3 -1.22 0.0035 
6-phosphofructo-2-kinase/fructose-2,6-
bisphosphatase 4;6-phosphofructo-2-
kinase;Fructose-2,6-bisphosphatase 
Pfkfb4 -1.22 0.0029 
Vacuolar protein sorting-associated protein 33A Vps33a -1.22 0.0024 
Sestrin-1 Sesn1 -1.22 0.0115 
Nucleoporin NUP188 homolog Nup188 -1.22 0.01 
 Nbeal1 -1.22 0.0076 
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Ubiquitin-conjugating enzyme E2 Q1 Ube2q1 -1.22 0.0069 
26S proteasome non-ATPase regulatory subunit 5 Psmd5 -1.22 0.0002 
LIM and cysteine-rich domains protein 1 Lmcd1 -1.22 0.0045 
Transmembrane protein 214 Tmem214 -1.22 0.0006 
Tyrosine-protein kinase STYK1 Styk1 -1.23 0.0096 
Ras-related protein Ral-A Rala -1.23 0.0073 
Diacylglycerol kinase alpha Dgka -1.23 0.0027 
Transmembrane protein 230 Tmem230 -1.23 0.008 
Protein-associating with the carboxyl-terminal 
domain of ezrin 
Scyl3 -1.23 0.0021 
SCY1-like protein 2 Scyl2 -1.23 0.0038 
Protein Hikeshi L7rn6;l7Rn6 -1.23 0.0002 
ORM1-like protein 1 Gm28778;Ormdl1 -1.23 0.0006 
Cullin-5 Cul5 -1.23 0.0061 
Ferrochelatase;Ferrochelatase, mitochondrial Fech -1.23 0.0032 
Protein FAM49B Fam49b -1.23 0.0053 
Ubiquitin carboxyl-terminal hydrolase CYLD Cyld -1.23 0.0079 
Cell death activator CIDE-B Cideb -1.23 0.0004 
Selenocysteine-specific elongation factor Eefsec -1.23 0.0115 
Serine/threonine-protein kinase TAO1 Taok1 -1.23 0.011 
DNA primase large subunit Prim2 -1.23 0.0092 
Conserved oligomeric Golgi complex subunit 6 Cog6 -1.23 0.004 
Phosphatidylinositol 4-kinase type 2-alpha Pi4k2a -1.23 0.0113 
Cyclin-T1 Ccnt1 -1.23 0.0069 
Zinc transporter 7 Slc30a7 -1.23 0.0008 
Cullin-3 Cul3 -1.23 0.0069 
Interferon-stimulated 20 kDa exonuclease-like 2 Isg20l2 -1.23 0.0064 
Leucine-rich repeat protein SHOC-2 Shoc2 -1.23 0.0121 
V-type proton ATPase subunit a;V-type proton 
ATPase 116 kDa subunit a isoform 1 
Atp6v0a1 -1.23 0.0105 
Galactose-3-O-sulfotransferase 2 
Gm6086;Gm9994
;Gal3st2 
-1.23 0.0011 
mRNA turnover protein 4 homolog Mrto4 -1.23 0.0055 
Glycogen synthase kinase-3 alpha Gsk3a -1.23 0.0017 
Signal recognition particle subunit SRP72 Srp72 -1.23 0.006 
Condensin-2 complex subunit D3 Ncapd3 -1.23 0.0093 
Tubulin-specific chaperone E Tbce -1.23 0.0028 
Polypeptide N-acetylgalactosaminyltransferase 12 Galnt12 -1.23 0.0064 
ATP-binding cassette sub-family D member 4 Abcd4 -1.23 0.0051 
Replication protein A 32 kDa subunit Rpa2 -1.23 0.0098 
ATP-dependent RNA helicase Dhx29 Dhx29 -1.23 0.0045 
Cohesin subunit SA-1 Stag1 -1.23 0.0043 
[Pyruvate dehydrogenase (acetyl-transferring)] 
kinase isozyme 3, mitochondrial 
Pdk3 -1.23 0.0035 
Nuclear RNA export factor 1 Nxf1 -1.24 0.0046 
Laminin subunit beta-1 Lamb1 -1.24 0.0069 
Choline transporter-like protein 1 Slc44a1 -1.24 0.0104 
ADP-dependent glucokinase Adpgk -1.24 0.0002 
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Active breakpoint cluster region-related protein Abr -1.24 0.0053 
Cytoplasmic dynein 1 light intermediate chain 2 Dync1li2 -1.24 0.0157 
Nuclear receptor subfamily 2 group F member 6 Nr2f6 -1.24 0.0132 
Ribosomal protein S6 kinase alpha-3 Rps6ka3 -1.24 0.0109 
 Gtf3c3 -1.24 0.0006 
Serine/threonine-protein kinase ULK3 Ulk3 -1.24 0.0116 
CXXC-type zinc finger protein 1 Cxxc1 -1.24 0.01 
ER membrane protein complex subunit 3 Emc3 -1.24 0.0045 
Histone acetyltransferase KAT8 Kat8 -1.24 0.0019 
Mothers against decapentaplegic 
homolog;Mothers against decapentaplegic 
homolog 1;Mothers against decapentaplegic 
homolog 5 
Smad1;Smad5 -1.24 0.0058 
 Ncapg -1.24 0.0132 
CCR4-NOT transcription complex subunit 10 Cnot10 -1.24 0.0082 
Vacuolar protein sorting-associated protein 52 
homolog 
Vps52 -1.24 0.0039 
Cytochrome c oxidase subunit 7A-related protein, 
mitochondrial 
Cox7a2l -1.24 0.0102 
Interferon-induced very large GTPase 1 Gvin1 -1.24 0.0143 
FSD1-like protein Fsd1l -1.24 0.0109 
Exocyst complex component 4 Exoc4 -1.24 0.0051 
Transcriptional adapter 1 Tada1 -1.24 0.0019 
Pyrroline-5-carboxylate reductase 2 Pycr2 -1.24 0.004 
Metastasis-associated protein MTA3 Mta3 -1.24 0.0079 
ATP-dependent RNA helicase DDX51 Ddx51 -1.24 0.011 
Pre-mRNA-splicing factor CWC22 homolog 
Cwc22;Gm13695;
Gm13697 
-1.24 0.0022 
DEP domain-containing mTOR-interacting protein Deptor -1.24 0.005 
 Gcn1l1 -1.24 0.0113 
Retinoblastoma-associated protein Rb1 -1.24 0.0053 
Serine/threonine-protein 
phosphatase;Serine/threonine-protein 
phosphatase 2B catalytic subunit beta isoform 
Ppp3cb -1.24 0.0027 
Poly(rC)-binding protein 2 Pcbp2 -1.24 0.0053 
tRNA pseudouridine synthase-like 1 Pusl1 -1.24 0.003 
Cullin-4A Cul4a -1.24 0.0048 
Prostaglandin G/H synthase 1 Ptgs1 -1.24 0.0021 
40S ribosomal protein S27-like;40S ribosomal 
protein S27 
Rps27l -1.24 0.0136 
Eukaryotic translation initiation factor 4E type 2 Eif4e2 -1.24 0.0002 
Leukocyte surface antigen CD47 Cd47 -1.24 0.0057 
Protein RMD5 homolog A Rmnd5a -1.24 0.0162 
Signal transducer and activator of transcription 
3;Signal transducer and activator of transcription 
Stat3 -1.24 0.0033 
Tripartite motif-containing protein 14 Trim14 -1.24 0.0031 
Casein kinase I isoform gamma-1 Csnk1g1 -1.25 0.0021 
Vacuolar protein-sorting-associated protein 36 Vps36 -1.25 0.0021 
299 
 
Phosphatidylinositol 5-phosphate 4-kinase type-2 
beta 
Pip4k2b -1.25 0.0133 
CWF19-like protein 1 Cwf19l1 -1.25 0.0049 
Calcium/calmodulin-dependent protein kinase 
type II subunit delta 
Camk2d -1.25 0.0166 
28S ribosomal protein S24, mitochondrial Mrps24 -1.25 0.0021 
Leucine-rich repeat-containing protein 40 Lrrc40 -1.25 0.0061 
Guanylate-binding protein 4 Gbp4 -1.25 0.0039 
Importin-7 Ipo7 -1.25 0.0022 
Corticosteroid 11-beta-dehydrogenase isozyme 2 Hsd11b2 -1.25 0.0028 
Coiled-coil domain-containing protein 167 Ccdc167 -1.25 0.0045 
Pancreatic lipase-related protein 2 Pnliprp2 -1.25 0.02 
Eukaryotic translation initiation factor 3 subunit L Eif3l -1.25 0.0183 
Structural maintenance of chromosomes protein 2 Smc2 -1.25 0.0131 
Methyltransferase-like protein 13 Mettl13 -1.25 0.0003 
Serine hydrolase-like protein Serhl -1.25 0.0138 
MAP kinase-activated protein kinase 3 Mapkapk3 -1.25 0.0115 
Integrator complex subunit 5 Ints5 -1.25 0.0058 
Mitochondrial Rho GTPase 1 Rhot1 -1.25 0.0136 
Interferon-inducible double-stranded RNA-
dependent protein kinase activator A 
Prkra -1.25 0.0222 
E3 ubiquitin-protein ligase UBR5 Ubr5 -1.25 0.0045 
Rho guanine nucleotide exchange factor 2 Arhgef2 -1.25 0.0013 
Signal recognition particle subunit SRP68 Srp68 -1.26 0.0023 
Inhibitor of nuclear factor kappa-B kinase subunit 
beta 
Ikbkb -1.26 0.0055 
RWD domain-containing protein 2B Rwdd2b -1.26 0.0052 
Talin-2 Tln2 -1.26 0.0193 
Sphingomyelin phosphodiesterase 4 Smpd4 -1.26 0.0005 
E3 ubiquitin-protein ligase MARCH5 38412 -1.26 0.018 
Putative ribosome-binding factor A, mitochondrial Rbfa -1.26 0.0163 
Membrane magnesium transporter 1 Mmgt1 -1.26 0.0038 
DNA mismatch repair protein Msh6 Msh6 -1.26 0.012 
Ribosomal protein S6 kinase;Ribosomal protein S6 
kinase alpha-1 
Rps6ka1 -1.26 0.0067 
Breast carcinoma-amplified sequence 3 homolog Bcas3 -1.26 0.0177 
E3 ubiquitin-protein ligase RNF128 Rnf128 -1.26 0.0117 
DENN domain-containing protein 3 Dennd3 -1.26 0.0198 
Pantothenate kinase 3 Pank3 -1.26 0.0114 
YTH domain-containing family protein 1 Ythdf1 -1.26 0.0136 
DNA polymerase delta catalytic subunit;DNA 
polymerase 
Pold1 -1.26 0.0082 
Glycogen synthase kinase-3 beta Gsk3b -1.26 0.0067 
Katanin p60 ATPase-containing subunit A1 Katna1 -1.26 0.0231 
Golgi to ER traffic protein 4 homolog Get4 -1.26 0.0139 
AP-3 complex subunit beta-1 Ap3b1 -1.26 0.0083 
L-aminoadipate-semialdehyde dehydrogenase-
phosphopantetheinyl transferase 
Aasdhppt -1.26 0.0015 
Glutamine-rich protein 1 Qrich1 -1.26 0.0032 
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Apoptosis-resistant E3 ubiquitin protein ligase 1 Arel1 -1.26 0.0099 
Tensin-3 Tns3 -1.26 0.0003 
DNA repair protein complementing XP-C cells 
homolog 
Xpc -1.26 0.0243 
Peroxisomal membrane protein PEX16 Pex16 -1.26 0.0069 
Syntaxin-binding protein 1 Stxbp1 -1.26 0.016 
Syntaxin-binding protein 5 Stxbp5 -1.26 0.0049 
Coatomer subunit gamma-2 Copg2 -1.26 0.0163 
Histone deacetylase;Histone deacetylase 3 Hdac3 -1.26 0.0212 
Serine/threonine-protein kinase N1 Pkn1 -1.26 0.0028 
60S ribosomal export protein NMD3 Nmd3 -1.26 0.001 
ADP-ribosylation factor 4 Arf4 -1.26 0.017 
Activating signal cointegrator 1 complex subunit 3 Ascc3 -1.26 0.0028 
Protein SCO2 homolog, mitochondrial Sco2 -1.26 0.0098 
Copine-1 Cpne1 -1.26 0.0087 
Phospholipid-transporting ATPase Atp11b -1.26 0.0017 
Probable ATP-dependent RNA helicase DDX41 Ddx41 -1.26 0.0019 
Chloride intracellular channel protein 4 Clic4 -1.26 0.0008 
E3 ubiquitin-protein ligase Itchy Itch -1.26 0.0126 
Uridine 5-monophosphate synthase;Orotate 
phosphoribosyltransferase;Orotidine 5-phosphate 
decarboxylase 
Umps -1.27 0.0034 
DENN domain-containing protein 1B Dennd1b -1.27 0.0166 
BRO1 domain-containing protein BROX Brox -1.27 0.0028 
Condensin complex subunit 1 Ncapd2 -1.27 0.0247 
Polypeptide N-acetylgalactosaminyltransferase 
2;Polypeptide N-acetylgalactosaminyltransferase 2 
soluble form 
Galnt2 -1.27 0.0006 
Interleukin enhancer-binding factor 2 Ilf2 -1.27 0.0009 
Pancreatic secretory granule membrane major 
glycoprotein GP2 
Gp2 -1.27 0.0197 
Nucleolar GTP-binding protein 1 Gtpbp4 -1.27 0.0171 
ATP-binding cassette sub-family F member 3 Abcf3 -1.27 0.0037 
Cytokine receptor-like factor 3 Crlf3 -1.27 0.0084 
DENN domain-containing protein 2D Dennd2d -1.27 0.0052 
Exocyst complex component 3 Exoc3 -1.27 0.0004 
Required for meiotic nuclear division protein 1 
homolog 
Rmnd1 -1.27 0.0162 
N-alpha-acetyltransferase 16, NatA auxiliary 
subunit 
Naa16 -1.27 0.0097 
 Trim12c;Trim5 -1.27 0.0032 
Elongation factor 1-alpha 1 Eef1a1 -1.27 0.0144 
Putative glutathione-specific gamma-
glutamylcyclotransferase 2 
Chac2 -1.27 0.0074 
Hepatocyte nuclear factor 4-alpha Hnf4a -1.27 0.008 
Elongator complex protein 3 Elp3 -1.27 0.0116 
E3 ubiquitin-protein ligase AMFR Amfr -1.27 0.0005 
ADP-ribosylation factor-like protein 2 Arl2 -1.27 0.0117 
GPI-anchor transamidase Pigk -1.27 0.006 
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Tyrosine-protein phosphatase non-receptor type 6 Ptpn6 -1.27 0.0124 
ATP-binding cassette sub-family E member 1 Abce1 -1.28 0.017 
 Bcl2l15 -1.28 0.0165 
Protein misato homolog 1 Msto1 -1.28 0.0072 
 Arhgef5 -1.28 0.0162 
Eukaryotic initiation factor 4A-I Eif4a1 -1.28 0.0103 
Protein diaphanous homolog 2 Diap2;Diaph2 -1.28 0.0079 
Putative pre-mRNA-splicing factor ATP-dependent 
RNA helicase DHX32 
Dhx32 -1.28 0.007 
Protein DENND6A Dennd6a -1.28 0.002 
X-ray repair cross-complementing protein 6 Xrcc6 -1.28 0.0128 
Dual specificity mitogen-activated protein kinase 
kinase 6 
Map2k6 -1.28 0.0131 
Rhophilin-2 Rhpn2 -1.28 0.0126 
Complement C3 C3 -1.28 0.0258 
PAB-dependent poly(A)-specific ribonuclease 
subunit PAN3 
Pan3 -1.28 0.0113 
Dimethylaniline monooxygenase [N-oxide-forming] 
2 
Fmo2 -1.28 0.0134 
Protein lifeguard 3 Tmbim1 -1.28 0.0213 
Methyltransferase-like protein 17, mitochondrial Mettl17 -1.28 0.0162 
Myotubularin-related protein 9 Mtmr9 -1.28 0.0238 
Uncharacterized protein KIAA2013 Kiaa2013 -1.28 0.0007 
Beta-adrenergic receptor kinase 1 Adrbk1 -1.28 0.0019 
Integrin-linked protein kinase Ilk -1.28 0.0204 
Transmembrane protein 126A Tmem126a -1.28 0.0157 
TraB domain-containing protein Trabd -1.28 0.0005 
Mini-chromosome maintenance complex-binding 
protein 
Mcmbp -1.28 0.0018 
GPN-loop GTPase 3 Gpn3 -1.28 0.0099 
WASH complex subunit 7 Kiaa1033 -1.28 0.005 
Endoplasmic reticulum-Golgi intermediate 
compartment protein 1 
Ergic1 -1.28 0.0162 
RAF proto-oncogene serine/threonine-protein 
kinase 
Raf1 -1.28 0.0149 
ADP-ribosylation factor-like protein 1 Arl1 -1.28 0.0084 
Glucocorticoid receptor Nr3c1 -1.28 0.0069 
Developmentally-regulated GTP-binding protein 2 Drg2 -1.28 0.0189 
LIM domain kinase 2 Limk2 -1.29 0.0186 
Translation initiation factor eIF-2B subunit alpha Eif2b1 -1.29 0.0007 
Casein kinase I isoform delta;Casein kinase I 
isoform epsilon 
Csnk1d;Csnk1e -1.29 0.0118 
Probable ergosterol biosynthetic protein 28 
ORF11;0610007P
14Rik 
-1.29 0.0236 
Complex I assembly factor TIMMDC1, 
mitochondrial 
Timmdc1 -1.29 0.0255 
Vacuolar protein sorting-associated protein 16 
homolog 
Vps16 -1.29 0.0079 
Activating signal cointegrator 1 complex subunit 1 Ascc1 -1.29 0.0033 
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Replication protein A 70 kDa DNA-binding 
subunit;Replication protein A 70 kDa DNA-binding 
subunit, N-terminally processed 
Rpa1 -1.29 0.004 
39S ribosomal protein L16, mitochondrial Mrpl16 -1.29 0.0024 
Transmembrane protein 70, mitochondrial Tmem70 -1.29 0.0067 
Uridine-cytidine kinase 2 Uck2 -1.29 0.0083 
Inter-alpha-trypsin inhibitor heavy chain H5 Itih5 -1.29 0.0092 
DNA replication licensing factor MCM3 Mcm3 -1.29 0.0267 
Poly [ADP-ribose] polymerase 12 Parp12 -1.29 0.0158 
Junction-mediating and -regulatory protein Jmy -1.29 0.0096 
Cell division cycle protein 16 homolog Cdc16 -1.29 0.001 
 Dhx37 -1.29 0.0211 
Death-associated protein kinase 3 Dapk3 -1.29 0.0038 
Histone-lysine N-methyltransferase setd3 Setd3 -1.29 0.005 
C-Maf-inducing protein Cmip -1.29 0.0004 
Serine/threonine-protein kinase Chk2 Chek2 -1.29 0.02 
Mitogen-activated protein kinase 13 Mapk13 -1.29 0.0006 
Rho guanine nucleotide exchange factor 1 Arhgef1 -1.29 0.0052 
AP2-associated protein kinase 1 Aak1 -1.29 0.0003 
Transmembrane protein 258 Tmem258 -1.29 0.0022 
Structural maintenance of chromosomes 
protein;Structural maintenance of chromosomes 
protein 4 
Smc4 -1.29 0.0192 
 Gbp7 -1.29 0.0272 
Proteasome inhibitor PI31 subunit Psmf1 -1.3 0.026 
Cytochrome c oxidase assembly protein COX15 
homolog 
Cox15 -1.3 0.0026 
Importin-9 Ipo9 -1.3 0.0063 
Kinesin-like protein;Kinesin-like protein KIF2A Kif2a -1.3 0.0032 
ADP-ribosylation factor-like protein 8A Arl8a -1.3 0.003 
Helicase-like transcription factor Hltf -1.3 0.0022 
Mitochondrial fission 1 protein Fis1 -1.3 0.0019 
Hexokinase;Hexokinase-1 Hk1 -1.3 0.0279 
Exportin-2 Cse1l -1.3 0.0025 
Growth factor receptor-bound protein 7 Grb7 -1.3 0.0159 
Protein O-linked-mannose beta-1,4-N-
acetylglucosaminyltransferase 2 
Pomgnt2 -1.3 0.0124 
Myosin-9 Myh9 -1.3 0.0182 
Inactive phospholipase C-like protein 2 Plcl2 -1.3 0.0007 
Mitogen-activated protein kinase kinase kinase 4 Map3k4 -1.3 0.0019 
Golgin-45 Blzf1 -1.3 0.0174 
Rap guanine nucleotide exchange factor 2 Rapgef2 -1.3 0.0024 
DNA replication licensing factor MCM4 Mcm4 -1.31 0.0118 
Bromodomain adjacent to zinc finger domain 
protein 2A 
Baz2a -1.31 0.006 
Protein FAM83F Fam83f -1.31 0.0238 
Oxysterol-binding protein-related protein 2 Osbpl2 -1.31 0.0019 
DNA-dependent protein kinase catalytic subunit Prkdc -1.31 0.0234 
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Golgi integral membrane protein 4 Golim4 -1.31 0.0065 
Amino acid transporter;Neutral amino acid 
transporter B(0) 
Slc1a5 -1.31 0.0244 
Cyclin-dependent kinase 7 Cdk7 -1.31 0.0182 
Peroxisomal membrane protein PEX13 Pex13 -1.31 0.0062 
Serine/threonine-protein kinase WNK2 Wnk2 -1.31 0.0011 
Inositol-trisphosphate 3-kinase C Itpkc -1.31 0.0085 
60S ribosomal protein L10;60S ribosomal protein 
L10-like 
Rpl10;Rpl10l -1.31 0.0335 
Calpain-2 catalytic subunit Capn2 -1.31 0.0033 
DNA replication licensing factor MCM2 Mcm2 -1.31 0.0214 
Zinc finger MYND domain-containing protein 11 Zmynd11 -1.31 0.0371 
Transient receptor potential cation channel 
subfamily M member 7 
Trpm7 -1.31 0.0128 
60S ribosomal protein L23 Rpl23 -1.31 0.0113 
Ubiquitin-protein ligase E3C Ube3c -1.31 0.0015 
rRNA methyltransferase 3, mitochondrial Rnmtl1 -1.31 0.0181 
TAF5-like RNA polymerase II p300/CBP-associated 
factor-associated factor 65 kDa subunit 5L 
Taf5l -1.31 0.0154 
Heterochromatin protein 1-binding protein 3 Hp1bp3 -1.31 0.0254 
Protein spinster homolog 1 Spns1 -1.31 0.0364 
Unconventional myosin-Ie Myo1e -1.32 0.009 
Rab-like protein 6 Rabl6 -1.32 0.0005 
 Hp1bp3 -1.32 0.024 
Vesicle transport protein GOT1B Golt1b -1.32 0.0261 
Myotubularin-related protein 7 Mtmr7 -1.32 0.0002 
Replication factor C subunit 2 Rfc2 -1.32 0.0033 
Ribosomal protein L19;60S ribosomal protein L19 Rpl19 -1.32 0.015 
Nucleolar GTP-binding protein 2 Gnl2 -1.32 0.015 
Sorting nexin;Sorting nexin-18 Snx18 -1.32 0.0191 
Inositol polyphosphate multikinase Ipmk -1.32 0.0015 
DNA primase small subunit;DNA primase Prim1 -1.32 0.0163 
Asparagine synthetase [glutamine-hydrolyzing] Asns -1.32 0.027 
Coiled-coil domain-containing protein 61 Ccdc61 -1.32 0.0006 
Septin-1 37135 -1.32 0.0062 
ATP-dependent RNA helicase DDX19A Ddx19a -1.32 0.0126 
Sigma non-opioid intracellular receptor 1 Sigmar1 -1.32 0.0124 
Cleft lip and palate transmembrane protein 1 
homolog 
Clptm1 -1.32 0.0221 
NEDD4-like E3 ubiquitin-protein ligase WWP1 Wwp1 -1.32 0.0012 
NADH dehydrogenase [ubiquinone] 1 alpha 
subcomplex subunit 6 
Ndufa6 -1.33 0.0222 
Phosphatidylinositol glycan anchor biosynthesis 
class U protein 
Pigu -1.33 0.0319 
Band 4.1-like protein 5 Epb41l5 -1.33 0.0002 
DNA mismatch repair protein Msh2 Msh2 -1.33 0.0109 
Nuclear factor 1;Nuclear factor 1 B-type Nfib -1.33 0.0158 
N-alpha-acetyltransferase 40 Naa40 -1.33 0.016 
Aurora kinase A-interacting protein Aurkaip1 -1.33 0.0041 
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Cyclin-dependent kinase 2 Cdk2 -1.33 0.0023 
Phosphoinositide 3-kinase regulatory subunit 4 Pik3r4 -1.33 0.0143 
Surfeit locus protein 1 Surf1 -1.33 0.0141 
Protein PAT1 homolog 1 Patl1 -1.33 0.0006 
Zinc transporter 5 Slc30a5 -1.33 0.0406 
Serine/threonine-protein kinase STK11 Stk11 -1.33 0.0164 
Vesicle-associated membrane protein 7 Vamp7 -1.33 0.0395 
Phosphatidate cytidylyltransferase 1 Cds1 -1.33 0.0168 
Annexin A6 Anxa6 -1.33 0.0133 
Thioredoxin-related transmembrane protein 2 Tmx2 -1.34 0.0041 
NADH dehydrogenase [ubiquinone] 1 beta 
subcomplex subunit 4 
Ndufb4 -1.34 0.0404 
Mitochondrial ribosome-associated GTPase 1 Mtg1 -1.34 0.0026 
Putative RNA polymerase II subunit B1 CTD 
phosphatase Rpap2 
Rpap2 -1.34 0.0073 
Signal transducer and activator of transcription Stat1 -1.34 0.0285 
CAD protein;Glutamine-dependent carbamoyl-
phosphate synthase;Aspartate 
carbamoyltransferase;Dihydroorotase 
Cad -1.34 0.0448 
Zinc finger protein 512 Znf512 -1.34 0.005 
Lanosterol 14-alpha demethylase Cyp51a1 -1.34 0.0023 
HEAT repeat-containing protein 3 Heatr3 -1.34 0.0163 
Serine/threonine-protein kinase 38 Stk38 -1.34 0.0075 
15-hydroxyprostaglandin dehydrogenase [NAD(+)] Hpgd -1.34 0.0298 
Methylsterol monooxygenase 1 Msmo1 -1.34 0.0259 
40S ribosomal protein S9 Rps9 -1.35 0.0162 
Probable ATP-dependent RNA helicase DDX17 Ddx17 -1.35 0.0048 
Vitamin K epoxide reductase complex subunit 1-
like protein 1 
Vkorc1l1 -1.35 0.042 
DNA ligase;DNA ligase 1 Lig1 -1.35 0.0205 
Metalloendopeptidase OMA1, mitochondrial Oma1 -1.35 0.0174 
Extended synaptotagmin-1 Esyt1 -1.35 0.0056 
 Dab1 -1.35 0.0003 
 Serpinb9 -1.35 0.0441 
Probable U3 small nucleolar RNA-associated 
protein 11 
Utp11l -1.35 0.0236 
Protein zwilch homolog Zwilch -1.35 0.0124 
Prohibitin-2 Phb2 -1.35 0.0434 
Transmembrane protein 135 Tmem135 -1.35 0.0177 
Eosinophil peroxidase;Eosinophil peroxidase light 
chain;Eosinophil peroxidase heavy chain 
Epx -1.35 0.043 
Polynucleotide 5-hydroxyl-kinase NOL9 Nol9 -1.35 0.0006 
Peroxisomal biogenesis factor 3 Pex3 -1.35 0.0323 
Diphthamide biosynthesis protein 2 Dph2 -1.36 0.0069 
SPATS2-like protein Spats2l -1.36 0.0093 
Fermitin family homolog 2 Fermt2 -1.36 0.0412 
Solute carrier family 52, riboflavin transporter, 
member 3 
Slc52a3 -1.36 0.0204 
DNA polymerase alpha catalytic subunit Pola1 -1.36 0.016 
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ATP-binding cassette sub-family F member 2 Abcf2 -1.36 0.0076 
Mitochondrial import inner membrane translocase 
subunit Tim23 
Timm23 -1.36 0.0115 
Importin-8 Ipo8 -1.36 0.0029 
Exportin-5 Xpo5 -1.36 0.0046 
Chromodomain-helicase-DNA-binding protein 
8;Chromodomain-helicase-DNA-binding protein 9 
Chd8;Chd9 -1.36 0.009 
Fibronectin;Anastellin Fn1 -1.36 0.0296 
CDP-diacylglycerol--inositol 3-
phosphatidyltransferase 
Cdipt -1.36 0.0422 
CAAX prenyl protease 1 homolog Zmpste24 -1.36 0.037 
Protein Niban Fam129a -1.36 0.0006 
Ubiquitin-conjugating enzyme E2 J2 Ube2j2 -1.36 0.036 
Anoctamin-10 Ano10 -1.36 0.0286 
Protein RER1 Rer1 -1.36 0.0345 
Oxysterol-binding protein;Oxysterol-binding 
protein-related protein 11 
Osbpl11 -1.37 0.0099 
Serine/threonine-protein kinase MRCK gamma Cdc42bpg -1.37 0.0051 
 Inpp5a -1.37 0.0018 
 Mettl7a1 -1.37 0.0253 
Uncharacterized protein C1orf43 homolog 4933434E20Rik -1.37 0.0015 
Mitochondrial import receptor subunit TOM40 
homolog 
Tomm40 -1.37 0.0269 
 Myl10 -1.37 0.0302 
GTPase IMAP family member 8 Gimap8 -1.37 0.023 
Serine/threonine-protein kinase 17B Stk17b -1.37 0.0234 
Cytochrome P450 20A1 Cyp20a1 -1.37 0.0033 
DNA replication licensing factor MCM7 Mcm7 -1.37 0.0133 
Histidine triad nucleotide-binding protein 3 Hint3 -1.38 0.0286 
Ras-related protein Rab-19 Rab19 -1.38 0.0103 
Antigen peptide transporter 1 Tap1 -1.38 0.0317 
60S ribosomal protein L13a Rpl13a -1.38 0.0045 
WW domain-binding protein 2 Wbp2 -1.38 0.0234 
Rho GTPase-activating protein 35 Arhgap35 -1.38 0.0245 
Neutrophil cytosol factor 1 Ncf1 -1.38 0.0274 
Cyclin-dependent kinase 1 Cdk1 -1.38 0.0051 
Peroxisomal membrane protein 11B Pex11b -1.38 0.0146 
Mimecan Ogn -1.38 0.0121 
Eukaryotic initiation factor 4A-II; Eif4a2 -1.39 0.0158 
Methyltransferase-like protein 16 Mettl16 -1.39 0.0012 
Kinetochore-associated protein 1 Kntc1 -1.39 0.0348 
Probable 18S rRNA (guanine-N(7))-
methyltransferase 
Wbscr22 -1.39 0.0066 
Exportin-1 Xpo1 -1.39 0.0109 
Protein jagunal homolog 1 Jagn1 -1.39 0.0016 
Tyrosine-protein phosphatase non-receptor type 2 Ptpn2 -1.39 0.0428 
DnaJ homolog subfamily C member 11 Dnajc11 -1.39 0.0119 
Lymphokine-activated killer T-cell-originated 
protein kinase 
Pbk -1.39 0.006 
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Twinfilin-2 Twf2 -1.39 0.0325 
PX domain-containing protein kinase-like protein Pxk -1.39 0.0029 
 Slfn9 -1.39 0.0254 
Collagen alpha-1(XIV) chain Col14a1 -1.39 0.0083 
 Mkrn2os -1.39 0.0043 
Translocating chain-associated membrane protein 
1 
Tram1 -1.4 0.049 
Ceramide synthase 5 Cers5 -1.4 0.0027 
Dynamin-2 Dnm2 -1.4 0.0073 
L-lactate dehydrogenase;L-lactate dehydrogenase 
B chain 
Ldhb -1.41 0.0101 
Protein FAM210B Fam210b -1.41 0.0215 
Glomulin Glmn -1.41 0.0037 
Lymphocyte-specific helicase Hells -1.41 0.0089 
DNA polymerase alpha subunit B Pola2 -1.41 0.0051 
Developmentally-regulated GTP-binding protein 1 Drg1 -1.41 0.0048 
Transmembrane protein 194A 
Tmem194;Tmem1
94a 
-1.41 0.04 
Dolichyl-diphosphooligosaccharide--protein 
glycosyltransferase subunit STT3B 
Stt3b -1.41 0.0283 
B-cell receptor-associated protein 29 Bcap29 -1.41 0.044 
Tenascin Tnc -1.42 0.0077 
Zinc finger FYVE domain-containing protein 16 Zfyve16 -1.42 0.0043 
Ribosome production factor 2 homolog Rpf2 -1.42 0.0471 
Interferon regulatory factor 8 Irf8 -1.43 0.0277 
Histone acetyltransferase type B catalytic subunit Hat1 -1.43 0.0051 
Nucleoporin NDC1 Ndc1 -1.43 0.0157 
Peroxisomal membrane protein 11C Pex11g -1.43 0.0422 
E3 ubiquitin-protein ligase NEDD4 Nedd4 -1.43 0.006 
Transmembrane protein 165 Tmem165 -1.43 0.0038 
Alpha-1,6-mannosyl-glycoprotein 2-beta-N-
acetylglucosaminyltransferase 
Mgat2 -1.43 0.0276 
GTPase IMAP family member 1 Gimap1 -1.44 0.0158 
Ribonucleoside-diphosphate reductase large 
subunit 
Rrm1 -1.44 0.0176 
Acylglycerol kinase, mitochondrial Agk -1.44 0.0135 
Chromodomain-helicase-DNA-binding protein 5 Chd5 -1.45 0.0129 
 2010107G12Rik -1.45 0.0494 
Sorting and assembly machinery component 50 
homolog 
Samm50 -1.45 0.0217 
ATP-dependent RNA helicase DDX3Y Ddx3y -1.46 0.0044 
Myosin-10 Myh10 -1.46 0.0138 
N-acylneuraminate-9-phosphatase Nanp -1.47 0.0063 
Transmembrane emp24 domain-containing protein 
11 
Tmed11 -1.47 0.0143 
Transmembrane protein 161B Tmem161b -1.47 0.0253 
Glutamyl-tRNA(Gln) amidotransferase subunit C, 
mitochondrial 
Gatc -1.47 0.0007 
 Pank2 -1.47 0.0001 
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Transforming growth factor-beta-induced protein 
ig-h3 
Tgfbi -1.47 0.0359 
G protein-coupled receptor kinase 6 Grk6 -1.48 0.0044 
Protein crumbs homolog 3 Crb3 -1.48 0.0098 
Biglycan Bgn -1.48 0.0001 
Transmembrane protein 205 Tmem205 -1.49 0.0413 
Fermitin family homolog 3 Fermt3 -1.49 0.0076 
Myristoylated alanine-rich C-kinase substrate Marcks -1.5 0.0301 
Phosphatidate cytidylyltransferase;Phosphatidate 
cytidylyltransferase 2 
Cds2 -1.5 0.0222 
Collagen alpha-1(XII) chain Col12a1 -1.5 0.0177 
Ras association domain-containing protein 2 Rassf2 -1.5 0.009 
Plasminogen receptor (KT) Plgrkt -1.51 0.0192 
2-phosphoxylose phosphatase 1 Pxylp1 -1.51 0.0234 
 Urb2 -1.52 0.0206 
Sterol O-acyltransferase 2 Soat2 -1.52 0.0356 
Phospholipid scramblase 3 Plscr3 -1.53 0.0038 
Dynein heavy chain 17, axonemal Dnah17 -1.55 0.0278 
Sterol O-acyltransferase 1 Soat1 -1.55 0.0267 
Laminin subunit gamma-1 Lamc1 -1.55 0.0419 
GDP-fucose transporter 1 Slc35c1 -1.55 0.0305 
Transmembrane protein 143 Tmem143 -1.55 0.0277 
 Ctrl -1.56 0.0117 
RNA-binding protein PNO1 Pno1 -1.56 0.0323 
Mitotic spindle assembly checkpoint protein 
MAD2A 
Mad2l1 -1.57 0.0232 
Calcium/calmodulin-dependent protein kinase 
type II subunit gamma 
Camk2g -1.57 0.0116 
Interferon-induced guanylate-binding protein 2 Gbp2 -1.58 0.0304 
Thymidine kinase, cytosolic Tk1 -1.58 0.007 
Very-long-chain (3R)-3-hydroxyacyl-CoA 
dehydratase 2 
Hacd2 -1.58 0.0214 
5-phosphohydroxy-L-lysine phospho-lyase Phykpl -1.59 0.0293 
Basement membrane-specific heparan sulfate 
proteoglycan core protein;Endorepellin;LG3 
peptide 
Hspg2 -1.59 0.0007 
Guanine nucleotide-binding protein G(o) subunit 
alpha 
Gnao1 -1.59 0.0033 
Pancreatic triacylglycerol lipase Pnlip -1.62 0.0488 
CMP-sialic acid transporter Slc35a1 -1.62 0.041 
Leiomodin-1 Lmod1 -1.62 0.0451 
Non-specific serine/threonine protein 
kinase;Serine/threonine-protein kinase MRCK 
alpha 
Cdc42bpa -1.62 0.0198 
Ubiquitin-protein ligase E3B Ube3b -1.63 0.0044 
Colipase Clps -1.65 0.0063 
Organic solute transporter subunit beta Slc51b -1.65 0.0074 
Brain acid soluble protein 1 Basp1 -1.66 0.0114 
Microfibril-associated glycoprotein 4 Mfap4 -1.67 0.0367 
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 2210010C04Rik -1.69 0.0045 
ATP synthase subunit e, mitochondrial Atp5i;Atp5k -1.7 0.0077 
NUAK family SNF1-like kinase 2 Nuak2 -1.7 0.0188 
Poly(A) RNA polymerase GLD2 Papd4 -1.7 0.0004 
Laminin subunit alpha-5 Lama5 -1.7 0.0421 
5-nucleotidase Nt5e -1.73 0.0222 
Adenosine 3-phospho 5-phosphosulfate 
transporter 1 
Slc35b2 -1.74 0.046 
Sodium-dependent phosphate transport protein 
2B 
Slc34a2 -1.74 0.0336 
Interferon-induced guanylate-binding protein 1 Gbp1;Gbp2b -1.76 0.0131 
 Gimap7 -1.76 0.0497 
Collagen alpha-2(VI) chain Col6a2 -1.8 0.0266 
Collagen alpha-4(VI) chain Col6a4 -1.83 0.0058 
 Actn1 -1.87 0.0404 
Chymotrypsin-like elastase family member 1 Cela1 -1.9 0.0468 
 Tns1 -1.91 0.0185 
Bile salt-activated lipase Cel -1.96 0.0017 
Endoplasmic reticulum resident protein 27 Erp27 -2.05 0.0209 
Cystathionine beta-synthase Cbs -2.11 0.0139 
Collagen alpha-1(VI) chain Col6a1 -2.15 0.0359 
Peptidyl-prolyl cis-trans isomerase FKBP11 Fkbp11 -2.16 0.0001 
carboxypeptidase B1 Cpb1 -2.17 0.0204 
Tropomyosin alpha-1 chain Tpm1 -2.22 0.0309 
Protein disulfide-isomerase A2 Pdia2 -2.29 0.0133 
Tubulointerstitial nephritis antigen-like Tinagl1 -2.4 0.0418 
collagen type VI alpha 3 chain Col6a3 -2.55 0.007 
Tropomodulin-1 Tmod1 -2.55 0.0198 
Myosin heavy chain 11 Myh11 -2.58 0.005 
Carboxypeptidase A1 Cpa1 -3.4 0.0141 
Otolin-1 Otol1 -4.16 0.0162 
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Appendix 5: Proteins that are exclusively changed in regulation in LPS-treated       
Nfҡb1-/- compared with LPS-treated C57BL/6J small intestinal mucosa (excluding 
significant changes between Nfҡb1-/- and C57BL/6J at baseline) 
Protein names Gene names 
Regulation 
fold 
changes 
P value 
Solute carrier family 35 member B1 Slc35b1 7.642 0.0034 
NADH-ubiquinone oxidoreductase chain 5 Mtnd5 3.766 0.0301 
NADH:ubiquinone oxidoreductase core subunit S1 Ndufs1 3.546 0.0005 
85/88 kDa calcium-independent phospholipase A2 Pla2g6 3.246 0.0002 
Protein transport protein Sec61 subunit gamma Sec61g 3.158 0.0007 
Oligosaccharyltransferase complex subunit OSTC Ostc 3.012 0.0442 
Apolipoprotein C-I;Truncated apolipoprotein C-I Apoc1 2.749 0.0042 
ATP synthase subunit e, mitochondrial Atp5i;Atp5k 2.615 0.0005 
interferon gamma induced GTPase Igtp 2.526 0.0014 
DNA-dependent protein kinase catalytic subunit Prkdc 2.488 0.0005 
Keratin, type II cytoskeletal 2 oral Krt76 2.456 0.0384 
 Cpb1 2.415 0.048 
 Irgm2 2.308 0.0039 
Dynein light chain 1, cytoplasmic Dynll1;BC048507 2.304 0.0002 
NADH-ubiquinone oxidoreductase chain 2 Mtnd2 2.286 0.0228 
Krueppel-like factor 5 Klf5 2.273 0.0029 
Hydroxymethylglutaryl-CoA synthase, cytoplasmic Hmgcs1 2.258 0.0028 
Transmembrane emp24 domain-containing protein 
3 
Tmed3 2.236 0.0022 
E3 ubiquitin-protein ligase RNF213 Rnf213 2.159 0.0012 
H-2 class II histocompatibility antigen, E-B beta 
chain 
H2-Eb1 2.155 0.0494 
 Ptbp1 2.152 0.0296 
Dynein heavy chain 17, axonemal Dnah17 2.13 0.0155 
Anionic trypsin-2 Prss2 2.13 0.0248 
GDP-fucose transporter 1 Slc35c1 2.128 0.0356 
2-5-oligoadenylate synthase 3 Oas3 2.086 0.0013 
CTTNBP2 N-terminal-like protein Cttnbp2nl 2.074 0.0003 
E3 ubiquitin-protein ligase RBX1;E3 ubiquitin-
protein ligase RBX1, N-terminally processed 
Rbx1 2.057 0.0006 
 Ddx60 2.055 0.0017 
Exosome complex component CSL4 Exosc1 2.045 0.0041 
60S ribosomal protein L34 Rpl34 2.023 0.0002 
Zinc finger HIT domain-containing protein 2 Znhit2 2.004 0.0011 
40S ribosomal protein S16 Rps16 1.995 0.0005 
Signal transducer and activator of 
transcription;Signal transducer and activator of 
transcription 1 
Stat1 1.983 0.0008 
60S ribosomal protein L13a Rpl13a 1.973 0.0014 
UMP-CMP kinase 2, mitochondrial Cmpk2 1.967 0.0013 
ATP-dependent RNA helicase DDX18 Ddx18 1.95 0.0055 
H/ACA ribonucleoprotein complex subunit 3 Nop10 1.943 0.0066 
V-type proton ATPase subunit a Tcirg1 1.929 0.0056 
Immunity-related GTPase family M protein 1 Irgm1 1.901 0.0017 
Annexin A5 Anxa5 1.898 0.0803 
 Gsn 1.889 0.003 
 Gbp6;Gbp10 1.857 0.0044 
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60S ribosomal protein L4 Rpl4 1.839 0.0064 
S-methyl-5-thioadenosine phosphorylase Mtap 1.837 0.0007 
Annexin A6 Anxa6 1.829 0.1031 
CD151 antigen Cd151 1.828 0.0051 
Fibrous sheath-interacting protein 2 Fsip2 1.826 0.001 
Mixed lineage kinase domain-like protein Mlkl 1.803 0.0017 
Protein unc-93 homolog B1 Unc93b1 1.8 0.0091 
Charged multivesicular body protein 6 Chmp6 1.784 0.0037 
Serine/threonine-protein phosphatase PP1-gamma 
catalytic subunit 
Ppp1cc 1.774 0.0001 
Nucleoside diphosphate-linked moiety X motif 19, 
mitochondrial 
Nudt19 1.768 0.0009 
Antigen peptide transporter 2 Tap2 1.767 0.0063 
Activated RNA polymerase II transcriptional 
coactivator p15 
Sub1 1.756 0.0002 
Gamma-aminobutyric acid receptor-associated 
protein;Gamma-aminobutyric acid receptor-
associated protein-like 1 
Gabarap;Gabarapl1 1.755 0.0121 
14-3-3 protein gamma;14-3-3 protein gamma, N-
terminally processed 
Ywhag 1.753 0.0006 
Prolyl endopeptidase-like Prepl 1.736 0.0017 
40S ribosomal protein S15 Rps15 1.736 0.0085 
60S ribosomal protein L37a Rpl37a 1.731 0.0001 
Elongation of very long chain fatty acids protein 7 Elovl7 1.724 0.0485 
2-5-oligoadenylate synthase-like protein 1 Oasl1 1.724 0.0005 
Antigen peptide transporter 1 Tap1 1.724 0.0177 
Ubiquitin-like protein ISG15 Isg15 1.718 0.0032 
Casein kinase I isoform delta;Casein kinase I 
isoform epsilon 
Csnk1d;Csnk1e 1.712 0.0207 
40S ribosomal protein S11 Rps11 1.711 0.0002 
 Immt 1.703 0.0188 
 Gm5431;9930111J21
Rik2;9930111J21Rik1 
1.703 0.0012 
60S ribosomal protein L12 Rpl12 1.69 0.0047 
Kinetochore-associated protein 1 Kntc1 1.675 0.0051 
Eukaryotic translation initiation factor 2 subunit 3, 
X-linked;Eukaryotic translation initiation factor 2 
subunit 3, Y-linked 
Eif2s3x;Eif2s3y 1.672 0.0029 
60S ribosomal protein L35a Rpl35a 1.669 0.0002 
Activator of 90 kDa heat shock protein ATPase 
homolog 1 
Ahsa1 1.668 0.0025 
Acetoacetyl-CoA synthetase Aacs 1.662 0.0008 
5-AMP-activated protein kinase catalytic subunit 
alpha-1 
Prkaa1 1.659 0.0019 
Heterogeneous nuclear ribonucleoprotein A0 Hnrnpa0 1.658 0.0006 
Mitotic spindle assembly checkpoint protein 
MAD2A 
Mad2l1 1.658 0.0008 
60S ribosomal protein L9 Rpl9 1.658 0.0005 
Ribonuclease P protein subunit p30 Rpp30 1.655 0.0052 
Spermatogenesis-associated protein 5 Spata5 1.651 0.0017 
60S ribosomal protein L28 Rpl28 1.649 0.0012 
Tubulin-folding cofactor B Tbcb 1.642 0.0002 
Ribosomal protein L19;60S ribosomal protein L19 Rpl19 1.638 0.0056 
Thioredoxin-related transmembrane protein 2 Tmx2 1.637 0.0127 
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N-acetyllactosaminide beta-1,3-N-
acetylglucosaminyltransferase 3 
B3gnt3 1.633 0.0034 
Poly(rC)-binding protein 2 Pcbp2 1.631 0.002 
Cat eye syndrome critical region protein 5 homolog Cecr5 1.625 0.0008 
S-adenosylmethionine synthase isoform type-2 Mat2a 1.624 0.0012 
Interferon-induced, double-stranded RNA-
activated protein kinase 
Eif2ak2 1.621 0.0049 
 Nans 1.62 0.0002 
AP-1 complex subunit gamma-1 Ap1g1 1.6 0.0021 
28S ribosomal protein S11, mitochondrial Mrps11 1.594 0.0028 
60S ribosomal protein L30 Rpl30 1.587 0.0004 
Ribose-phosphate pyrophosphokinase 1 Prps1l3;Prps1 1.585 0.0002 
Phosphoribosyl pyrophosphate synthase-
associated protein 2 
Prpsap2 1.569 0.0002 
Peptidyl-prolyl cis-trans isomerase FKBP4;Peptidyl-
prolyl cis-trans isomerase FKBP4, N-terminally 
processed;Peptidyl-prolyl cis-trans isomerase 
Fkbp4 1.563 0.0004 
Phosphoribosyl pyrophosphate synthase-
associated protein 1 
Prpsap1 1.547 0.0005 
Bis(5-nucleosyl)-tetraphosphatase [asymmetrical] Nudt2 1.535 0.0002 
Bcl-2-like protein 15 Bcl2l15 1.19 0.0114 
5-oxoprolinase Oplah -1.55 0.0004 
Transmembrane protein 9B Tmem9b -1.57 0.0007 
UPF0585 protein C16orf13 homolog 0610011F06Rik -1.58 0.0009 
Pre-mRNA-processing factor 40 homolog A Prpf40a -1.6 0.0019 
Protein C19orf12 homolog 1600014C10Rik -1.61 0.0003 
Gastric inhibitory polypeptide Gip -1.61 0.0074 
 Slc2a9 -1.62 0.0019 
Ubiquitin-fold modifier 1 Ufm1 -1.62 0.0015 
Cubilin Cubn -1.64 0.0103 
MAGUK p55 subfamily member 5 Mpp5 -1.66 0.0001 
Phospholipid scramblase 1 Plscr1 -1.66 0.0087 
Glutamyl aminopeptidase Enpep -1.66 0.0121 
[3-methyl-2-oxobutanoate dehydrogenase 
[lipoamide]] kinase, mitochondrial 
Bckdk -1.67 0.0079 
Solute carrier family 2, facilitated glucose 
transporter member 5 
Slc2a5 -1.67 0.0078 
Chromosome transmission fidelity protein 18 
homolog 
Chtf18 -1.67 0.0086 
Annexin A13;Annexin Anxa13 -1.67 0.001 
Retinol dehydrogenase 7 Rdh7 -1.68 0.0171 
Ankyrin repeat and SAM domain-containing 
protein 4B 
Anks4b -1.72 0.0126 
 Mgam -1.73 0.0258 
Zinc transporter 10 Slc30a10 -1.74 0.0297 
Transporter;Sodium- and chloride-dependent 
transporter XTRP3A;Sodium- and chloride-
dependent transporter XTRP3B 
Slc6a20a;Slc6a20b -1.76 0.0062 
E3 SUMO-protein ligase PIAS1;E3 SUMO-protein 
ligase PIAS2 
Pias1;Pias2 -1.76 0.0004 
Solute carrier family 26 member 6 Slc26a6 -1.76 0.0139 
Anoctamin-6 Ano6 -1.77 0.001 
Calcium-activated chloride channel regulator 1 Clca1 -1.78 0.0009 
3-ketoacyl-CoA thiolase B, peroxisomal Acaa1b -1.79 0.0384 
39S ribosomal protein L21, mitochondrial Mrpl21 -1.79 0.0011 
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Pancreatic lipase-related protein 2 Pnliprp2 -1.81 0.0044 
Bile salt export pump Abcb11 -1.82 0.0412 
Sodium/myo-inositol cotransporter 2 Slc5a11 -1.84 0.0062 
N-acetylneuraminate lyase Npl -1.86 0.0182 
Ensconsin Map7 -1.87 0.0177 
 2010106E10Rik -1.88 0.0191 
Meprin A subunit alpha Mep1a -1.88 0.0022 
Hepatoma-derived growth factor-related protein 2 Hdgfrp2 -1.89 0.0039 
Epidermal growth factor receptor kinase substrate 
8-like protein 3 
Eps8l3 -1.89 0.0084 
Choline transporter-like protein 4 Slc44a4 -1.89 0.001 
Peroxisomal acyl-coenzyme A oxidase 2 Acox2 -1.9 0.0022 
Alkaline phosphatase Alpi -1.92 0.0039 
Niemann-Pick C1-like protein 1 Npc1l1 -1.94 0.004 
Uncharacterized protein KIAA1211 
C530008M17Rik;Kiaa
1211 
-1.94 0.0133 
Solute carrier family 2, facilitated glucose 
transporter member 7 
Slc2a7 -1.98 0.0114 
Gastric intrinsic factor Gif -2.01 0.0025 
Neutral ceramidase;Neutral ceramidase soluble 
form 
Asah2 -2.04 0.0076 
Sodium-dependent neutral amino acid transporter 
B(0)AT1 
Slc6a19 -2.06 0.004 
Canalicular multispecific organic anion transporter 
1 
Abcc2 -2.06 0.0025 
Thymidylate synthase Tyms -2.06 0.0006 
Neutral and basic amino acid transport protein 
rBAT 
Slc3a1 -2.07 0.0023 
Cysteine-rich and transmembrane domain-
containing protein 1 
Cystm1 -2.07 0.0198 
Pantetheinase Vnn1 -2.08 0.0005 
Multidrug resistance protein 1A Abcb1a -2.1 0.0132 
Angiotensin-converting enzyme;Angiotensin-
converting enzyme, soluble form 
Ace -2.11 0.0054 
A-kinase anchor protein 7 isoform alpha;A-kinase 
anchor protein 7 isoform gamma 
Akap7 -2.12 0.0052 
Gamma-glutamyltranspeptidase 1;Gamma-
glutamyltranspeptidase 1 heavy chain;Gamma-
glutamyltranspeptidase 1 light chain 
Ggt1 -2.13 0.0003 
  -2.2 0.0085 
Acid sphingomyelinase-like phosphodiesterase 3b Smpdl3b -2.27 0.0014 
Cytochrome c oxidase subunit 5A, mitochondrial Cox5a -2.28 0.0001 
b(0,+)-type amino acid transporter 1 Slc7a9 -2.28 0.0001 
 Enpp7 -2.29 0.0039 
 Adh6a -2.3 0.008 
Clarin-3 Clrn3 -2.31 0.0031 
N-acetylated-alpha-linked acidic dipeptidase-like 
protein 
Naaladl1 -2.32 0.0003 
Superoxide dismutase [Mn], mitochondrial Sod2 -2.33 0.0265 
Glutathione S-transferase A4 Gsta4 -2.34 0.0013 
Secretin Sct -2.38 0.0002 
Trehalase Treh -2.4 0.0016 
Carboxylesterase 1D Ces1d -2.46 0.0031 
 Lct -2.52 0.0011 
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Angiotensin-converting enzyme 2;Processed 
angiotensin-converting enzyme 2 
Ace2 -2.52 0.0006 
Proteasome subunit beta type-5 Psmb5 -2.53 0.0079 
Neprilysin Mme -2.54 0.001 
ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2 Bst1 -2.55 0.0008 
Ectonucleotide 
pyrophosphatase/phosphodiesterase 3 
Enpp3 -2.61 0.0078 
Solute carrier family 15 member 1 Slc15a1 -2.68 0.0006 
Syntaxin-3 Stx3 -2.77 0.0003 
Liver carboxylesterase 1 Ces1 -2.99 0.0016 
Reticulon;Reticulon-1 Rtn1 -3.36 0.0022 
Aminoacylase-1 Acy1 -3.39 0.0401 
Serine (or cysteine) peptidase inhibitor, clade B, 
member 9b and 9c 
Serpinb9b;Serpinb9c -3.5 0.001 
THAP domain-containing protein 4 Thap4 -7.04 0.0003 
PHD finger protein 10 Phf10 -7.91 0.0005 
 
 
Appendix 6: Proteins that are exclusively changed in regulation in LPS-treated       
Nfҡb2-/- compared with LPS-treated C57BL/6J small intestinal mucosa (excluding 
significant changes between Nfҡb2-/- and C57BL/6J at baseline) 
Protein names Gene names 
Regulation 
fold 
change 
P value 
NADH dehydrogenase [ubiquinone] 1 alpha 
subcomplex assembly factor 5 
Ndufaf5 2.962 0.0019 
Peripherin Prph 2.149 0.0033 
Interferon-induced guanylate-binding protein 2 Gbp2 1.809 0.0065 
Ras-related protein Rab-8B Rab8b 1.795 0.0004 
Volume-regulated anion channel subunit LRRC8A Lrrc8a 1.672 0.0003 
Translation factor Guf1, mitochondrial Guf1 1.596 0.0016 
Annexin Anxa6 1.595 0.0161 
Serine/threonine-protein kinase MRCK alpha Cdc42bpa 1.586 0.0019 
Disheveled-associated activator of morphogenesis 
1 
Daam1 1.582 0.0112 
Ufm1-specific protease 2 Ufsp2 1.566 0.0012 
cAMP-dependent protein kinase catalytic subunit 
beta 
Prkacb 1.546 0.01 
Receptor-interacting serine/threonine-protein 
kinase 3 
Ripk3 1.512 0.0002 
Hexokinase;Hexokinase-1 Hk1 1.495 0.0141 
Vacuole membrane protein 1 Vmp1 1.485 0.0018 
Zinc finger matrin-type protein 2 Zmat2 1.476 0.0007 
Calcium-activated chloride channel regulator 4A Clca4a 1.46 0.0325 
Kininogen-1;Kininogen-1 heavy 
chain;Bradykinin;Kininogen-1 light chain 
Kng1 1.454 0.0416 
40S ribosomal protein S14 Rps14 1.432 0.006 
Cytochrome b5 Cyb5a 1.416 0.021 
Selenide, water dikinase 2 Sephs2 1.412 0.008 
1-acyl-sn-glycerol-3-phosphate acyltransferase 
beta 
Agpat2 1.404 0.0027 
Radixin Rdx 1.395 0.1441 
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Ena/VASP-like protein Evl 1.384 0.1202 
Chloride intracellular channel protein 4 Clic4 1.383 0.0043 
Serine hydrolase-like protein Serhl 1.379 0.0007 
Phosphatidylinositol 3,4,5-trisphosphate 5-
phosphatase 1 
Inpp5d 1.377 0.0229 
Spermatogenesis-associated protein 5 Spata5 1.376 0.0029 
Protein-L-isoaspartate O-
methyltransferase;Protein-L-isoaspartate(D-
aspartate) O-methyltransferase 
Pcmt1 1.372 0.0004 
AP-1 complex subunit sigma-1A Ap1s1 1.361 0.0046 
Oxidoreductase NAD-binding domain-containing 
protein 1 
Oxnad1 1.355 0.0021 
Zinc finger protein 800 Znf800;Zfp800 1.345 0.0225 
BRO1 domain-containing protein BROX Brox 1.344 0.0015 
Cytochrome b-c1 complex subunit 9 Uqcr10 1.343 0.0164 
HRAS-like suppressor 3 Pla2g16 1.333 0.0087 
Fibrous sheath-interacting protein 2 Fsip2 1.331 0.0042 
DNA-directed RNA polymerase II subunit RPB11 Polr2j 1.324 0.0015 
Trafficking protein particle complex subunit 2-like 
protein 
Trappc2l 1.323 0.0005 
Reticulon-3 Rtn3 1.322 0.0006 
Ras-related GTP-binding protein C Rragc 1.321 0.0004 
UBX domain-containing protein 1 Ubxn1 -1.321 0.0001 
Vacuolar protein sorting-associated protein VTA1 
homolog 
Vta1 -1.324 0.0002 
Beta-catenin-like protein 1 Ctnnbl1 -1.325 0.0026 
Iron-sulfur cluster assembly 1 homolog, 
mitochondrial 
AK157302;Isca1 -1.34 0.0084 
 Tjp1 -1.344 0.0002 
Nucleoplasmin-3 Npm3 -1.344 0.0223 
Receptor-type tyrosine-protein phosphatase kappa Ptprk -1.345 0.0226 
Neutral ceramidase;Neutral ceramidase soluble 
form 
Asah2 -1.347 0.008 
Ran GTPase-activating protein 1 Rangap1 -1.349 0.001 
Bromodomain-containing protein 3 Brd3 -1.353 0.02 
Dystroglycan;Alpha-dystroglycan;Beta-
dystroglycan 
Dag1 -1.353 0.0008 
Glycosylphosphatidylinositol anchor attachment 1 
protein 
Gpaa1 -1.357 0.0196 
Constitutive coactivator of PPAR-gamma-like 
protein 2 
Fam120c -1.359 0.0086 
Aminopeptidase N Anpep -1.362 0.0018 
Actin-related protein 2/3 complex subunit 5-like 
protein 
Arpc5l -1.363 0.0013 
 Tfg -1.363 0.0284 
Lysosome membrane protein 2 Scarb2 -1.364 0.0046 
ORM1-like protein 2;ORM1-like protein 3 Ormdl2;Ormdl3 -1.365 0.04 
Calcium homeostasis endoplasmic reticulum 
protein 
Cherp -1.365 0.0065 
Protein odr-4 homolog Odr4;BC003331 -1.374 0.0067 
Selenoprotein M Selm -1.383 0.0095 
Interleukin-10 receptor subunit beta Il10rb;Gm21970 -1.386 0.0157 
Protein DEK Dek -1.388 0.0475 
Inositol 1,4,5-trisphosphate receptor type 2 Itpr2 -1.39 0.0019 
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Ubiquinone biosynthesis protein COQ9, 
mitochondrial 
Coq9 -1.39 0.0003 
Pterin-4-alpha-carbinolamine dehydratase Pcbd1 -1.393 0.0116 
Glutathione S-transferase Mu 2 Gstm2 -1.395 0.0427 
Prenylated Rab acceptor protein 1 Rabac1 -1.395 0.0002 
Protein NDRG2 Ndrg2 -1.404 0.0003 
Transmembrane channel-like 
protein;Transmembrane channel-like protein 4 
Tmc4 -1.41 0.0054 
Dehydrogenase/reductase SDR family member 4 Dhrs4 -1.415 0.0022 
Epithelial splicing regulatory protein 2 Esrp2 -1.42 0.0048 
Neprilysin Mme -1.422 0.0137 
DNA damage-regulated autophagy modulator 
protein 2 
Dram2 -1.435 0.0053 
Splicing factor U2AF 35 kDa subunit U2af1 -1.437 0.0013 
Thiosulfate sulfurtransferase Tst -1.438 0.0028 
Dynactin subunit 5 Dctn5 -1.438 0.0163 
Putative RNA-binding protein Luc7-like 1 Luc7l -1.44 0.0008 
Epsin-1 Epn1 -1.442 0.0005 
Pumilio domain-containing protein KIAA0020 Kiaa0020 -1.449 0.0228 
 2010106E10Rik -1.453 0.0156 
Zinc finger Ran-binding domain-containing protein 
2 
Zranb2 -1.465 0.0022 
General transcription factor 3C polypeptide 4 Gtf3c4 -1.465 0.0006 
Sulfiredoxin-1 Srxn1 -1.47 0.008 
RNA binding motif protein, X-linked-like-1 Rbmxl1 -1.473 0.004 
Copper-transporting ATPase 2 Atp7b -1.479 0.0102 
Sulfite oxidase, mitochondrial Suox -1.483 0.0044 
Ensconsin Map7 -1.487 0.0017 
Transmembrane protease serine 4 Tmprss4 -1.489 0.0079 
Pre-mRNA-processing factor 40 homolog A Prpf40a -1.494 0.0018 
Ankyrin repeat and SAM domain-containing 
protein 4B 
Anks4b -1.545 0.0106 
 Dnm1l -1.546 0.026 
Proteasome subunit beta type-6 Psmb6 -1.559 0.0015 
 Srsf11 -1.573 0.0004 
BET1-like protein Bet1l -1.601 0.0041 
Beta-hexosaminidase subunit alpha Hexa -1.619 0.0006 
Ribosome biogenesis protein BRX1 homolog Brix1 -1.631 0.0068 
Cell division cycle protein 23 homolog Cdc23 -1.638 0.0076 
Essential MCU regulator, mitochondrial Smdt1 -1.658 0.0067 
Kinesin-like protein KIF11 Kif11 -1.661 0.0003 
ER lumen protein-retaining receptor 1;ER lumen 
protein-retaining receptor 2;ER lumen protein-
retaining receptor 3 
Kdelr1;Kdelr2;Kdelr3 -1.674 0.0353 
Bcl-2-like protein 15 Bcl2l15 -1.674 0.0314 
Protein phosphatase 1 regulatory subunit 12C Ppp1r12c -1.675 0.0001 
Hepatoma-derived growth factor-related protein 2 Hdgfrp2 -1.689 0.0025 
39S ribosomal protein L21, mitochondrial Mrpl21 -1.747 0.0016 
Ly6/PLAUR domain-containing protein 8 Lypd8 -1.838 0.0122 
PHD finger protein 10 Phf10 -9.489 0.0004 
 
 
316 
 
Appendix 7: Proteins that are exclusively changed in regulation in LPS-treated              
c-Rel-/- compared with LPS-treated C57BL/6J small intestinal mucosa (excluding 
significant changes between c-Rel-/- and C57BL/6J at baseline) 
Protein names Gene names 
Regulation 
fold 
change 
P value 
Unconventional myosin-IXb Myo9b 3.989 0.0018 
Transformation/transcription domain-associated 
protein 
Trrap 3.884 0.0495 
 Mptx2 3.254 0.0493 
Uncharacterized protein KIAA0556 
D430042O09Rik;Kiaa
0556 
3.001 0.019 
1,4-alpha-glucan-branching enzyme Gbe1 2.711 0.0387 
Regenerating islet-derived protein 3-gamma Reg3g 2.487 0.0003 
Sorting nexin-3 Snx3 2.222 0.0002 
Polymeric immunoglobulin receptor;Secretory 
component 
Pigr 2.201 0.0003 
MLV-related proviral Env polyprotein;Surface protein;Transmembrane 
protein 
1.971 0.0102 
Nectin-2 Pvrl2 1.853 0.0007 
Ribose-5-phosphate isomerase Rpia 1.81 0.003 
Mitochondrial pyruvate carrier 1 Mpc1 1.806 0.0002 
Dynein light chain 1, cytoplasmic Dynll1;BC048507 1.77 0.0023 
Uroporphyrinogen decarboxylase Urod 1.769 0.0075 
Transcriptional repressor protein YY1 Yy1 1.747 0.0089 
Fatty acid-binding protein, epidermal Fabp5 1.705 0.0075 
Sideroflexin-3 Sfxn3 1.698 0.0005 
Glycerol-3-phosphate dehydrogenase 1-like 
protein 
Gpd1l 1.68 0.0039 
 Parp3 1.673 0.0007 
 Chn2 1.666 0.013 
Molybdenum cofactor biosynthesis protein 1;Cyclic 
pyranopterin monophosphate synthase;Cyclic 
pyranopterin monophosphate synthase accessory 
protein 
Mocs1 1.654 0.0068 
Sodium/hydrogen exchanger 1 Slc9a1 1.647 0.0017 
Serum paraoxonase/lactonase 3 Pon3 1.646 0.0181 
Protein-tyrosine kinase 6 Ptk6 1.638 0.0157 
 Syne2 1.611 0.0011 
O-phosphoseryl-tRNA(Sec) selenium transferase Sepsecs 1.59 0.005 
SH3 domain-containing protein 21 Sh3d21 1.588 0.0069 
Trinucleotide repeat-containing gene 6B protein Tnrc6b 1.587 0.0029 
Transmembrane protein 260 Tmem260 1.582 0.0058 
Adiponectin receptor protein 2 Adipor2 1.569 0.0009 
S-methyl-5-thioadenosine phosphorylase Mtap 1.549 0.0094 
Serine/threonine-protein phosphatase 6 catalytic 
subunit;Serine/threonine-protein phosphatase 6 
catalytic subunit, N-terminally processed 
Ppp6c 1.546 0.0008 
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Succinyl-CoA:3-ketoacid coenzyme A transferase 1, 
mitochondrial 
Oxct1 1.543 0.0112 
Purine nucleoside phosphorylase Pnp2 1.537 0.0117 
Transmembrane protein 9B Tmem9b 1.514 0.0023 
Proteasome subunit beta type-2 Psmb2 1.503 0.0149 
Peroxisomal 2,4-dienoyl-CoA reductase Decr2 1.502 0.0132 
Ig kappa chain C region Igkc 1.494 0.0083 
UDP-GlcNAc:betaGal beta-1,3-N-
acetylglucosaminyltransferase 7 
B3gnt7 1.482 0.0071 
THAP domain-containing protein 4 Thap4 1.457 0.0009 
LIM and senescent cell antigen-like-containing 
domain protein 1 
Lims1 1.456 0.0075 
Kininogen-1;Kininogen-1 heavy 
chain;Bradykinin;Kininogen-1 light chain 
Kng1 1.449 0.0092 
ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2 Bst1 1.44 0.0046 
OTU domain-containing protein 4 Otud4 1.44 0.0013 
[3-methyl-2-oxobutanoate dehydrogenase 
[lipoamide]] kinase, mitochondrial 
Bckdk 1.428 0.0061 
Signal peptidase complex subunit 2 Spcs2 1.423 0.0011 
Choline transporter-like protein 1 Slc44a1 1.414 0.0002 
Reticulon;Reticulon-1 Rtn1 1.412 0.0022 
Host cell factor 1 Hcfc1 1.396 0.0014 
Integrin beta;Integrin beta-6 Itgb6 1.381 0.0019 
Cysteine-rich and transmembrane domain-
containing protein 1 
Cystm1 1.373 0.002 
Ubiquitin-fold modifier 1 Ufm1 1.373 0.0003 
Ensconsin Map7 1.37 0.0005 
Vacuolar protein sorting-associated protein 29 Vps29 1.369 0.0003 
E3 ubiquitin-protein ligase MYCBP2 Mycbp2 1.366 0.0002 
 Muc3 1.364 0.0008 
Cytochrome c oxidase subunit 7A-related protein, 
mitochondrial 
Cox7a2l 1.332 0.0001 
Alpha/beta hydrolase domain-containing protein 
14B 
Abhd14b -1.34 0.0005 
Insulin-degrading enzyme Ide -1.35 0.0011 
 Lmo7 -1.35 0.001 
CB1 cannabinoid receptor-interacting protein 1 Cnrip1 -1.36 0.0004 
Serine/threonine-protein kinase N2 Pkn2 -1.38 0.0021 
 Akr1c19 -1.39 0.0022 
Hydroxyacylglutathione hydrolase, mitochondrial Hagh -1.39 0.0008 
 Pde4dip -1.39 0.0004 
PHD finger protein 10 Phf10 -1.4 0.0019 
Arginase-2, mitochondrial Arg2 -1.41 0.0005 
Disintegrin and metalloproteinase domain-
containing protein 10 
Adam10 -1.41 0.0034 
Epididymis-specific alpha-mannosidase Man2b2 -1.41 0.0013 
Membrane-associated progesterone receptor 
component 1 
Pgrmc1 -1.44 0.002 
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A-kinase anchor protein 7 isoform alpha;A-kinase 
anchor protein 7 isoform gamma 
Akap7 -1.44 0.0014 
H-2 class II histocompatibility antigen, E-B beta 
chain 
H2-Eb1 -1.44 0.0005 
H-2 class II histocompatibility antigen gamma chain Cd74 -1.45 0.0004 
H-2 class II histocompatibility antigen, A beta chain H2-Ab1 -1.46 0.0085 
UDP-glucuronosyltransferase 2B17 
Ugt2b5;Ugt2b17;Ugt
2b38 
-1.48 0.0006 
CD63 antigen Cd63 -1.48 0.0091 
Enoyl-CoA delta isomerase 1, mitochondrial Eci1 -1.48 0.0099 
Adrenodoxin, mitochondrial Fdx1 -1.49 0.0047 
Dynein light chain Tctex-type 1 Dynlt1 -1.49 0.0109 
Acyl-coenzyme A thioesterase 8 Acot8 -1.51 0.0002 
Serine/threonine-protein phosphatase PP1-gamma 
catalytic subunit 
Ppp1cc -1.52 0.0163 
Cholinesterase Bche -1.53 0.0108 
ATP synthase subunit e, mitochondrial Atp5i;Atp5k -1.53 0.002 
Secretin Sct -1.53 0.0166 
Protein phosphatase 1 regulatory subunit 12C Ppp1r12c -1.53 0.0092 
Mimitin, mitochondrial Ndufaf2 -1.54 0.0034 
Alpha-defensin 24 Defa24 -1.54 0.0094 
 Cyp2c66 -1.54 0.0128 
Asparagine synthetase [glutamine-hydrolyzing] Asns -1.55 0.0029 
Leukocyte surface antigen CD47 Cd47 -1.56 0.0158 
Histone H2A type 2-B Hist2h2ab -1.57 0.0006 
Syntaxin-3 Stx3 -1.57 0.0051 
N-acetylglucosamine-1-phosphotransferase 
subunits alpha/beta 
Gnptab -1.59 0.0003 
E3 ubiquitin-protein ligase UBR2 Ubr2 -1.61 0.0019 
Up-regulated during skeletal muscle growth 
protein 5 
Usmg5 -1.61 0.0115 
StAR-related lipid transfer protein 4 Stard4 -1.61 0.0153 
Serine/threonine-protein kinase VRK1 Vrk1 -1.64 0.0014 
Disheveled-associated activator of morphogenesis 
1 
Daam1 -1.64 0.003 
Consortin Cnst -1.66 0.0001 
Dynactin subunit 4 Dctn4 -1.66 0.0039 
Riboflavin kinase Rfk -1.66 0.001 
Histone H2B type 3-B;Histone H2B type 3-
A;Histone H2B type 2-E 
Hist3h2bb;Hist3h2ba;
Hist2h2be 
-1.66 0.0004 
CCA tRNA nucleotidyltransferase 1, mitochondrial Trnt1 -1.68 0.0011 
BRO1 domain-containing protein BROX Brox -1.68 0.0009 
Ankyrin repeat and SAM domain-containing 
protein 4B 
Anks4b -1.69 0.0005 
Liver carboxylesterase 1 Ces1 -1.7 0.0119 
Polymerase delta-interacting protein 2 Poldip2 -1.72 0.0064 
Probable ATP-dependent RNA helicase DDX41 Ddx41 -1.74 0.0003 
Atlastin-3 Atl3 -1.76 0.0042 
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ER lumen protein-retaining receptor 1;ER lumen 
protein-retaining receptor 2;ER lumen protein-
retaining receptor 3 
Kdelr1;Kdelr2;Kdelr3 -1.82 0.002 
Dehydrogenase/reductase SDR family member 4 Dhrs4 -1.82 0.0046 
Trafficking protein particle complex subunit 5 Trappc5 -1.85 0.0283 
H/ACA ribonucleoprotein complex subunit 2 Nhp2 -1.87 0.0281 
39S ribosomal protein L21, mitochondrial Mrpl21 -1.93 0.0002 
39S ribosomal protein L17, mitochondrial Mrpl17 -2 0.0004 
Acyl-coenzyme A thioesterase 2, mitochondrial Acot2 -2.24 0.0005 
Replication factor C subunit 2 Rfc2 -3.26 0.0013 
Sodium/potassium-transporting ATPase subunit 
alpha-4 
Atp1a4 -3.79 0.0019 
Solute carrier family 2, facilitated glucose 
transporter member 5 
Slc2a5 -4.38 0.0006 
Krueppel-like factor 5 Klf5 -8.69 0.0005 
 
 
 
 
